{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"],"fields":{"title":{"boost":1000.0},"text":{"boost":1.0},"tags":{"boost":1000000.0}}},"docs":[{"location":"","title":"Getting Started","text":""},{"location":"#getting-started","title":"Getting Started","text":""},{"location":"#i-start-in-lu-lab","title":"I. Start in Lu Lab","text":""},{"location":"#welcome","title":"Welcome","text":"<ul> <li> Lab Introduction</li> <li> Lab Meetings  &amp;  Lab Calendar</li> <li> FAQ</li> </ul> <p> \u6e05\u534e\u6821\u56ed\u5b9e\u7528\u4fe1\u606f \uff08 \u6821\u5386\uff0c\u5730\u56fe \uff0c... )</p> <p>\u201cThe mediocre teacher tells. The good teacher explains. The superior teacher demonstrates. The great teacher inspires.\u201d  - William A. Ward</p>"},{"location":"#learning","title":"Learning","text":"<ul> <li>Course: Courses @Tsinghua  &amp;  Bioinformatics Tutorial by Lu Lab</li> <li>Read: Tips for Literature Reading</li> <li>Presentation: PPT Templates</li> </ul> <p> \u6b63\u5f0f\u53c2\u4e0e\u751f\u7269\u4fe1\u606f\u79d1\u7814\u8bfe\u9898\u4e4b\u524d\u8be5\u505a\u54ea\u4e9b\u51c6\u5907\uff1f\uff08\u5305\u62ec\u9884\u4fee\u8bfe\u63a8\u8350\u7b49\uff09</p> <ul> <li>\u201cI cannot teach anybody anything; I can only make them think.\" - Socrates</li> <li>\"Tell me and I forget. Teach me and I remember. Involve me and I learn.\"  - Benjamin Franklin</li> </ul>"},{"location":"#ii-research-in-lu-lab","title":"II. Research in Lu Lab","text":"<ul> <li>Intranet Wiki @ \u3010WPS\u91d1\u5c71\u4e91\u6587\u6863\u3011<ul> <li>Instructions of Dry Lab &amp; Wet Lab</li> <li>Lab Internal Docs</li> <li>Lab Metadata</li> <li>...</li> </ul> </li> <li>Large Files @ \u3010\u6e05\u534e\u4e91\u76d8\u3011<ul> <li>Lu Lab - Shared (R and RW) </li> <li>Lu Lab - Photos</li> <li>...</li> </ul> </li> </ul> <ul> <li>\u201c\u52e4\u800c\u5584\u609f\u201d ;  \u201c\u5929\u9053\u916c\u52e4\u201d -- \u300a\u5468\u6613\u300b</li> <li>\"Study while others are sleeping;  work while others are loafing; prepare while others are playing; dream while others are wishing.\"  - William A. Ward</li> </ul>"},{"location":"#iii-publish-in-lu-lab","title":"III. Publish in Lu Lab","text":"<ul> <li>Paper<ul> <li>\u5386\u5c4a\u6bd5\u4e1a\u8bba\u6587: \u6e05\u534e\u4e91\u76d8 - Lu Lab Shared-R/3.Thesis</li> <li>Manuscripts: \u6e05\u534e\u4e91\u76d8 - Lu Lab Shared-R/5.Manuscript</li> <li>Tips for manuscript writing</li> </ul> </li> <li>Software</li> <li>Patent</li> </ul> <ul> <li>\"What sculpture is to a block of marble, education is to a human soul.\"  - Joseph Addison</li> <li>\u201cThe carving and chipping away to create a masterpiece take years of dedication. Teachers help students discover their interests, passions, and ultimately themselves.\u201d</li> </ul> <ul> <li>Lu Lab @ Tsinghua University</li> <li>Software:  software.ncRNAlab.org</li> <li>Courses:  courses.ncRNAlab.org</li> <li>Books: book.ncRNAlab.org ( bioinfo.gitbook.io ) </li> <li>Docs: docs.ncRNAlab.org </li> </ul> \"\u751f\u7269\u4fe1\u606f\u5b66\"\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4 MOE Key Lab of Bioinformatics \u6e05\u534e\u5927\u5b66 \u751f\u547d\u79d1\u5b66\u5b66\u9662 School of Life Sciences, Tsinghua University \u7535\u8bdd/\u4f20\u771f\uff1a010-627-89217 Tel/FAX: +86-010-627-89217 \u7f51\u5740\uff1ahttp://lulab.life.tsinghua.edu.cn Website: http://www.ncRNAlab.org"},{"location":"archive/proj/background/","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"archive/proj/background/#_1","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"archive/proj/background/#backgroundintroduction","title":"Background/Introduction","text":"<p>About 20 thousand protein-coding genes in human were transcribed and tranlsated from only ~1.5% of human genome sequence. On the other hand, ~70% or more of the human genome  are transcribed into RNAs. Many of them are noncoding RNAs (ncRNAs), which are not well studied yet.</p> <p>\u201cBy 2020 the ENCODE project said it had identified around 37,600 noncoding genes\u2014that is, DNA stretches with instructions for RNA molecules that do not code for proteins. That is almost twice as many as there are protein-coding genes. Other tallies vary widely, from around 18,000 to close to 96,000. \u2026 In a 2024 commentary for the journal Science, the duo described these findings as part of an RNA revolution. \u2026 they undercut the way we think our biology works. Ever since the epochal discovery about DNA\u2019s double helix and how it encodes information, the bedrock idea of molecular biology has been that there are precisely encoded instructions that program specific molecules for particular tasks. But ncRNAs seem to point to a fuzzier, more collective, logic to life. It is a logic that is harder to discern and harder to understand. But if scientists can learn to live with the fuzziness, this view of life may turn out to be more complete.\u201d ( Revolutionary Genetics Research Shows RNA May Rule Our Genome | Scientific American 2024.7. Cover Story)</p> <p>\u201cRNA, not DNA, is the computational engine of the cell.\u201d ( Revolutionary Genetics Research Shows RNA May Rule Our Genome | Scientific American 2024.7. Cover Story).  </p> <p>Leveraging new AI technologies for RNA modeling (i.e., RNA-Talk models) that tokenize information at sequence and/or structure levels, we discover and decipher the various molecular interactions and biological regulatory networks mediated by RNA.</p> <p>We develop bioinformatics technology on noncoding RNAs from multiple perspectives/models of RNA structure and post-transcriptional regulation (e.g., splicing and editing); and explore its practice in the precise diagnosis and treatment of complex diseases. We utilize bioinformatics based on new AI technologies and multi-omics data to explore novel targets in the form of noncoding RNA in complex diseases such as cancer and autoimmune diseases, through cooperation with front-line doctors and experts.  While studying RNA regulation network, some targets can be used as biomarkers for personalized and precise diagnosis and treatment, and some targets can be used as drug targets for drug design through AI. </p> <p>\u4eba\u7c7b\u6709\u5927\u7ea62\u4e07\u4e2a\u86cb\u767d\u7f16\u7801\u57fa\u56e0\uff0c\u4f46\u5176\u5e8f\u5217\u7684\u603b\u957f\u5ea6\u4ec5\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u76841.5%\u5de6\u53f3\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u4eba\u7c7b\u57fa\u56e0\u7ec4\u5e8f\u5217\u7684~70%\u751a\u81f3\u66f4\u591a\u90fd\u4f1a\u88ab\u8f6c\u5f55\u6210RNA\uff0c\u5b83\u4eec\u5f88\u591a\u90fd\u662f\u975e\u7f16\u7801\u7684RNA\uff08noncoding RNA\uff0cncRNA)\u3002\u4f46\u5bf9\u4e8e\u4e3a\u6570\u4f17\u591a\u7684\u975e\u7f16\u7801RNA (ncRNA)\uff0c\u6211\u4eec\u4ecd\u7136\u77e5\u4e4b\u751a\u5c11\u3002</p> <p>\u201d\u622a\u6b622020 \u5e74\uff0cENCODE \u9879\u76ee\u5df2\u9274\u5b9a\u51fa\u7ea6 37,600 \u4e2a\u975e\u7f16\u7801RNA\u7684\u57fa\u56e0\uff0c\u8fd9\u51e0\u4e4e\u662f\u86cb\u767d\u8d28\u7f16\u7801\u57fa\u56e0\u7684\u4e24\u500d\u3002\u5176\u4ed6\u7edf\u8ba1\u6570\u636e\u76f8\u5dee\u5f88\u5927\uff0c\u4ece\u7ea6 18,000 \u4e2a\u5230\u63a5\u8fd1 96,000 \u4e2a\u3002... \u5728 2024 \u5e74\u300a\u79d1\u5b66\u300b\u6742\u5fd7\u7684\u4e00\u7bc7\u8bc4\u8bba\u4e2d\uff0c\u5c06\u8fd9\u4e9b\u53d1\u73b0\u63cf\u8ff0\u4e3a RNA \u9769\u547d \u7684\u4e00\u90e8\u5206\u3002... \u8fd9\u4e9b\u975e\u7f16\u7801RNA\u52a8\u6447\u4e86\u6211\u4eec\u5bf9\u751f\u7269\u5b66\u8fd0\u4f5c\u65b9\u5f0f\u7684\u7406\u89e3\u3002\u81ea\u4ece\u5173\u4e8e DNA \u53cc\u87ba\u65cb\u7ed3\u6784\u53ca\u5176\u5982\u4f55\u7f16\u7801\u4fe1\u606f\u7684\u5212\u65f6\u4ee3\u53d1\u73b0\u4ee5\u6765\uff0c\u5206\u5b50\u751f\u7269\u5b66\u7684\u57fa\u672c\u601d\u60f3\u4e00\u76f4\u662f\uff0c\u751f\u7269\u4f53\u5b58\u5728\u7cbe\u786e\u7f16\u7801\u7684\u6307\u4ee4\uff0c\u8fd9\u4e9b\u6307\u4ee4\u53ef\u4ee5\u5bf9\u7279\u5b9a\u5206\u5b50\u8fdb\u884c\u7279\u5b9a\u4efb\u52a1\u7f16\u7a0b\u3002\u4f46\u975e\u7f16\u7801RNA \u4f3c\u4e4e\u6307\u5411\u4e86\u4e00\u79cd\u66f4\u6a21\u7cca\u3001\u66f4\u96c6\u4f53\u7684\u751f\u547d\u903b\u8f91\u3002\u8fd9\u79cd\u903b\u8f91\u66f4\u96be\u8fa8\u522b\uff0c\u66f4\u96be\u7406\u89e3\u3002\u4f46\u5982\u679c\u79d1\u5b66\u5bb6\u80fd\u591f\u5b66\u4f1a\u9002\u5e94\u8fd9\u79cd\u6a21\u7cca\u6027\uff0c\u8fd9\u79cd\u5173\u4e8e\u751f\u547d\u7684\u89c2\u70b9\u53ef\u80fd\u4f1a\u66f4\u52a0\u5b8c\u6574\u3002\u201c \uff08 RNA: \u638c\u63a7\u751f\u547d\u540e\u53f0 | \u300a\u73af\u7403\u79d1\u5b66\u300b 2024\u5e747\u6708\u520a\u5c01\u9762\u6587\u7ae0\uff09</p> <p>\u201cRNA \u800c\u4e0d\u662f DNA \u624d\u662f\u7ec6\u80de\u7684\u8ba1\u7b97\u5f15\u64ce\u3002\u201d \uff08 RNA: \u638c\u63a7\u751f\u547d\u540e\u53f0 | \u300a\u73af\u7403\u79d1\u5b66\u300b 2024\u5e747\u6708\u520a\u5c01\u9762\u6587\u7ae0\uff09</p> <p>\u6211\u4eec\u5229\u7528\u6700\u65b0\u7684\u4eba\u5de5\u667a\u80fd\u6280\u672f\u4ece\u201c\u5e8f\u5217\u201d\u548c\u201c\u7ed3\u6784\u201d\u4e24\u4e2a\u4e0d\u540c\u7684\u8868\u5f81\u5c42\u9762\u5f00\u53d1\u5404\u7c7b\u6838\u9178\u6a21\u578b\uff0c\u53bb\u53d1\u73b0\u548c\u7406\u89e3RNA\u5728\u590d\u6742\u7684\u751f\u7269\u5206\u5b50\u4e92\u4f5c\u548c\u8c03\u63a7\u7f51\u7edc\u4e2d\u7684\u4f5c\u7528\u548c\u673a\u5236\u3002</p> <p>\u6211\u4eec\u56f4\u7ed5\u975e\u7f16\u7801RNA\u53d1\u5c55\u751f\u7269\u4fe1\u606f\u5b66\u6280\u672f\uff0c\u4ece\u7ed3\u6784\u548c\u8f6c\u5f55\u540e\u8c03\u63a7\uff08\u4f8b\u5982\u526a\u63a5\u548c\u7f16\u8f91\uff09\u7b49\u591a\u4e2a\u89d2\u5ea6\u3001\u591a\u4e2a\u6a21\u578b\u63a2\u8ba8\u975e\u7f16\u7801RNA\u7684\u8c03\u63a7\u4f5c\u7528\uff0c\u5e76\u63a2\u7d22\u5176\u5728\u590d\u6742\u75be\u75c5\u7cbe\u51c6\u8bca\u7597\u4e0a\u7684\u5177\u4f53\u5b9e\u8df5\u3002\u6211\u4eec\u5145\u5206\u53d1\u6325\u751f\u7269\u4fe1\u606f\u5b66\u8fd9\u4e00\u4ea4\u53c9\u5b66\u79d1\u4f18\u52bf\uff0c\u5229\u7528\u6700\u65b0\u7684AI\u6280\u672f\u548c\u591a\u7ec4\u5b66\u6570\u636e\uff0c\u901a\u8fc7\u548c\u3010\u5317\u4eac\u534f\u548c\u3011\u3001\u3010\u5317\u5927\u4e00\u9662\u3011\u3001\u3010\u6e05\u534e\u957f\u5e9a\u3011\u7b49\u4e00\u7ebf\u533b\u751f\u4e13\u5bb6\u7684\u5408\u4f5c\uff0c\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u7b49\u590d\u6742\u75be\u75c5\u4e0a\u63a2\u7d22\u65b0\u7684\u4ee5\u975e\u7f16\u7801 RNA \u4e3a\u8868\u73b0\u5f62\u5f0f\u7684\u9776\u6807\u3002\u5728\u7814\u7a76\u5176\u514d\u75ab\u8c03\u63a7\u7f51\u7edc\u7684\u540c\u65f6\uff0c\u90e8\u5206\u9776\u6807\u53ef\u4ee5\u5e94\u7528\u4e3a\u4e2a\u6027\u5316\u7cbe\u51c6\u8bca\u7597\u65f6\u7684\u751f\u7269\u6807\u5fd7\u7269\uff0c\u90e8\u5206\u9776\u6807\u53ef\u4ee5\u505a\u4e3a\u836f\u7269\u9776\u70b9\u901a\u8fc7AI\u8fdb\u884c\u836f\u7269\u8bbe\u8ba1\uff0c\u5728\u590d\u6742\u75be\u75c5\uff08\u5982\u764c\u75c7\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff09\u7684\u4e34\u5e8a\u8bca\u65ad\u548c\u6cbb\u7597\u4e24\u4e2a\u65b9\u9762\u5b9e\u73b0\u5e94\u7528\u4ef7\u503c\u3002</p>"},{"location":"archive/proj/funding/","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"archive/proj/funding/#_1","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"archive/proj/funding/#funding","title":"Funding","text":"<ul> <li>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u96be\u6cbb\u6027\u81ea\u8eab\u514d\u75ab\u75c5\u7cbe\u51c6\u8bca\u6cbb\u4e0e\u521b\u65b0\u7597\u6cd5\u7814\u7a76\uff0c2024.12-2027.11 \u8bfe\u9898\u7ec4\u957f</li> <li>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u975e\u7f16\u7801RNA\u9ad8\u901a\u91cf\u89e3\u6790\u6280\u672f\u4e0e\u4e34\u5e8a\u5e94\u7528\u7814\u53d1\uff0c2024.12-2027.11 \u8bfe\u9898\u9aa8\u5e72</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c82371855\uff0c\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7cbe\u51c6\u8bca\u7597\u4e2d\u57fa\u4e8e\u975e\u7f16\u7801RNA\u7ec4\u5b66\u548c\u751f\u7269\u4fe1\u606f\u5b66\u7684\u65b0\u65b9\u6cd5\u7814\u7a76\uff0c2024-2027  \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u4e13\u9879\u9879\u76ee\uff0c82341101\uff0c\u57fa\u4e8eAI\u6280\u672f\u7684\u9776\u5411RNA\u7684\u836f\u7269\u8bbe\u8ba1\uff0c2024-2026  \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c32170671\uff0c\u4f53\u6db2\u591a\u7ec4\u5b66\u6570\u636e\u6574\u5408\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u53ca\u5176\u5728\u764c\u75c7\u65e0\u521b\u68c0\u6d4b\u4e0a\u7684\u5e94\u7528\uff0c2022-2025     \u4e3b\u6301</li> <li>\u6e05\u534e\u5927\u5b66\u7cbe\u51c6\u533b\u5b66\u7814\u7a76\u9662 \u7cbe\u51c6\u533b\u7597\u6218\u7565\u9879\u76ee\uff0c \u57fa\u4e8e\u591a\u7ec4\u5b66\u6570\u636e\u7684\u667a\u80fd\u5316\u4e2d\u665a\u671f\u809d\u764c\u8f6c\u5316\u6cbb\u7597\u51b3\u7b56\u7814\u7a76\uff0c2022-2025 \u5171\u540c\u4e3b\u6301</li> <li>\u5408\u80a5\u7efc\u5408\u6027\u56fd\u5bb6\u79d1\u5b66\u4e2d\u5fc3\u5927\u5065\u5eb7\u7814\u7a76\u9662\u201c\u5168\u7403\u9074\u9009\u201d\u9879\u76ee\uff0cLX202401\uff0ccfRNA\u4e3a\u6838\u5fc3\u7684\u591a\u7ec4\u5b66\u5728\u80ba\u764c\u7b5b\u67e5\u4e0a\u7684\u5e94\u7528\u7814\u7a76\uff0c2024-2027 \u4e3b\u6301</li> </ul> <ul> <li>2024-2027     Precision diagnosis and treatment and innovative therapy research for refractory autoimmune diseases (AIDs), co-PI, National Key Research and Development Program of China</li> <li>2024-2027     Development of high-throughput analysis  technology of non-coding RNA and its  clinical applicationd, key member, National Key Research and Development Program of China</li> <li>2024-2027     Bioinformatics study of noncoding RNA omics in precision diagnosis and treatment of autoimmune diseases, PI, National Natural Science Foundation of China</li> <li>2024-2026     AI-driven drug design targeting RNAs, PI, National Natural Science Foundation of China</li> <li>2022-2025     Bioinformatics study of body fluid multi-omics data integration for cancer diagnosis Novel, PI, National Natural Science Foundation of China</li> <li>2022-2025     Multi-Omics study for personalized neoadjuvant therapy of HCC, co-PI, Tsinghua Precision Medicine Institute</li> <li>2024-2027     cfRNA-based multi-omics application research in lung cancer screening, PI,  Hefei Comprehensive National Science Center General Health Research Institute \"Global Selection\" Project </li> </ul>"},{"location":"archive/proj/proj/","title":"\u79d1\u7814\u8bfe\u9898-\u6e05\u534e\u5927\u5b66\u9c81\u5fd7\u5b9e\u9a8c\u5ba4","text":""},{"location":"archive/proj/proj/#_1","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"archive/proj/proj/#research-projects","title":"Research Projects","text":"<ul> <li>\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898</li> <li>Research Projects<ul> <li>A. RNA Finder (Bioinfo-Driven Precision Medicine)<ul> <li>A1. [dsRNA] Double-stranded RNA (dsRNA) as Immune Regulator</li> <li>A2. [cfRNA] Cell-free RNA (cfRNA) as Disease Biomarker</li> </ul> </li> <li>B. RNA Modeling (AI-Driven RNA Modeling &amp; Drug Design)<ul> <li>B1. [RNA-Talk] RNA Interaction &amp; Regulation</li> <li>B2-1. [RNA-Structure] Ribozyme Design</li> <li>B2-2. [RNA-Structure] Drug Design</li> </ul> </li> </ul> </li> </ul> <p>We work on two major research projects centered on noncoding RNA (ncRNA): I. RNA Finder (Bioinfo-Driven Precision Medicine), II. RNA Modeling (AI-Driven RNA Modeling &amp; Drug Design).</p> <p>\u6211\u4eec\u56f4\u7ed5\u975e\u7f16\u7801 RNA\uff08ncRNA\uff09\u5728\u4e24\u4e2a\u4e3b\u8981\u7684\u79d1\u7814\u65b9\u5411\u4e0a\u8fdb\u884c\u63a2\u7d22\u548c\u7814\u7a76\uff1aI. RNA Finder\uff08\u751f\u4fe1\u9a71\u52a8\u7684\u7cbe\u51c6\u533b\u7597\uff09\uff1bII. RNA Modeling\uff08AI\u9a71\u52a8\u7684\u6838\u9178\u6a21\u578b\u548c\u836f\u7269\u8bbe\u8ba1\uff09\u3002 </p> <p></p>"},{"location":"archive/proj/proj/#a-rna-finder-bioinfo-driven-precision-medicine","title":"A. RNA Finder (Bioinfo-Driven Precision Medicine)","text":"<p>By integrating transcriptomics data with other multiomics data, we aim to explain development of complex diseases based on an integrative, multi-dimensional level.  We develop sequencing and bioinformatics methods to study cellular and extracellular transcriptome of coding and noncoding RNAs (ncRNAs) for varous immune cells of patients at the single-cell level and multi-molecular level. </p> <p>Accurately selecting the best diagnosis and treatment plan is important but difficult for complex diseases. For instance, some targeted drugs have been approved for many complex diseases, but the which benefit groups of different drugs are not yet clear, requiring accurate biomarkers. Therefore, by combining the immune cell data m with cfDNA/cfRNA in plasma and clinical data, we develop a drug-efficacy prediction model to provide a multi-modal biomarker for a precise drug instruction in the treatment of complex diseases. Meanwhile, we explore deep learning, transfer learning, similarity network fusion and other bioinformatics analysis techniques for these data. </p> <p>We apply the above methods to precision medicine, focusing on two types of diseases:  1) Immune-medicated diseases\uff1b2) Cancer.</p> <p>Cancer and autoimmune diseases are like two sides of a coin: if cancer cells escape the immune system's surveillance through some mechanism and cannot be eliminated, malignant tumors begin to grow; and when normal cells break the body's original immune tolerance mechanism for some reason, autoimmune diseases may be caused. \" -- Reverse Vaccine: A Miraculous Solution to Autoimmune Diseases, Scientific American, 2024.12.</p> <p>\u901a\u8fc7\u5c06\u8f6c\u5f55\u7ec4\u5b66\u6570\u636e\u4e0e\u5176\u4ed6\u591a\u7ec4\u5b66\u6570\u636e\u6574\u5408\uff0c\u6211\u4eec\u65e8\u5728\u4ece\u7efc\u5408\u7684\u3001\u591a\u7ef4\u7684\u6c34\u5e73\u4e0a\u53bb\u89e3\u91ca\u590d\u6742\u75be\u75c5\u7684\u53d1\u5c55\u3002 \u6211\u4eec\u5f00\u53d1\u6d4b\u5e8f\u548c\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u6cd5\u6765\u7814\u7a76\u7f16\u7801\u548c\u975e\u7f16\u7801 RNA (ncRNA) \u7684\u7ec6\u80de\u548c\u7ec6\u80de\u5916\u8f6c\u5f55\u7ec4\uff0c\u4ece\u5355\u7ec6\u80de\u6c34\u5e73\u548c\u591a\u5206\u5b50\u6c34\u5e73\u7814\u7a76\u60a3\u8005\u5404\u79cd\u514d\u75ab\u7ec6\u80de\u5185\u5916\u7f16\u7801\u548c\u975e\u7f16\u7801\u57fa\u56e0\u7684\u8c03\u63a7\u56fe\u8c31\u3002</p> <p>\u5bf9\u4e8e\u590d\u6742\u75be\u75c5\u6765\u8bf4\uff0c\u51c6\u786e\u9009\u62e9\u6700\u4f73\u7684\u8bca\u7597\u65b9\u6848\u5f88\u91cd\u8981\uff0c\u4f46\u4e5f\u5f88\u56f0\u96be\u3002 \u4f8b\u5982\uff0c\u4e00\u4e9b\u9776\u5411\u836f\u7269\u5df2\u88ab\u6279\u51c6\u7528\u4e8e\u8bb8\u591a\u590d\u6742\u75be\u75c5\uff0c\u4f46\u4e0d\u540c\u836f\u7269\u7684\u53d7\u76ca\u4eba\u7fa4\u5c1a\u4e0d\u6e05\u695a\uff0c\u9700\u8981\u51c6\u786e\u7684\u751f\u7269\u6807\u5fd7\u7269\u3002 \u56e0\u6b64\uff0c\u901a\u8fc7\u5c06\u514d\u75ab\u7ec6\u80de\u6570\u636e\u4e0e\u8840\u6d46\u4e2d\u7684cfDNA/cfRNA\u6570\u636e\u4ee5\u53ca\u4e34\u5e8a\u6570\u636e\u76f8\u7ed3\u5408\uff0c\u6211\u4eec\u5f00\u53d1\u836f\u6548\u9884\u6d4b\u6a21\u578b\uff0c\u4e3a\u6cbb\u7597\u590d\u6742\u75be\u75c5\u7684\u7cbe\u786e\u836f\u7269\u6307\u5bfc\u63d0\u4f9b\u591a\u6a21\u6001\u6807\u5fd7\u7269\u6a21\u578b\u3002\u540c\u65f6\uff0c\u6211\u4eec\u9488\u5bf9\u8fd9\u4e9b\u6570\u636e\u63a2\u7d22\u6df1\u5ea6\u5b66\u4e60\u3001\u8fc1\u79fb\u5b66\u4e60\u3001\u76f8\u4f3c\u6027\u7f51\u7edc\u878d\u5408\uff0c\u4ee5\u53ca\u5176\u4ed6\u751f\u7269\u4fe1\u606f\u5b66\u5206\u6790\u6280\u672f\u3002</p> <p>\u6211\u4eec\u5c06\u4e0a\u8ff0\u65b9\u6cd5\u5e94\u7528\u4e8e\u7cbe\u51c6\u533b\u7597\uff0c\u91cd\u70b9\u5173\u6ce8\u4e24\u7c7b\u75be\u75c5\uff1a1\uff09\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff1b2\uff09\u764c\u75c7\u3002</p> <p>\u201c\u764c\u75c7\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff0c\u8fd9\u4e24\u8005\u5c31\u50cf\u786c\u5e01\u7684\u4e24\u9762\uff1a\u82e5\u764c\u7ec6\u80de\u901a\u8fc7\u67d0\u79cd\u673a\u5236\u9003\u8131\u4e86\u514d\u75ab\u7cfb\u7edf\u76d1\u89c6\u3001\u65e0\u6cd5\u88ab\u6e05\u9664\uff0c\u6076\u6027\u80bf\u7624\u4fbf\u5f00\u59cb\u6ecb\u957f\uff1b\u800c\u5f53\u6b63\u5e38\u7ec6\u80de\u56e0\u67d0\u79cd\u539f\u56e0\u6253\u7834\u4e86\u8eab\u4f53\u539f\u672c\u7684\u514d\u75ab\u8010\u53d7\u673a\u5236\uff0c\u5c31\u53ef\u80fd\u5f15\u53d1\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3002\u201d  -- \u53cd\u5411\u75ab\u82d7\uff1a\u81ea\u8eab\u514d\u75ab\u75c5\u5947\u89e3\u300a\u73af\u7403\u79d1\u5b66\u300b(Scientific American) 2024\u5e7412\u6708\u53f7</p> <p></p>"},{"location":"archive/proj/proj/#dsRNA","title":"A1. [dsRNA] Double-stranded RNA (dsRNA) as Immune Regulator","text":"<p>Discoverying novel noncoding RNAs. With the advancement of sequencing technology, especially the development and maturity of sequencing technology at the single-cell and single-molecule level, we have the ability to discover new noncoding RNAs from more species, more tissues, and more cell types. For example, we can discover and study new noncoding RNAs under different environments and conditions from the metatranscriptome of diverse microbial communities. These studies will not only expand our understanding of the diversity of life, but may also reveal new biological mechanisms cross-species.</p> <p>Discoverying novel noncoding RNAs: \u968f\u7740\u6d4b\u5e8f\u6280\u672f\u7684\u8fdb\u6b65\uff0c\u5c24\u5176\u662f\u5355\u7ec6\u80de\u3001\u5355\u5206\u5b50\u6c34\u5e73\u7684\u6d4b\u5e8f\u6280\u672f\u7684\u53d1\u5c55\u548c\u6210\u719f\uff0c\u6211\u4eec\u6709\u80fd\u529b\u4ece\u66f4\u591a\u7269\u79cd\u3001\u66f4\u591a\u7ec4\u7ec7\u3001\u66f4\u591a\u7ec6\u80de\u7c7b\u578b\u4e2d\u53d1\u73b0\u65b0\u7684\u975e\u7f16\u7801RNA\u3002\u4f8b\u5982\uff0c\u6211\u4eec\u53ef\u4ee5\u4ece\u7eb7\u7e41\u590d\u6742\u7684\u5fae\u751f\u7269\u7fa4\u843d\u7684\u5b8f\u8f6c\u5f55\u7ec4\u4e2d\u53d1\u73b0\u548c\u7814\u7a76\u4e0d\u540c\u73af\u5883\u548c\u6761\u4ef6\u4e0b\u7684\u65b0\u975e\u7f16\u7801 RNA\u3002\u8fd9\u4e9b\u7814\u7a76\u4e0d\u4ec5\u5c06\u6269\u5927\u6211\u4eec\u5bf9\u751f\u547d\u591a\u6837\u6027\u7684\u7406\u89e3\uff0c\u8fd8\u53ef\u80fd\u63ed\u793a\u65b0\u7684\u3001\u8de8\u7269\u79cd\u7684\u751f\u7269\u5b66\u673a\u5236\u3002</p> <p>dsRNA. Three well-known types of noncoding RNA include miRNA, siRNA, and piRNA. These are distinct RNA types generated through double-stranded RNA (dsRNA) processing. Double-stranded RNA (dsRNA) is a molecule composed of two complementary RNA strands. RNA interference typically requires dsRNA, which can be introduced exogenously (such as viruses) or produced endogenously (such as repetitive sequences in human genome). Advances in research have revealed that there are far more than just these three types of dsRNA. These diverse dsRNAs play important roles in the immune system, particularly in antiviral and anti-tumor immune responses. For example, srpRNAs exert intercellular regulatory functions through exosome trafficking within the cancer microenvironment.</p> <p>dsRNA: \u8457\u540d\u7684\u975e\u7f16\u7801RNA\u6709miRNA/siRNA/piRNA\u8fd9\u4e09\u7c7bsmall RNA\uff0c\u4ed6\u4eec\u662f\u901a\u8fc7\u53cc\u94feRNA\uff08dsRNA\uff09\u52a0\u5de5\u751f\u6210\u7684\u4e0d\u540cRNA\u7c7b\u578b\u3002\u53cc\u94feRNA\uff08double stranded RNA, dsRNA\uff09\u662f\u4e00\u79cd\u7531\u4e24\u6761\u4e92\u8865RNA\u94fe\u7ec4\u6210\u7684\u5206\u5b50\uff0cRNA\u5e72\u6270\u7684\u542f\u52a8\u901a\u5e38\u9700\u8981\u53cc\u94feRNA\uff08dsRNA\uff09\uff0c\u8fd9\u4e9b\u53cc\u94feRNA\u53ef\u4ee5\u662f\u5916\u6e90\uff08\u5982\u75c5\u6bd2\uff09\u5f15\u5165\u7684\uff0c\u4e5f\u53ef\u4ee5\u662f\u5185\u6e90\uff08\u5982\u4eba\u7c7b\u57fa\u56e0\u7ec4\u91cc\u7684\u91cd\u590d\u5e8f\u5217\uff09\u4ea7\u751f\u7684\u3002\u968f\u7740\u79d1\u7814\u7684\u8fdb\u5c55\uff0c\u4eba\u4eec\u53d1\u73b0\u53cc\u94feRNA\uff08dsRNA\uff09\u8fdc\u4e0d\u6b62\u4e0a\u8ff03\u79cd\u3002\u8fd9\u4e9b\u4e0d\u540c\u7684dsRNAs\u5728\u514d\u75ab\u7cfb\u7edf\u4e2d\u5177\u6709\u91cd\u8981\u4f5c\u7528\uff0c\u5c24\u5176\u662f\u5728\u6297\u75c5\u6bd2\u548c\u6297\u80bf\u7624\u514d\u75ab\u53cd\u5e94\u4e2d\u3002\u6bd4\u5982\uff0csrpRNA\u5c31\u901a\u8fc7\u764c\u75c7\u5fae\u73af\u5883\u7684\u5916\u6ccc\u4f53\u8fd0\u8f93\u53d1\u6325\u7ec6\u80de\u95f4\u7684\u8c03\u63a7\u529f\u80fd\u3002</p> <p>RNA regulation in immune system. RNAs are dynamicly regulated during transcription. In addition, after RNA is transcribed, it will also have very complex and fine post-transcriptional regulation, such as alternative splicing (AS), alternative polyadenylation (APA), degradation, editing, modification, cellular localization and so on. These are closely related to the structure of RNA itself and the proteins that recognize RNA sequence and structure. At the same time, RNAs, especially noncoding RNAs (ncRNAs), also regulate other macromolecules, thus playing important roles in innate immune response to viruses and cancer immunity. We explore these complex regulatory processes in complex diseases such as cancer and autoimmune diseases, which are applied to immunotherapy.</p> <p>RNA regulation in immune system: RNA\u4e0d\u4ec5\u5728\u8f6c\u5f55\u65f6\u88ab\u52a8\u6001\u8c03\u63a7\uff0c\u800c\u4e14\u5728\u88ab\u8f6c\u5f55\u540e\u4e5f\u4f1a\u6709\u7740\u975e\u5e38\u590d\u6742\u800c\u7cbe\u7ec6\u7684\u8c03\u63a7\u5de5\u7a0b\uff0c\u4f8b\u5982\u526a\u63a5\uff0c\u4fee\u9970\uff0c\u7ec6\u80de\u5b9a\u4f4d\uff0c\u7f16\u8f91\uff0c\u52a0\u5c3e\uff0c\u964d\u89e3\u7b49\u7b49\u3002\u800c\u8fd9\u4e9b\u53c8\u548cRNA\u81ea\u8eab\u7684\u7ed3\u6784\u4ee5\u53ca\u8bc6\u522bRNA\u5e8f\u5217\u548c\u7ed3\u6784\u7684\u86cb\u767d\u606f\u606f\u76f8\u5173\u3002\u540c\u65f6\uff0cRNA\uff0c\u5c24\u5176\u662f\u975e\u7f16\u7801 RNA (ncRNA)\uff0c\u8fd8\u4f1a\u8c03\u63a7\u5176\u4ed6\u5927\u5206\u5b50\uff0c\u4ece\u800c\u5728\u4eba\u4f53\u5bf9\u75c5\u6bd2\u7684\u514d\u75ab\u5e94\u7b54\u4ee5\u53ca\u764c\u75c7\u514d\u75ab\u7b49\u91cd\u8981\u751f\u547d\u8fc7\u7a0b\u4e2d\u53d1\u6325\u4f5c\u7528\u3002\u6211\u4eec\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u7b49\u590d\u6742\u6027\u75be\u75c5\u4e2d\u63a2\u7d22\u8fd9\u4e9b\u590d\u6742\u7684\u8c03\u63a7\u8fc7\u7a0b\uff0c\u5e76\u5e94\u7528\u4e8e\u514d\u75ab\u6cbb\u7597\u3002</p> <p></p>"},{"location":"archive/proj/proj/#cfRNA","title":"A2. [cfRNA] Cell-free RNA (cfRNA) as Disease Biomarker","text":"<p>cell-free RNAs (cfRNAs). The cfRNA content in clinical plasma samples is very low and fragmented. Therefore, it is necessary to solve the problems of low signal-to-noise ratio and high cost of sequencing data. We apply technologies such as TSO, early barcoding, UMI, and CRISPR-Cas9 to develop novel cfRNA-seq technologies that reduce the cost of high-throughput sequencing, and improve the signal-to-noise ratio of sequencing data.</p> <p>In clinical studies like liquid biopsy, exRNA (extra-cellular RNA) is also called cfRNA (cell free RNA). Many exRNAs are noncoding RNAs (ncRNAs), like miRNA, lncRNA, srpRNA, circRN, etc. </p> <p>cell-free RNAs (cfRNAs): \u4e34\u5e8a\u8840\u6d46\u6837\u672c\u4e2d\u7684 cfRNA \u542b\u91cf\u5f88\u4f4e\u4e14\u788e\u7247\u5316\uff0c\u9700\u8981\u89e3\u51b3\u6d4b\u5e8f\u6570\u636e\u4fe1\u566a\u6bd4\u4f4e\u3001\u6210\u672c\u6602\u8d35\u7b49\u95ee\u9898\u3002\u6211\u4eec\u5e94\u7528\u6a21\u677f\u8f6c\u6362\u3001\u65e9\u671f\u6807\u8bb0\u3001\u5206\u5b50\u6807\u7b7e\u548cCRISPR-Cas9\u7b49\u6280\u672f\uff0c\u5f00\u53d1\u65b0\u578b cfRNA-seq \u6280\u672f\uff0c\u964d\u4f4e\u6784\u5efa\u9ad8\u901a\u91cf\u6d4b\u5e8f\u6587\u5e93\u7684\u7ecf\u6d4e\u6210\u672c\u5e76\u63d0\u9ad8\u4e86\u6d4b\u5e8f\u6570\u636e\u7684\u4fe1\u566a\u6bd4\u3002</p> <p>exRNA (extra-cellular RNA) \u5728\u5f88\u591a\u4e34\u5e8a\u7814\u7a76\u5c24\u5176\u662f\u6db2\u4f53\u6d3b\u68c0\u7814\u7a76\u4e2d\u53c8\u79f0\u4e3a cfRNA (cell free RNA) \uff0c\u5305\u62ec\u4e86\u5f88\u591a\u975e\u7f16\u7801 RNA (ncRNA)\uff0c\u5982 miRNA\uff0clncRNA\uff0csrpRNA\uff0ccircRNA\u7b49\u3002</p> <p></p> <p>Multi-modal data integration. Multiple regulation events (e.g., expression, splicing, editing, fusion) can be quantified by bioinformatic analysis from NGS data like cfRNA-seq.  For the multi-modal data, such as cfRNA-seq derived multi-view data and/or multi-omics data, we need 4 steps for machine learning analysis, including 1) Data Cleaning, 2) Feature extraction and engineering, 3) Model Fitting, 4) Classifier. We develop corresponding bioinformatics method, software, database and other tools for these four steps (see more in Software). For instance, we integrate these multi-modal data using new AI technologies like large language and deep learning models. </p> <p>Multi-modal data integration:  \u6211\u4eec\u53ef\u4ee5\u7531cfRNA-seq\u7b49\u9ad8\u901a\u91cf\u6d4b\u5e8f\u65b9\u6cd5\u901a\u8fc7\u751f\u7269\u4fe1\u606f\u5206\u6790\u8ba1\u7b97\u5f97\u5230\u591a\u6a21\u6001\u6570\u636e\uff08\u4f8b\u5982\u8868\u8fbe\u3001\u526a\u63a5\u3001\u7f16\u8f91\u3001\u878d\u5408\u7b49\uff09\u3002\u5bf9\u4e8e\u8fd9\u4e9b\u591a\u7ef4\u5ea6\u3001\u591a\u6a21\u6001\u7684\u9ad8\u901a\u91cf\u6570\u636e\uff08\u4f8b\u5982 cfRNA-seq\u5206\u6790\u5f97\u5230\u7684\u591a\u6a21\u6001\u6570\u636e\uff0c\u4ee5\u53camulti-omics\u6570\u636e\uff09\uff0c\u6211\u4eec\u9700\u8981\u8fdb\u884c4\u4e2a\u6b65\u9aa4\u6765\u8fdb\u884c\u673a\u5668\u5b66\u4e60\u7b49\u5206\u6790\uff0c\u5305\u62ec 1) Data Cleaning, 2) Feature extraction and engineering, 3) Model Fitting, 4) Classifier\u3002\u6211\u4eec\u9488\u5bf9\u8fd94\u4e2a\u6b65\u9aa4\u5f00\u53d1\u76f8\u5e94\u7684\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u6cd5\u3001\u8f6f\u4ef6\u3001\u6570\u636e\u5e93\u7b49\u5de5\u5177\uff08\u8be6\u89c1\uff1a Software\uff09\uff0c\u4f8b\u5982\uff0c\u6211\u4eec\u63a2\u7d22\u548c\u5229\u7528\u5927\u8bed\u8a00\u6a21\u578b\u548c\u6df1\u5ea6\u5b66\u4e60\u6a21\u578b\u7b49\u65b0\u578bAI \u6280\u672f\uff0c\u8fdb\u884c\u591a\u6a21\u6001\u6570\u636e\u6574\u5408\u3002</p> <p>Clinical application for cancer screen. Subsequently,  by applying these methods to liquid biopsy, we help many clinical studies like cancer screen.</p> <p>Clinical application for cancer screen: \u6700\u540e\uff0c\u6211\u4eec\u5c06\u8fd9\u4e9b\u65b9\u6cd5\u5e94\u7528\u5728\u6db2\u4f53\u6d3b\u68c0\u4e0a\uff0c\u52a9\u529b\u89e3\u51b3\u4e34\u5e8a\u95ee\u9898\uff0c\u4f8b\u5982\u764c\u75c7\u65e9\u7b5b\u3002</p> <p></p>"},{"location":"archive/proj/proj/#b-rna-modeling-ai-driven-rna-modeling-drug-design","title":"B. RNA Modeling (AI-Driven RNA Modeling &amp; Drug Design)","text":"<p>\u201cRNA, not DNA, is the computational engine of the cell.\u201d ( Revolutionary Genetics Research Shows RNA May Rule Our Genome | Scientific American 2024.7. Cover Story).  </p> <p>Leveraging new AI technologies for RNA modeling (i.e., RNA-Talk models) that tokenize information at sequence and/or structural levels, we discover and decipher the various molecular interactions and biological regulatory networks mediated by RNA.</p> <p>\u201cRNA \u800c\u4e0d\u662f DNA \u624d\u662f\u7ec6\u80de\u7684\u8ba1\u7b97\u5f15\u64ce\u3002\u201d \uff08 RNA: \u638c\u63a7\u751f\u547d\u540e\u53f0 | \u300a\u73af\u7403\u79d1\u5b66\u300b 2024\u5e747\u6708\u520a\u5c01\u9762\u6587\u7ae0\uff09</p> <p>\u6211\u4eec\u5229\u7528\u6700\u65b0\u7684\u4eba\u5de5\u667a\u80fd\u6280\u672f\u4ece\u201c\u5e8f\u5217\u201d\u548c\u201c\u7ed3\u6784\u201d\u4e24\u4e2a\u4e0d\u540c\u7684\u8868\u5f81\u5c42\u9762\u5f00\u53d1\u5404\u7c7b\u6838\u9178\u6a21\u578b\uff08 RNA-Talk\uff09\uff0c\u53bb\u53d1\u73b0\u548c\u7406\u89e3RNA\u5728\u590d\u6742\u7684\u751f\u7269\u5206\u5b50\u4e92\u4f5c\u548c\u8c03\u63a7\u7f51\u7edc\u4e2d\u7684\u4f5c\u7528\u548c\u673a\u5236\u3002</p> <p></p>"},{"location":"archive/proj/proj/#b1-rna-talk-rna-interaction-regulation","title":"B1. [RNA-Talk] RNA Interaction &amp; Regulation","text":"<p>RNA modeling based on SEQUENCE</p> <p></p> <p>RNA-RNA interaction (trans-pair) (RNA targeting RNA) plays a crucial role in various biological processes, including gene regulation, RNA processing, and viral replication. Predicting RNA-RNA interactions involves identifying and characterizing the binding sites between two RNA molecules, which can provide insights into their functional relationships and regulatory mechanisms. It's important to note that predicting RNA-RNA interactions remains a challenging problem due to the complexity of RNA structures, the vast sequence space, and the limited availability of experimentally validated interaction data. Therefore, the accuracy of predictions can vary depending on the specific method used and the quality of input data. We develop and refine computational approaches for predicting RNA-RNA interactions, aiming to improve the understanding of RNA biology and facilitate the discovery of new therapeutic targets and RNA-based regulatory mechanisms.</p> <p>RNA-RNA interaction (trans-pair) : RNA\u9776\u5411RNA\u5728\u5404\u79cd\u751f\u7269\u8fc7\u7a0b\u4e2d\u53d1\u6325\u7740\u81f3\u5173\u91cd\u8981\u7684\u4f5c\u7528\uff0c\u5305\u62ec\u57fa\u56e0\u8c03\u63a7\u3001RNA\u52a0\u5de5\u548c\u75c5\u6bd2\u590d\u5236\u3002 \u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u6d89\u53ca\u8bc6\u522b\u548c\u8868\u5f81\u4e24\u4e2a RNA \u5206\u5b50\u4e4b\u95f4\u7684\u7ed3\u5408\u4f4d\u70b9\uff0c\u8fd9\u53ef\u4ee5\u6df1\u5165\u4e86\u89e3\u5b83\u4eec\u7684\u529f\u80fd\u5173\u7cfb\u548c\u8c03\u63a7\u673a\u5236\u3002 \u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u7531\u4e8e RNA \u7ed3\u6784\u7684\u590d\u6742\u6027\u3001\u5de8\u5927\u7684\u5e8f\u5217\u7a7a\u95f4\u4ee5\u53ca\u7ecf\u8fc7\u5b9e\u9a8c\u9a8c\u8bc1\u7684\u76f8\u4e92\u4f5c\u7528\u6570\u636e\u7684\u6709\u9650\u6027\uff0c\u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u4ecd\u7136\u662f\u4e00\u4e2a\u5177\u6709\u6311\u6218\u6027\u7684\u95ee\u9898\u3002 \u56e0\u6b64\uff0c\u9884\u6d4b\u7684\u51c6\u786e\u6027\u53ef\u80fd\u4f1a\u6839\u636e\u6240\u4f7f\u7528\u7684\u5177\u4f53\u65b9\u6cd5\u548c\u8f93\u5165\u6570\u636e\u7684\u8d28\u91cf\u800c\u6709\u6240\u4e0d\u540c\u3002 \u6211\u4eec\u5f00\u53d1\u548c\u5b8c\u5584\u7528\u4e8e\u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u7684\u8ba1\u7b97\u65b9\u6cd5\uff0c\u65e8\u5728\u63d0\u9ad8\u5bf9 RNA \u751f\u7269\u5b66\u7684\u7406\u89e3\uff0c\u5e76\u4fc3\u8fdb\u65b0\u7684\u6cbb\u7597\u9776\u70b9\u548c\u57fa\u4e8e RNA \u7684\u8c03\u63a7\u673a\u5236\u7684\u53d1\u73b0\u3002</p> <p>siRNA design. Small interfering RNA (siRNA) has become a widely used experimental approach for post-transcriptional regulation and is increasingly showing its potential as future targeted drugs. However, the prediction of highly efficient siRNAs is still hindered by dataset biases, the inadequacy of prediction methods, and the presence of off-target effects. To overcome these limitations, we develop novel AI approaches for the prediction and design of efficient siRNA.</p> <p>siRNA design: siRNA\u5df2\u6210\u4e3a\u4e00\u79cd\u5e7f\u6cdb\u4f7f\u7528\u7684\u8f6c\u5f55\u540e\u8c03\u63a7\u5b9e\u9a8c\u65b9\u6cd5\uff0c\u5e76\u4e14\u8d8a\u6765\u8d8a\u663e\u793a\u51fa\u5176\u4f5c\u4e3a\u672a\u6765\u9776\u5411\u836f\u7269\u7684\u6f5c\u529b\u3002 \u7136\u800c\uff0c\u9ad8\u6548siRNA\u7684\u9884\u6d4b\u4ecd\u7136\u53d7\u5230\u6570\u636e\u96c6\u504f\u5dee\u3001\u9884\u6d4b\u65b9\u6cd5\u7684\u4e0d\u8db3\u4ee5\u53ca\u8131\u9776\u6548\u5e94\u7684\u5b58\u5728\u7684\u963b\u788d\u3002\u4e3a\u4e86\u514b\u670d\u8fd9\u4e9b\u9650\u5236\uff0c\u6211\u4eec\u5f00\u53d1\u65b0\u7684\u4eba\u5de5\u667a\u80fd\u65b9\u6cd5\u6765\u9884\u6d4b\u548c\u8bbe\u8ba1\u9ad8\u6548\u7684siRNA\u3002</p>"},{"location":"archive/proj/proj/#b2-1-rna-structure-ribozyme-design","title":"B2-1. [RNA-Structure] Ribozyme Design","text":"<p>RNA modeling based on STRUCTURE</p> <p></p> <p>RNA structure prediction.  We develop structure prediction models and algorithms for RNA. The accurate prediction of RNA structure will help us better understand its regulation and function, thus improving RNA-based enzyme and vaccince design. For instance, mRNA, as well as other RNAs like circular RNA, can be used as RNA vaccines. In the design of RNA vaccines, the design of RNA structure, codons and modifications are very important research directions. Improving the stability of RNA in storage and transportation, and the effectiveness and targeting of delivery to cells and the human body are very important and cutting-edge research directions.</p> <p>RNA structure prediction: \u6211\u4eec\u5f00\u53d1\u9488\u5bf9 RNA\u7ed3\u6784\u7684\u9884\u6d4b\u6a21\u578b\u548c\u7b97\u6cd5\uff0c\u5bf9 RNA \u7ed3\u6784\u7684\u51c6\u786e\u9884\u6d4b\uff0c\u5c06\u5e2e\u52a9\u6211\u4eec\u66f4\u597d\u5730\u7406\u89e3 RNA \u7684\u8c03\u63a7\u548c\u529f\u80fd\uff0c\u5e76\u5e94\u7528\u4e8e\u57fa\u4e8e RNA\u9176\u548cRNA\u75ab\u82d7\u7684\u8bbe\u8ba1\u3002\u4f8b\u5982\uff0cmRNA\uff0c\u4ee5\u53ca\u73af\u88c5RNA\uff08circular RNA\uff09\u7b49\uff0c\u53ef\u4ee5\u7528\u6765\u505a\u4e3aRNA\u75ab\u82d7\u3002\u5728 RNA \u75ab\u82d7\u8bbe\u8ba1\u4e2d\uff0cRNA \u7ed3\u6784\u3001\u5bc6\u7801\u5b50\u548c\u4fee\u9970\u7684\u8bbe\u8ba1\u90fd\u662f\u975e\u5e38\u91cd\u8981\u7684\u7814\u7a76\u65b9\u5411\u3002\u4e0d\u8bba\u662f RNA\u5e72\u6270\u8fd8\u662fRNA\u75ab\u82d7\uff0c\u63d0\u9ad8RNA \u5728\u5b58\u50a8\u548c\u8fd0\u8f93\u4e2d\u7684\u7a33\u5b9a\u6027\uff0c\u9012\u9001\u5230\u7ec6\u80de\u548c\u4eba\u4f53\u5185\u7684\u6709\u6548\u6027\u548c\u9776\u5411\u6027\uff0c\u90fd\u662f\u975e\u5e38\u91cd\u8981\u548c\u524d\u6cbf\u7684\u7814\u7a76\u65b9\u5411\u3002</p> <p>RNA Design.  The introduction of new methods and new thinking in different fields can often lead to breakthrough progress in this discipline, so we pay special attention to introducing new technologies and new thinking in the latest computing field (such as new AI technologies based on large language models) into biological data. We develop novel RNA models to explore basic scientific questions such as the structure, regulation and target of RNA, especially noncoding RNA (ncRNA). Finally, these novel models will bring us a new era of enzyme and drug design.</p> <p>RNA Design:  \u4e0d\u540c\u9886\u57df\u7684\u65b0\u65b9\u6cd5\u548c\u65b0\u601d\u7ef4\u7684\u5f15\u5165\uff0c\u5f80\u5f80\u80fd\u5e26\u6765\u672c\u5b66\u79d1\u7684\u7a81\u7834\u6027\u8fdb\u5c55\uff0c\u6240\u4ee5\u6211\u4eec\u5c24\u5176\u6ce8\u610f\u5c06\u6700\u65b0\u7684\u8ba1\u7b97\u9886\u57df\u7684\u65b0\u6280\u672f\u548c\u65b0\u601d\u7ef4\uff08\u4f8b\u5982\u57fa\u4e8e\u5927\u8bed\u8a00\u6a21\u578b\u7684\u65b0\u578b AI \u6280\u672f\uff09\u5f15\u5165\u5230\u751f\u7269\u6570\u636e\u7684\u7814\u7a76\u4e0a\u3002\u6211\u4eec\u9488\u5bf9RNA\uff0c\u5c24\u5176\u662f \u975e\u7f16\u7801 RNA (ncRNA\uff09\uff0c\u7684\u7ed3\u6784\u3001\u8c03\u63a7\u548c\u9776\u6807\u7b49\u95ee\u9898\uff0c\u5f00\u53d1\u65b0\u578b\u7684\u6838\u9178\u6a21\u578b\u3002\u6700\u7ec8\uff0c\u8fd9\u4e9b\u65b0\u578b\u7684\u6a21\u578b\u5c06\u4f1a\u5e26\u9886\u6211\u4eec\u8fdb\u5165\u4e00\u4e2a\u5d2d\u65b0\u601d\u7ef4\u7684\u9176\u8bbe\u8ba1\u548c\u836f\u7269\u8bbe\u8ba1\u7684\u65b0\u65f6\u4ee3\u3002</p>"},{"location":"archive/proj/proj/#b2-2-rna-structure-drug-design","title":"B2-2. [RNA-Structure] Drug Design","text":"<p>RNA modeling based on STRUCTURE</p> <p></p> <p>The potential RNA-targeted druggable genome (Warner, et al., Nature Reviews | Drug Discovery\u00a0 2018)</p> <p>Small molecule drug design targeting RNA. The number of human proteins that can be used as small-molecule drug targets is very limited\uff1aOf the ~20 thousand protein-coding genes in human (~1.5% of human genome sequence),  about 10%-15% are directly related to diseases; among these genes, it is estimated that less than 700 protein products are druggable (only ~0.05% of human genome sequence). On the other hand, ~70% or more of the human genome  are transcribed into RNAs. Most of them are noncoding RNAs (ncRNAs). In recent years, more and more researchers have tried to use RNA as a drug target, and initially proved the feasibility of this strategy. In particular, it is worth noting that Coronavirus (COVID-19) is an RNA virus, and its genome itself is also promising as a drug target. In addition, using noncoding RNA for disease treatment is also a promising research direction, for example, siRNA-based RNA interference (RNAi) system has aleady been used to develop new gene therapy methods. Due to the high complexity and variability of RNA structure and the limitations of experimental methods, our current understanding of the three-dimensional structure of RNA is still very limited, and the development of RNA-targeting drugs is still in its infancy. We will use the latest artificial intelligence technologies such as deep learning to integrate various information,  and subsequently to design drugs targeting RNAs. </p> <p>Small molecule drug design targeting RNA: \u53ef\u4f5c\u4e3a\u5c0f\u5206\u5b50\u836f\u7269\u9776\u6807\u7684\u4eba\u7c7b\u86cb\u767d\u6570\u91cf\u975e\u5e38\u6709\u9650\uff1a\u5728\u4eba\u7c7b\u76842\u4e07\u4e2a\u5de6\u53f3\u7684\u86cb\u767d\u7f16\u7801\u57fa\u56e0\uff08\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u76841.5%\u5de6\u53f3\uff09\u4e2d\uff0c\u5927\u7ea6\u6709 10%-15%\u4e0e\u75be\u75c5\u76f4\u63a5\u76f8\u5173\uff1b\u800c\u5728\u8fd9\u4e9b\u57fa\u56e0\u4e2d\uff0c\u636e\u4f30\u8ba1\u4ec5\u6709\u4e0d\u5230 700 \u4e2a\u7684\u86cb\u767d\u4ea7\u7269\u662f\u53ef\u4ee5\u6210\u836f\u7684 \uff08\u4ec5\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u7684 0.05%\u5de6\u53f3\uff09\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u4eba\u7c7b\u57fa\u56e0\u7ec4\u7684~70%\u751a\u81f3\u66f4\u591a\u90fd\u4f1a\u88ab\u8f6c\u5f55\u6210 RNA\uff0c\u5176\u4e2d\u5927\u591a\u662f\u975e\u7f16\u7801 RNA (ncRNA)\u3002\u56e0\u6b64\uff0c\u8fd1\u5e74\u5f00\u59cb\u6709\u8d8a\u6765\u8d8a\u591a\u7684\u7814\u7a76\u8005\u8bd5\u56fe\u5c06 RNA \u4f5c\u4e3a\u836f\u7269\u9776\u6807\uff0c\u5e76\u521d\u6b65\u8bc1\u660e\u4e86\u8fd9\u4e00\u7b56\u7565\u7684\u53ef\u884c\u6027\u3002\u5c24\u5176\u503c\u5f97\u6211\u4eec\u6ce8\u610f\u7684\u662f\uff0c\u65b0\u51a0\u75c5\u6bd2\u5c31\u662f RNA \u75c5\u6bd2\uff0c\u5176\u57fa\u56e0\u7ec4\u672c\u8eab\u4e5f\u6709\u5e0c\u671b\u88ab\u4f5c\u4e3a\u836f\u7269\u9776\u6807\u3002\u6b64\u5916\uff0c\u5229\u7528\u975e\u7f16\u7801RNA\u8fdb\u884c\u75be\u75c5\u6cbb\u7597\u4e5f\u662f\u4e00\u4e2a\u6709\u524d\u666f\u7684\u7814\u7a76\u65b9\u5411\uff0c\u4f8b\u5982\uff0c\u57fa\u4e8e siRNA \u7684RNA\u5e72\u6270\uff08RNA interference, RNAi\uff09\u7cfb\u7edf\u7b49\u5df2\u7ecf\u88ab\u7528\u4e8e\u5f00\u53d1\u65b0\u7684\u57fa\u56e0\u6cbb\u7597\u65b9\u6cd5\u3002\u7531\u4e8e RNA \u7ed3\u6784\u7684\u9ad8\u5ea6\u590d\u6742\u6027\u548c\u53ef\u53d8\u6027\uff0c\u4ee5\u53ca\u5b9e\u9a8c\u65b9\u6cd5\u7684\u9650\u5236\uff0c\u76ee\u524d\u6211\u4eec\u5bf9\u4e8e RNA \u7684\u4e09\u7ef4\u7ed3\u6784\u7684\u4e86\u89e3\u4ecd\u975e\u5e38\u6709\u9650\uff0c\u9776\u5411 RNA \u7684\u836f\u7269\u7814\u53d1\u4e5f\u5904\u5728\u8d77\u6b65\u9636\u6bb5\u3002 \u6211\u4eec\u5c06\u5145\u5206\u53d1\u6325\u4eba\u5de5\u667a\u80fd\u7684\u4f18\u52bf\uff0c\u5229\u7528\u6df1\u5ea6\u5b66\u4e60\u7b49\u6700\u65b0\u7684\u8ba1\u7b97\u6280\u672f\u6574\u5408\u591a\u65b9\u9762\u7684\u4fe1\u606f\uff0c\u8bbe\u8ba1\u65b0\u836f\u7269\u9776\u6807RNA\u3002</p>"},{"location":"courses/","title":"Courses","text":""},{"location":"courses/#courses-tsinghua","title":"Courses @ Tsinghua","text":"<p>Major Courses \u4e3b\u8bb2\u8bfe\u7a0b</p> <ul> <li>\u6625\u5b63\u5b66\u671f\uff1aBioinformatics\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b<ul> <li>\u5bf9\u8c61\uff1a\u672c\u79d1\u751f 50-80\u4eba     </li> </ul> </li> <li>\u79cb\u5b63\u5b66\u671f\uff1aAI for Biomedicine\u300a\u751f\u7269\u533b\u5b66\u4e2d\u7684AI\u5b9e\u8df5\u300b<ul> <li>\u5bf9\u8c61\uff1a\u535a\u58eb\u751f 10-15\u4eba; \u672c\u79d1\u751f 3-5\u4eba </li> </ul> </li> <li>\u79cb\u5b63\u5b66\u671f\uff1aGenomics\u300a\u57fa\u56e0\u7ec4\u5b66\u5bfc\u8bba\u300b- PTN<ul> <li>\u5bf9\u8c61\uff1a\u535a\u58eb\u751f 50-80\u4eba </li> </ul> </li> </ul>"},{"location":"courses/#other-courses","title":"Other Courses \u5176\u4ed6\u8bfe\u7a0b:","text":"<ul> <li>Courses @ Tsinghua</li> <li>Other Courses \u5176\u4ed6\u8bfe\u7a0b:<ul> <li>Autumn Semester \u79cb\u5b63\u5b66\u671f<ul> <li>Advanced Courses \u535a\u58eb\u751f\u8bfe\u7a0b</li> <li>Basic Courses \u672c\u79d1\u751f\u8bfe\u7a0b</li> </ul> </li> <li>Spring Semester \u6625\u5b63\u5b66\u671f<ul> <li>Advanced Courses \u535a\u58eb\u751f\u8bfe\u7a0b</li> <li>Basic Courses \u672c\u79d1\u751f\u8bfe\u7a0b</li> <li>Other Courses \u5176\u4ed6\u8bfe\u7a0b</li> </ul> </li> <li>Summer School \u590f\u5b63\u5c0f\u5b66\u671f<ul> <li>Basic Courses \u672c\u79d1\u751f\u8bfe\u7a0b</li> </ul> </li> </ul> </li> </ul>"},{"location":"courses/#autumn-semester","title":"Autumn Semester \u79cb\u5b63\u5b66\u671f","text":""},{"location":"courses/#advanced-courses","title":"Advanced Courses\u00a0 \u535a\u58eb\u751f\u8bfe\u7a0b","text":""},{"location":"courses/#bioinfo2","title":"Bioinformatics in Action\u300a\u751f\u7269\u4fe1\u606f\u5b66\u5b9e\u8df5\u300b","text":"<ul> <li>\u5bf9\u8c61\uff1a\u535a\u58eb\u751f ~30\u4eba; \u672c\u79d1\u751f ~10\u4eba   </li> </ul>"},{"location":"courses/#basic-courses","title":"Basic Courses\u00a0\u672c\u79d1\u751f\u8bfe\u7a0b","text":""},{"location":"courses/#frontier-of-life-sciences","title":"Frontier of Life Sciences \u300a\u751f\u547d\u79d1\u5b66\u524d\u6cbf\u300b","text":"<p>\u8bb2\u6388\u5355\u5143\uff1a\u751f\u7269\u4fe1\u606f\u548c\u57fa\u56e0\u7ec4\u5b66\u4ecb\u7ecd -- 2hr</p> <ul> <li>\u65f6\u95f4\uff1a\u79cb\u5b63\u5b66\u671f</li> <li>\u5b66\u65f6\uff1a2/32\u00a0</li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u65bd\u4e00\u516c | \u5408\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7 \u7b49\u00a0</li> <li>\u5bf9\u8c61\uff1a\u5927\u4e00\u65b0\u751f</li> </ul> <p>\u3010\u8bfe\u7a0b\u7b80\u4ecb\u3011</p> <p>\u672c\u8bfe\u7a0b\u91cd\u70b9\u4ecb\u7ecd\u751f\u547d\u79d1\u5b66\u524d\u6cbf\u9886\u57df\u751f\u5316\u3001\u7ec6\u80de\u3001\u53d1\u80b2\u3001\u9057\u4f20\u3001\u514d\u75ab\u3001\u5316\u751f\u3001\u751f\u7269\u7269\u7406\u3001\u7cfb\u7edf\u751f\u7269\u5b66\u7b49\u7684\u53d1\u5c55\u5386\u53f2\u3001\u73b0\u72b6\u3001\u53ca\u5c55\u671b\uff0c\u4f7f\u5b66\u751f\u5bf9\u57fa\u672c\u751f\u547d\u79d1\u5b66\u7684\u6982\u8c8c\u6709\u8f83\u5168\u9762\u4e86\u89e3\u3002\u672c\u8bfe\u7a0b\u91cd\u5728\u8bad\u7ec3\u5b66\u751f\u601d\u7ef4\u53ca\u903b\u8f91\uff0c\u666e\u53ca\u4f5c\u4e3a\u751f\u547d\u5b66\u79d1\u7684\u672c\u79d1\u751f\u5e94\u8be5\u4e86\u89e3\u4e13\u4e1a\u5185\u5bb9\u3002</p>"},{"location":"courses/#spring-semester","title":"Spring Semester \u6625\u5b63\u5b66\u671f","text":""},{"location":"courses/#advanced-courses_1","title":"Advanced Courses\u00a0 \u535a\u58eb\u751f\u8bfe\u7a0b","text":""},{"location":"courses/#bioinformatics-and-systems-biology","title":"Bioinformatics and Systems Biology\u300a\u751f\u7269\u4fe1\u606f\u5b66\u548c\u7cfb\u7edf\u751f\u7269\u5b66\u300b","text":"<p>\u8bb2\u6388\u5355\u5143\uff1aModels and Algorithms in Bioinformatics -- 9hr</p> <ul> <li>\u65f6\u95f4\uff1a\u6625\u5b63\u5b66\u671f</li> <li>\u5b66\u65f6\uff1a48\u00a0</li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u6768\u96ea\u745e | \u5408\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7  \u7b49</li> <li>\u5bf9\u8c61\uff1a\u6e05\u534e\u535a\u58eb\u751f</li> </ul>"},{"location":"courses/#RNA","title":"RNA Biology\u300aRNA\u751f\u7269\u5b66\u300b","text":"<p>\u8bb2\u6388\u5355\u5143\uff1aRNA\u751f\u7269\u4fe1\u606f\u5b66 -- 2hr</p> <ul> <li>\u65f6\u95f4\uff1a\u6625\u5b63\u5b66\u671f\u00a0</li> <li>\u5b66\u65f6\uff1a32\u00a0</li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u621a\u76ca\u519b\u00a0 | \u5408\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7  \u7b49</li> <li>\u5bf9\u8c61\uff1a\u6e05\u534e\u535a\u58eb\u751f</li> </ul>"},{"location":"courses/#basic-courses_1","title":"Basic Courses\u00a0\u672c\u79d1\u751f\u8bfe\u7a0b","text":""},{"location":"courses/#biophysics","title":"Biophysics \u300a\u751f\u7269\u7269\u7406\u5b66\u300b","text":"<p>\u8bb2\u6388\u5355\u5143\uff1aRNA Secondary Structure Prediction -- 6hr</p> <ul> <li>\u65f6\u95f4\uff1a\u6625\u5b63\u5b66\u671f</li> <li>\u5b66\u65f6\uff1a32\u00a0</li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u9f9a\u6d77\u9e4f | \u5408\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7  \u7b49\u00a0</li> <li>\u5bf9\u8c61\uff1a\u5927\u4e09\u5927\u56db\u672c\u79d1\u751f\uff0c \u4e13\u4e1a\u9009\u4fee\u8bfe</li> <li>\u8bfe\u4ef6\u4e0b\u8f7d:  Link</li> <li>\u66f4\u591a\u9605\u8bfb:  Link</li> <li>\u8bb2\u8bfe\u89c6\u9891:  Link</li> </ul>"},{"location":"courses/#other-courses_1","title":"Other Courses\u00a0\u5176\u4ed6\u8bfe\u7a0b","text":"<ul> <li>\u300a\u9ad8\u4e2d\u5965\u6797\u5339\u514b\u7ade\u8d5b\u8003\u5bdf\u8bfe\u300b\u2014 1 hr</li> <li>\u300a\u9ad8\u4e2d\u6559\u5e08\u57f9\u8bad\u8bfe\u300b\u2014  1hr</li> </ul>"},{"location":"courses/#summer-school","title":"Summer School  \u590f\u5b63\u5c0f\u5b66\u671f","text":""},{"location":"courses/#basic-courses_2","title":"Basic Courses \u672c\u79d1\u751f\u8bfe\u7a0b","text":""},{"location":"courses/#bioinfo3","title":"\u300a\u751f\u547d\u4fe1\u606f\u7684\u89e3\u8bfb\u548c\u91cd\u7f16\u7a0b\u300b","text":"<p>\u81f4\u7406\u4e66\u9662\u57fa\u7840\u5b66\u79d1\u4ea4\u53c9\u5b9e\u8df5\u8bfe\u7a0b</p> <ul> <li>\u8bfe\u53f7\uff1a44710062  \uff08\u5e8f\u53f7\uff1a12\uff09</li> <li>\u5468\u6570\uff1a \u51713\u5468\uff0c\u7b2c1\u5468 8\u8bfe\u65f6\uff1b \u7b2c2\u5468\uff1a 8\u8bfe\u65f6\uff1b\u7b2c\u4e09\u5468\uff1a16\u8bfe\u65f6</li> <li>\u4e3b\u8981\u6559\u6750\uff1a\u300aBioinformatics Tutorial\u300b</li> <li>\u6559\u5b66\u65e5\u5386\u548c\u6559\u6848: Syllabus</li> </ul>"},{"location":"courses/ai/","title":"AI for Biomedicine","text":""},{"location":"courses/ai/#ai-","title":"\u3010\u751f\u7269\u533b\u5b66\u4e2d\u7684AI\u5b9e\u8df5\u3011- \u79cb\u5b63\u5b66\u671f\u8bfe\u7a0b","text":"<p>AI for Biomedicine</p>"},{"location":"courses/ai/#_1","title":"\u3010\u8bfe\u7a0b\u4fe1\u606f\u3011","text":"<ul> <li>\u4e0a\u8bfe\u65f6\u95f4\uff1a\u79cb\u5b63\u5b66\u671f \u5468\u56db\u7b2c\u4e8c\u5927\u8282\uff089\uff1a50-11\uff1a25\uff09</li> <li>\u4e0a\u8bfe\u5730\u70b9\uff1a\u6e05\u534e\u5927\u5b66 \u751f\u7269\u6280\u672f\u99862-201 \u6216\u8005 2-105</li> <li>\u6559\u5b66\u5927\u7eb2\uff1aSyllabus</li> <li>\u5b66\u65f6\uff1a32</li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7\u7b49</li> <li>\u5bf9\u8c61\uff1a\u535a\u58eb\u751f 10-15\u4eba\uff1b\u672c\u79d1\u751f 3-5\u4eba</li> </ul>"},{"location":"courses/ai/#_2","title":"\u3010\u6559\u5b66\u7406\u5ff5\u3011","text":"<p>Teaching Philosophy</p> <p>\u201cStudy and Practice\u201d   \u77e5\u884c\u5408\u4e00</p> <ul> <li>\u201cI cannot teach anybody anything; I can only make them think.\" - Socrates</li> <li>\"Tell me and I forget. Teach me and I remember. Involve me and I learn.\" - Benjamin Franklin</li> </ul>"},{"location":"courses/ai/#_3","title":"\u3010\u8bfe\u7a0b\u7b80\u4ecb\u3011","text":"<p>\u8be5\u8bfe\u7a0b\u662f\u4e00\u95e8\u9762\u5411\u751f\u7269\u533b\u5b66\u76f8\u5173\u4e13\u4e1a\u5b66\u751f\u7684\u4e13\u4e1a\u9009\u4fee\u8bfe\u3002\u8be5\u8bfe\u7a0b\u65e8\u5728\u5e2e\u52a9\u5b66\u751f\u4e86\u89e3\u548c\u638c\u63e1\u4eba\u5de5\u667a\u80fd\u6280\u672f\u5728\u751f\u7269\u533b\u5b66\u9886\u57df\u7684\u5e94\u7528\uff0c\u5305\u62ec\u5e38\u89c1AI\u6a21\u578b\u7684\u539f\u7406\u4ee5\u53ca\u5728\u751f\u7269\u533b\u5b66\u7814\u7a76\u4e2d\u7684\u5b9e\u9645\u5e94\u7528\u3002\u901a\u8fc7\u7406\u8bba\u8bb2\u6388\u3001\u6848\u4f8b\u5206\u6790\u3001\u5b9e\u9a8c\u64cd\u4f5c\u548c\u5c0f\u7ec4\u8ba8\u8bba\u7b49\u591a\u79cd\u6559\u5b66\u65b9\u5f0f\uff0c\u8bfe\u7a0b\u65e8\u5728\u57f9\u517b\u5b66\u751f\u7684\u6570\u636e\u5206\u6790\u80fd\u529b\u3001\u6a21\u578b\u6784\u5efa\u80fd\u529b\u548c\u89e3\u51b3\u5b9e\u9645\u751f\u7269\u533b\u5b66\u95ee\u9898\u7684\u5b9e\u8df5\u80fd\u529b\u3002</p>"},{"location":"courses/ai/#_4","title":"\u3010\u9884\u4fee\u8bfe\u7a0b\u3011","text":"<ul> <li>\u751f\u7269\u4fe1\u606f\u8bfe\u7a0b\uff1a\u5982\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b</li> <li>AI\u8bfe\u7a0b\uff1a \u5982\u300a\u6df1\u5ea6\u5b66\u4e60\u300b\u548c/\u6216 \u300a\u673a\u5668\u5b66\u4e60\u300b</li> </ul>"},{"location":"courses/bioinfo/","title":"Bioinformatics","text":""},{"location":"courses/bioinfo/#-","title":"\u3010\u751f\u7269\u4fe1\u606f\u5b66\u3011- \u6625\u5b63\u5b66\u671f\u8bfe\u7a0b","text":"<p>Bioinformatics</p>"},{"location":"courses/bioinfo/#_1","title":"\u3010\u8bfe\u7a0b\u4fe1\u606f\u3011","text":"<ul> <li>\u4e0a\u8bfe\u65f6\u95f4\uff1a2026 \u6625\u5b63\u5b66\u671f \u5468\u56db\u7b2c\u4e00\u5927\u8282\uff088:00-9:35\uff09\u5168\u5468</li> <li>\u4e0a\u8bfe\u5730\u70b9\uff1a\u6e05\u534e\u5927\u5b66 \u56db\u65594404</li> <li>\u6559\u5b66\u5927\u7eb2\uff1aSyllabus</li> <li> <p>\u5b9e\u8df5\u6559\u7a0b\uff1aBioinformatics Tutorial</p> </li> <li> <p>\u5b66\u65f6\uff1a32</p> </li> <li>\u5b66\u5206\uff1a2</li> <li>\u4e3b\u8bb2\u8001\u5e08\uff1a\u9c81\u5fd7</li> <li>\u5bf9\u8c61\uff1a\u672c\u79d1\u751f 30-80\u4eba</li> </ul>"},{"location":"courses/bioinfo/#_2","title":"\u3010\u6559\u5b66\u7406\u5ff5\u3011","text":"<p>Teaching Philosophy\uff1a</p> <p>\u201cStudy and Practice\u201d  \u683c\u7269\u81f4\u77e5 | \u77e5\u884c\u5408\u4e00</p> <p>We teach professional skills in bioinformatics. These skills are not just running software. They will give you freedom of exploring various real data.</p>"},{"location":"courses/bioinfo/#_3","title":"\u3010\u8bfe\u7a0b\u7b80\u4ecb\u3011","text":"<p>\u76f8\u5bf9\u4e8e\u8fc7\u53bb\uff0c\u7a81\u7136\u5730\uff0c\u6211\u4eec\u53d1\u73b0\u6570\u636e\u4e0d\u662f\u592a\u5c11\u800c\u662f\u592a\u591a\uff0c\u4fe1\u606f\u4e0d\u662f\u532e\u4e4f\u800c\u662f\u7e41\u6742\uff0c\u65b0\u4e00\u4ee3\u4eba\u7684\u91cd\u8981\u80fd\u529b\u662f\u201c\u9274\u522b\u201d\u548c\u201c\u6316\u6398\u201d\u3002\u6211\u4eec\u5c06\u6559\u6388\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u9762\u7684\u4e13\u4e1a\u6280\u80fd\uff0c \u8fd9\u4e9b\u6280\u80fd\u4e0d\u662f\u5355\u7eaf\u5730\u8fd0\u884c\u8f6f\u4ef6\u7684\u80fd\u529b\uff0c\u800c\u662f\u8ba9\u4f60\u4eec\u62e5\u6709\u63a2\u7d22\u5404\u79cd\u771f\u5b9e\u6570\u636e\u7684\u81ea\u7531\u3002</p> <p>\u751f\u7269\u4fe1\u606f\u5b66\u662f\u91c7\u7528\u6570\u5b66\u3001\u7edf\u8ba1\u5b66\u3001\u8ba1\u7b97\u673a\u7b49\u65b9\u6cd5\u5206\u6790\u751f\u7269\u533b\u5b66\u6570\u636e\u7684\u4e00\u79cd\u4ea4\u53c9\u6027\u5b66\u79d1\u3002</p> <p>\u8be5\u8bfe\u7a0b\u7684\u6559\u5b66\u76ee\u7684\u662f\u4e3a\u4e86\u8ba9\u5b66\u751f\u5bf9\u751f\u7269\u4fe1\u606f\u7684\u57fa\u7840\u77e5\u8bc6\u6709\u6240\u4e86\u89e3\u548c\u638c\u63e1\uff0c\u540c\u65f6\u8ba9\u5b66\u751f\u80fd\u591f\u638c\u63e1\u5b9e\u7528\u7684\u751f\u7269\u4fe1\u606f\u5b66\u5b9e\u7528\u6280\u80fd\u548c\u7f16\u7a0b\u6280\u672f\u3002\u8bfe\u7a0b\u8bbe\u8ba1\u662f\u8ba9\u5b66\u751f\u9010\u6b65\u5b66\u4e60\u751f\u7269\u4fe1\u606f\u57fa\u7840\u77e5\u8bc6\u548c\u7ec3\u4e60\u57fa\u7840\u8ba1\u7b97\u673a\u6280\u80fd\uff0c\u80fd\u591f\u5bf9\u57fa\u672c\u7684\u751f\u7269\u4fe1\u606f\u5b66\u6280\u672f\u6709\u6240\u638c\u63e1\u3002\u8bfe\u7a0b\u5c06\u8ba9\u5b66\u751f\u4ece\u4e86\u89e3\u548c\u7ec3\u4e60\u57fa\u672c\u7684Linux\u64cd\u4f5c\u5f00\u59cb\uff0c\u901a\u8fc7\u751f\u7269\u4fe1\u606f\u5fc5\u5907\u7684\u8ba1\u7b97\u8bed\u8a00\uff08\u5982Bash, R\u7b49\uff09\u7684\u7f16\u7a0b\u8bad\u7ec3\uff0c\u638c\u63e1\u751f\u7269\u4fe1\u606f\u5b66\u5728\u65b0\u4e00\u4ee3\u9ad8\u901a\u91cf\u6d4b\u5e8f\u6570\u636e\u4e0a\u7684\u57fa\u672c\u5206\u6790\u65b9\u6cd5\u3002</p> <p>\u8be5\u8bfe\u7a0b\u9664\u4e86\u7406\u8bba\u6559\u5b66\uff0c\u52a0\u5f3a\u8865\u5145\u4e86\u5b9e\u8df5\u7ec3\u4e60\u7684\u8bad\u7ec3\u73af\u8282\uff0c\u66f4\u5f3a\u8c03\u5b66\u751f\u5bf9\u751f\u7269\u4fe1\u606f\u5b66\u5b9e\u9645\u5e94\u7528\u7684\u5b9e\u8df5\u5b66\u4e60\u548c\u4e0a\u673a\u7ec3\u4e60\uff0c\u5728\u5f80\u5e74\u57fa\u7840\u4e0a\u52a0\u5927\u4e86\u8bfe\u7a0b\u7684\u6311\u6218\u6027\u548c\u5b9e\u7528\u6027\u3002</p>"},{"location":"courses/bioinfo/#_4","title":"\u3010\u9884\u4fee\u8bfe\u7a0b\u3011","text":"<ol> <li>\u57fa\u672c\u751f\u7269\u8bfe\u7a0b\uff1a \u5982\u300a\u666e\u901a\u751f\u7269\u5b66\u300b\u548c/\u6216 \u300a\u9057\u4f20\u5b66\u300b\u548c/\u6216 \u300a\u5206\u5b50\u751f\u7269\u5b66\u300b</li> <li>\u57fa\u672c\u7edf\u8ba1\u8bfe\u7a0b\uff1a \u5982\u300a\u6982\u7387\u8bba\u300b\u548c/\u6216\u300a\u751f\u7269\u7edf\u8ba1\u300b</li> <li>\u57fa\u672c\u6570\u5b66\u8bfe\u7a0b\uff1a \u5982\u300a\u7ebf\u6027\u4ee3\u6570\u300b</li> <li>\u57fa\u672c\u8ba1\u7b97\u673a\u6280\u80fd\uff1a\u5982 Linux\u3001Python \u7b49</li> </ol>"},{"location":"courses/bioinfo/#_5","title":"\u3010\u63d0\u524d\u7ec3\u4e60\u3011","text":"<p>\u8be5\u8bfe\u7a0b\u7684\u4f5c\u4e1a\u4e2d\u4f1a\u6d89\u53ca\u5927\u91cf Linux \u64cd\u4f5c\u548c\u7f16\u7a0b\uff0c\u8bfe\u7a0b\u76ee\u7684\u662f\u8ba9\u5927\u5bb6 \u201c\u5b9e\u8df5\u201d \u7f16\u7a0b\u89e3\u51b3\u751f\u7269\u95ee\u9898\uff0c\u800c\u4e0d\u662f\u201c\u5b66\u4e60\u7f16\u7a0b\u201d\uff0c\u56e0\u6b64\uff0c\u9700\u8981\u5df2\u7ecf\u6709\u4e00\u5b9a\u7684Linux\u63a5\u89e6\u548c\u7f16\u7a0b\u57fa\u7840\u7684\u540c\u5b66\u624d\u9002\u5408\u9009\u4fee\u3002</p> <p>\u5efa\u8bae\u540c\u5b66\u4eec\u5148\u4fee\u4e00\u4e9b\u8ba1\u7b97\u673a\u57fa\u7840\u8bfe\u6216\u8005\u81ea\u5b66\u4e00\u4e9b\u8ba1\u7b97\u673a\u7684\u7f51\u7edc\u8bfe\u7a0b\uff0c\u52a0\u5f3a\u4e00\u4e0b\u8ba1\u7b97\u673a\u7f16\u7a0b\u7684\u57fa\u672c\u6280\u80fd\u3002\u6bd4\u5982\uff0c\u5efa\u8bae\u5927\u5bb6\u5728\u5bd2\u5047\u901a\u8fc7\u7f51\u7edc\u89c6\u9891\u7b49\u8d44\u6e90\u5b66\u4e60\u4e00\u4e9bLinux\u4e2d\u547d\u4ee4\u884c\u7684\u57fa\u672c\u64cd\u4f5c\u3002</p> <p>\u7279\u522b\u8981\u63d0\u9192\u7684\u662f\uff0c\u5b66\u8ba1\u7b97\u673a\u65f6\u4e00\u5b9a\u8981\u6ce8\u610f\u4e0a\u673a\u64cd\u4f5c\u548c\u5b9e\u8df5\u7ec3\u4e60\u3002\u540c\u5b66\u4eec\u53ef\u4ee5\u5728\u81ea\u5df1\u7684Windows\u6216\u8005MacOS\u4e0a\u88c5\u4e00\u4e2adocker\u6765\u865a\u62dfLinux\u7cfb\u7edf\u8fdb\u884c\u7ec3\u4e60\uff0c\u6211\u4eec\u4e3a\u6b64\u5199\u4e86\u4e00\u4e2adocker\u5b89\u88c5\u548c\u4f7f\u7528\u7684\u7b80\u5355\u6307\u5357\uff0c\u89c1 Run Jobs in a Docker \u3002</p>"},{"location":"courses/genomics/","title":"Genomics - PTN","text":""},{"location":"courses/genomics/#-ptn","title":"\u3010\u57fa\u56e0\u7ec4\u5b66\u5bfc\u8bba\u3011- \u79cb\u5b63\u5b66\u671fPTN\u8bfe\u7a0b","text":"<p>Introduction to Genomics - PTN</p>"},{"location":"courses/genomics/#_1","title":"\u3010\u8bfe\u7a0b\u4fe1\u606f\u3011","text":"<ul> <li>\u7c7b\u578b\uff1aPTN \u57fa\u7840\u8bfe</li> <li>\u65f6\u95f4\uff1a\u79cb\u5b63\u5b66\u671f</li> <li>\u5b66\u65f6\uff1a8\u00a0</li> <li>\u4e3b\u8bb2\uff1a\u9c81\u5fd7\u00a0</li> <li>\u5bf9\u8c61\uff1a\u5317\u5927-\u6e05\u534e-NIBS \u535a\u58eb\u751f</li> </ul>"},{"location":"courses/genomics/#_2","title":"\u3010\u4e0a\u8bfe\u8981\u6c42\u3011","text":"<ul> <li>\u57fa\u7840\u8bfe1-14\u9009\u62e9\u5176\u4e2d10\u95e8\u4e0a\u8bfe\uff0c\u4efb\u9009\u5176\u4e2d4\u95e8\u4ea4\u4f5c\u4e1a\uff0c\u5e73\u5747\u5206\u8bb0\u5728\u9009\u8bfe\u7cfb\u7edf\u4e2d\u73b0\u4ee3\u751f\u7269\u5b66\u57fa\u7840\u548c\u5206\u5b50\u7ec6\u80de\u751f\u7269\u5b66\u7814\u7a76\u8fdb\u5c55\u6210\u7ee9\u4e0a\u3002</li> </ul>"},{"location":"courses/genomics/#_3","title":"\u3010\u6559\u5b66\u8d44\u6e90\u3011","text":"<ul> <li>\u8bfe\u4ef6\u4e0b\u8f7d</li> </ul>"},{"location":"courses/genomics/#_4","title":"\u3010\u671f\u672b\u4f5c\u4e1a\u3011","text":"<p>\u6587\u732e\u9605\u8bfb:  (Due: Dec. 31.) Pick one of the papers (NOT the Reviews papers) and write a brief summary, including your discussion and perspectives (1-2 pages). Note: Please list the key points of your thoughts in the last paragraph.</p> <ul> <li>Recommended Papers</li> </ul>"},{"location":"faq/faq-1/","title":"I.\u79d1\u7814\u65b9\u6cd5","text":""},{"location":"faq/faq-1/#faq-i","title":"FAQ - I. \u79d1\u7814\u65b9\u6cd5","text":"<p>Tips</p> <ul> <li> <p>\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357  |  A grad school survival guide</p> </li> <li> <p>Want to get great at something? Get a coach !TED (16:36)   Bilibili (2:50)</p> </li> </ul>"},{"location":"faq/faq-1/#1","title":"1) \u79d1\u7814\u4e2d\u5efa\u8bae\u517b\u6210\u54ea\u4e9b\u597d\u7684\u4e60\u60ef\uff1f","text":"<p>\"What sculpture is to a block of marble, education is to a human soul.\"  - Joseph Addison</p> <p>\u201cThe carving and chipping away to create a masterpiece take years of dedication.</p> <p>Teachers help students discover their interests, passions, and ultimately themselves.\u201d</p> <p>\u80b2\u4eba\u7684\u76ee\u7684\u5e94\u8be5\u662f\u5e2e\u52a9\u5b66\u751f\u57f9\u517b\u597d\u7684\u4e60\u60ef\u91cd\u4e8e\u8ffd\u6c42\u6210\u679c\u7684\u5927\u5c0f\uff0c\u597d\u7684\u4e60\u60ef\u5305\u62ec\uff1a</p> <ul> <li>\u81ea\u5f3a\u4e0d\u606f\uff08\u6709\u4e0a\u8fdb\u5fc3\u4e0d\u61d2\u6563\uff0c\u6b62\u4e8e\u81f3\u5584\uff09</li> <li>\u539a\u5fb7\u8f7d\u7269\uff08\u5bf9\u4ed6\u4eba\u7684\u5c0a\u91cd\u548c\u5584\u610f\uff09</li> <li>\u4f5c\u606f\u89c4\u5f8b\u4e14\u6709\u6548\u7387\uff08see detail)</li> <li>\u52e4\u4e8e\u9605\u8bfb\u3001\u52e4\u4e8e\u601d\u8003 \uff08Stay Hungry &amp; Think Different\uff09</li> <li>\u7ecf\u5e38\u953b\u70bc\u8eab\u4f53</li> <li>\u2026 \u2026</li> </ul> <p>\u5b9e\u64cd\u5efa\u8bae\uff1a</p> <ol> <li>\u5bf9\u4e8e\u91cd\u8981\u800c\u4e0d\u7d27\u6025\u7684\u4e8b\u60c5\uff0c\u591a\u7528 email \u5c11\u7528\u5fae\u4fe1   \uff08see detail)</li> <li>\u505a\u4e8b\u8981\u63d0\u524d\uff08\u6bd4\u5982\u8bf7\u5047\u3001\u6bd4\u5982\u5b8c\u6210\u4efb\u52a1\uff09   (see detail)</li> <li>\"\u7814\u7a76\u201c \u4e3a\u4e3b  \"\u5b66\u4e60\u201c\u4e3a\u8f85   (see detail )</li> <li>\u5e26\u4e0a\u201c\u7eb8\u201d\u548c\u201c\u7b14\u201d  (\u624b\u5199\u7b14\u8bb0\u6709\u76ca\u5b66\u4e60 \u2013  \u300a\u73af\u7403\u79d1\u5b66\u300b  2024.5. \u8ba4\u77e5\u79d1\u5b66)</li> <li>\u9ad8\u7ea7\u51a5\u60f3 \u53ef\u80fd\u4f1a\u6fc0\u53d1\u4eba\u4eec\u7684\u7075\u611f\uff0c\u5e76\u4e3a\u5982\u4f55\u5b9e\u73b0\u751f\u547d\u7684\u610f\u4e49\u63d0\u4f9b\u6df1\u523b\u7684\u89c1\u89e3\u548c\u6e05\u6670\u7684\u601d\u8def\u3002\u2013  \u300a\u73af\u7403\u79d1\u5b66\u300b 2024.9.</li> </ol>"},{"location":"faq/faq-1/#2","title":"2) \u5982\u4f55\u5b66\u4e60\u65b0\u77e5\u8bc6\u548c\u65b0\u6280\u80fd\uff1f","text":"<p>\u542c\u3001\u8bfb\u3001\u89c6\u542c\u3001\u6f14\u793a\u90fd\u5c5e\u4e8e\u88ab\u52a8\u7684\u5b66\u4e60\uff1b\u8ba8\u8bba\u3001\u5b9e\u8df5\u3001\u6559\u6388\u522b\u4eba\u662f\u4e3b\u52a8\u5b66\u4e60\u3002 \u5176\u4e2d\u6559\u6388\u7ed9\u4ed6\u4eba\u7559\u5b58\u7387\u6700\u9ad8\uff0c\u8fbe\u523090%\u3002 \u8fd9\u4e00\u6b65\u662f\u8d39\u66fc\u5b66\u4e60\u6cd5\u7684\u7cbe\u9ad3\uff0c\u4e5f\u5c31\u662f\u201c\u4ee5\u6559\u4fc3\u5b66\u201d\u3002\u6240\u4ee5senior students mentor junior students\u4e0d\u4ec5\u662f\u4e00\u79cd\u56e2\u961f\u5408\u4f5c\u548c\u9886\u5bfc\u529b\u7684\u57f9\u517b\uff0c\u4e5f\u662f\u5bf9\u81ea\u5df1\u77e5\u8bc6\u7684\u5de9\u56fa\u3002</p> <p></p>"},{"location":"faq/faq-1/#3","title":"3) \u5982\u4f55\u6210\u4e3a\u4e00\u4e2a\u597d\u7684\u7814\u7a76\u751f\u548c\u79d1\u7814\u5de5\u4f5c\u8005\uff1f","text":"<p>\"Tell me and I forget. Teach me and I remember. Involve me and I learn.\"  - Benjamin Franklin</p> <p>\u505a\u597d\u4ece\u672c\u79d1\u751f\u5230\u7814\u7a76\u751f\u7684\u89d2\u8272\u8f6c\u53d8\uff0c\u4e0d\u80fd\u53ea\u77e5\u9053\u201c\u5b66\u4e60\u201d\uff0c\u8981\u4fa7\u91cd\u201c\u7814\u7a76\u201d\u3002</p> <ul> <li>\u79d1\u7814\u751f\u6daf\u7684\u56db\u6212\u5f8b</li> <li>1. \u8fb9\u5e72\u8fb9\u5b66\uff0c\u4e0d\u8981\u5f77\u5fa8\uff1b</li> <li>2. \u52c7\u4e8e\u521b\u65b0\uff0c\u6562\u4e8e\u6311\u6218\uff1b</li> <li>3. \u5fcd\u53d7\u5bc2\u5bde\uff0c\u6ce8\u91cd\u8fc7\u7a0b\uff1b</li> <li>4. \u638c\u63e1\u5386\u53f2\uff0c\u6811\u7acb\u4fe1\u5fc3\u3002</li> <li>\u5341\u51c6\u5219</li> <li>1. Craft good questions</li> <li>2. Ask for help</li> <li>3. Respect and appreciate your lab mates</li> <li>4. Have at least two projects</li> <li>5. Sleep on it</li> <li>6. If you need guidance from your mentor, set up a meeting</li> <li>7. Learn when to be obsessive</li> <li>8. Start with the task you are least excited about, and do it right away</li> <li>9. Balance bouts of focused work with short breaks</li> <li>10. Get organized</li> <li>\u8036\u9c81\u5927\u5b66\u7684\u5fc3\u6001\u7406\u5ff5\uff08\u5bf9\u4e8e\u5fc3\u6001\u65b9\u9762\u7684\u4e03\u4e2a\u5efa\u8bae\uff09 \uff08\u89c6\u9891\u94fe\u63a5\uff1a \u4f18\u9177 | \u817e\u8baf | \u6296\u97f3@\u6e05\u534e\u4e91\uff09</li> <li>1. \u8981\u65e0\u6761\u4ef6\u81ea\u4fe1\uff0c\u5373\u4f7f\u5728\u505a\u9519\u7684\u65f6\u5019\uff1b</li> <li>2. \u4e0d\u8981\u60f3\u592a\u591a\uff0c\u5b9a\u65f6\u6e05\u9664\u6d88\u6781\u601d\u60f3\uff1b</li> <li>3. \u5b66\u4f1a\u5fd8\u8bb0\u75db\u82e6\uff0c\u4e3a\u9633\u5149\u8bb0\u5fc6\u817e\u51fa\u7a7a\u95f4\uff1b</li> <li>4. \u6562\u4e8e\u5c1d\u8bd5\uff0c\u4e0d\u6015\u4e22\u8138\uff1b</li> <li>5. \u6bcf\u5929\u90fd\u662f\u65b0\u7684\uff0c\u70e6\u607c\u75db\u82e6\u4e0d\u8fc7\u591c\uff1b</li> <li>6. \u9762\u5bf9\u522b\u4eba\u7684\u4f18\u79c0\uff0c\u53d1\u81ea\u5185\u5fc3\u8d5e\u7f8e\uff1b</li> <li>7. \u505a\u4eba\u6700\u9ad8\u5883\u754c\u4e0d\u662f\u4e00\u5473\u4f4e\u8c03\uff0c\u4e5f\u4e0d\u662f\u4e00\u5473\u5f20\u626c\uff0c\u800c\u662f\u59cb\u7ec8\u5982\u4e00\u7684\u4e0d\u5351\u4e0d\u4ea2</li> <li>See More</li> <li>\u79d1\u7814\u751f\u6daf\u7684\u56db\u6212\u5f8b\u548c\u5341\u51c6\u5219</li> <li>\u597d\u5bfc\u5e08\u7684 16 \u4e2a\u6807\u51c6</li> <li>\u5982\u4f55\u6210\u4e3a\u5bfc\u5e08\u773c\u4e2d\u7684\u597d\u5b66\u751f\uff1f\u5982\u4f55\u6210\u4e3a\u5b66\u751f\u773c\u4e2d\u7684\u597d\u5bfc\u5e08\uff1f</li> </ul>"},{"location":"faq/faq-1/#4","title":"4) \u5982\u4f55\u624d\u80fd\u9ad8\u6548\u7387\u5730\u5b8c\u6210\u4e0d\u559c\u6b22\u7684\u5de5\u4f5c\u6216\u5b66\u4e60\u4efb\u52a1\uff1f","text":"<p>\"\u7edd\u62db\u53ea\u6709\u4e00\u4e2a\uff1a\u4e0d\u8981\u8fc7\u5ea6\u51c6\u5907\uff0c\u5148\u968f\u4fbf\u5f00\u4e2a\u5934\u3002</p> <p>\u4eba\u7684\u5927\u8111\u5f88\u5947\u602a\uff0c\u5de5\u4f5c\u7684\u538b\u529b\u8d8a\u5927\uff0c\u5927\u8111\u8d8a\u4f1a\u627e\u501f\u53e3\u53bb\u62d6\u5ef6\u3002\u6709\u65f6\u5019\u5927\u8111\u544a\u8bc9\u4f60\uff0c\u8fd9\u4e48\u96be\u7684\u5de5\u4f5c\uff0c\u8fd8\u662f\u4e0a\u7f51\u67e5\u4e00\u4e0b\u8d44\u6599\u5427\uff0c\u8fd8\u662f\u627e\u627e\u76f8\u4f3c\u6848\u4f8b\u5427\uff0c\u4f60\u4f1a\u8bef\u4ee5\u4e3a\u81ea\u5df1\u5728\u505a\u5fc5\u8981\u51c6\u5907\uff0c\u5176\u5b9e\u662f\u5927\u8111\u5728\u5e2e\u4f60\u9003\u907f\u538b\u529b\u3002\u4f60\u4fe1\u4e86\u5b83\u7684\uff0c\u5c31\u4f1a\u628a\u65f6\u95f4\u6d6a\u8d39\u5230\u5237\u7f51\u9875\u4e0a\uff0c\u968f\u7740\u671f\u9650\u8d8a\u6765\u8d8a\u8fd1\uff0c\u4f60\u5c31\u8d8a\u6765\u8d8a\u7d27\u5f20\uff0c\u53cd\u800c\u4f1a\u66f4\u52a0\u62d6\u5ef6\u3002</p> <p>\u5f88\u591a\u4eba\u7ed9\u81ea\u5df1\u6253\u6c14\u7684\u65b9\u5f0f\u662f\u544a\u8bc9\u81ea\u5df1\u8fd9\u9879\u5de5\u4f5c\u975e\u5e38\u91cd\u8981\uff0c\u4e00\u5b9a\u8981\u8ba4\u771f\u5bf9\u5f85\u3002\u8fd9\u4e48\u505a\uff0c\u4e00\u5b9a\u4f1a\u8d77\u53cd\u4f5c\u7528\u7684\uff01\u4f60\u8981\u76f8\u4fe1\uff0c\u4eba\u4ece\u6765\u90fd\u4e0d\u662f\u7406\u6027\u9a71\u52a8\u7684\u751f\u7269\uff0c\u4e0e\u5176\u4f9d\u8d56\u81ea\u5df1\u7684\u610f\u5fd7\u529b\uff0c\u4e0d\u5982\u987a\u5e94\u81ea\u5df1\u7684\u5929\u6027\u3002\u4eba\u7684\u5929\u6027\u662f\u4ec0\u4e48\uff1f\u8ffd\u6c42\u5b89\u9038\u548c\u8f7b\u677e\u554a\u3002\u591a\u6570\u4eba\u90fd\u6709\u62d6\u5ef6\u75c7\uff0c\u4f46\u6211\u6ca1\u89c1\u8fc7\u4e00\u4e2a\u73a9\u6e38\u620f\uff0c\u5403\u597d\u5403\u7684\u62d6\u5ef6\u7684\uff01\u6211\u4eec\u8981\u987a\u5e94\u5929\u6027\uff0c\u5c31\u4e0d\u8981\u628a\u5de5\u4f5c\u60f3\u5f97\u90a3\u4e48\u6c89\u91cd\u3002\u505a\u4e0d\u5230\u50cf\u5bf9\u5f85\u6e38\u620f\u673a\u90a3\u6837\u559c\u7231\u5de5\u4f5c\uff0c\u4e5f\u4e00\u5b9a\u8981\u63a7\u5236\u81ea\u5df1\uff0c\u4e0d\u8981\u628a\u601d\u7ef4\u805a\u7126\u5230\u538b\u529b\u4e0a\uff0c\u800c\u662f\u8981\u8f7b\u89c6\u5b83\u3002</p> <p>\u4f60\u5c31\u8fd9\u4e48\u60f3\uff0c\u6211\u5148\u968f\u4fbf\u5f00\u4e2a\u5934\u518d\u8bf4\u5427\u3002\u5176\u5b9e\u4e00\u8d77\u5934\u4f60\u5c31\u4f1a\u53d1\u73b0\uff0c\u6839\u672c\u4e0d\u50cf\u4f60\u60f3\u7684\u90a3\u4e48\u75db\u82e6\uff0c\u5f88\u591a\u65f6\u5019\u4f60\u5f00\u4e86\u4e2a\u5934\u5c31\u5239\u4e0d\u4f4f\u4e86\uff0c\u4e0d\u77e5\u4e0d\u89c9\u5c31\u505a\u5b8c\u4e86\u3002\"</p> <p>\u4f5c\u8005\uff1a@\u82cd\u6ce0</p> <p>\u66f4\u591a\u65b9\u6cd5\uff1a https://www.zhihu.com/question/50353727</p>"},{"location":"faq/faq-2/","title":"II.\u79d1\u7814\u5b9e\u8df5","text":""},{"location":"faq/faq-2/#faq-ii","title":"FAQ - II. \u79d1\u7814\u5b9e\u8df5","text":""},{"location":"faq/faq-2/#0","title":"0) \u6b63\u5f0f\u53c2\u4e0e\u751f\u7269\u4fe1\u606f\u79d1\u7814\u8bfe\u9898\u4e4b\u524d\u8be5\u505a\u54ea\u4e9b\u51c6\u5907\uff1f","text":"<p>\u6211\u4eec\u51c6\u5907\u4e86\u4e00\u4e9b\u53ef\u4ee5\u53c2\u8003\u548c\u81ea\u5b66\u7684\u6750\u6599\uff0c\u5e0c\u671b\u5bf9\u5927\u5bb6\u6709\u6240\u5e2e\u52a9\uff0c\u4e3a\u4e4b\u540e\u505a\u79d1\u7814\u5b9e\u4e60\u751a\u81f3\u8bfb\u535a\u6253\u597d\u57fa\u7840\u3002</p> <p>\u5c24\u5176\u662f\u60f3\u505a\u7eafdrylab\u8bfe\u9898\u7684\u540c\u5b66\uff0c\u5efa\u8bae\u5b8c\u6210\u4e0b\u9762\u7684\u51e0\u4ef6\u4e8b\u4e4b\u540e\u518d\u5f00\u59cb\u6b63\u5f0f\u7684\u79d1\u7814\u5b9e\u4e60\u8bfe\u9898\u3002</p> <p>(a) \u9884\u4fee\u8bfe\u7a0b\u51c6\u5907</p> <ul> <li>\u57fa\u672c\u6570\u5b66\u8bfe\u7a0b\uff1a \u5982\u300a\u5fae\u79ef\u5206\u300b\u548c\u300a\u7ebf\u6027\u4ee3\u6570\u300b</li> <li>\u57fa\u672c\u7edf\u8ba1\u8bfe\u7a0b\uff1a \u5982\u300a\u6982\u7387\u8bba\u300b\u6216\u300a\u751f\u7269\u7edf\u8ba1\u300b</li> <li>\u57fa\u672c\u8ba1\u7b97\u673a\u8bfe\u7a0b\uff1a\u5982\u300aLinux\u300b\u3001\u300aR\u300b\u3001\u300aPython\u300b\u7b49</li> <li>\u57fa\u672c\u751f\u7269\u8bfe\u7a0b\uff1a \u5982\u300a\u666e\u901a\u751f\u7269\u5b66\u300b\u300a\u9057\u4f20\u5b66\u300b\u6216\u300a\u5206\u5b50\u751f\u7269\u5b66\u300b</li> <li>\u673a\u5668\u5b66\u4e60\u8bfe\u7a0b\uff1a\u5982\u300a\u673a\u5668\u5b66\u4e60\u300b\u6216\u300a\u6df1\u5ea6\u5b66\u4e60\u300b</li> <li>\u751f\u7269\u4fe1\u606f\u8bfe\u7a0b\uff1a \u5982\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b\uff08\u672c\u79d1\u751f\u8bfe-\u6625\u5b63\u5b66\u671f\uff09</li> </ul> <p>\u6e05\u534e\u5927\u5b66Python \u8bfe\u7a0b\u63a8\u8350 \uff08\u4e09\u9009\u4e00\uff09\uff1a</p> <ul> <li>\u3010\u63a8\u8350\u3011 00310352 \u57fa\u4e8ePython\u7684\u79d1\u5b66\u4e0e\u6570\u503c\u8ba1\u7b97  2\u5b66\u5206</li> <li>00740282 \u8ba1\u7b97\u673a\u7a0b\u5e8f\u8bbe\u8ba1\u57fa\u7840 (Python)  2\u5b66\u5206</li> <li>00740292 Python\u7a0b\u5e8f\u8bbe\u8ba1\u8fdb\u9636  2\u5b66\u5206</li> </ul> <p>\u6e05\u534e\u5927\u5b66\u8fdb\u9636\u4eba\u5de5\u667a\u80fd\u8bfe\u7a0b\u63a8\u8350\uff1a</p> <ul> <li>00420214  \u673a\u5668\u5b66\u4e60\u7684\u6570\u5b66\u539f\u7406</li> <li>00130372  \u673a\u5668\u5b66\u4e60\u4e0e\u7c7b\u8111\u667a\u80fd</li> <li>00240332  \u6df1\u5ea6\u5b66\u4e60\u5bfc\u8bba</li> <li>30240312  \u4eba\u5de5\u795e\u7ecf\u7f51\u7edc</li> <li>00240042  \u4eba\u5de5\u667a\u80fd\u5bfc\u8bba</li> <li>44100102  \u4eba\u5de5\u667a\u80fd\u5bfc\u8bba</li> <li>40240902  \u4eba\u5de5\u667a\u80fd\u6280\u672f</li> <li>40240372  \u4fe1\u606f\u68c0\u7d22</li> <li>40240532  \u673a\u5668\u5b66\u4e60\u6982\u8bba</li> <li>00240342  \u6570\u636e\u79d1\u5b66\u5bfc\u8bba</li> <li>00240392  \u4eba\u5de5\u667a\u80fd\u57fa\u7840\u4e0e\u7f16\u7a0b\u5b9e\u8df5</li> <li>00740262  \u5de5\u4e1a\u6570\u636e\u6316\u6398\u4e0e\u5206\u6790</li> </ul> <p>(b) \u6587\u732e\u9605\u8bfb \u901a\u8fc7\u6587\u732e\u9605\u8bfb\u4e86\u89e3\u6211\u4eec\u5b9e\u9a8c\u5ba4\u7684\u7814\u7a76\u65b9\u5411\uff0c\u6839\u636e\u81ea\u5df1\u7684\u57fa\u7840\u548c\u7231\u597d\uff0c\u53ef\u4ee5\u53c2\u9605 Literature Reading - Startup</p> <p>\u6b64\u5916\uff0c\u66f4\u591a\u7684\u6587\u732e\u6211\u6574\u7406\u653e\u5728\u4e86\uff1aTips for paper reading</p> <p>(c) Document your work </p> <p>\u5efa\u8bae\u5b66\u4f1a\u4f7f\u7528github\u548cmarkdown\u8bed\u8a00\uff0c\u53ef\u4ee5\u81ea\u5df1\u6ce8\u518c\u4e00\u4e2agithub\u8d26\u53f7\uff0c\u901a\u8fc7google\u7b49\u5de5\u5177\u81ea\u5df1\u5b66\u4e60\u5229\u7528markdown\u8bed\u8a00\uff0c\u751a\u81f3\u53ef\u4ee5\u5229\u7528github page\u6784\u5efa\u4e00\u4e2a\u81ea\u5df1\u7684\u7f51\u9875\u3002 \u5173\u4e8egithub\u548cmarkdown\uff0c\u6211\u4eec\u6709\u4e00\u4e2a\u7b80\u5355\u7684\u4ecb\u7ecd\uff1aGetting Started - Bioinformatics Tutorial</p> <p>(d) \u751f\u7269\u4fe1\u606f\u5b66\u7684\u57fa\u672c\u6280\u80fd\u7684\u5b66\u4e60</p> <p>\u5177\u4f53\u53ef\u4ee5\u53c2\u8003\u6211\u4eec\u7684\u751f\u7269\u4fe1\u606f\u5b66\u6559\u6750\uff1a\uff08 https://bioinfo.gitbook.io/\uff09\u3002\u8be5\u6559\u6750\u4e3b\u8981\u7528\u4e8e\u6211\u7ed9\u5927\u5bb6\u5f00\u7684\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b\uff08\u672c\u79d1\u751f\u8bfe-\u6625\u5b63\u5b66\u671f\uff09\u3002</p> <ul> <li>\u6ce8\u610f\u719f\u6089\u4e09\u4e2a\u8ba1\u7b97\u673a\u6280\u80fd\uff1aLinux, R, Python </li> <li>\u6709\u4f59\u529b\u7684\u8bdd\uff0c\u8fd8\u53ef\u4ee5\u63d0\u524d\u5b66\u4e60\u4e0a\u8ff0\u6559\u6750\u7684PART I, II\u548cIII\uff08\u4e0d\u7740\u6025\u7684\u8bdd\u53ef\u4ee5\u7b49\u5165\u5b66\u540e\u9009\u4fee\u8fd9\u95e8\u8bfe\uff09</li> <li>\u8fd8\u53ef\u4ee5\u6839\u636e\u81ea\u5df1\u7684\u57fa\u7840\u5b66\u4e60\u6559\u6750\u91cc\u9762\u63a8\u8350\u7684\u4e00\u4e9b\u5176\u4ed6\u53c2\u8003\u5185\u5bb9\uff08Appendix I. Keep Learning - Bioinformatics Tutorial\uff09</li> </ul> <p>(e) \u5fc5\u5907\u6280\u80fd\u5927\u5168</p> <p></p>"},{"location":"faq/faq-2/#1","title":"1) \u5982\u4f55\u5c3d\u5feb\u878d\u5165\u5230\u5b9e\u9a8c\u5ba4\u7684\u79d1\u7814\u6c1b\u56f4\u4e2d\uff1f","text":"<p>\"Study while others are sleeping; work while others are loafing; prepare while others are playing; dream while others are wishing.\"  - William A. Ward</p> <p>\u8981\u79ef\u6781\u4e86\u89e3\u5b9e\u9a8c\u5ba4\u7684\u51e0\u4e2a\u7814\u7a76\u65b9\u5411\uff0c\u8ba4\u6e05\u81ea\u5df1\u7684\u5174\u8da3\u6240\u5728\uff1b\u95f2\u6687\u65f6\u95f4\u8981\u591a\u548c\u5e08\u5144\u5e08\u59d0\u4ea4\u6d41\u4ed6\u4eec\u7684\u79d1\u7814\u7ecf\u9a8c\uff0c\u6c72\u53d6\u7cbe\u534e\uff0c\u8981\u591a\u95ee \uff08\u5f53\u7136\u5f88\u591a\u95ee\u9898\u53ef\u80fdGOOGLE\u66f4\u65b9\u4fbf\u66f4\u9ad8\u6548\uff09\u3002\u603b\u7ed3\u4e0b\u6765\u5c31\u662f\u8981\u505a\u5230\u4e3b\u52a8\u79ef\u6781\uff0c\u52e4\u5b66\u597d\u95ee\u3002</p> <p></p>"},{"location":"faq/faq-2/#2","title":"2) \u5bfc\u5e08\u3001\u540c\u5b66\u3001\u540c\u4e8b\u4e4b\u95f4\u5982\u4f55\u4ea4\u6d41\u79d1\u7814\u8bfe\u9898\u7684\u8fdb\u5c55\uff1f","text":"<p>\u201cI cannot teach anybody anything; I can only make them think.\" - Socrates</p> <p>\u57fa\u672c\u539f\u5219\uff1a \u5bfc\u5e08\u5bf9\u5b66\u751f\u7684\u65f6\u95f4\u5e94\u5f53\u5c0a\u91cd\uff0c\u4e0d\u5e94\u5f53\u968f\u6027\u5c31\u5fae\u4fe1\u7d22\u8981\u5b9e\u9a8c\u7ed3\u679c\u6216\u8005\u5206\u6790\u7ed3\u679c\uff1b\u540c\u6837\u7684\uff0c\u5b66\u751f\u4e5f\u5e94\u5f53\u5c0a\u91cd\u5bfc\u5e08\u548c\u5176\u4ed6\u540c\u4e8b\u7684\u65f6\u95f4\uff0c\u6709\u4e8b\u60c5\u8981\u8ba8\u8bba\u5c3d\u91cf\u63d0\u524d\u9884\u7ea6\u3002\u56e0\u6b64\uff0c\u9664\u975e\u4e8b\u51fa\u7d27\u6025\uff0cemail \u4ea4\u6d41\u91cd\u8981\u800c\u4e0d\u7d27\u6025\u7684\u4e8b\u60c5\u4f1a\u7ed9\u5f7c\u6b64\u66f4\u591a\u7684\u7a7a\u95f4\u548c\u65f6\u95f4\uff0c\u5927\u5bb6\u7684\u8bfe\u9898\u8ba8\u8bba\u548c\u4f1a\u8bae\u7b49\u4ea4\u6d41\u65b9\u5f0f\u4e5f\u5e94\u5f53\u7ed3\u6784\u5316\u3002\u4e8b\u5b9e\u4e0a\uff0c\u7edd\u5927\u591a\u6570\u7684\u91cd\u8981\u7684\u4e8b\u60c5\u90fd\u4e0d\u7d27\u6025\uff0c\u9700\u8981\u7d27\u6025\u56de\u590d\u7684\u53cd\u800c\u662f\u5f62\u5f0f\u5316\u7684\u7410\u4e8b\u3002</p> <ul> <li>Group Meeting: sharing and talk practicing</li> <li>Subgroup Meeting: research results' report &amp; discussion</li> <li>WECHAT (urgent: need answer within 24 hours or less)</li> <li>EMAIL (not urgent, need answer in a day or more)</li> <li>EMAIL+WECHAT (\u56e0\u4e3a\u6e05\u534e\u90ae\u7bb1\u6709\u65f6\u4f1a\u4e22\u90ae\u4ef6\uff0c\u867d\u4e0d\u7d27\u6025\u4f46\u5f88\u91cd\u8981\u7684\u4fe1\u606f\u4e0d\u5f97\u4e0d\u7528\u5fae\u4fe1\u6216\u8005\u5fae\u4fe1+email)</li> </ul> <p>\u201c\u4e3a\u4ec0\u4e48\u56fd\u5916\u628a\u90ae\u4ef6(email)\u5f53\u5fae\u4fe1\u4e00\u6837\u53d1\uff1f</p> <p>\u90ae\u4ef6(email)\u529e\u516c\u6700\u5927\u7684\u597d\u5904\uff0c\u662f\u4e0d\u4f1a\u671f\u5f85\u5bf9\u65b9\u201c\u79d2\u56de\u201d\uff0c\u6240\u4ee5\u6536\u4ef6\u65b9\u6709\u8db3\u591f\u7684\u65f6\u95f4\u53bb\u6574\u7406\u4fe1\u606f\uff0c\u6709\u66f4\u591a\u7684\u5f39\u6027\u65f6\u95f4\uff0c\u5373\u4fbf\u5468\u672b\u6536\u5230\u4e5f\u53ef\u4ee5\u7b49\u5230\u5468\u4e00\u4e0a\u73ed\u518d\u56de\u3002 \u800c\u4e14\u56e0\u4e3a\u90ae\u4ef6\u201c\u975e\u5373\u65f6\u6027\u201d\u7684\u7279\u70b9\uff0c\u53d1\u8d77\u90ae\u4ef6\u5bf9\u8bdd\u7684\u4e00\u65b9\uff08\u901a\u5e38\u662f\u8001\u677f\u3001\u6216\u8005\u7532\u65b9\uff09\u4f1a\u5bf9\u81ea\u5df1\u7f16\u5199\u7684\u4fe1\u606f\u66f4\u8ba4\u771f\uff0c\u4f1a\u60f3\u6e05\u695a\u81ea\u5df1\u5230\u5e95\u8981\u5e03\u7f6e\u4ec0\u4e48\u4efb\u52a1\u624d\u4f1a\u53d1\u9001\uff0c \u4e0d\u4f1a\u50cf\u5fae\u4fe1\u8fd9\u79cd\u201c\u5373\u65f6\u6027\u201d\u8f6f\u4ef6\u4e00\u6837\uff0c\u5f88\u591a\u662f\u7a81\u7136\u5174\u8d77 \u3002\u3002\u3002</p> <p>\u6240\u4ee5\uff0c\u5ba2\u89c2\u4e0a\u90ae\u4ef6(email)\u662f\u4e0d\u65b9\u4fbf\u7684\uff0c\u4f46\u5c31\u662f\u8fd9\u79cd\u4e0d\u65b9\u4fbf\u53cd\u800c\u5229\u4e8e\u52b3\u52a8\u8005\uff0c \u8fd9\u662f\u5bf9\u52b3\u52a8\u8005\u79c1\u4eba\u7a7a\u95f4\u7684\u5c0a\u91cd\uff0c \u662f\u5bf9\u4e0a/\u4e0b\u73ed\u754c\u9650\u7684\u660e\u6670\u3002\u201d</p> <p>\u674e\u5c0f\u7ca5@\u77e5\u4e4e</p>"},{"location":"faq/faq-2/#3","title":"3) \u7ec4\u4f1a\u548c\u8bfe\u9898\u8ba8\u8bba\u5c0f\u7ec4\u4f1a\u4e4b\u95f4\u7684\u5dee\u522b\u662f\u4ec0\u4e48\uff1f","text":"<ul> <li>\u8bfe\u9898\u8ba8\u8bba\u5c0f\u7ec4\u4f1a\u7684\u5f62\u5f0f\u968f\u610f\uff0c\u4e3b\u8981\u4ee5\u8ba8\u8bba\u7ed3\u679c\u548c\u7ec6\u8282\u4e3a\u76ee\u7684\u3002 \u4e0d\u8bba\u672c\u79d1\u751f\u8fd8\u662f\u7814\u7a76\u751f\uff0c\u505a\u7814\u7a76\u4e3b\u8981\u5305\u62ec\u4e09\u5757\uff0c\u6c47\u62a5\u4e5f\u662f\u8fd9\u4e09\u5757\uff1a</li> <li>\uff081\uff09\u6587\u732e\u8c03\u7814\u7ed3\u8bba\uff08\u5bf9\u4e00\u4e2a\u79d1\u5b66\u95ee\u9898\u6216\u8005\u6280\u672f\u7684\u8c03\u7814\u548c\u7406\u89e3\uff09</li> <li>\uff082\uff09\u6e7f\u5b9e\u9a8c\u7ed3\u679c</li> <li>\uff083\uff09\u5e72\u5b9e\u9a8c\uff08\u6570\u636e\u5206\u6790\uff09\u7ed3\u679c</li> <li>\u7ec4\u4f1a\u62a5\u544a\u8981\u6b63\u5f0f\u4e00\u4e9b\uff0c\u6bcf\u5468\u4e00\u6b21\uff0c\u6bcf\u4e2a\u540c\u5b66\u57fa\u672c\u6bcf\u5b66\u671f\u4f1a\u8f6e\u5230\u4e00\u6b21\u7684\u7ec4\u4f1a\u62a5\u544a\uff0c\u4ee5\u7ec3\u4e60\u6b63\u5f0f\u62a5\u544a\u751a\u81f3\u662f\u7b54\u8fa9\u62a5\u544a\u7684\u80fd\u529b\u4e3a\u76ee\u7684\uff0c\u53ef\u4ee5\u4eff\u7167\u201c\u7b54\u8fa9ppt\u201d\u7684\u5f62\u5f0f\uff0c\u5305\u62ecI. Background, II. Method, III. Result, IV. Perspective (Future Plan)\u51e0\u4e2a\u90e8\u5206\u3002</li> </ul> <p>\u5927\u5bb6\u505a\u5b8c\u62a5\u544a\u4e4b\u540e\u90fd\u9f13\u52b1ppt\u4e0a\u4f20\u5230\u6e05\u534e\u4e91\u8fd9\u4e2a\u6587\u4ef6\u5939\u4e0b\uff083a.PPT - Project Presentation\uff09\uff0c\u5bf9\u4e8e\u540c\u4e00\u4e2a\u8bfe\u9898\u7684\u540c\u5b66\uff0c\u5b9e\u9a8c\u5185\u90e8\u9ed8\u8ba4background\u7684slides\u662f\u5171\u4eab\u7684\uff0c\u505a\u62a5\u544a\u7684\u540c\u5b66\u53ef\u4ee5\u76f4\u63a5\u4f7f\u7528\u4e4b\u524d\u4eba\u505a\u8fc7\uff08\u5305\u62ecPI\u7684\uff09\u4e00\u4e9b\u597d\u7684background slides\uff0c\u8fd9\u6837\u53ef\u4ee5\u4e0d\u65ad\u4f18\u5316\u548c\u79ef\u7d2fbackground\u7684slides\u3002</p> <p>\u6e05\u534e\u4e91\u4e0a\u8fd8\u63d0\u4f9b\u4e86\u4e00\u4e9b\u6b63\u5f0f\u7684presentation\u7684\u6a21\u677f\uff1a4.Sharing - PPT and Poster Templates; 3.Thesis/\u4f18\u79c0\u7b54\u8fa9ppt\u3002</p>"},{"location":"faq/faq-2/#4","title":"4) \u66f4\u591a","text":"<ul> <li>More Tips for Research @everhub</li> </ul>"},{"location":"faq/faq-3/","title":"III.\u5b9e\u9a8c\u5ba4\u89c4\u8303","text":""},{"location":"faq/faq-3/#faq-iii","title":"FAQ - III. \u5b9e\u9a8c\u5ba4\u89c4\u8303","text":""},{"location":"faq/faq-3/#1","title":"1) \u5982\u4f55\u4f5c\u606f\u89c4\u5f8b\u4e14\u6709\u6548\u7387\uff1f","text":"<p>\u5230\u5e95\u9700\u8981\u6bcf\u5468\u5728\u5b9e\u9a8c\u5ba4\u5de5\u4f5c\u591a\u4e45\uff1f\u4e0d\u5c11\u6770\u51fa\u7684\u79d1\u5b66\u5bb6\u7ed9\u5b66\u751f\u505a\u51fa\u7684\u5de5\u4f5c\u65f6\u95f4\u7684\u770b\u6cd5\u548c\u5efa\u8bae\uff08\u8ba4\u4e3a\u6bcf\u5468\u9700\u8981\u5de5\u4f5c60\u4e2a\u5c0f\u65f6\u4ee5\u4e0a\uff09\uff0c\u90fd\u662f\u975e\u5e38\u503c\u5f97\u6211\u4eec\u501f\u9274\u7684\u3002 \u3010\u539f\u6587\u94fe\u63a5\u3011</p> <p>\u201c\u5929\u9053\u916c\u52e4\u201d  \u201c\u52e4\u800c\u5584\u609f\u201d  </p> <p>\"Study while others are sleeping;  work while others are loafing;</p> <p>prepare while others are playing; dream while others are wishing.\"    - William A. Ward</p> <p>\u89c4\u5f8b\u800c\u6709\u6548\u7684\u4f5c\u606f\u65f6\u95f4\u5efa\u8bae\uff1a</p> <p>Good Timing</p> <ul> <li>9:00am-12pm (3) + 1:30-6:00pm (4.5) + 7:30-10pm (2.5) = ~10  X 6 \u5929 = ~60 \u5c0f\u65f6<ul> <li>8:00am-12pm (4) + 1:00-6:00pm (5) + 9-10pm (1) = ~10  X 6 \u5929 = ~60 \u5c0f\u65f6</li> </ul> </li> </ul> <p>\u6548\u7387\u5bf9\u6bd4\uff1a</p> <p>\u540c\u6837\u662f\u65e9\u4e0a\u201c9\u70b9\u591a\u201d\u6765\uff0c\u665a\u4e0a\u201c\u5feb10\u70b9\u201d\u8d70\uff0c\u4f46\u5982\u679c\u7a0d\u5fae\u653e\u677e\u61d2\u6563\u4e00\u70b9\uff0c\u611f\u89c9\u4e0a\u5dee\u4e0d\u591a\u7684\u4f5c\u606f\u65f6\u95f4\uff0c\u5b9e\u8d28\u4e0a\u4e00\u5468\u4e0b\u6765\u5c31\u5f88\u5bb9\u6613\u4f1a\u53d8\u6210\uff1a</p> <p>Bad Timing</p> <ul> <li>9:50-11:20am(1.5) + 2-5:30pm(3.5) + 7:30-9:30pm(2)= 7X5\u5929+5X1\u5929(SAT)=~40\u5c0f\u65f6</li> </ul> <p>\u6ce8\uff1a\u4e0a\u4e3a\u6bcf\u5929\u7684\u5e73\u5747\u65f6\u95f4\uff0c\u5b9e\u9645\u6267\u884c\u65f6\u5468\u4e00\u5230\u5468\u4e94\u591a\u4e00\u70b9\u3001\u5468\u516d\u5c11\u4e00\u70b9\uff0c\u66f4\u7b26\u5408\u5e38\u60c5\u4e5f\u66f4\u5bb9\u6613\u505a\u5230\u3002\u6bcf\u5929\u548c\u6bcf\u5468\u7684\u5de5\u4f5c\u65f6\u95f4\u548c\u65b9\u5f0f\uff0c\u8981\u56e0\u4eba\u800c\u5f02\uff0c\u9002\u5408\u81ea\u5df1\u624d\u662f\u6700\u91cd\u8981\u7684\u3002\u540c\u65f6\uff0c\u5de5\u4f5c\u6548\u7387\u8981\u6bd4\u7edd\u5bf9\u65f6\u95f4\u66f4\u4e3a\u91cd\u8981\u3002</p>"},{"location":"faq/faq-3/#2","title":"2) \u5047\u671f\u5982\u4f55\u5b89\u6392\uff1f","text":""},{"location":"faq/faq-3/#a","title":"A. \u7814\u7a76\u751f","text":"<ul> <li>\u3010\u57fa\u672c\u8981\u6c42\u3011 \u9075\u5b88\u56fd\u5bb6\u3001\u5b66\u6821\u548c\u5b66\u9662\u7684\u4f5c\u606f\u548c\u653e\u5047\u89c4\u5b9a\uff0c\u4e0d\u968f\u610f\u4e0d\u6765\u5b9e\u9a8c\u5ba4\u3002</li> <li>\u3010\u8f83\u9ad8\u8981\u6c42\u3011 \u5efa\u8bae\u5982\u4e0b\uff1a</li> <li>\u6691\u50471-2\u5468\u5de6\u53f3\uff0c\u5bd2\u50471-2\u5468\u5de6\u53f3\uff08\u5efa\u8bae\u4e0d\u8fde\u7eed\u957f\u65f6\u95f4\u8131\u4ea7\uff0c\u5426\u5219\u5047\u671f\u540e\u8981\u5f88\u957f\u65f6\u95f4\u624d\u80fd\u6062\u590d\u5de5\u4f5c\u72b6\u6001\uff09\uff1b</li> <li>\u4e94\u4e00\u3001\u5341\u4e00\u4f11\u606f\u4e00\u534a\u5de6\u53f3\u7684\u5929\u6570\uff1b</li> <li>\u6709\u7279\u6b8a\u9700\u6c42\u7684\uff0c\u4e0a\u8ff0\u5929\u6570\u53ef\u4ee5\u6539\u4e3a\u5e74\u5047\u5e73\u5e38\u4fee\u3002</li> <li>\u6ce8\u610f\u540c\u4e00\u8bfe\u9898\u4e0d\u540c\u4eba\u5458\u9519\u5cf0\uff08\u6700\u597d\u4fdd\u8bc1\u5b9e\u9a8c\u5ba4\u540c\u4e00\u8bfe\u9898\u6700\u591a\u53ea\u6709\u9664\u5915\u5230\u521d\u4e09\u7684\u56db\u5929\u6ca1\u6709\u4eba\uff09\u3002</li> <li>\u7279\u6b8a\u60c5\u51b5\u8005\u53ef\u4ee5\u7533\u8bf7\u8fdc\u7a0b\u5de5\u4f5c\u3002</li> <li>\u4e8b\u5047\u4ece\u4e0a\u8ff0\u5929\u6570\u4e2d\u6263\u9664\uff0c\u75c5\u5047\u89c6\u5177\u4f53\u60c5\u51b5\u914c\u60c5\u8bc4\u4f30\u3002</li> </ul>"},{"location":"faq/faq-3/#b","title":"B. \u535a\u58eb\u540e\u548c\u5176\u4ed6\u5de5\u4f5c\u4eba\u5458","text":"<ul> <li>\u53ef\u9009\u62e9\u548c\u5b66\u751f\u5047\u671f\u540c\u6b65\uff1b</li> <li>\u4e5f\u53ef\u9009\u62e9\u666e\u901a\u793e\u4f1a\u653e\u5047\u5236\u5ea6\uff08\u6bcf\u5468\u53cc\u4f11 + \u56fd\u5bb6\u6cd5\u5b9a\u5047\u65e5+\u5e26\u85aa\u5e74\u5047\uff1b \u5e26\u85aa\u5e74\u5047\u6309\u7167\u52b3\u52a8\u6cd5\u7684\u89c4\u5b9a\uff0c\u5de5\u4f5c\u6ee11\u5e74\u4e0d\u6ee110\u5e74\uff0c\u5e26\u85aa\u5e74\u4f11\u50475\u4e2a\u5de5\u4f5c\u65e5\uff1b\u5de5\u4f5c10-20\u5e74\uff0c\u5e26\u85aa\u5e74\u4f11\u504710\u4e2a\u5de5\u4f5c\u65e5\uff1b \u4e8b\u5047\u53ef\u4ece\u5e74\u5047\u4e2d\u6263\u9664\uff1b \u75c5\u5047\u89c6\u5177\u4f53\u60c5\u51b5\u914c\u60c5\u8bc4\u4f30\uff09\u3002</li> </ul>"},{"location":"faq/faq-3/#3","title":"3) \u6709\u4e8b\u6ca1\u6cd5\u6765\u5b9e\u9a8c\u5ba4\u5982\u4f55\u8bf7\u5047\uff1f","text":"<p>\u5efa\u8bae\u517b\u6210\u505a\u4e8b\u63d0\u524d\u89c4\u5212\u7684\u4e60\u60ef:</p> <ul> <li>\u5982\u975e\u4e8b\u51fa\u7a81\u7136/\u7279\u6b8a\u56e0\u7531\uff0c\u8bf7\u63d0\u524d\u4e00\u5468\u53d1email\u7ed9PI\uff08\u6284\u9001\u5b9e\u9a8c\u5ba4\u7ba1\u7406\u5458\uff09\u8bf7\u5047\uff1b</li> <li>\u5bd2\u6691\u5047\u3001\u56fd\u5e86\u957f\u5047\u7b49\u63d0\u524d\u534a\u4e2a\u6708\u52301\u4e2a\u6708\u5b89\u6392\u597d\u5de5\u4f5c\u4ea4\u63a5\u548c\u5047\u65e5\u503c\u73ed\uff1b</li> <li>\u5982\u679c\u53ea\u662f\u77ed\u6682\u79bb\u5f00\u51e0\u4e2a\u5c0f\u65f6\uff0c\u53ef\u4ee5\u4e0d\u7528\u8bf7\u5047;</li> <li>\u5982\u9047\u5230\u75ab\u60c5\u5c01\u63a7\u3001\u5929\u707e\u7b49\u4e0d\u53ef\u6297\u529b\uff0c\u4e0a\u8ff0\u89c4\u5b9a\u6839\u636e\u5177\u4f53\u60c5\u51b5\u5177\u4f53\u8c03\u6574\u3002 </li> </ul>"},{"location":"faq/faq-4/","title":"IV.\u751f\u6d3b\u548c\u8d22\u52a1","text":""},{"location":"faq/faq-4/#faq-iv","title":"FAQ - IV. \u751f\u6d3b\u548c\u8d22\u52a1","text":""},{"location":"faq/faq-4/#1","title":"1) \u6821\u56ed\u5185\u6709\u54ea\u4e9b\u9910\u5385\u53ef\u4ee5\u7528\u652f\u4ed8\u5b9d\u548c\u5fae\u4fe1\u652f\u4ed8\uff1f","text":"<p>\u9910\u5385\u3001\u6e05\u9752\u7cfb\u5217\u53ef\u4f7f\u7528\u5fae\u4fe1\u3001\u652f\u4ed8\u5b9d\u7ed3\u7b97\uff1a</p> <ul> <li>\u6e05\u9752\u7cfb\u5217\uff1a</li> <li>\u6e05\u9752\u725b\u62c9 \uff08\u542c\u6d9b\u56ed2\u5c42\uff09 - \u63a8\u8350</li> <li>\u6e05\u9752\u6c38\u548c\u9910\u5385 \uff08\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff091\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u5496\u5561\u5385 \uff08\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff091\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u5feb\u9910\u5385 \uff08\u6e05\u82ac\u56ed\u5730\u4e0b1\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u4f11\u95f2\u9910\u5385 \uff08\u6843\u674e\u56ed\u5730\u4e0b1\u5c42\uff09</li> <li>\u6e05\u9752\u62ab\u8428\u9910\u5385 \uff08\u7d2b\u8346\u56ed\u5730\u4e0b1\u5c42\uff09</li> <li>\u7b80\u7ea6\u5feb\u9910\u5385\uff1a</li> <li>\u7389\u6811\u56ed\u4e8c\u5c42 \uff08\u7559\u5b66\u751f\u697c\uff09- \u63a8\u8350</li> <li>\u829d\u5170\u56ed \uff08\u7559\u5b66\u751f\u697c\uff09</li> <li>\u7b80\u7ea6\u9910\u5385\uff08\u6843\u674e\u56ed3\u5c42\uff09</li> <li>\u6c34\u6728\u9ea6\u539f\u9762\u5305\u574a</li> <li>\u684c\u9910\u9910\u5385\uff1a</li> <li>\u7199\u6625\u56ed</li> <li>\u7532\u6240\u9910\u5385</li> <li>\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff09\u4e09\u5c42</li> </ul> <p>\u8be6\u7ec6\u4fe1\u606f\u53ef\u4ee5\u5173\u6ce8 \u201d\u6e05\u534e\u540e\u52e4\u201c \u7b49\u5fae\u4fe1\u516c\u4f17\u53f7</p>"},{"location":"faq/faq-4/#2","title":"2) \u5927\u5bb6\u5e73\u65f6\u7528\u4ec0\u4e48\u65b9\u5f0f\u953b\u70bc\u8eab\u4f53\uff1f","text":"<p>\u5b9e\u9a8c\u5ba4\u6709\u4e24\u4e2a\u8fd0\u52a8\u5c0f\u7ec4\uff0c\u5176\u4e2d\u4e4b\u4e00\u662f\u7fbd\u6bdb\u7403\u5c0f\u7ec4\uff0c\u53e6\u4e00\u4e2a\u662f\u6e38\u6cf3\u5c0f\u7ec4\uff0c\u5b9a\u671f\u4f1a\u7ec4\u7ec7\u5927\u5bb6\u4e00\u8d77\u953b\u70bc\u3002</p>"},{"location":"faq/faq-4/#3","title":"3) \u8d2d\u4e70\u79d1\u7814\u76f8\u5173\u7684\u4e66\u7c4d\u6216\u8005\u529e\u516c\u7528\u54c1\u9700\u8981\u5f00\u53d1\u7968\u65f6\uff0c\u9700\u8981\u4e00\u822c\u7eb3\u7a0e\u4eba\u4fe1\u606f\u600e\u4e48\u529e\uff1f","text":"<p>\u6211\u6821\u7684\u589e\u503c\u7a0e\u53d1\u7968\u5f00\u7968\u4fe1\u606f\u5982\u4e0b\uff1a</p> <ul> <li>\u5355\u4f4d\u540d\u79f0\uff1a\u6e05\u534e\u5927\u5b66</li> <li>\u7eb3\u7a0e\u4eba\u8bc6\u522b\u53f7\uff1a12100000400000624D</li> <li>\u5176\u4ed6\uff08\u5730\u5740\u3001\u7535\u8bdd\u3001\u5f00\u6237\u884c\u53ca\u8d26\u53f7\u7b49\uff09\uff1a\u4e0d\u8981\u586b\uff0c\u4e00\u5b9a\u7a7a\u7740</li> </ul>"},{"location":"faq/faq-5/","title":"V.\u529e\u516c\u786c\u4ef6\u548c\u8f6f\u4ef6","text":""},{"location":"faq/faq-5/#faq-v","title":"FAQ -  V. \u529e\u516c\u786c\u4ef6\u548c\u8f6f\u4ef6","text":""},{"location":"faq/faq-5/#1","title":"1) \u79d1\u7814\u529e\u516c\u4e2d\u7684\u4e2a\u4eba\u786c\u4ef6\u5982\u4f55\u8d2d\u4e70\uff1f","text":"<ul> <li>\u627e\u7ba1\u7406\u5458\u5148\u7533\u8bf7\u540e\u8d2d\u4e70\uff08\u548c\u7f6e\u6362\uff09\uff0c\u9700\u8981\u7ba1\u7406\u5458\u6574\u4f53\u534f\u8c03\u597d\u4e4b\u540e\u62a5PI\u5ba1\u6279\u540c\u610f\u3002</li> <li>\u6bcf\u5e74\u65b0\u5b9a\u5bfc\u7684\u7814\u7a76\u751f\u90fd\u4f1a\u6709\u4e00\u4e2a\u56fa\u5b9a\u91d1\u989d\uff08\u54a8\u8be2\u7ba1\u7406\u5458\uff09\u5c01\u9876\u7684\u4e2a\u4eba\u7535\u8111\u786c\u4ef6\u8d2d\u7f6e\u8d39\uff08\u4e2a\u4eba\u7535\u8111+\u5916\u56f4\u6bd4\u5982\u663e\u793a\u5668\u3001\u9f20\u6807\u952e\u76d8\u7b49\uff09\u3002 \u4e00\u822c\u5f97\u7b49\u5230\u5e74\u5e95\uff08\u4e00\u822c12\u6708\u4efd\u5de6\u53f3\uff09\u786c\u4ef6\u8d39\u4e0b\u6765\u4e4b\u540e\u518d\u8d2d\u7f6e\u3002 \u4f46\u662f\u5927\u5bb6\u5982\u679c\u7740\u6025\u60f3\u7528\u65b0\u7684\uff0c\u4e5f\u53ef\u4ee5\u6bcf\u5e74\u7684618\u671f\u95f4\u81ea\u5df1\u5728\u4eac\u4e1c\u4e0a\u5148\u4e70\u7740\uff08\u6bd4\u5982\u53ef\u4ee5\u5148\u4e70\u4e2a\u663e\u793a\u5668\u548c\u9f20\u6807\u952e\u76d8\u4e4b\u7c7b\u7684\uff09\uff0c\u5f00\u597d\u7535\u5b50\u53d1\u7968\uff08\u53d1\u7968\u62ac\u5934\u7a0e\u53f7\u7b49\u6709\u4e25\u683c\u8981\u6c42\uff0c\u95ee\u4e00\u4e0b\u7ba1\u7406\u5458\uff09\uff0c\u7b49\u5e74\u5e95\u7ecf\u8d39\u5230\u4e86\u518d\u62a5\u9500\u5c31\u597d\u3002</li> <li>\u7279\u522b\u63d0\u9192\uff1a \u5728\u603b\u989d\u5ea6\u4e00\u5b9a\u7684\u524d\u63d0\u4e0b\uff0c\u63a8\u8350\u5927\u5bb6\u4f18\u5148\u5c06\u9884\u7b97\u7528\u4e8e\u8d2d\u4e70\u4e00\u4e9b\u5bf9\u773c\u775b\u548c\u4eba\u4f53\u529f\u80fd\u6709\u76ca\u7684\u53c2\u6570\u548c\u6027\u80fd\u3002\u5c24\u5176\u662f\u7b14\u8bb0\u672c\u7535\u8111\u7684\u9884\u7b97\u8981\u6ce8\u610f\uff1a\u56e0\u4e3a\u7b14\u8bb0\u672c\u7535\u8111\u4e3b\u8981\u7528\u6765\u529e\u516c\u800c\u4e0d\u662f\u5927\u89c4\u6a21\u8ba1\u7b97\uff08\u79d1\u7814\u76f8\u5173\u7684\u8ba1\u7b97\u90fd\u662f\u5728\u5b9e\u9a8c\u5ba4\u7684\u5927\u578b\u673a\u5668\u4e0a\u8fdc\u7a0b\u8fd0\u7b97\uff09\uff0c\u4e0d\u63a8\u8350\u8ffd\u6c42 CPU\u3001GPU \u7b49\u53c2\u6570\uff0c\u6211\u4eec\u66f4\u662f\u53cd\u5bf9\u8d2d\u4e70\u9ad8\u6027\u80fd\u7b14\u8bb0\u672c\u7535\u8111\u540e\u8ba9\u81ea\u5df1\u6c89\u8ff7\u6e38\u620f\u3002</li> <li>\u4e2a\u4eba\u7535\u8111\u548c\u914d\u4ef6\u5e73\u5e38\u4f7f\u7528\u4e2d\u5982\u679c\u975e\u4e2a\u4eba\u884c\u4e3a\u4e0d\u5f53\u800c\u610f\u5916\u635f\u574f\u7684\uff0c\u53ef\u4ee5\u62a5\u7ba1\u7406\u5458\u7ef4\u4fee\u6216\u8005\u8d2d\u7f6e\u65b0\u7684\u3002 \u4e2a\u4eba\u7535\u8111\u914d\u4ef6\uff08\u9f20\u6807\u3001\u952e\u76d8\u3001\u7535\u8111\u652f\u67b6\u3001\u7535\u8111\u5305\u7b49\uff09\u4ece\u8d2d\u4e70\u65e5\u8d773\u5e74\u4ee5\u4e0a\u3001\u663e\u793a\u5668\u548c\u4e2a\u4eba\u7535\u8111\u4ece\u8d2d\u4e70\u65e5\u8d775\u5e74\u4ee5\u4e0a\u7684\uff0c\u53ef\u4ee5\u8ddf\u7ba1\u7406\u5458\u7533\u8bf7\u66ff\u6362\u6216\u8d2d\u7f6e\u65b0\u7684\u3002</li> </ul>"},{"location":"faq/faq-5/#2","title":"2) \u79d1\u7814\u529e\u516c\u4e2d\u7684\u5e38\u7528\u8f6f\u4ef6\u5982\u4f55\u83b7\u53d6\u548c\u8d2d\u4e70\uff1f","text":"<ul> <li>\u6e05\u534e\u5927\u5b66\u8d2d\u4e70\u548c\u63d0\u4f9b\u4e86\u5f88\u591a\u5e38\u7528\u7684\u8f6f\u4ef6\uff0c\u4f9b\u6821\u5185\u5e08\u751f\u4e0b\u8f7d\u548c\u4f7f\u7528\uff0c\u5305\u62ec Windows Pro, Office, WPS\uff0cAdobe, ENDNOTE, MATLAB\uff0cNOD32\uff0c\u5361\u5df4\u65af\u57fa\u7b49\u3002\uff08 \u4e0b\u8f7d\u5730\u5740\uff1a\u6e05\u534e\u5927\u5b66\u4fe1\u606f\u5316\u670d\u52a1\u5e73\u53f0 \uff09</li> <li>\u5982\u9700\u8d2d\u4e70\u5176\u4ed6\u7279\u5b9a\u8f6f\u4ef6\uff0c\u8bf7\u5411\u5b9e\u9a8c\u5ba4\u7ba1\u7406\u5458\u9012\u4ea4\u7533\u8bf7\uff0c\u5199\u660e\u9700\u8981\u54ea\u79cd\u8f6f\u4ef6\uff0c\u4ee5\u53ca\u7248\u672c\u53f7\u7b49\u4fe1\u606f\u3002</li> <li>\u6b64\u5916\uff0c\u5bf9\u5927\u591a\u7684\u5f00\u6e90\u8f6f\u4ef6\uff0c\u6e05\u534e\u4e5f\u63d0\u4f9b\u4e00\u4e2a\u955c\u50cf\u7f51\u7ad9\uff0c\u5730\u5740\uff1a \u6e05\u534e\u5927\u5b66\u5f00\u6e90\u8f6f\u4ef6\u955c\u50cf\u7ad9</li> </ul>"},{"location":"faq/faq-5/#3-how-to-automatically-receive-related-literature-update-every-week","title":"3) How to automatically receive related literature update every week?","text":"<p>see  Tips for paper reading - Literature Search</p>"},{"location":"faq/faq-6/","title":"VI.\u5176\u4ed6\u95ee\u9898","text":""},{"location":"faq/faq-6/#faq-vi","title":"FAQ - VI. \u5176\u4ed6","text":""},{"location":"faq/faq-6/#1","title":"1) \u6211\u4eec\u8981\u7ecf\u5e38\u5907\u4efd\u6570\u636e\u5417\uff1f","text":"<ul> <li>\u65e5\u5e38\u7684\u6570\u636e\u5907\u4efd\u662f\u5fc5\u9700\u7684\uff1aHow to backup your data\uff1f</li> </ul>"},{"location":"faq/faq-6/#2","title":"2) \u5982\u4f55\u5f55\u5236\u8bb2\u8bfe\u89c6\u9891\uff1f","text":"<ul> <li>\u65b9\u6cd5\u4e00\uff1aPPT \u81ea\u5e26\u5f55\u97f3\u529f\u80fd (PPT\u5f55\u5236\u65b9\u6cd5\uff1a\u6253\u5f00PPT\u2014\u70b9\u51fb\u201c\u5e7b\u706f\u7247\u653e\u6620\u201d\u2014\u5f55\u5236\u5e7b\u706f\u7247\u6f14\u793a-\u4ece\u5934\u5f00\u59cb\u5f55\u5236\u2014\u5f55\u5236\u5b8c\u9009\u62e9\u201c\u6587\u4ef6\u201d \u2014 \u4fdd\u5b58 \u6216\u8005 \u53e6\u5b58\u4e3appsx\u683c\u5f0f \u6216\u8005 \u5bfc\u51famp4\u683c\u5f0f\uff09\uff08 \u5f55\u5236\u6307\u5357\u94fe\u63a5  |  \u89c6\u9891\u6559\u7a0b\u94fe\u63a5\uff09\uff08\u6ce8\uff1a\u53ef\u4ee5\u76f4\u63a5\u4fdd\u5b58\u548c\u5206\u4eabppt\u6587\u4ef6\uff0c\u70b9\u64ad\u653e\u65f6\u4f1a\u81ea\u52a8\u6709\u58f0\u97f3\uff1b\u5982\u679c\u4e0d\u60f3\u5206\u4eab\u6e90\u6587\u4ef6\uff0c\u53ef\u4ee5\u5b58\u4e3a\u5e26\u914d\u97f3\u7684\uff0a.pps\u6216\uff0a.ppsx\u6f14\u793a\u6587\u7a3f\uff0c\u4e5f\u53ef\u901a\u8fc7Powerpoint\u8f6f\u4ef6\u5bfc\u51famp4\uff08\u4f1a\u5f88\u6162\uff0c\u6ce8\u610f\u7b49\u5f85\u8f83\u957f\u65f6\u95f4\u5b8c\u6210\u5bfc\u51fa\uff09\uff09</li> <li>\u65b9\u6cd5\u4e8c\uff1a \u5728Mac\u4e0a\u4f7f\u7528Quicktime\u5f55\u5c4f, \u5feb\u6377\u952e\uff1a (shift+CMD+5)</li> </ul>"},{"location":"faq/faq-6/#3-how-to-remove-cache-of-a-web-page","title":"3) How to remove cache of a web page?","text":"<p>\u6709\u4e9b\u65f6\u5019\u5b9e\u9a8c\u5ba4\u7684\u57df\u540d\u66f4\u6362\u4e86host\u7684\u670d\u52a1\u5668\uff0c\u4f46\u662f\u81ea\u5df1\u7535\u8111cache\u91cc\u8fd8\u662f\u5b58\u7684\u8001\u670d\u52a1\u5668\u5730\u5740\uff0c\u9020\u6210\u4e00\u4e9b\u94fe\u63a5\u6ca1\u6cd5\u8bbf\u95ee\uff0c\u53ef\u4ee5\u6e05\u9664\u81ea\u5df1\u6d4f\u89c8\u5668\u7684cache\uff0c\u91cd\u65b0\u5237\u65b0\u4e00\u4e0b\u3002</p> <p>To refresh the cache in Chrome and hard reload a page, you can use the shortcut Ctrl+Shift+R on Windows/Linux or Cmd+Shift+R on Mac. This forces the browser to load the latest version of the page, ignoring cached data.</p> <p>Alternatively, you can clear browsing data, including cache and cookies, by going to Chrome's settings, selecting \"Deleting browsing data,\" and choosing the desired time range and data to remove.</p>"},{"location":"faq/survival-guide/","title":"Survival Guide","text":""},{"location":"faq/survival-guide/#survival-guide","title":"Survival Guide","text":""},{"location":"faq/survival-guide/#-a-grad-school-survival-guide","title":"\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357 - a grad school survival guide","text":"<p>\u4f5c\u8005\uff1aAndrew Gaudet</p> <p>\u6253\u5370\u7248\uff1aPDF</p> <p>\u97f3\u9891\uff1a\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357.mp3</p> <p>\u539f\u6587\uff1aA grad school survival guide, Science 2015</p> <p>\u81ea\u4ece\u6210\u4e3a\u535a\u58eb\u540e\u4ee5\u6765\uff0c\u6211\u6307\u5bfc\u4e86\u51e0\u4f4d\u5373\u5c06\u5165\u5b66\u7684\u7814\u7a76\u751f\u3002\u5728\u6b64\u671f\u95f4\uff0c\u6211\u53cd\u601d\u4e86\u81ea\u5df1\u5728\u810a\u9ad3\u635f\u4f24\u4fee\u590d\u7814\u7a76\u65b9\u9762\u7684\u79d1\u7814\u7ecf\u5386\u3002\u6211\u7f16\u5199\u4e86\u4e00\u4e2a\u7b80\u77ed\u7684\u6559\u7a0b\uff0c\u65e8\u5728\u8ba9\u535a\u58eb\u4e4b\u8def\u66f4\u52a0\u987a\u7545\uff0c\u91cd\u70b9\u4ecb\u7ecd\u7814\u7a76\u751f\u751f\u6d3b\u4e2d\u7684\u65e5\u5e38\u4e8b\u52a1\u3001\u9700\u8981\u907f\u514d\u7684\u5e38\u89c1\u98ce\u9669\u4ee5\u53ca\u53ef\u4ee5\u91c7\u53d6\u7684\u6377\u5f84\u3002\u8fd9\u4e9b\u6280\u5de7\u5c06\u5e2e\u52a9\u4f60\u5efa\u7acb\u548c\u4fdd\u6301\u52a8\u529b\uff0c\u8ba9\u4f60\u7684\u9879\u76ee\u4e0d\u65ad\u63a8\u8fdb\u3002\u4e0d\u59a8\u628a\u5b83\u770b\u4f5c\u662f\u7814\u7a76\u751f\u7684\u5b9e\u7528\u751f\u5b58\u6307\u5357\u3002</p> <ol> <li>\u6784\u601d\u548c\u6253\u78e8\u597d\u7684\u95ee\u9898\u3002\u4e0d\u8981\u53ea\u662f\u8ffd\u6c42\u8868\u73b0\uff0c\u5b8c\u6210\u773c\u524d\u7684\u5de5\u4f5c\u3002\u9605\u8bfb\u76f8\u5173\u8d44\u6599\uff0c\u601d\u8003\u95ee\u9898\uff0c\u4e0e\u5176\u4ed6\u79d1\u5b66\u5bb6\u4ea4\u6d41\uff0c\u5e76\u5236\u5b9a\u8ba1\u5212\u3002\u5c16\u9510\u7684\u95ee\u9898\u548c\u6df1\u5165\u7684\u601d\u8003\u80fd\u591f\u5e26\u6765\u65b0\u7684\u3001\u66f4\u597d\u7684\u60f3\u6cd5\u3002\u968f\u7740\u65b0\u6210\u679c\u7684\u6d8c\u73b0\uff0c\u91cd\u65b0\u5ba1\u89c6\u3001\u4fee\u6539\u548c\u6253\u78e8\u4f60\u7684\u95ee\u9898\u3002</li> <li>\u5bfb\u6c42\u5e2e\u52a9\u3002\u5411\u5934\u53d1\u82b1\u767d\u7684\u8001\u535a\u58eb\u540e\u8bf7\u6559\u5b9e\u9a8c\u8bbe\u8ba1\u65b9\u9762\u7684\u5efa\u8bae\uff0c\u6216\u8005\u5411\u5b9e\u9a8c\u5ba4\u6280\u672f\u5458\u5bfb\u6c42PCR\u65b9\u9762\u7684\u5e2e\u52a9\u3002\u4e3a\u4e86\u89e3\u51b3\u6211\u7684\u7ec6\u80de\u8fc1\u79fb\u5b9e\u9a8c\u95ee\u9898\uff0c\u6211\u54a8\u8be2\u4e86\u53e6\u4e00\u4e2a\u5b9e\u9a8c\u5ba4\u7684\u535a\u58eb\u540e\u3002\u4e00\u8def\u8d70\u6765\uff0c\u6211\u5b66\u5230\u4e86\u5f88\u591a\u7ec6\u80de\u57f9\u517b\u6280\u672f\uff0c\u5728\u4e00\u5bb6\u77e5\u540d\u671f\u520a\u4e0a\u53d1\u8868\u4e86\u8bba\u6587\uff0c\u5e76\u5b8c\u6210\u4e86\u535a\u58eb\u5b66\u4f4d\u3002\u72ec\u81ea\u4e00\u4eba\u5b8c\u6210\u8fd9\u4e9b\u4e8b\u4e0d\u4f1a\u83b7\u5f97\u989d\u5916\u7684\u52a0\u5206\u3002</li> <li>\u5c0a\u91cd\u5e76\u611f\u6fc0\u4f60\u7684\u5b9e\u9a8c\u5ba4\u4f19\u4f34\u3002\u5982\u679c\u4f60\u7ecf\u5e38\u548c\u672c\u79d1\u751f\u6216\u6280\u672f\u5458\u4e00\u8d77\u5de5\u4f5c\uff0c\u53ef\u4ee5\u8bf7\u4ed6\u4eec\u5403\u5348\u996d\u4ee5\u8868\u8fbe\u4f60\u7684\u611f\u6fc0\u4e4b\u60c5\u3002\u5982\u679c\u6709\u4eba\u5e2e\u4e86\u4f60\u4e00\u70b9\u5fd9\uff0c\u4e5f\u8981\u5728\u4f60\u7684\u62a5\u544a\u4e2d\u6177\u6168\u5730\u81f4\u8c22\u3002</li> <li>\u81f3\u5c11\u8981\u6709\u4e24\u4e2a\u9879\u76ee\u3002\u5982\u679c\u5176\u4e2d\u4e00\u4e2a\u9879\u76ee\u8ba9\u4f60\u505c\u5de5\uff0c\u4f60\u53ef\u4ee5\u4e13\u6ce8\u4e8e\u53e6\u4e00\u4e2a\u9879\u76ee\uff0c\u4fdd\u6301\u52a8\u529b\u3002\u6211\u5728\u4fc4\u4ea5\u4fc4\u5dde\u7acb\u5927\u5b66\u505a\u535a\u58eb\u540e\u671f\u95f4\uff0c\u7814\u7a76\u4e86\u4e00\u79cd\u810a\u9ad3\u635f\u4f24\u540e\u8868\u8fbe\u7684\u86cb\u767d\u8d28\uff0c\u8d77\u521d\u770b\u8d77\u6765\u5f88\u6709\u5e0c\u671b\uff0c\u4f46\u6700\u7ec8\u6ca1\u6709\u53d6\u5f97\u4efb\u4f55\u8fdb\u5c55\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u7b2c\u4e8c\u79cd\u5206\u5b50\u4e0d\u4ec5\u5728\u810a\u9ad3\u635f\u4f24\u4e2d\u5f88\u91cd\u8981\uff0c\u800c\u4e14\u5728\u80a5\u80d6\u548c\u6291\u90c1\u75c7\u4e2d\u4e5f\u5f88\u91cd\u8981\u3002\u901a\u8fc7\u5c06\u7cbe\u529b\u5206\u6563\u5230\u591a\u4e2a\u9879\u76ee\u4e0a\uff0c\u4f60\u5c31\u80fd\u589e\u52a0\u53d1\u73b0\u65b0\u5947\u4e8b\u7269\u7684\u673a\u4f1a\u3002</li> <li>\u4e09\u601d\u800c\u540e\u884c\u3002\u5982\u679c\u5b9e\u9a8c\u5ba4\u4f19\u4f34\u6216\u5bfc\u5e08\u60f9\u607c\u4e86\u4f60\uff0c\u8bf7\u5199\u4e0b\u4f60\u7684\u60f3\u6cd5\uff08\u8c28\u614e\u800c\u7a33\u59a5\uff09\uff0c\u4f46\u4e0d\u8981\u7acb\u5373\u56de\u590d\u3002\u7761\u4e00\u89c9\u53ef\u4ee5\u6e05\u9192\u5934\u8111\uff0c\u8ba9\u4f60\u5728\u7b2c\u4e8c\u5929\u6784\u601d\u51fa\u5e73\u8861\u3001\u5c0a\u91cd\u7684\u56de\u590d\u2014\u2014\u5982\u679c\u4f60\u51b3\u5b9a\u56de\u590d\u7684\u8bdd\u3002</li> <li>\u5982\u679c\u4f60\u9700\u8981\u5bfc\u5e08\u7684\u6307\u5bfc\uff0c\u53ef\u4ee5\u9884\u7ea6\u4e00\u6b21\u4f1a\u9762\u3002\u9664\u975e\u5979\u559c\u6b22\u4fdd\u6301\u975e\u6b63\u5f0f\u7684\u6c14\u6c1b\uff0c\u5426\u5219\u6700\u597d\u5b89\u6392\u4e00\u4e2a\u65f6\u95f4\u6765\u5bfb\u6c42\u6307\u5bfc\u3002</li> <li>\u5b66\u4f1a\u4f55\u65f6\u4e13\u6ce8\u3002\u8bb8\u591a\u5b9e\u9a8c\u65b9\u6848\u90fd\u6709\u5fc5\u987b\u4ee5\u7279\u5b9a\u65b9\u5f0f\u6267\u884c\u7684\u90e8\u5206\uff0c\u800c\u5176\u4ed6\u90e8\u5206\u5219\u66f4\u7075\u6d3b\u3002\u5982\u679c\u4f60\u4e86\u89e3\u6bcf\u4e2a\u6b65\u9aa4\u7684\u529f\u80fd\uff0c\u4f60\u5c31\u77e5\u9053\u54ea\u4e9b\u6b65\u9aa4\u53ef\u4ee5\u5feb\u901f\u5b8c\u6210\uff0c\u54ea\u4e9b\u6b65\u9aa4\u4f1a\u8ba9\u4f60\u5bf9\u7ec6\u8282\u7684\u4e13\u6ce8\u83b7\u5f97\u56de\u62a5\u3002</li> <li>\u4ece\u4f60\u6700\u4e0d\u611f\u5174\u8da3\u7684\u4efb\u52a1\u5f00\u59cb\uff0c\u7acb\u5373\u5b8c\u6210\u3002\u5728\u7814\u7a76\u751f\u9662\u5b66\u4e60\u671f\u95f4\uff0c\u6211\u5927\u7ea6\u4e0a\u5348 10 \u70b9\u5230\u8fbe\u5de5\u4f5c\u5730\u70b9\uff0c\u7136\u540e\u5148\u9605\u8bfb\u7535\u5b50\u90ae\u4ef6\u3001\u65b0\u95fb\u548c \u300aPHD \u6f2b\u753b\u300b\uff0c\u7136\u540e\u518d\u8003\u8651\u6211\u7684\u7b2c\u4e00\u4e2a\u4efb\u52a1\u3002\u662f\u7684\uff0c\u6211\u5728\u62d6\u5ef6\u3002\u6709\u65f6\uff0c\u4e00\u4e2a\u7b80\u5355\u7684\u4efb\u52a1\u2014\u2014\u68c0\u67e5\u52a8\u7269\u6216\u66f4\u6362\u7ec6\u80de\u57f9\u517b\u57fa\u2014\u2014\u4f1a\u8ba9\u6211\u6574\u5929\u90fd\u96be\u4ee5\u5e94\u5bf9\uff1b\u6211\u4e0d\u60f3\u505a\u8fd9\u4ef6\u4e8b\uff0c\u6240\u4ee5\u5b83\u963b\u788d\u4e86\u5176\u4ed6\u4e00\u5207\u3002\u6240\u4ee5\uff0c\u65e9\u4e0a\u9192\u6765\u540e\uff0c\u5728\u67e5\u770b\u7535\u5b50\u90ae\u4ef6\u4e4b\u524d\uff0c\u5148\u5b8c\u6210\u4e00\u4e9b\u77ed\u671f\u7684\u5c0f\u4efb\u52a1\u3002\u4f60\u4f1a\u53d1\u73b0\uff0c\u5904\u7406\u597d\u8fd9\u4e9b\u4efb\u52a1\u540e\uff0c\u4f60\u4e00\u5929\u7684\u5269\u4f59\u65f6\u95f4\u4f1a\u8fc7\u5f97\u66f4\u597d\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u5bf9\u4e8e\u66f4\u8270\u5de8\u3001\u66f4\u957f\u671f\u7684\u4efb\u52a1\uff0c\u8bf7\u5236\u5b9a\u8ba1\u5212\uff0c\u5e76\u5c3d\u5feb\u8fc8\u51fa\u7b2c\u4e00\u6b65\u3002</li> <li>\u5728\u4e13\u6ce8\u5de5\u4f5c\u548c\u77ed\u6682\u4f11\u606f\u4e4b\u95f4\u53d6\u5f97\u5e73\u8861\u3002\u95f4\u6b47\u6027\u7684\u4f11\u606f\u4ee4\u4eba\u7cbe\u795e\u7115\u53d1\uff0c\u5e76\u5e2e\u52a9\u4f60\u4fdd\u6301\u4e00\u6574\u5929\u7684\u4e13\u6ce8\u529b\u3002</li> <li>\u53d8\u5f97\u6709\u8c03\u7406\u3002\u5728\u7ebf\u65e5\u5386\u53ef\u4ee5\u786e\u4fdd\u4f60\u4e0d\u4f1a\u9519\u8fc7\u4efb\u4f55\u91cd\u8981\u7684\u4f1a\u8bae\u3001\u5b9e\u9a8c\u6216\u7814\u8ba8\u4f1a\u3002\u4e91\u7aef\u6574\u7406\u5de5\u5177\uff08\u4f8b\u5982 Evernote\uff09\u53ef\u4ee5\u8ba9\u4f60\u8bbf\u95ee\u5b9e\u7528\u4fe1\u606f\uff0c\u4f8b\u5982\u8ba2\u8d2d\u8017\u6750\u7684\u8be6\u7ec6\u4fe1\u606f\u3001\u5b9e\u9a8c\u5ba4\u6837\u54c1\u7684\u4f4d\u7f6e\u4ee5\u53ca\u672a\u6765\u5b9e\u9a8c\u7684\u60f3\u6cd5\u3002\\</li> </ol> <p>\u5728\u653b\u8bfb\u535a\u58eb\u5b66\u4f4d\u7684\u9053\u8def\u4e0a\uff0c\u98ce\u6d6a\u53ef\u4ee5\u88ab\u9a7e\u9a6d\u6216\u5b8c\u5168\u907f\u514d\u3002\u4f60\u9700\u8981\u6bcf\u5929\u53d6\u5f97\u8bb8\u591a\u5c0f\u6210\u5c31\uff0c\u624d\u80fd\u5b9e\u73b0\u4f60\u7684\u957f\u671f\u76ee\u6807\u3002\u6240\u4ee5\u8981\u4fdd\u6301\u4e13\u6ce8\u3002</p> <p> Along the route to a Ph.D., rough seas can be navigated or avoided entirely.\u201d ILLUSTRATION: ROBERT NEUBECKER</p>"},{"location":"faq/survival-guide/#a-grad-school-survival-guide","title":"A grad school survival guide","text":"<p>Andrew Gaudet</p> <p>Science 20 Mar 2015. Vol 347, Issue 6228p. 1386 DOI: 10.1126/science.347.6228.1386</p> <p>Since becoming a postdoc, I've mentored several incoming graduate students. In doing so, I've reflected on my own scientific experiences studying spinal cord injury repair. I've compiled a short tutorial aimed at making the road to a Ph.D. less bumpy, with a focus on the day-to-day tasks that fill a graduate student's life, common hazards to avoid, and useful shortcuts you can take. These tips will help you build and maintain momentum and keep your projects moving forward. Think of it as a practical survival guide for graduate students.</p> <p>Craft good questions. Don't just show up and do the work in front of you. Read about it, think about it, talk about it with other scientists, and plan it out. Hard questions and deep thinking lead to new and better ideas. Revisit and revise your questions as new results come in.</p> <p>Ask for help. Ask that grizzled old postdoc for advice on experimental design, or ask the lab technician for assistance with PCR. To troubleshoot my cell migration assays, I sought the advice of a postdoc in a different lab. Along the way I learned a lot about cell culture techniques, published a paper in a respectable journal, and finished my Ph.D. You don't get extra points for doing it on your own.</p> <p>Respect and appreciate your lab mates. If you often work with undergraduates or technicians, take them to lunch to show your appreciation. If someone helps you even a little, acknowledge them generously in your presentations.</p> <p>Have at least two projects. If you have downtime on one, you can focus on another and keep your momentum. During my postdoc at Ohio State University, a certain protein expressed after spinal cord injury looked promising at first but didn't lead anywhere. Fortunately, a second molecule turned out to be important not only in spinal cord injury but also in obesity and depression. By spreading energy among multiple projects, you increase the chances of discovering something novel and exciting.</p> <p>Sleep on it. If a lab mate or mentor irritates you, write down your thoughts (discreetly and securely), but don't respond right away. Sleeping on it will clear your head and allow you to compose a balanced, respectful response the next day\u2014if you decide to reply at all.\\</p> <p>If you need guidance from your mentor, set up a meeting. Unless she prefers to keep things informal, schedule a time to seek direction.</p> <p>Learn when to be obsessive. Many protocols have parts that must be performed in a specific manner and other parts that are more flexible. If you know each step's function, you know which steps you can do quickly and which will reward your obsessive attention to detail.</p> <p>Start with the task you are least excited about, and do it right away. Midway through graduate school, I was arriving at work around 10 a.m. and then reading email, news, and PHD Comics before thinking about my first task. Yes, I was procrastinating. Sometimes a simple task\u2014checking animals or changing cell culture media\u2014hung over my head all day; I didn't want to do it, so it blocked everything else. So finish small, short-term tasks first thing in the morning, before you check your e-mail. You'll find the rest of your day goes better with that out of the way. For more daunting, longer term tasks, plan them out and take the first steps as soon as you can.</p> <p>Balance bouts of focused work with short breaks. Intermittent breaks are invigorating and help you maintain focus for the entire day.</p> <p>Get organized. Online calendars can ensure that you never miss an important meeting, experiment, or workshop. Cloud-based aggregators (e.g., Evernote) allow you to access practical information such as details for ordering supplies, locations of samples in the lab, and ideas for future experiments.</p> <p>Along the route to a Ph.D., rough seas can be navigated or avoided entirely. It takes many small successes, achieved day by day, to reach your long-term goals. So stay focused.</p>"},{"location":"home/","title":"Redirect to homepage","text":""},{"location":"home/#redirect-to-homepage","title":"Redirect to homepage","text":"<pre><code># Add these to mkdocs.yml:\n- redirects:\n      redirect_maps:\n        'ncrnalab/index.md': 'http://www.ncrnalab.org/home'\n        'ncrnalab/software/index.md': 'http://www.ncrnalab.org/software'\n</code></pre>"},{"location":"home/ai/","title":"Redirect to software page","text":""},{"location":"home/ai/#redirect-to-software-page","title":"Redirect to software page","text":"<pre><code># Add these to mkdocs.yml:\n  - redirects:\n      redirect_maps:\n        'home/index.md': 'https://www.ncrnalab.org/home'\n        'home/software/index.md': 'https://www.ncrnalab.org/home/software'\n        'home/ai/index.md': 'https://www.ncrnalab.org/home/ai'\n</code></pre>"},{"location":"home/software/","title":"Redirect to software page","text":""},{"location":"home/software/#redirect-to-software-page","title":"Redirect to software page","text":"<pre><code># Add these to mkdocs.yml:\n- redirects:\n      redirect_maps:\n        'ncrnalab/index.md': 'http://www.ncrnalab.org/home'\n        'ncrnalab/software/index.md': 'http://www.ncrnalab.org/software'\n</code></pre>"},{"location":"intranet/","title":"Intranet","text":""},{"location":"intranet/#lu-lab-intranet","title":"Lu Lab Intranet","text":""},{"location":"intranet/#lu-lab-wiki-internal","title":"Lu Lab Wiki (internal)","text":"<p>Important</p> <p>Please ask Lab Admin to join in Lu Lab Wiki @WPS. </p> <p>Wiki Content:</p> <ul> <li>Wet-lab Facilities &amp; Instructions<ul> <li>Lab Internal Docs/Intranet Meeting - Checking List.xlsx \uff082. Check Wetlab Instructions)</li> <li>Wetlab Instructions/</li> </ul> </li> <li>Dry-lab Machines &amp; Instructions<ul> <li>Lab Internal Docs/Intranet Meeting - Checking List.xlsx \uff081. Check Drylab Instructions)</li> <li>Drylab Instructions</li> </ul> </li> <li>Lab Internal Docs</li> <li>Lab Internal Metadata</li> <li>Lab Internal Tutorials</li> <li>\u3002\u3002\u3002</li> </ul>"},{"location":"intranet/#computers","title":"Computers","text":"<ul> <li>\u5b9e\u9a8c\u5ba4\u81ea\u6709\u673a\u5668\uff1a<ul> <li>\u9ad8\u6027\u80fd\u8ba1\u7b97\u670d\u52a1\u56682\u53f0\uff08cnode\uff0cfat\uff09</li> <li>\u5927\u5bb9\u91cf\u5b58\u50a8\u670d\u52a1\u5668\u82e5\u5e72</li> <li>NAS\uff08\u7fa4\u6656\uff09\u5c0f\u578b\u5b58\u50a8\u670d\u52a1\u56681\u53f0</li> </ul> </li> <li>\u79df\u7528\u8ba1\u7b97\u5e73\u53f0\u96c6\u7fa4\uff1a<ul> <li>4\u4e2a\u8ba1\u7b97\u8282\u70b9 \uff084 X 20 \u7ebf\u7a0b\uff09- \u5305\u5e74</li> </ul> </li> <li>\u5176\u4ed6\u8ba1\u7b97\u5e73\u53f0\u96c6\u7fa4\uff1a<ul> <li>\u6559\u5b66GPU\u8ba1\u7b97\u5e73\u53f0</li> <li>AI \u5b66\u79d1\u4ea4\u53c9GPU\u5e73\u53f0</li> <li>\u8d35\u5ddeGPU\u8ba1\u7b97\u5e73\u53f0</li> <li>\u51e4\u51f0\u5de5\u7a0b\u8ba1\u7b97\u5e73\u53f0</li> <li>\u3002\u3002\u3002</li> </ul> </li> </ul> <p>\u5982\u679c\u9700\u8981\u4f7f\u7528\u4ee5\u4e0a\u5404\u7c7b\u8ba1\u7b97\u5e73\u53f0\u7684\uff0c\u53ef\u4ee5\u7533\u8bf7\u4e00\u4e0b\u8d26\u53f7\u548c\u6743\u9650\uff0c\u6ce8\u610f\u8bf4\u660e\u8bfe\u9898\u5185\u5bb9\u548c\u786c\u4ef6\u5b58\u50a8\u7b49\u9700\u6c42\uff0cemail\u7ed9PI\u5e76\u6284\u9001\u7ed9\u8ba1\u7b97\u7ba1\u7406\u5458\u548c\u5b9e\u9a8c\u5ba4\u7ba1\u7406\u5458\u3002</p> <p>\u672c\u79d1\u751f\u53ef\u4ee5\u901a\u8fc7\u540c\u8bfe\u9898\u7684\u4e3b\u5bfc\u7814\u7a76\u751f\u6765\u53d1email\u7533\u8bf7\u3002</p>"},{"location":"intranet/#network","title":"Network","text":""},{"location":"intranet/#_1","title":"\u5b9e\u9a8c\u5ba4\u5185\u4e0a\u7f51","text":"<p>\u76ee\u524d\u5b9e\u9a8c\u5ba4\u5206\u6821\u56ed\u7f51\uff08\u5916\u7f51\uff1a166.156.\u3002\u3002\u3002\uff09\u53ca\u5185\u90e8\u7f51\uff08172.22.220\u2026.\uff09\u3002</p> <p>\u6bcf\u4e2a\u5ea7\u4f4d\u90fd\u6709\u6807\u7b7e\u6807\u660e\u5916\u7f51\u3001\u5185\u7f51\u3002 </p> <p>\u6bcf\u95f4\u5c4b\u5b50\u90fd\u6709\u65e0\u7ebf\u4fe1\u53f7\u8986\u76d6\uff08\u63a5\u5185\u7f51\uff09\uff0c\u5bc6\u7801\u8054\u7cfb\u8ba1\u7b97\u673a\u7ba1\u7406\u5458\u83b7\u5f97\u3002</p>"},{"location":"intranet/#_2","title":"\u6821\u5185\u4e0a\u7f51","text":"<p>\u63a8\u8350\u4f7f\u7528 Tsinghua-Secure SSID \u8bbf\u95ee\u6821\u56ed\u7f51\uff0c\u8bbf\u95ee\u8be5\u65e0\u7ebf\u7f51\u7edc\u91c7\u7528\u7684\u5bc6\u7801\u9700\u4e0e\u6821\u56ed\u7f51\u8d26\u53f7\u5bc6\u7801\u4e0d\u540c,\u8bf7\u63d0\u524d\u5728 https://usereg.tsinghua.edu.cn \u4e2d\u8fdb\u884c\u5bc6\u7801\u4fee\u6539\uff08\u4ece\u9875\u9762\u4e2d\u201c\u7528\u6237\u201d\u4e0b\u7684\u201c\u4fee\u6539Tsinghua-secure\u5bc6\u7801\u201d\u4e2d\u8fdb\u884c\u4fee\u6539\uff0c\u4fee\u6539\u540e\u7684\u5bc6\u7801\u4ec5\u7528\u4e8e Tsinghua-Secure SSID\uff09\u3002\u5bf9\u4e8e\u5927\u90e8\u5206\u7ec8\u7aef\uff0c\u8fde\u63a5\u8be5 SSID \u540e\uff0c\u76f4\u63a5\u8f93\u5165\u7528\u6237\u540d\u548c\u5bc6\u7801\u5373\u53ef\u3002\u5bf9\u4e8e Windows7 \u7b49\u65e7\u7cfb\u7edf\uff0c\u9700\u901a\u8fc7\u5ba2\u6237\u7aef\u914d\u7f6e\u4e0a\u7f51\uff0c\u914d\u7f6e\u8bf4\u660e\u8be6\u89c1\u65e0\u7ebf\u6821\u56ed\u7f51802.1x\uff08Tsinghua-Secure\uff09\u8ba4\u8bc1\u767b\u5f55\u914d\u7f6e\u8bf4\u660e\u3002</p> <p>\u8fde\u63a5Tsinghua\u3001Tsinghua-5G\u3001 Tsinghua-IPv4\u3001Tsinghua-IPv6\u7b49\u65e0\u7ebf\u7f51SSID \u540e\uff0c\u91c7\u7528\u4e0e\u6709\u7ebf\u7f51\u76f8\u540c\u7684\u8ba4\u8bc1\u673a\u5236\u3002\u6253\u5f00\u6d4f\u89c8\u5668\u65f6\uff0c\u7cfb\u7edf\u4f1a\u81ea\u52a8\u5f39\u51fa\u6821\u56ed\u7f51\u8ba4\u8bc1\u7cfb\u7edf\u767b\u5f55\u9875\u9762\uff0c\u6216\u5728\u6d4f\u89c8\u5668\u4e2d\u8f93\u5165\u8ba4\u8bc1\u7cfb\u7edf\u7f51\u5740 https://login.tsinghua.edu.cn \u8fdb\u884c\u8ba4\u8bc1\u64cd\u4f5c\uff1b\u4e0d\u518d\u4f7f\u7528\u7f51\u7edc\u65f6\uff0c\u9700\u518d\u6b21\u8bbf\u95ee\u8ba4\u8bc1\u7cfb\u7edf\u201c\u65ad\u5f00\u8fde\u63a5\u201d\u3002</p> <p>\u66f4\u591a\u5e2e\u52a9\uff1ahttps://its.tsinghua.edu.cn -- \u6821\u56ed\u7f51\u7edc</p>"},{"location":"intranet/#_3","title":"\u6821\u5916\u4e0a\u7f51","text":"<p>\u5728\u6821\u5916\u9700\u8981\u4e0b\u8f7d\u8bba\u6587\u6216\u8005\u767b\u5f55\u6821\u56ed\u7f51\uff0c\u5982\u4f55\u8fde\u63a5\u6e05\u534eVPN?</p> <ul> <li>\u65b9\u6cd51. \u6e05\u534e\u5927\u5b66WebVPN</li> <li>\u65b9\u6cd52. SSL VPN</li> </ul> <p>\u66f4\u591a\u5e2e\u52a9\uff1ahttps://its.tsinghua.edu.cn -- \u6821\u5916\u8bbf\u95ee\uff08VPN\uff09</p>"},{"location":"intranet/cal/","title":"Lab Calendars","text":""},{"location":"intranet/cal/#lab-calendars","title":"Lab Calendars","text":"<p>Caution</p> <p>Visitors from China need VPN to visit the following calendars hosted at Google.</p> <ul> <li>Lu Lab Calendar hosted at Google Calendar<ul> <li>html: https://calendar.google.com/calendar/embed?src=rhfq9d5sr46lqjpg3vd1ncbosc%40group.calendar.google.com&amp;ctz=Asia%2FShanghai&amp;mode=week</li> <li>ics: https://calendar.google.com/calendar/ical/rhfq9d5sr46lqjpg3vd1ncbosc%40group.calendar.google.com/public/basic.ics</li> </ul> </li> <li>Seminar Calendar hosted at Google Calendar<ul> <li>html: https://calendar.google.com/calendar/embed?src=hrabiq5okeupg1tfnpa7g9qqr0%40group.calendar.google.com&amp;ctz=Asia%2FShanghai&amp;mode=week</li> <li>ics: https://calendar.google.com/calendar/ical/hrabiq5okeupg1tfnpa7g9qqr0%40group.calendar.google.com/public/basic.ics</li> </ul> </li> </ul> <p>You can copy the above links (*.ics: ical format) to subscribe Lu Lab Calendars on the Calendar app on your phone and computer. Windows APP: Outlook; MAC APP: Calendar; iPhone APP: Calendar, Outlook; Android APP: Google Calendar, Outlook.</p>"},{"location":"intranet/cal/#holiday-calendars","title":"Holiday Calendars","text":""},{"location":"intranet/cal/#ics","title":"\u82f9\u679c\u63d0\u4f9b\u7684\u5730\u5740ics\u683c\u5f0f:","text":"<ul> <li>\u4e2d\u56fd\u519c\u5386:  webcal://ical.mac.com/ical/China32Lunar32Simplified32Holidays.ics</li> <li>\u4e2d\u56fd\u8282\u65e5:  webcal://ical.mac.com/ical/China32Holidays.ics</li> <li>US Holidays:  webcal://ical.mac.com/ical/US32Holidays.ics</li> </ul>"},{"location":"intranet/cal/#ics_1","title":"\u8c37\u6b4c\u63d0\u4f9b\u7684\u5730\u5740 ics\u683c\u5f0f:","text":"<ul> <li>\u4e2d\u56fd\u8282\u6c14: webcal://www.google.com/calendar/ical/orp22j75kcj10gqhol530ftucs@group.calendar.google.com/public/basic.ics</li> <li>\u4e2d\u56fd\u519c\u5386: http://www.google.com/calendar/ical/lunar__zh_cn@holiday.calendar.google.com/public/basic.ics</li> <li>\u4e2d\u56fd\u8282\u5047\u65e5: http://www.google.com/calendar/ical/china__zh_cn@holiday.calendar.google.com/public/basic.ics</li> <li>U.S. Holidays: https://calendar.google.com/calendar/ical/en.usa%23holiday%40group.v.calendar.google.com/public/basic.ics</li> </ul>"},{"location":"intranet/meeting/","title":"Lab Meetings","text":""},{"location":"intranet/meeting/#lab-meetings","title":"Lab Meetings","text":"<ul> <li>Lab Calendars</li> </ul>"},{"location":"intranet/meeting/#group-meeting","title":"Group Meeting","text":"<p>Weekly meeting for all</p> <ul> <li>Group Meeting <ul> <li>see meeting schedule and PPTs of group meetings in Lu Lab Wiki @WPS\u91d1\u5c71\u4e91\u6587\u6863</li> </ul> </li> </ul>"},{"location":"intranet/meeting/#subgroup-meetings","title":"Subgroup Meetings","text":"<p>Project discussion for subgroups</p> <ul> <li>Project Report and Minutes<ul> <li>see reporting results in \"Project Progress/\" @ \u3010\u6e05\u534e\u4e91\u3011or\u3010WPS\u91d1\u5c71\u4e91\u6587\u6863\u3011</li> </ul> </li> </ul> <p>\u517b\u6210\u597d\u7684\u4e60\u60ef\uff1a</p> <ul> <li> <p>\u5f00\u4f1a\u524d\uff1a\u63d0\u524d\u4e0a\u4f20PPT (\"Project Progress/\" @\u3010\u6e05\u534e\u4e91\u3011or\u3010WPS\u91d1\u5c71\u4e91\u6587\u6863\u3011)\u3002</p> </li> <li> <p>\u5f00\u4f1a\u540e\uff1a\u5c3d\u5feb\u6574\u7406Meeting Minutes\uff08\u5f62\u5f0f\uff1appt \u6700\u540e\u4e00\u9875\uff0c\u7535\u5b50\u7b14\u8bb0\u6216email\uff09\u3002</p> </li> </ul>"},{"location":"people/","title":"People","text":""},{"location":"people/#people","title":"People","text":"<p>Important</p> <p></p><p>\u5c11\u5e74\u5e94\u6709\u9e3f\u9e44\u5fd7 \u5f53\u9a91\u9a8f\u9a6c\u8e0f\u5e73\u5ddd</p><p></p> <p></p>Honored Students @ Lu Lab<p></p> <p>\"What sculpture is to a block of marble, education is to a human soul.\"  --  Joseph Addison</p> <p> </p> 2025 Summer <p>\u201cThe carving and chipping away to create a masterpiece take years of dedication.  Teachers help students discover their interests, passions, and ultimately themselves.\u201d</p> <p> </p> 2024  |  2023  <p> </p> 2022  |  2021  <p> </p> 2020  |  2019  <p> </p> 2018  |  2017  <p> </p> 2016 Summer <p> More Photos ...</p> <ul> <li>Lab Members &amp; Alumni</li> <li>Academic Tree</li> </ul>"},{"location":"people/academic/","title":"Academic Tree","text":""},{"location":"people/academic/#academic-tree-of-lu-lab","title":"Academic Tree of Lu Lab","text":"Generation Name Born Year Death Year Ph.D./Degree Year Ph.D./Degree Institution 30 Zhi J. Lu 2008 University  of Rochester, USA 29 David Mathews 2002 University  of Rochester, USA 28 Douglas H. Turner 1972 Columbia  University, USA 27 Norman Sutin 1953 University  of Cambridge, UK 26 Alfred  Gavin Maddock 1917 2009 1942 Imperial  College London, UK 25 Harry  J. Emel\u00e9us 1903 1993 1929 Imperial  College London, UK 24 Herbert  B. Baker 1862 1935 1884 University  of Oxford, UK 23 Harold  Baily Dixon 1852 1930 1875 University  of Oxford, UK 22 Augustus  George Vernon Harcourt 1834 1919 1858 University  of Oxford, UK 21 Benjamin  Collins Brodie 1817 1880 1850 Giessen  University, Germany 20 Justus  Von Liebig 1803 1873 1822 University  of Erlangen, Germany 19 Karl  Friedrich Wilhelm Gottlob Kastner 1783 1857 1805 University  of Jena, Germany 18 Johann  Friedrich August Gottling 1753 1809 1775 Apothecary  degree, Langensalza, Germany 17 Johann  Christian Wiegleb 1732 1800 1765 Apothecary  degree, Langensalza, Germany 16 Ernst  Gottfried Baldinger 1738 1804 1760 University  of Jena, Germany 15 Ernst  Anton Nicolai 1722 1802 1745 University  of Halle, Germany 14 Johann  Gottlob Kr\u00fcger 1715 1759 1742 University  of Halle, Germany 13 Friedrich  Hoffmann 1660 1742 1681 University  of Jena, Germany 12 Augustin  Heinrich Fasch 1639 1690 1665 University  of Jena, Germany 11 Werner  Rolfinck 1599 1673 1618/1625 Leucorea  University in Wittenberg/University of Jena, Germany 10.2 Adriaan  van den Spieghel 1578 1625 1603 University  of Padua, Italy 10.1 Daniel  Sennert 1572 1637 1601 Leucorea  University in Wittenberg, Germany 9.2 Giulio  Cesare Casseri 1561 1619 1580 University  of Padua, Italy 9.1 Jan  Jessenius 1566 1621 1591 University  of Padua, Italy 8 Girolamo  (Hieronymus Fabricus) Fabrici d'Acquapendente 1537 1619 1559 University  of Padua, Italy 7 Gabriel  Falloppio 1523 1562 1548 University  of Ferrara, Italy 6 Antonio  Musa Brasavola 1490 1554 1520 University  of Padua, Italy 5 Nicolo  (Leoniceno) da Lonigo 1428 1524 1453 University  of Padua, Italy 4 Pietro  Roccabonella 1427 1491 1455 University  of Padua, Italy 3 Sigismondo  Polcastro 1384 1473 1424 University  of Padua, Italy 2 Michele  Savonarola 1385 1468 Research  assistant to Giacomo Dalla Torre University  of Padua, Italy 1 Giacomo  Della Torre da Forl\u00ec 1364 1414 No  advisor University  of Padua, Italy"},{"location":"people/grads/","title":"Representative Graduates","text":""},{"location":"people/grads/#representative-graduates","title":"Representative Graduates","text":""},{"location":"people/grads/#2018-li-yang","title":"2018' Li, Yang","text":"<ol> <li>Shuaishuai Teng<sup>1</sup>, Yang Eric Li<sup>1</sup>, Ming Yang, Rui Qi, Yiming Huang, Qianyu Wang, Shasha Li, Kequan Lin, Yujing Cheng, Zhi John Lu*, Dong Wang*. (2020) Epigenetic Reprogramming of Tissue-Specific Transcription Promotes Metastasis. Cell Research (IF=18)  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Yang Eric Li<sup>1</sup>, Mu Xiao<sup>1</sup>, Binbin Shi<sup>1</sup>, Yu-Cheng T. Yang, Dong Wang, Fei Wang, Marco Marcia, Zhi John Lu. (2017) Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA-protein binding sites. _Genome Biology*_  18:169. (IF=13) (<sup>1</sup>contributed equally)</li> <li>Yang Yang#, Lei Chen#, Jin Gu#, Hanshuo Zhang#, Jiapei Yuan, Qiuyu Lian, Guishuai Lv, Siqi Wang, Yang Wu, Yu-Cheng T. Yang, Dongfang Wang, Yang Liu, Jing Tang, Guijuan Luo, Yang Li, Long Hu, Xinbao Sun, Dong Wang, Mingzhou Guo, Qiaoran Xi, Jianzhong Xi, Hongyang Wang, Michael Q. Zhang, Zhi John Lu (2017) Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nature Communications. 8, 14421. (SCI, IF=12.124)</li> <li>Yang Wu#, Rihao Qu#, Yiming Huang#, Binbin Shi, Mengrong Liu, Yang Li, Zhi John Lu (2016) RNAex: an RNA secondary structure prediction server enhanced by high-throughput structure probing data. Nucleic Acids Research. 44* (W1): W294-W301. (SCI, IF=10.162)</li> <li>Yu-Cheng T. Yang#, Chao Di#, Boqin Hu#, Meifeng Zhou, Yifang Liu, Nanxi Song, Yang Li, Jumpei Umetsu, Zhi John Lu. (2015) CLIPdb: a CLIP-seq database for protein-RNA interactions. BMC Genomics*. 16 (1):51-58. (SCI, IF=3.729)</li> <li>Long Hu, Chao Di, Mingxuan Kai, Yu-Cheng T. Yang, Yang Li, Yunjiang Qiu, Xihao Hu, Kevin Y. Yip, Michael Q. Zhang, Zhi John Lu. (2015) A common set of distinct features that characterize noncoding RNAs across multiple species. Nucleic Acids Research. 43 (1): 104-114. (SCI, IF=10.162)</li> </ol>"},{"location":"people/grads/#2017-yang-yang","title":"2017' Yang, Yang","text":"<ol> <li>Yang Y, Yang YCT, Yuan J, Lu ZJ and Li JJ (2017) Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell differentiation states. Nucleic Acids Research 45 (4): 1657-1672</li> <li>Yang Y,ChenL,GuJ,ZhangH,YuanJ,LianQ,LvG,WangS,WuY,YangYCT, Wang D, Liu Y, Tang J, Luo G, Li Y, Hu L, Sun X, Wang D, Guo M, Xi Q, Xi J, Wang H, Zhang MQ and Lu ZJ (2017) Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nature Communications 8, 14421</li> <li>CaoB,SongN,ZhangM,DiC,Yang Y,LuYou,ChenR,LuZJ,GuoM(2016) Systematic study of novel lncRNAs in different gastrointestinal cancer cells. Discovery Medicine, 21(115): 159-71</li> <li>TangZ,WuY,YangYL,YangYC,WangZ,YuanJ,Yang Y,HuaC,FanX,NiuG, Zhang Y, Lu ZJ, Li K (2017) Comprehensive analysis of long non-coding RNAs highlights their spatio-temporal expression patterns and evolutional conservation in Sus Scrofa. Scientific Reports, 7: 43166</li> <li>Xi X, Li T, Huang Y, Sun J, Zhu Y, Yang Y and Lu ZJ (2017) RNA biomarkers: Frontiers of Precision Medicine for Cancer. Non-Coding RNA 3,9</li> </ol>"},{"location":"people/grads/#2016-hu-long","title":"2016' Hu, Long","text":"<ol> <li>Zhiyu Xu<sup>1</sup>, Long Hu<sup>1</sup>, Binbin Shi, SiSi Geng, Longchen Xu, Dong Wang* and Zhi John Lu* (2018) Ribosome elongating footprints denoised by wavelet transform comprehensively characterize dynamic cellular translation events. Nucleic Acids Research 46 (18), e109-e109  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Long Hu, Zhiyu Xu, Boqin Hu and Zhi John Lu (2017) COME: a robust coding potential calculator for lncRNA identification and characterization based on multiple features. Nucleic Acids Research 45 (1): e2</li> <li>Hu L,Di C,Kai MX,Yang T.YC,Li Y,Qiu YJ,Hu XH,Yip K,Zhang M. QW&amp;Lu ZJ. (2014) A common set of distinct features that characterize noncoding RNAs across multiple species. Nucleic Acids Research doi: 10.1093/nar/gku1316</li> <li>Tan X,Hu L,LuquetteLJ,GaoG,LiuYF,QuHJ,XiRB,LuZJ,ParkPJ&amp;ElledgeSJ. (2012) Systematic Identification of Synergistic Drug Pairs Targeting HIV. Nature Biotech, 30:1125-1130</li> <li>Tan X,Lu Z,Gao G,Xu QK,Hu L,FellmannC,LiMZ,QuHJ,LoweSW,HannonGJ&amp; Elledge SJ. (2012) Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. Proc. Natl. Acad. Sci. U. S. A., 109(3): 869-74</li> <li>Gerstein MB, ... , Hu L, ... (2014) Comparative analysis of the transcriptome across distant speices. Nature, 512:445-448</li> <li>DiC,YuanJP,WuY,LiJR,LinHX,Hu L,ZhangT,QiYJ,GersteinMB,GuoY,LuZ. (2014) Characterization of stress-responsive lncRNA in Arabidopsis Thaliana by integrating expression, epigenetic and structural features. The Plant Journal, 80(5): 848-61</li> </ol>"},{"location":"people/grads/#2016-yang-yc","title":"2016' Yang, YC","text":"<ol> <li>Yumin Zhu<sup>1</sup>, Gang Xu<sup>1</sup>, Yucheng T Yang<sup>1</sup>, Zhiyu Xu, Xinduo Chen, Binbin Shi, Daoxin Xie, Zhi John Lu*, Pengyuan Wang* (2019) POSTAR2: deciphering the post-transcriptional regulatory logics Nucleic Acids Research (D1):D203-D211  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Boqin Hu<sup>1</sup>, Yu-Cheng T. Yang<sup>1</sup>, Yiming Huang, Yumin Zhu and Zhi John Lu (2017) POSTAR: a platform of post-transcriptional regulation coordinated by RNA binding proteins. Nucleic Acids Research 45 (D1): D104-D114 (<sup>1</sup>contributed equally)</li> <li>Yang YC, Di C, Hu B, Zhou M, Liu Y, Song N, Li Y, Umetsu J and Lu ZJ (2015) CLIPdb: a CLIP-seq database for protein-RNA interactions. BMC Genomics.</li> <li>Yang YC, Umetsu J and Lu ZJ (2014) Global signatures of protein binding on structured RNAs in Saccharomyces cerevisiae. Science China Life Sciences</li> <li>Hu L, Di C, Kai M, Yang YC, Li Y, Qiu Y, Hu X, Yip KY, Zhang MQ and Lu ZJ (2015) A common set of distinct features that characterize noncoding RNAs across multiple species. Nucleic Acids Research</li> <li>Freeberg MA, Han T, Moresco JJ, Kong A, Yang YC, Lu ZJ, Yates JR and Kim JK. (2013) Pervasive and dynamic protein binding sites of the mRNA transcriptome in Saccharomyces cerevisiae. Genome Biology</li> </ol>"},{"location":"people/join-us/","title":"Join Us! - Welcome to Lu Lab @ Tsinghua","text":""},{"location":"people/join-us/#_1","title":"\u6b22\u8fce\u52a0\u5165\u6e05\u534e\u5927\u5b66\u751f\u547d\u5b66\u9662\u9c81\u5fd7\u5b9e\u9a8c\u5ba4","text":"<p>Bioinformatics Lab for noncoding RNA</p>"},{"location":"people/join-us/#_2","title":"\u5b9e\u9a8c\u5ba4\u7b80\u4ecb","text":"<p>\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\uff08 \u5b9e\u9a8c\u5ba4\u4e3b\u9875 \uff09\u4e0b\u5c5e\u4e8e\u6e05\u534e\u5927\u5b66\u751f\u547d\u79d1\u5b66\u5b66\u9662\uff0c\u5b9e\u9a8c\u5ba4\u6210\u5458\u5305\u62ec\u535a\u58eb\u751f10\u4f59\u540d\u548c\u672c\u79d1\u5b9e\u4e60\u751f\u82e5\u5e72\uff0c\u6765\u81ea\u751f\u7269\u5b66\u3001\u7edf\u8ba1\u5b66\u3001\u8ba1\u7b97\u673a\u79d1\u5b66\u7b49\u591a\u5b66\u79d1\u3002\u5b9e\u9a8c\u5ba4\u4f9d\u6258\u4e8e\u201c\u751f\u7269\u4fe1\u606f\u5b66\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u201d\u3001\u201c\u7eff\u8272\u751f\u7269\u5236\u9020\u5168\u56fd\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u201d\u3001\u6e05\u534e\u5927\u5b66\u201c\u5408\u6210\u4e0e\u7cfb\u7edf\u751f\u7269\u5b66\u7814\u7a76\u4e2d\u5fc3\u201d\u3001\u751f\u547d\u5b66\u9662AI\u4eba\u5de5\u667a\u80fd\u4e2d\u5fc3\u7b49\uff0c\u62e5\u6709\u5f88\u597d\u7684\u4eba\u624d\u652f\u6491\u3001\u786c\u4ef6\u5e73\u53f0\u548c\u5408\u4f5c\u79d1\u7814\u73af\u5883\u3002</p> <p>\u6211\u4eec\u5b9e\u9a8c\u5ba4\u81f4\u529b\u4e8e\u53d1\u5c55\u751f\u7269\u4fe1\u606f\u5b66\u6280\u672f\uff0c\u5e76\u63a2\u7d22\u5176\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u7b49\u590d\u6742\u75be\u75c5\u7684\u7cbe\u51c6\u8bca\u7597\u4e0a\u7684\u5177\u4f53\u5e94\u7528\u3002\u6211\u4eec\u5229\u7528\u673a\u5668\u5b66\u4e60\u7b49\u4eba\u5de5\u667a\u80fd\u6280\u672f\uff0c\u7ed3\u5408\u975e\u7f16\u7801RNA (ncRNA)\u4e3a\u6838\u5fc3\u7684\u9ad8\u901a\u91cf\u6d4b\u5e8f\u548c\u9ad8\u901a\u91cf\u7b5b\u9009\u7b49\u6570\u636e\uff0c\u6765\u7814\u7a76\u9057\u4f20\u4fe1\u606f\u662f\u5982\u4f55\u88ab\u7f16\u7801\u5728\u7ed3\u6784\u5316\u7684DNA\u548cRNA\u5206\u5b50\u4e4b\u4e2d\uff0c\u4ee5\u53ca\u5b83\u4eec\u662f\u5982\u4f55\u5728\u4e00\u4e2a\u751f\u547d\u4f53\u7cfb\u4e2d\u76f8\u4e92\u4f5c\u7528\u3001\u5f7c\u6b64\u8c03\u63a7\u3002 \u6211\u4eec\u7684\u4e00\u4e2a\u91cd\u8981\u4f7f\u547d\uff0c\u662f\u5e2e\u52a9\u4eba\u4eec\u66f4\u65e9\u671f\u7684\u53d1\u73b0\u548c\u6cbb\u7597\u75be\u75c5\u3002\u6211\u4eec\u76f8\u4fe1\uff0c\u8fd9\u79cd\u4f7f\u547d\u611f\u4ee5\u53ca\u4e3a\u6b64\u4ed8\u51fa\u7684\u5b9e\u8df5\u548c\u52aa\u529b\uff0c\u5c06\u5e2e\u52a9\u6211\u4eec\u7406\u89e3\u548c\u6cbb\u7597\u4eba\u7c7b\u75be\u75c5\uff0c\u5e76\u6700\u7ec8\u8ba4\u8bc6\u548c\u63d0\u9ad8\u6211\u4eec\u81ea\u5df1\u3002</p> <p>\u5b9e\u9a8c\u5ba4\u56f4\u7ed5\u7740\u975e\u7f16\u7801RNA(ncRNA)\u4e3b\u8981\u6709\u4e24\u4e2a\u7814\u7a76\u65b9\u5411: 1\uff09AI\u9a71\u52a8\u7684\u6838\u9178\u6a21\u578b\u548c\u836f\u7269\u8bbe\u8ba1\uff1b2\uff09\u751f\u4fe1\u9a71\u52a8\u7684\u7cbe\u51c6\u533b\u7597\u3002 \u8be6\u89c1 Projects \u3002</p> <p>\u5b9e\u9a8c\u5ba4\u8d1f\u8d23\u4eba\u9c81\u5fd7\u535a\u58eb (\u4e2a\u4eba\u5b98\u65b9\u4e3b\u9875)\uff0c\u6e05\u534e\u5927\u5b66\u751f\u547d\u79d1\u5b66\u5b66\u9662\u957f\u8058\u526f\u6559\u6388\uff08tenured\uff09\u3001\u7279\u522b\u7814\u7a76\u5458\u3001\u535a\u58eb\u751f\u5bfc\u5e08\uff0c\u56fd\u5bb6\u57fa\u91d1\u59d4\u201c\u4f18\u79c0\u9752\u5e74\u201d\u57fa\u91d1\u3001\u67d0\u9752\u5e74\u4eba\u624d\u9879\u76ee\u3001\u201c\u970d\u82f1\u4e1c\u201d\u9752\u5e74\u57fa\u91d1\u83b7\u5f97\u8005\u3002\u9c81\u5fd7\u535a\u58eb\u8fd120\u5e74\u6765\u4e00\u76f4\u81f4\u529b\u4e8e\u975e\u7f16\u7801RNA\u76f8\u5173\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\uff0c\u53d1\u8868\u56fd\u9645\u91cd\u8981\u671f\u520a\u6587\u7ae0~80\u7bc7\uff0c\u5305\u62ec\u901a\u8baf\u4f5c\u8005\u6587\u7ae030\u4f59\u7bc7\uff1b\u6587\u7ae0\u6240\u53d1\u8868\u671f\u520a\u5305\u62ec Science, Nature, Cell, PNAS, e-Life, Genome Biology\u7b49\uff0c\u603b\u5f15\u7528\u8d85\u8fc72\u4e07\u6b21\u3002</p> <p>\u5b9e\u9a8c\u5ba4\u4e3b\u9875\uff1ahttp://lulab.life.tsinghua.edu.cn | https://www.ncRNAlab.org</p>"},{"location":"people/join-us/#_3","title":"\u5bfb\u6c42\u9879\u76ee\u5408\u4f5c","text":"<ul> <li>\u6e05\u534e\u5927\u5b66\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\u79d1\u7814\u9879\u76ee\u53ca\u5176\u8f6c\u5316\u5bfb\u6c42\u5408\u4f5c</li> </ul>"},{"location":"people/join-us/#_4","title":"\u79d1\u7814\u65b9\u5411\u4eba\u624d\u62db\u52df","text":""},{"location":"people/join-us/#_5","title":"\u201c\u751f\u7269\u4fe1\u606f\u5b66\u201d\u535a\u58eb\u751f\u62db\u751f","text":"<p>\u5b9e\u9a8c\u5ba4\u6bcf\u5e74\u67092-3\u540d\u535a\u58eb\u751f\u540d\u989d\uff0c\u53ef\u4ee5\u901a\u8fc7\u4e24\u4e2a\u535a\u58eb\u62db\u751f\u590f\u4ee4\u8425\u5f55\u53d6\uff1a </p> <ol> <li>\u5317\u5927-\u6e05\u534e-NIBS \u8054\u5408\u7684 PTN \u590f\u4ee4\u8425\u3002</li> <li>\u6e05\u534e\u535a\u58eb\u62db\u751f\u590f\u4ee4\u8425\uff08\u5305\u62ecCLS\u3001\u751f\u547d\u5b66\u9662\u3001\u533b\u5b66\u9662\u3001\u836f\u5b66\u9662\u56db\u65b9\u8054\u5408\u7edf\u4e00\u62db\u751f\uff09\uff1b\u5bf9\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\u53ef\u4ee5\u7533\u8bf7\u5176\u4e2d\u4e00\u4e2a\u548c\u8ba1\u7b97\u673a\u7cfb\u3001\u81ea\u52a8\u5316\u7cfb\u8054\u5408\u57f9\u517b\u7684\u201c\u667a\u80fd\u201d\u65b9\u5411\u3002</li> </ol> <p>\u611f\u5174\u8da3\u7684\u540c\u5b66\u8bf7\u5173\u6ce8\u8fd9\u51e0\u4e2a\u590f\u4ee4\u8425\u7684\u5b98\u65b9\u7533\u8bf7\u901a\u77e5\u8fdb\u884c\u7533\u8bf7\uff0c\u672c\u79d1\u751f\u548c\u7855\u58eb\u751f\u90fd\u53ef\u4ee5\u7533\u8bf7\u3002\u6bcf\u5e747\u6708\u30019\u6708\u548c\u6765\u5e743\u6708\u6709\u4e09\u6b21\u7533\u8bf7\u673a\u4f1a\u3002\u5f55\u53d6\u540e\uff0c\u4e00\u822c\u8981\u7ecf\u8fc7\u5927\u534a\u5e74\u5728\u4e0d\u540c\u5b9e\u9a8c\u5ba4\u7684\u8f6e\u8f6c\u4f53\u9a8c\u4e4b\u540e\u6700\u540e\u5728\u4e00\u4e2a\u5b9e\u9a8c\u5ba4\u5b9a\u5bfc\u3002\u6ce8\u610f\uff1a\u56e0\u4e3a\u5404\u4e2a\u9879\u76ee\u540d\u989d\u9650\u5236\u4e0d\u540c\uff0c\u9009\u62e9 PTN \u9879\u76ee\u7684\u5b66\u751f\u66f4\u6709\u53ef\u80fd\u83b7\u5f97\u5728\u6211\u4eec\u5b9e\u9a8c\u5ba4\u6700\u7ec8\u5b9a\u5bfc\u7684\u673a\u4f1a\uff0c\u5177\u4f53\u53ef\u4ee5 email \u54a8\u8be2\u6211\u4eec\u5b9e\u9a8c\u5ba4\u3002</p> <p>\u6b64\u5916\uff0c\u5bf9\u4e8e\u5728\u804c\u4eba\u5458\uff0c\u53ef\u4ee5\u7533\u8bf7\u6e05\u534e\u5927\u5b66\u201c\u521b\u65b0\u9886\u519b\u5de5\u7a0b\u535a\u58eb\u201d\uff0c\u4e00\u822c\u6bcf\u5e7411\u6708\u5728\u7f51\u4e0a\u63d0\u4ea4\u7533\u8bf7\u6750\u6599\uff0c\u6211\u4eec\u5b9e\u9a8c\u5ba4\u53ef\u4ee5\u5728\u91cc\u9762\u7684\u751f\u7269\u4e0e\u533b\u836f\uff080860\uff09\u7c7b\u62db\u751f\u3002</p>"},{"location":"people/join-us/#ai","title":"AI\u548c\u6570\u636e\u5206\u6790\u65b9\u5411\u7684\u535a\u58eb\u540e\u62db\u8058","text":"<p>\u6765\u5b9e\u9a8c\u5ba4\u540e\u8fdb\u884c\u548c\u7cbe\u51c6\u533b\u7597\u3001\u6838\u9178\u6a21\u578b\u548c\u836f\u7269\u8bbe\u8ba1\u7b49\u76f8\u5173\u7684\u4eba\u5de5\u667a\u80fd\u6280\u672f\u7684\u7814\u53d1\u548c\u5e94\u7528\u3002</p> <p>\u57fa\u672c\u8981\u6c42\uff1a</p> <ul> <li>\u7b26\u5408\u6e05\u534e\u5927\u5b66\u535a\u58eb\u540e\u62db\u6536\u7684\u57fa\u672c\u6761\u4ef6\uff0c\u62e5\u6709\u535a\u58eb\u5b66\u4f4d\uff0c\u6709\u8f83\u5f3a\u72ec\u7acb\u4ece\u4e8b\u8bfe\u9898\u7814\u7a76\u7684\u80fd\u529b\uff1b</li> <li>\u5728\u751f\u7269\u4fe1\u606f\u3001\u751f\u7269\u8ba1\u7b97\u3001\u5927\u6570\u636e\u6316\u6398\u7b49\u65b9\u9762\u6709\u7279\u957f\u548c\u7ecf\u9a8c\u7684\u4eba\u624d\u4f18\u5148\uff1b</li> <li>\u6709\u624e\u5b9e\u7684 AI \u6280\u672f\u80fd\u529b\u7684\u4eba\u624d\u4f18\u5148\u3002</li> </ul>"},{"location":"people/join-us/#_6","title":"\u9ad8\u901a\u91cf\u5b9e\u9a8c\u65b9\u5411\u7684\u535a\u58eb\u540e\u62db\u8058","text":"<p>\u8be5\u65b9\u5411\u7684\u91cd\u70b9\u62db\u52df\u5bf9\u8c61\u662f \u5206\u5b50\u751f\u7269\u5b66\u548cNGS\u6280\u672f\u5f00\u53d1\u65b9\u5411\u7684\u4eba\u624d, \u6765\u5b9e\u9a8c\u5ba4\u540e\u8fdb\u884c\u6700\u65b0\u7684\u6db2\u4f53\u6d3b\u68c0\u3001\u9ad8\u901a\u91cf\u6d4b\u5e8f\u3001\u9ad8\u901a\u91cf\u836f\u7269\u7b5b\u9009\u7b49\u6280\u672f\u7684\u5f00\u53d1\u3002</p> <p>\u57fa\u672c\u8981\u6c42\uff1a</p> <ul> <li>\u7b26\u5408\u6e05\u534e\u5927\u5b66\u535a\u58eb\u540e\u62db\u6536\u7684\u57fa\u672c\u6761\u4ef6\uff0c\u62e5\u6709\u535a\u58eb\u5b66\u4f4d\uff0c\u6709\u8f83\u5f3a\u72ec\u7acb\u4ece\u4e8b\u8bfe\u9898\u7814\u7a76\u7684\u80fd\u529b\uff1b</li> <li>\u719f\u6089\u5206\u5b50\u751f\u7269\u5b66\u5b9e\u9a8c\u6280\u672f\uff0c\u52a8\u624b\u548c\u603b\u7ed3\u80fd\u529b\u51fa\u4f17\uff1b</li> <li>\u6709\u5982\u4e0b\u6280\u80fd\u548c\u7ecf\u9a8c\u8005\u4f18\u5148\uff1a<ul> <li>\u5bf9\u9ad8\u901a\u91cf\u6d4b\u5e8f\u6280\u672f\uff0c\u5c24\u5176\u662f\u4e13\u4e1a\u7684\u5efa\u5e93\u6280\u672f\uff0c\u6709\u8f83\u591a\u7ecf\u9a8c\uff1b</li> <li>\u5bf9\u9ad8\u901a\u91cf\u7b5b\u9009\u6280\u672f\uff0c\u5982shRNA\u7b5b\u9009\u3001CRISPR\u7b5b\u9009\u7b49\u6709\u8f83\u591a\u7ecf\u9a8c\uff1b</li> <li>\u719f\u7ec3\u638c\u63e1\u5206\u5b50\u514b\u9686\u7b49\u5206\u5b50\u751f\u7269\u5b66\u5b9e\u9a8c\uff0c\u5c24\u5176\u662f RNAi\u3001CRISPR \u7b49\uff1b</li> <li>\u5bf9RNA\u5c24\u5176\u662f\u975e\u7f16\u7801RNA\u7684\u76f8\u5173\u7814\u7a76\u548c\u5b9e\u9a8c\u6709\u8f83\u591a\u7ecf\u9a8c\u3002</li> </ul> </li> </ul>"},{"location":"people/join-us/#_7","title":"\u5c97\u4f4d\u5f85\u9047","text":"<p>\u5f85\u9047\u4e30\u539a\uff0c\u79d1\u7814\u5e73\u53f0\u57fa\u7840\u9ad8\u3002\u53ef\u901a\u8fc7\u534f\u52a9\u7533\u8bf7\u4ee5\u4e0b\u4e00\u4e2a\u6216\u591a\u4e2a\u4eba\u624d\u652f\u6301\u8ba1\u5212\u4ee5\u53ca\u4ea7\u4e1a\u5316\u65b9\u5411\u652f\u6301\u8ba1\u5212\u8fdb\u884c\u8058\u7528\uff0c\u63d0\u4f9b\u5177\u6709\u56fd\u9645\u7ade\u4e89\u529b\u7684\u5f85\u9047\u548c\u79d1\u7814\u8d44\u52a9\uff1a</p> <ul> <li>\u6e05\u534e\u5927\u5b66\u6c34\u6728\u5b66\u8005\u652f\u6301\u8ba1\u5212</li> <li>\u6e05\u534e\u5927\u5b66-\u5317\u4eac\u5927\u5b66\u751f\u547d\u79d1\u5b66\u8054\u5408\u4e2d\u5fc3\u535a\u58eb\u540e\u57fa\u91d1</li> <li>\u535a\u58eb\u540e\u521b\u65b0\u4eba\u624d\u652f\u6301\u8ba1\u5212</li> <li>\u4ea7\u5b66\u7814\u7ed3\u5408\uff0c\u4ea7\u4e1a\u5316\u65b9\u5411\u8d44\u52a9</li> <li>more \u3002\u3002\u3002</li> </ul>"},{"location":"people/join-us/#_8","title":"\u7533\u8bf7\u548c\u8054\u7cfb\u65b9\u6cd5","text":"<p>\u5e94\u8058\u8005\u8bf7\u5c06\u4e00\u4efd\u8be6\u5c3d\u7684CV\u548c\u4e00\u5c01\u9610\u8ff0\u7814\u7a76\u548c/\u6216\u4ea7\u4e1a\u5316\u5174\u8da3\u7684\u7b80\u4fe1\uff0c \u53d1\u9001\u7ed9 lulab1@tsinghua.edu.cn \u3002\u535a\u58eb\u540e\u5e94\u8058\u8005\u7a0d\u540e\u8fd8\u9700\u8981\u8054\u7cfb\u5305\u542b\u81ea\u5df1\u5bfc\u5e08\u5728\u5185\u76842-3\u4f4d\u63a8\u8350\u4eba\u53d1\u9001\u63a8\u8350\u4fe1\u81f3\u4e0a\u8ff0\u90ae\u7bb1\u3002</p> <p>Email\u4e3b\u9898\u8bf7\u6807\u6ce8\u201c\u5e94\u8058\u8ba1\u7b97\u5206\u6790\u535a\u58eb\u540e\u201d\u6216\u8005\u201c\u5e94\u8058\u6e7f\u5b9e\u9a8c\u535a\u58eb\u540e\u201d\uff0c\u5e76\u6ce8\u660e\u62db\u8058\u4fe1\u606f\u6765\u6e90\uff0c\u8c22\u8c22\u3002</p>"},{"location":"people/join-us/#_9","title":"\u4ea7\u4e1a\u5316\u65b9\u5411\u4eba\u624d\u62db\u52df","text":"<ul> <li>\u65b0\u7ef4\u5ea6\u57fa\u56e0</li> </ul>"},{"location":"people/open/","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u5bfb\u6c42\u5408\u4f5c","text":""},{"location":"people/open/#_1","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\u79d1\u7814\u9879\u76ee\u53ca\u5176\u8f6c\u5316\u5bfb\u6c42\u5408\u4f5c","text":"<ul> <li>\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\u79d1\u7814\u9879\u76ee\u53ca\u5176\u8f6c\u5316\u5bfb\u6c42\u5408\u4f5c<ul> <li>\u5b9e\u9a8c\u5ba4\u7b80\u4ecb</li> <li>\u4ee3\u8868\u6027\u5728\u7814\u9879\u76ee</li> <li>\u9879\u76ee\u4e00\uff1a\u9488\u5bf9\u764c\u75c7\u7b49\u590d\u6742\u75be\u75c5\u7684\u6838\u9178\u68c0\u6d4b\u9879\u76ee - AI\u9a71\u52a8\u7684cfRNA\u68c0\u6d4b\u6280\u672f<ul> <li>\u57fa\u672c\u4fe1\u606f</li> <li>\u7814\u7a76\u76ee\u6807\u548c\u9879\u76ee\u7b80\u4ecb</li> <li>\u5408\u4f5c\u65b9\u5f0f</li> <li>\u5408\u4f5c\u65b9\u8d44\u8d28\u9700\u6c42\u548c\u5df2\u6709\u5408\u4f5c\u5355\u4f4d</li> </ul> </li> <li>\u9879\u76ee\u4e8c\uff1aRNA\u5236\u836f\u9879\u76ee - AI \u9a71\u52a8\u7684RNA\u836f\u7269\u8bbe\u8ba1\u6280\u672f<ul> <li>\u57fa\u672c\u4fe1\u606f</li> <li>\u7814\u7a76\u76ee\u6807</li> <li>\u9879\u76ee\u7b80\u4ecb</li> </ul> </li> <li>\u76f8\u5173\u4e13\u5229\u548c\u8f6f\u4ef6</li> <li>\u6280\u672f\u6210\u679c\u76f8\u5173\u62a5\u9053</li> <li>\u8054\u7cfb\u65b9\u5f0f</li> </ul> </li> </ul>"},{"location":"people/open/#_2","title":"\u5b9e\u9a8c\u5ba4\u7b80\u4ecb","text":"<p>\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\uff08 \u5b9e\u9a8c\u5ba4\u4e3b\u9875 \uff09\u4e0b\u5c5e\u4e8e\u6e05\u534e\u5927\u5b66\u751f\u547d\u79d1\u5b66\u5b66\u9662\uff0c\u5b9e\u9a8c\u5ba4\u6210\u5458\u5305\u62ec\u535a\u58eb\u751f10\u4f59\u540d\u548c\u672c\u79d1\u5b9e\u4e60\u751f\u82e5\u5e72\uff0c\u6765\u81ea\u751f\u7269\u5b66\u3001\u7edf\u8ba1\u5b66\u3001\u8ba1\u7b97\u673a\u79d1\u5b66\u7b49\u591a\u5b66\u79d1\u3002\u5b9e\u9a8c\u5ba4\u4f9d\u6258\u4e8e\u201c\u751f\u7269\u4fe1\u606f\u5b66\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u201d\u548c\u6e05\u534e\u5927\u5b66\u201c\u5408\u6210\u4e0e\u7cfb\u7edf\u751f\u7269\u5b66\u7814\u7a76\u4e2d\u5fc3\u201d\uff0c\u62e5\u6709\u5f88\u597d\u7684\u4eba\u624d\u652f\u6491\u3001\u786c\u4ef6\u5e73\u53f0\u548c\u5408\u4f5c\u79d1\u7814\u73af\u5883\u3002</p> <p>\u6211\u4eec\u5b9e\u9a8c\u5ba4\u81f4\u529b\u4e8e\u53d1\u5c55\u751f\u7269\u4fe1\u606f\u5b66\u6280\u672f\uff0c\u5e76\u63a2\u7d22\u5176\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u7b49\u590d\u6742\u75be\u75c5\u7684\u7cbe\u51c6\u8bca\u7597\u4e0a\u7684\u5177\u4f53\u5e94\u7528\u3002\u6211\u4eec\u5229\u7528\u673a\u5668\u5b66\u4e60\u7b49\u4eba\u5de5\u667a\u80fd\u6280\u672f\uff0c\u7ed3\u5408\u975e\u7f16\u7801RNA (ncRNA)\u4e3a\u6838\u5fc3\u7684\u591a\u7ec4\u5b66\u6570\u636e\uff0c\u6765\u7814\u7a76\u9057\u4f20\u4fe1\u606f\u662f\u5982\u4f55\u88ab\u7f16\u7801\u5728\u7ed3\u6784\u5316\u7684DNA\u548cRNA\u5206\u5b50\u4e4b\u4e2d\uff0c\u4ee5\u53ca\u5b83\u4eec\u662f\u5982\u4f55\u5728\u4e00\u4e2a\u751f\u547d\u4f53\u7cfb\u4e2d\u76f8\u4e92\u4f5c\u7528\u3001\u5f7c\u6b64\u8c03\u63a7\u3002</p> <p>\u201c\u4e0a\u5de5\u6cbb\u672a\u75c5\u201d\uff0c\u6211\u4eec\u7684\u4e00\u4e2a\u91cd\u8981\u4f7f\u547d\uff0c\u662f\u5e2e\u52a9\u4eba\u4eec\u66f4\u65e9\u671f\u7684\u53d1\u73b0\u548c\u6cbb\u7597\u75be\u75c5\u3002\u6211\u4eec\u76f8\u4fe1\uff0c\u8fd9\u79cd\u4f7f\u547d\u611f\u4ee5\u53ca\u4e3a\u6b64\u4ed8\u51fa\u7684\u5b9e\u8df5\u548c\u52aa\u529b\uff0c\u5c06\u5e2e\u52a9\u6211\u4eec\u7406\u89e3\u548c\u6cbb\u7597\u4eba\u7c7b\u75be\u75c5\uff0c\u5e76\u6700\u7ec8\u8ba4\u8bc6\u548c\u63d0\u9ad8\u6211\u4eec\u81ea\u5df1\u3002</p> <p>\u5b9e\u9a8c\u5ba4\u8d1f\u8d23\u4eba\u9c81\u5fd7\u535a\u58eb (\u4e2a\u4eba\u5b98\u65b9\u4e3b\u9875)\uff0c\u6e05\u534e\u5927\u5b66\u751f\u547d\u79d1\u5b66\u5b66\u9662\u957f\u8058\u526f\u6559\u6388\uff08tenured\uff09\u3001\u7279\u522b\u7814\u7a76\u5458\u3001\u535a\u58eb\u751f\u5bfc\u5e08\uff0c\u56fd\u5bb6\u57fa\u91d1\u59d4\u201c\u4f18\u79c0\u9752\u5e74\u201d\u57fa\u91d1\u3001\u67d0\u9752\u5e74\u4eba\u624d\u9879\u76ee\u3001\u201c\u970d\u82f1\u4e1c\u201d\u9752\u5e74\u57fa\u91d1\u83b7\u5f97\u8005\u3002\u9c81\u5fd7\u535a\u58eb\u4e13\u6ce8\u201c\u975e\u7f16\u7801RNA\u201d\u76f8\u5173\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\uff0c\u5728\u8be5\u9886\u57df\u6df1\u8015\u591a\u5e74\uff0c\u53d1\u8868\u76f8\u5173 SCI\u6587\u7ae070\u4f59\u7bc7(\u5f15\u7528\u6b21\u6570\u8d85\u8fc72\u4e07\u6b21)\uff0c\u5176\u4e2d\u901a\u8baf\u4f5c\u8005\u6587\u7ae030\u4f59\u7bc7\uff08ESI\u9ad8\u88ab\u5f15\u8bba\u65874\u7bc7\uff09\u3002\u4ee3\u8868\u6027\u5de5\u4f5c\u662f\u5173\u4e8e\u65b0\u578b\u975e\u7f16\u7801RNA\u6a21\u578b\u548c\u7b97\u6cd5\u7684\u5f00\u53d1 (Nucleic Acids Res. 2015a*\uff1b2015b*\uff1b2016*; 2017a*; 2017b*; 2017c*+; 2018*; 2019*+; 2022*; 2024*; Genome Biology 2017*; PNAS 2020*+; Bioinformatics 2024a*;2024b*; Nature Comp. Sci. 2025*\uff09\u53ca\u5176\u5728\u764c\u75c7\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u4e0a\u7684\u4ea4\u53c9\u5408\u4f5c\u4e0e\u5e94\u7528 (Nature Commn. 2017*, Cell Res. 2020*+, e-Life 2022*+, eBioMedicine 2023*+, Cell Rep. Med. 2023*, Clinical &amp; Trans. Med. 2024*, Genome Biology 2025*) \uff08*\u6700\u540e\uff0c*+\uff1a\u5171\u540c\u901a\u8baf\u6587\u7ae0\uff09\u3002</p> <p>\u5b9e\u9a8c\u5ba4\u56f4\u7ed5\u7740\u975e\u7f16\u7801RNA(ncRNA)\u4e3b\u8981\u6709\u4e24\u4e2a\u7814\u7a76\u65b9\u5411: 1\uff09AI\u9a71\u52a8\u7684\u6838\u9178\u6a21\u578b\uff1b2\uff09\u751f\u4fe1\u9a71\u52a8\u7684\u7cbe\u51c6\u533b\u7597\u3002 \u8be6\u89c1 Projects \u3002</p>"},{"location":"people/open/#_3","title":"\u4ee3\u8868\u6027\u5728\u7814\u9879\u76ee","text":"<ul> <li>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u96be\u6cbb\u6027\u81ea\u8eab\u514d\u75ab\u75c5\u7cbe\u51c6\u8bca\u6cbb\u4e0e\u521b\u65b0\u7597\u6cd5\u7814\u7a76\uff0c2024.12-2027.11 \u8bfe\u9898\u7ec4\u957f</li> <li>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u975e\u7f16\u7801RNA\u9ad8\u901a\u91cf\u89e3\u6790\u6280\u672f\u4e0e\u4e34\u5e8a\u5e94\u7528\u7814\u53d1\uff0c2024.12-2027.11 \u8bfe\u9898\u9aa8\u5e72</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u4e13\u9879\u9879\u76ee\uff0c82341101\uff0c\u57fa\u4e8eAI\u6280\u672f\u7684\u9776\u5411RNA\u7684\u836f\u7269\u8bbe\u8ba1\uff0c2024-2027 \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c82371855\uff0c\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7cbe\u51c6\u8bca\u7597\u4e2d\u57fa\u4e8e\u975e\u7f16\u7801RNA\u7ec4\u5b66\u548c\u751f\u7269\u4fe1\u606f\u5b66\u7684\u65b0\u65b9\u6cd5\u7814\u7a76\uff0c2024-2027 \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c3217040246\uff0c\u4f53\u6db2\u591a\u7ec4\u5b66\u6570\u636e\u6574\u5408\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u53ca\u5176\u5728\u764c\u75c7\u65e0\u521b\u68c0\u6d4b\u4e0a\u7684\u5e94\u7528\uff0c2022-2025 \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c81972798\uff0c\u9488\u5bf9\u764c\u75c7\u8bca\u65ad\u548c\u9884\u540e\u7684\u65b0\u578b\u4f53\u6db2exRNA\u6807\u5fd7\u7269\u7684\u7814\u7a76\uff0c2020-2023 \u4e3b\u6301</li> <li>\u56fd\u5bb6\u201c\u51e4\u51f0\u5de5\u7a0b\u201d \u6280\u672f\u521b\u65b0\u5f00\u653e\u5171\u4eab\u8bfe\u9898\uff0c2021-NCPSB-005\uff0c\u591a\u7ec4\u5b66\u6574\u5408\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\uff0c2021-2023 \u4e3b\u6301</li> <li>\u6e05\u534e\u5927\u5b66\u7cbe\u51c6\u533b\u5b66\u7814\u7a76\u9662 \u7cbe\u51c6\u533b\u7597\u6218\u7565\u9879\u76ee\uff0c \u57fa\u4e8e\u591a\u7ec4\u5b66\u6570\u636e\u7684\u667a\u80fd\u5316\u4e2d\u665a\u671f\u809d\u764c\u8f6c\u5316\u6cbb\u7597\u51b3\u7b56\u7814\u7a76\uff0c2022-2025 \u4e3b\u6301</li> <li>\u6e05\u534e\u5927\u5b66\u56fd\u5f3a\u7814\u7a76\u9662 \u4eba\u5de5\u667a\u80fd\u4e0e\u673a\u5668\u4eba\u9879\u76ee\uff0c2021GQG1020\uff0c\u751f\u7269\u8c03\u63a7\u7f51\u7edc\u77e5\u8bc6\u542f\u53d1\u4e0b\u7684\u65b0\u578bAI\u6a21\u578b\u7684\u6784\u5efa\u53ca\u5176\u5728\u764c\u75c7\u65e9\u8bca\u4e0a\u7684\u5e94\u7528\uff0c2022-2024 \u4e3b\u6301</li> <li>\u6e05\u534e\u5927\u5b66\u6625\u98ce\u57fa\u91d1\uff0c2021Z99CFY022\uff0c\u9488\u5bf9\u5fae\u751f\u7269\u611f\u67d3\u7684\u65b0\u578b\u6838\u9178\u68c0\u6d4b\u6280\u672f\u7814\u53d1\uff0c2021-2023 \u4e3b\u6301</li> <li>\u5408\u80a5\u7efc\u5408\u6027\u56fd\u5bb6\u79d1\u5b66\u4e2d\u5fc3\u5927\u5065\u5eb7\u7814\u7a76\u9662 \u5168\u7403\u9074\u9009\u9879\u76ee, cfRNA\u4e3a\u6838\u5fc3\u7684\u591a\u7ec4\u5b66\u5728\u80ba\u764c\u7b5b\u67e5\u4e0a\u7684\u5e94\u7528\u7814\u7a76, 2024-2027 \u4e3b\u6301</li> <li>Bayer AI\u5236\u836f\u9879\u76ee, AI driven drug design targeting RNAs\uff0c2023-2024 \u4e3b\u6301</li> </ul>"},{"location":"people/open/#-aicfrna","title":"\u9879\u76ee\u4e00\uff1a\u9488\u5bf9\u764c\u75c7\u7b49\u590d\u6742\u75be\u75c5\u7684\u6838\u9178\u68c0\u6d4b\u9879\u76ee - AI\u9a71\u52a8\u7684cfRNA\u68c0\u6d4b\u6280\u672f","text":""},{"location":"people/open/#_4","title":"\u57fa\u672c\u4fe1\u606f","text":"<ul> <li>\u5408\u4f5c\u8bfe\u9898\uff1a\u9488\u5bf9\u764c\u75c7\u7b49\u590d\u6742\u75be\u75c5\u7684AI\u9a71\u52a8\u7684cfRNA\u68c0\u6d4b\u6280\u672f </li> <li>\u62db\u52df\u673a\u6784\uff1a<ul> <li>1. \u533b\u9662\u3001\u4e34\u68c0\u673a\u6784\u7b49</li> <li>2. \u57fa\u56e0\u68c0\u6d4b\u516c\u53f8\u7b49</li> <li>3. \u4eba\u5de5\u667a\u80fd\u76f8\u5173\u7684\u5b9e\u9a8c\u5ba4</li> <li>4. \u68c0\u6d4b\u548c\u6d4b\u5e8f\u6280\u672f\u76f8\u5173\u7684\u5b9e\u9a8c\u5ba4</li> </ul> </li> <li>\u5408\u4f5c\u65b9\u5f0f\uff1a<ul> <li>\u5408\u4f5c\u4e34\u5e8a\u9879\u76ee\u53d1\u73b0\u65b0\u9776\u6807\u548c\u65b0\u6807\u5fd7\u7269</li> <li>\u5408\u4f5c\u4ea7\u4e1a\u5316\u9879\u76ee\u5f00\u53d1\u548c\u5e94\u7528\u68c0\u6d4b\u8bd5\u5242\u76d2</li> <li>\u5408\u4f5c\u79d1\u7814\u8bfe\u9898\u8fdb\u884c\u4eba\u5de5\u667a\u80fd\u6280\u672f\u5f00\u53d1</li> <li>\u5408\u4f5c\u79d1\u7814\u8bfe\u9898\u8fdb\u884c\u68c0\u6d4b\u548c\u6d4b\u5e8f\u6280\u672f\u5f00\u53d1</li> </ul> </li> <li>\u53d1\u8d77\u7ec4\u7ec7\uff1a\u6e05\u534e\u5927\u5b66\u751f\u547d\u5b66\u9662\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \uff08Lab of RNA Bioinformatics\uff09</li> <li>\u6709\u6548\u65f6\u95f4\uff1a\u957f\u671f</li> </ul>"},{"location":"people/open/#_5","title":"\u7814\u7a76\u76ee\u6807\u548c\u9879\u76ee\u7b80\u4ecb","text":"<ul> <li>\u7814\u7a76\u76ee\u6807\uff1a</li> </ul> <p>\u8be5\u764c\u75c7\u68c0\u6d4b\u9879\u76ee\u7684\u76ee\u7684\u662f\u8981\u4e3a\u764c\u75c7\u65e9\u671f\u7b5b\u67e5\u3001\u65e9\u671f\u8bca\u65ad\u4ee5\u53ca\u9884\u540e\u6cbb\u7597\u5bfb\u627e\u5230\u66f4\u597d\uff08\u7cbe\u51c6\u3001\u91cd\u590d\u6027\u9ad8\u3001\u7ecf\u6d4e\u4e0a\u5229\u4e8e\u666e\u53ca\u5927\u4f17\u3001\u64cd\u4f5c\u4e0a\u7b80\u5355\u65e0\u521b\uff09\u7684\u65b0\u578b\u4f53\u6db2\u6807\u5fd7\u7269\uff08exRNA/cfRNA\uff09\uff0c\u5e76\u6807\u51c6\u5316\u5176\u68c0\u6d4b\u548c\u89e3\u6790\u6d41\u7a0b\uff0c\u5f00\u53d1\u51fa\u65b0\u7684\u6db2\u4f53\u6d3b\u68c0\u6280\u672f\u3002\u201c\u4e0a\u5de5\u6cbb\u672a\u75c5\u201d\uff0c\u6211\u4eec\u8981\u5e2e\u52a9\u66f4\u591a\u4eba\u66f4\u65e9\u5730\u53d1\u73b0\u764c\u75c7\u3002</p> <ul> <li>\u9879\u76ee\u7b80\u4ecb\uff1a</li> </ul> <p>\u672c\u9879\u76ee\u5c06\u57fa\u4e8e\u57fa\u56e0\u7ec4\u5b66\u548c\u751f\u7269\u4fe1\u606f\u5b66\uff0c\u901a\u8fc7\u5f00\u53d1\u4f53\u6db2RNA\u5fae\u91cf\u6d4b\u5e8f\u6280\u672f\u548c\u673a\u5668\u5b66\u4e60\u65b9\u6cd5\uff0c\u5728\u4f53\u6db2\u4e2d\u53d1\u73b0\u548c\u9274\u5b9a\u4e0e\u764c\u75c7\u53d1\u751f\u53d1\u5c55\u76f8\u5173\u7684\u65b0\u578bexRNA\u6807\u5fd7\u7269\uff0c\u5e94\u7528\u4e8e\u56fd\u5185\u9ad8\u81f4\u6b7b\u764c\u75c7\u7684\u65e9\u671f\u8bca\u65ad\u548c\u9884\u540e\u8f85\u52a9\u6cbb\u7597\u3002exRNA\u6307\u7684\u662f\u80de\u5916RNA\uff0c\u53c8\u79f0cfRNA\uff0c\u5305\u62ec\u591a\u79cd\u7c7b\u578b\uff1amiRNA,Y RNA,circRNA,lncRNA\u7b49\u3002RNA\u6807\u5fd7\u7269\u4e0eDNA\u548c\u86cb\u767d\u6807\u5fd7\u7269\u76f8\u6bd4\uff0c\u5177\u6709\u66f4\u597d\u7684\u654f\u611f\u6027\u3001\u7ec4\u7ec7\u7279\u5f02\u6027\u548c\u591a\u6837\u6027\uff0c\u4e3a\u66f4\u597d\u7684\u4e34\u5e8a\u68c0\u9a8c\u5e26\u6765\u4e86\u65b0\u7684\u671f\u671b\u3002\u6211\u4eec\u5728\u65b0\u578b\u975e\u7f16\u7801RNA\u548c\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u65b9\u9762\u79ef\u7d2f\u4e86\u4e30\u5bcc\u7ecf\u9a8c\uff0c\u57fa\u4e8e\u6b64\uff0c\u6211\u4eec\u5c06\u5728\u764c\u75c7\u75c5\u4eba\u4f53\u6db2\uff08\u5982\u8840\u6db2\uff09\u4e2d\u53d1\u73b0\u548c\u5206\u6790\u6807\u5fd7\u764c\u75c7\u53d1\u751f\u53d1\u5c55\u7684\u65b0\u578bexRNA/cfRNA\uff0c\u5e76\u6574\u5408\u73b0\u6709\u6807\u5fd7\u7269\u6784\u5efa\u591a\u91cd\u6807\u5fd7\u7269\u7684\u667a\u80fd\u6a21\u578b\uff0c\u5728\u5927\u6837\u672c\u4e0a\u8fdb\u884c\u9a8c\u8bc1\uff0c\u5efa\u7acb\u5177\u6709\u66f4\u9ad8\u7cbe\u51c6\u5ea6\u548c\u53ef\u91cd\u590d\u6027\u7684\u65e0\u521b\u68c0\u9a8c\u65b9\u6cd5\u3002</p> <p>\u6211\u4eec\u5728\u975e\u7f16\u7801RNA(ncRNA)\u6d4b\u5e8f\u548c\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u4e2d\u79ef\u7d2f\u4e86\u8fd120\u5e74\u7684\u4e30\u5bcc\u7ecf\u9a8c\uff0c\u4f8b\u5982\uff1a</p> <ul> <li>\u6211\u4eec\u5728\u6a21\u5f0f\u751f\u7269\u548c\u809d\u764c\u6837\u672c\u4e2d\u901a\u8fc7\u6d4b\u5e8f\u548c\u751f\u7269\u4fe1\u606f\u5b66\u5206\u6790\u53d1\u73b0\u4e86\u5f88\u591a\u65b0\u7684\u975e\u7f16\u7801RNA\uff08Science 2010; Nature 2012; Nature 2014; Genome Biology 2017; Cell 2019; Cell Research 2020; PNAS 2020\uff09, \u5176\u4e2d\u6709\u4e0d\u5c11\u5177\u6709\u5f88\u597d\u7684\u6807\u5fd7\u7269\u7279\u6027\u3002</li> <li>\u81ea2015\u5e74\u8d77\uff0c\u5b9e\u9a8c\u5ba4\u5f00\u59cb\u5927\u529b\u53d1\u5c55\u9488\u5bf9\u4f53\u6db2\u65e0\u521b\u68c0\u6d4b\u6280\u672f\u7684\u7814\u7a76,\u4e3a\u590d\u6742\u75be\u75c5\u7684\u65e0\u521b\u68c0\u6d4b\u8bd5\u5242\u7684\u5f00\u53d1\u63d0\u4f9b\u4e86\u6709\u529b\u7684\u652f\u6301\uff1a<ul> <li>\u514b\u670d\u4e86\u4f53\u6db2\u6e38\u79bbRNA\u6613\u964d\u89e3\u53ca\u5fae\u91cf\u5efa\u5e93\u7684\u6280\u672f\u96be\u9898\uff0c\u5f00\u53d1\u4e86\u81ea\u4e3b\u7814\u53d1\u7684\u8d85\u5fae\u91cfRNA\u6d4b\u5e8f\u6280\u672fi-SMART(\u4e13\u5229\u53f7\uff1a201810607652X\uff09\u3001DETECTOR-seq (\u4e13\u5229\u7533\u8bf7\u53f7\uff1a202210579444.X) (elife 2022, Cell Rep. Med. 2023, Clinic. &amp; Tranl. Med. 2024)\uff1b</li> <li>\u5f00\u53d1\u4e86\u57fa\u4e8e\u673a\u5668\u5b66\u4e60\u548c\u4eba\u5de5\u667a\u80fd\u7684\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u6cd5RNAfinder\uff08\u4e13\u5229\u53f7\uff1a2016108069288\uff09\u548cexSEEK\uff08\u4e13\u5229\u7533\u8bf7\u53f7\uff1a202010618721.4\uff09(Genome Res. 2011; Nucleic Acids Res. 2015; Nucleic Acids Res. 2017a; Genome Biology 2025)\uff1b</li> <li>\u53d1\u73b0\u4e86\u4e00\u4e9b\u65b0\u7684exRNA\u6807\u5fd7\u7269\uff08\u4e13\u5229\u53f7:2018110094643\uff1b\u4e13\u5229\u53f7\uff1a202010927225.7) (Nature Communications 2017; Clinical Chemistry 2019; Theranositics 2021)\uff1b</li> <li>\u79ef\u7d2f\u4e86\u764c\u75c7\u76f8\u5173\u7684RNA\u6570\u636e\u5e93\uff08\u8457\u4f5c\u6743\u53f7\uff1a2016R11S367236\uff09(Nucleic Acids Res. 2017b; Nucleic Acids Res. 2019\uff1bNucleic Acids Res. 2022)\u3002</li> </ul> </li> </ul>"},{"location":"people/open/#_6","title":"\u5408\u4f5c\u65b9\u5f0f","text":""},{"location":"people/open/#1","title":"1) \u5408\u4f5c\u53d1\u8868\u79d1\u7814\u6587\u7ae0","text":"<p>\u5408\u4f5c\u53d1\u73b0\u548c\u7814\u7a76\u4f53\u6db2\u4e2d\u7684\u65b0\u578bexRNA/cfRNA\uff0c\u5171\u540c\u53d1\u8868\u79d1\u7814\u6587\u7ae0</p> <ul> <li>\u65b9\u6cd5\u5b66\u5f00\u53d1<ul> <li>\u5171\u540c\u5f00\u53d1\u9488\u5bf9\u591a\u7ec4\u5b66\u3001\u591a\u6a21\u6001\u6570\u636e\u6574\u5408\u7684\u4eba\u5de5\u667a\u80fd\u6a21\u578b</li> <li>\u5171\u540c\u5f00\u53d1\u9488\u5bf9cfRNA\uff08\u4ee5\u53ca\u591a\u7ec4\u5b66\uff09\u7684\u9ad8\u901a\u91cf\u6d4b\u5e8f\u6280\u672f</li> </ul> </li> <li>I\u671f. \u65b0\u578b\u6807\u5fd7\u7269\u7684\u201c\u53d1\u73b0\u548c\u63a2\u7d22\u201d\u9636\u6bb5<ul> <li>\u8d35\u5355\u4f4d\u6784\u8d1f\u8d23\u6536\u96c6 \u5c11\u91cf\uff0830-50\u4f8b\u8840\u6837\uff09 \u764c\u75c7\u75c5\u4eba\u548c/\u6216\u5065\u5eb7\u5bf9\u7167\u4eba\u7fa4\u7684\u8840\u6d46\uff0c\u59a5\u5584\u50a8\u5b58\u5e76\u8fd0\u8f93\uff1b</li> <li>\u6211\u4eec\u8d1f\u8d23\u8fdb\u884c\u9884\u5b9e\u9a8c\u548c\u5206\u6790\uff0c\u5b9e\u9a8c\u548c\u5206\u6790\u8d39\u7528\u7531\u6211\u4eec\u627f\u62c5\u3002</li> </ul> </li> <li>II\u671f. \u65b0\u578b\u6807\u5fd7\u7269\u7684\u201c\u9274\u5b9a\u548c\u9a8c\u8bc1\u201d\u9636\u6bb5<ul> <li>\u5728\u524d\u671f\u9884\u5b9e\u9a8c\u6548\u679c\u8f83\u597d\u7684\u524d\u63d0\u4e0b\uff0c\u8fd8\u9700\u8981\u5728 \u5927\u91cf\u6837\u672c\uff08200-500\u4f8b\u8840\u6837\uff09 \uff08\u6700\u597d\u90e8\u5206\u8840\u6837\u80fd\u914d\u5957\u7ec4\u7ec7\u6837\u672c\uff09\u4e2d\u8fdb\u884c\u6d4b\u5e8f\u548c\u9a8c\u8bc1\uff1b</li> <li>\u5b9e\u9a8c\u548c\u5206\u6790\u8d39\u7528\u7531\u53cc\u65b9\u5171\u540c\u627f\u62c5\uff0c\u5177\u4f53\u5408\u4f5c\u4e8b\u5b9c\u9762\u8bae\u3002</li> </ul> </li> </ul> <p>\u6837\u672c\u6536\u96c6\u4e0e\u4e34\u5e8a\u961f\u5217\u8bbe\u8ba1:</p>"},{"location":"people/open/#2","title":"2) \u5408\u4f5c\u5f00\u53d1\u8bd5\u5242\u76d2\u548c\u7533\u8bf7\u5668\u68b0\u8bc1","text":"<p>\u6211\u4eec\u63d0\u4f9b\u76f8\u5173\u8bd5\u5242\u76d2\u548c\u68c0\u6d4b\u65b9\u6cd5\u7684\u5f00\u53d1\u548c\u751f\u4ea7\u65b9\u6848</p> <ul> <li>III\u671f. \u65b0\u578b\u6807\u5fd7\u7269\u4f18\u5316\u548c\u8bd5\u5242\u76d2\u8bbe\u8ba1<ul> <li>\u6211\u4eec\u8d1f\u8d23\u4ece\u524d\u671f\u79d1\u7814\u6210\u679c\u548c\u81ea\u6709\u7684\u6db2\u4f53\u6d3b\u68c0\u751f\u7269\u6807\u5fd7\u7269\u6570\u636e\u5e93\uff08\u6ce81\uff09\u4e2d\u6839\u636e\u8d35\u5355\u4f4d\u9700\u6c42\u7b5b\u9009\u51fa\u8bc1\u636e\u7b49\u7ea7\u548c\u4e34\u5e8a\u5e94\u7528\u6f5c\u529b\u8f83\u9ad8\u7684\u5019\u9009\u751f\u7269\u6807\u5fd7\u7269\uff0c\u6db5\u76d6DNA\uff0cRNA\uff0c\u86cb\u767d\uff0c\u4ee3\u8c22\u7269\u7b49\u4e0d\u540c\u5206\u5b50\u7c7b\u578b\uff0c\u6211\u4eec\u5c06\u7efc\u5408\u8003\u8651\u6807\u5fd7\u7269\u7684\u4e00\u81f4\u6027\u62a5\u9053\u4e2a\u6570\u3001\u5df2\u9a8c\u8bc1\u7684\u6837\u672c\u6570\u3001\u751f\u7269\u5b66\u529f\u80fd\u548c\u8bca\u65ad\u6548\u679c\u7b49\uff1b</li> <li>\u8d35\u5355\u4f4d\u8d1f\u8d23\u5bf9\u7b5b\u9009\u7684\u6807\u5fd7\u7269\u5728200-500\u4f8b\u764c\u75c7\u75c5\u4eba\u548c\u5065\u5eb7\u5bf9\u7167\u4eba\u7fa4\u7684\u8840\u6d46\u6837\u672c\u4e2d\u8fdb\u884c\u4e8c\u6b21\u9a8c\u8bc1\uff1b</li> <li>\u6211\u4eec\u8d1f\u8d23\u5bf9\u9a8c\u8bc1\u6570\u636e\u8fdb\u884c\u518d\u5206\u6790\uff0c\u91c7\u7528\u673a\u5668\u5b66\u4e60\u7b49\u4eba\u5de5\u667a\u80fd\u65b9\u6cd5\u4f18\u5316\u51fa\u8bca\u65ad\u6a21\u578b\uff0c\u8bbe\u8ba1\u76f8\u5e94\u8bd5\u5242\u76d2\uff1b</li> <li>\u8d35\u5355\u4f4d\u8fdb\u884c\u76f8\u5e94\u8bd5\u5242\u76d2\u751f\u4ea7\u548c\u63a8\u5e7f\u3002</li> </ul> </li> <li>IV\u671f. \u5927\u89c4\u6a21\u4e34\u5e8a\u62a5\u8bc1\u548c\u4ea7\u4e1a\u5316\u9636\u6bb5<ul> <li>\u8fdb\u884c\u4e09\u7c7b\u533b\u7597\u5668\u68b0\u8bc1\u7684\u6ce8\u518c\u3001\u7533\u62a5\u548c\u63a8\u5e7f\uff0c\u5177\u4f53\u5408\u4f5c\u4e8b\u5b9c\u9762\u8bae\uff0c\u53ef\u4ee5\u5171\u540c\u5bfb\u627e\u5176\u4ed6\u6295\u8d44\u548c\u5408\u4f5c\u4f19\u4f34\u3002</li> </ul> </li> </ul> <p>\u6ce81\uff1a</p> <p>\u6211\u4eec\u5df2\u7ecf\u6784\u5efa\u4e86\u4e00\u4e2a\u5305\u542b DNA\uff0cRNA\uff0c\u86cb\u767d\u8d28\u548c\u4ee3\u8c22\u7269\u7684\u6574\u5408\u6027\u6db2\u4f53\u6d3b\u68c0\u751f\u7269\u6807\u5fd7\u7269\u6570\u636e\u5e93\u3002\u8be5\u6570\u636e\u5e93\u5305\u62ec\uff1a</p> <ul> <li>\u83b7 FDA/CFDA \u6279\u51c6\u7684\u8fd1\u767e\u4e2a\u7528\u4e8e\u4e34\u5e8a\u80bf\u7624\u8bca\u65ad\u3001\u6307\u5bfc\u7528\u836f\u548c\u9884\u540e\u7684\u751f\u7269\u6807\u5fd7\u7269\uff1b</li> <li>\u4ece \u4e0a\u5343\u7bc7\u5df2\u53d1\u8868\u79d1\u7814\u6587\u732e\u4e2d\u624b\u52a8\u6536\u96c6\u7684\u5177\u6709\u4e34\u5e8a\u5e94\u7528\u6f5c\u80fd\u7684\u751f\u7269\u6807\u5fd7\u7269\uff1b</li> <li>\u4ece\u516c\u5f00\u53d1\u8868\u7684\u51e0\u5343\u5957\u6db2\u4f53\u6d3b\u68c0\u9ad8\u901a\u91cf\u6570\u636e\u4e2d\u9274\u5b9a\u51fa\u6765\u7684\u5019\u9009\u751f\u7269\u6807\u5fd7\u7269\u3002</li> </ul> <p>\u6211\u4eec\u7684\u6570\u636e\u5e93\u6db5\u76d6\u4e86\u80ba\u764c\u3001\u4e73\u817a\u764c\u3001\u7ed3\u76f4\u80a0\u764c\u3001\u809d\u764c\u3001\u80f0\u817a\u764c\u3001\u80c3\u764c\u3001\u98df\u7ba1\u764c\u3001\u8111\u80f6\u8d28\u7624\u3001\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u3001\u524d\u5217\u817a\u764c\u3001\u5375\u5de2\u764c\u3001\u80be\u764c\u3001\u51a0\u5fc3\u75c5\u7b4931\u79cd\u4eba\u7c7b\u75be\u75c5\u3002\u540c\u65f6\uff0c\u6211\u4eec\u57fa\u4e8e\u6807\u5fd7\u7269\u7684\u8bc1\u636e\u6c34\u5e73\u53d1\u5c55\u4e86\u4e00\u5957\u6807\u5fd7\u7269\u5206\u7ea7\u7cfb\u7edf\uff0c\u7ed9\u6bcf\u4e00\u4e2a\u6807\u5fd7\u7269\u6307\u5b9a\u4e00\u4e2a\u8bc1\u636e\u7b49\u7ea7\uff0c\u5e2e\u52a9\u7528\u6237\u5feb\u901f\u5730\u8ba4\u8bc6\u6240\u611f\u5174\u8da3\u7684\u6807\u5fd7\u7269\u7684\u4e34\u5e8a\u5e94\u7528\u6f5c\u529b\u3002</p>"},{"location":"people/open/#3","title":"3) \u63d0\u4f9b\u6807\u5fd7\u7269\u53d1\u73b0\u548c\u4f18\u5316\u7684\u5b9e\u9a8c\u65b9\u6848","text":"<p>\u6211\u4eec\u63d0\u4f9b\u4f53\u6db2\u4e2d\u65b0\u578b\u6807\u5fd7\u7269\u7684\u53d1\u73b0\u3001\u9274\u5b9a\u548c\u4f18\u5316\u65b9\u6cd5 - \u5b9e\u9a8c\u65b9\u6848</p> <p>\u6211\u4eec\u5728\u524d\u671f\u7814\u7a76exRNA\u7684\u8fc7\u7a0b\u4e2d\uff0c\u53c2\u8003\u6700\u65b0\u7684\u5355\u7ec6\u80de\u6d4b\u5e8f\u65b9\u6cd5\uff0c\u6478\u7d22\u4e86\u4e00\u5957\u53ef\u4ee5\u4ece\u4f53\u6db2\u4e2d\u9ad8\u6548\u7387\u5730\u6355\u83b7\u4e0d\u540c\u957f\u5ea6\u3001\u4e0d\u540c\u7c7b\u578b\u7684exRNA\uff08\u53c8\u79f0\u4e3acfRNA\uff09\u7684\u5b9e\u9a8c\u6d41\u7a0b\u3002\u6211\u4eec\u5c06\u6839\u636e\u8d35\u5355\u4f4d\u9700\u6c42\u5f00\u53d1\u76f8\u5e94\u8bd5\u5242\u76d2\uff0c\u53ef\u4ee5\u5e2e\u52a9\u4f7f\u7528\u8005\u4ece\u591a\u79cd\u4f53\u6db2\u4e2d\u8fdb\u884cexRNA/cfRNA\u7684\u7814\u7a76\uff0c\u6db5\u76d6\u4e86\u63d0\u53d6\u3001\u7eaf\u5316\u3001\u6355\u83b7\u3001\u6269\u589e\u7b49\u4e00\u7cfb\u5217\u6b65\u9aa4\u7684\u8bd5\u5242\u53ca\u65b9\u6cd5\uff0c\u53ef\u57281-2\u5929\u5185\u5b8c\u6210\u4ece\u4f53\u6db2\u83b7\u53d6\u5230exRNA/cfRNA\u4e0a\u673a\u6d4b\u5e8f\u7684\u5168\u90e8\u51c6\u5907\uff0c\u5b9e\u7528\u4fbf\u6377\u3002</p> <p>\u5305\u542bsmall cfRNA/exRNA\u548ctotal cfRNA/exRNA\u7684\u5168\u8f6c\u5f55\u7ec4\u6355\u83b7\u3001\u5bcc\u96c6\u548c\u6d4b\u5e8f\u65b9\u6848:</p>"},{"location":"people/open/#4","title":"4) \u63d0\u4f9b\u6807\u5fd7\u7269\u53d1\u73b0\u548c\u4f18\u5316\u7684\u751f\u4fe1\u5206\u6790","text":"<p>\u6211\u4eec\u63d0\u4f9b\u4f53\u6db2\u4e2d\u65b0\u578b\u6807\u5fd7\u7269\u7684\u53d1\u73b0\u3001\u9274\u5b9a\u548c\u4f18\u5316\u65b9\u6cd5 - \u751f\u7269\u4fe1\u606f\u5b66\u5206\u6790\u548c\u8f6f\u4ef6\u5b9a\u5236\u3002</p> <p>\u6211\u4eec\u5728\u5f00\u5c55\u5e7f\u6cdb\u5e94\u7528\u4e8e\u57fa\u56e0\u7ec4\u5b66\u548c\u764c\u75c7\u751f\u7269\u5b66\u7684\u79d1\u5b66\u5b9e\u8df5\u7684\u540c\u65f6\uff0c\u5f00\u53d1\u4e86\u4e00\u7cfb\u5217\u5206\u6790\u5de5\u5177\u548c\u5e73\u53f0\u3002\u4e3b\u8981\u5305\u62ecRNAfinder\u3001RNAtarget\u3001RNAstructurome\u3001RNAmed\u56db\u4e2a\u7cfb\u5217:</p> <ul> <li>a) RNAfinder<ul> <li>Ribowave:  \u7528\u4e8e\u6838\u7cd6\u4f53\u6d4b\u5e8f\u6570\u636e\uff08Ribo-seq\uff09\u7684\u5206\u6790\uff0c\u5229\u7528\u5c0f\u6ce2\u53d8\u6362\u6a21\u578b\u6765\u63d0\u53d6\u6838\u7cd6\u4f533-nt\u5468\u671f\uff08\u5373\u4fe1\u53f7\u9891\u7387\uff09\u6765\u4f7f\u539f\u59cb\u4fe1\u53f7\u53bb\u566a\u58f0\u5316\uff0c\u5e76\u7cbe\u786e\u5b9a\u4f4d\u5176\u8db3\u8ff9\u4fe1\u606f (Nucleic Acids Research 2018)\u3002</li> <li>COME:  \u7528\u4e8emRNA\u548clncRNA\u4e2d\u86cb\u767d\u7f16\u7801\u6f5c\u80fd\u7684\u5206\u6790 (Nucleic Acids Research 2017)\u3002</li> <li>RNAfeature: \u7528\u4e8e\u591a\u4e2a\u7269\u79cd\u95f4\u975e\u7f16\u7801RNA\u4fdd\u5b88\u6027\u4fe1\u606f\u7684\u5206\u6790 (Nucleic Acids Research 2015)\u3002</li> </ul> </li> <li>b) RNAtarget<ul> <li>RBPgroup: \u5229\u7528NMF\uff08\u975e\u8d1f\u77e9\u9635\u5206\u89e3\uff09\u5bf9\u5404\u79cdCLIP-seq\u6570\u636e\u8fdb\u884c\u6574\u5408\u5206\u6790  (Genome Biology  2017)\u3002</li> <li>POSTAR: \u4e00\u4e2a\u63a2\u7a76RNA\u8f6c\u5f55\u540e\u8c03\u63a7\u4e8b\u4ef6\u7684\u6570\u636e\u5e93\u548c\u5206\u6790\u5e73\u53f0\uff0c\u80fd\u63d0\u4f9b\u591a\u4e2a\u7269\u79cd\u95f4RNA-\u86cb\u767d\u7684\u76f8\u4e92\u4f5c\u7528\u3001\u81f4\u75c5\u7a81\u53d8\u4f4d\u70b9\u7b49\u4fe1\u606f (Nucleic Acids Research 2017/2019/2022)\u3002</li> <li>CLIPdb: \u4e00\u4e2a\u96c6\u6210\u4e86\u5404\u79cd\u7c7b\u578bCLIP-seq\u6570\u636e\u7684\u6570\u636e\u5e93\uff0c\u63cf\u8ff0RNA\u7ed3\u5408\u86cb\u767d\u548c\u5404\u79cdRNA\u8c03\u63a7\u7f51\u7edc\u7684\u96c6\u6210\u8d44\u6e90\u6570\u636e\u5e93 (BMC Genomics 2015)\u3002</li> </ul> </li> <li>c) RNAstructurome<ul> <li>RME/RNAex:  \u4e00\u79cdRNA\u4e8c\u7ea7\u7ed3\u6784\u9884\u6d4b\u7b97\u6cd5\uff0c\u540c\u65f6\u63d0\u4f9b\u4e86\u591a\u79cd\u7c7b\u578b\u7684RNA\u4e8c\u7ea7\u7ed3\u6784\u5b9e\u9a8c\u6570\u636e (Nucleic Acids Research 2015/2016)\u3002</li> </ul> </li> <li>d) RNAmed<ul> <li>cfPeak: cfPeak is a CNN model finding fragmented cell-free RNAs for disease diagnoisis and prognosis.</li> <li>exSeek: \u7528\u4e8e\u6574\u5408\u5206\u6790\u548c\u8bc4\u4f30\u7ec6\u80de\u5916RNA\u4f5c\u4e3a\u751f\u7269\u6807\u5fd7\u7269\u7684\u8ba1\u7b97\u6846\u67b6\u3002</li> <li>cfOmics: \u591a\u7c7b\u578b\u751f\u7269\u6807\u5fd7\u7269\u7684\u6574\u5408\u6570\u636e\u5e93\uff0c\u4e5f\u53ef\u4ee5\u7528\u6765\u9884\u6d4b\u5404\u79cd\u75be\u75c5\u60a3\u75c5\u53ef\u80fd\u6027\u3002</li> </ul> </li> </ul>"},{"location":"people/open/#_7","title":"\u5408\u4f5c\u65b9\u8d44\u8d28\u9700\u6c42\u548c\u5df2\u6709\u5408\u4f5c\u5355\u4f4d","text":"<p>\u5177\u6709\u6536\u96c6\u764c\u75c7\u75c5\u4eba\u548c/\u6216\u5065\u5eb7\u5bf9\u7167\u4eba\u7fa4\u4f53\u6db2\u548c/\u6216\u7ec4\u7ec7\u6837\u54c1\u7684\u8d44\u8d28 \uff0c\u6216\u5177\u6709\u8bd5\u5242\u76d2\u5f00\u53d1\u53ca\u63a8\u5e7f\u7ecf\u9a8c\u548c\u8d44\u8d28\u7684\u673a\u6784\u53ca\u516c\u53f8\u3002</p> <ul> <li>\u5df2\u6709\u5408\u4f5c\u5355\u4f4d:<ul> <li>\u5317\u4eac \u5317\u4eac\u534f\u548c\u533b\u9662</li> <li>\u5317\u4eac \u5317\u4eac\u5927\u5b66\u7b2c\u4e00\u533b\u9662</li> <li>\u5317\u4eac \u6e05\u534e\u957f\u5e9a\u533b\u9662</li> <li>\u5929\u6d25 \u5929\u6d25\u80bf\u7624\u533b\u9662</li> <li>\u4e0a\u6d77 \u6d77\u519b\u519b\u533b\u5927\u5b66</li> <li>\u6210\u90fd \u534e\u897f\u533b\u9662</li> <li>\u3002\u3002\u3002</li> </ul> </li> </ul>"},{"location":"people/open/#rna-ai-rna","title":"\u9879\u76ee\u4e8c\uff1aRNA\u5236\u836f\u9879\u76ee - AI \u9a71\u52a8\u7684RNA\u836f\u7269\u8bbe\u8ba1\u6280\u672f","text":""},{"location":"people/open/#_8","title":"\u57fa\u672c\u4fe1\u606f","text":"<ul> <li>\u5408\u4f5c\u8bfe\u9898\uff1aAI\u9a71\u52a8\u7684RNA\u836f\u7269\u8bbe\u8ba1\u5728\u75be\u75c5\u6cbb\u7597\u4e0a\u7684\u5e94\u7528 </li> <li>\u62db\u52df\u673a\u6784\uff1a<ul> <li>1. \u5236\u836f\u516c\u53f8\u3001\u65b0\u836f\u7814\u53d1\u516c\u53f8\u7b49</li> <li>2. \u4eba\u5de5\u667a\u80fd\u76f8\u5173\u7684\u5b9e\u9a8c\u5ba4</li> <li>3. \u836f\u5b66\u548c\u7ed3\u6784\u7814\u7a76\u76f8\u5173\u7684\u5b9e\u9a8c\u5ba4</li> <li>4. CRO\u516c\u53f8\u7b49</li> </ul> </li> <li>\u836f\u7269\u8bbe\u8ba1\u7c7b\u578b\uff1a<ul> <li>\u5229\u7528\u548c\u4f18\u5316\u6211\u4eec\u7684 AI \u65b9\u6cd5 (OligoFormer) \u7b5b\u9009\u548c\u8bbe\u8ba1\u9488\u5bf9RNA\u5e8f\u5217\u7684\u5c0fRNA (siRNA) \u836f\u7269</li> <li>\u5229\u7528\u548c\u4f18\u5316\u6211\u4eec\u7684 AI \u65b9\u6cd5 (RNAsmol) \u7b5b\u9009\u548c\u8bbe\u8ba1\u9488\u5bf9RNA\u7ed3\u6784\u7684\u5c0f\u5206\u5b50\u836f\u7269</li> <li>\u5229\u7528\u548c\u4f18\u5316\u6211\u4eec\u7684\u8ba1\u7b97\u65b9\u6cd5 (RBPgroup)\u548c\u6570\u636e\u5e93 (POSTAR) \u7b5b\u9009\u548c\u8bbe\u8ba1\u9488\u5bf9RNA\u7ed3\u6784\u7684\u86cb\u767d\u836f\u7269</li> </ul> </li> <li>\u5408\u4f5c\u65b9\u5f0f\uff1a<ul> <li>\u79d1\u7814\u8bfe\u9898\uff1a\u5408\u4f5c\u65b9\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u6280\u672f\uff0c\u5171\u540c\u5e94\u7528\u5728RNA\u836f\u7269\u8bbe\u8ba1\u4f18\u5316\u4e0a</li> <li>\u79d1\u7814\u8bfe\u9898\uff1a\u5408\u4f5c\u65b9\u63d0\u4f9b\u836f\u5b66\u8bbe\u8ba1\u6280\u672f\uff0c\u5171\u540c\u5e94\u7528\u5728RNA\u836f\u7269\u8bbe\u8ba1\u4f18\u5316\u4e0a</li> <li>\u79d1\u7814\u8bfe\u9898\uff1a\u5408\u4f5c\u65b9\u9488\u5bf9\u6211\u4eec\u9884\u6d4b\u51fa\u6765\u7684\u5c0f\u5206\u5b50\u6216\u8005\u5c0f RNA\u836f\u7269\u8fdb\u884c\u65e9\u671f\u5b9e\u9a8c\u9a8c\u8bc1\u548c\u4f18\u5316</li> <li>\u79d1\u7814\u548c\u4ea7\u4e1a\u5316\u8bfe\u9898\uff1a\u5408\u4f5c\u65b9\u63d0\u4f9b\u836f\u7b5b\u5e73\u53f0\u8fdb\u884c\u836f\u7269\u7b5b\u9009</li> <li>\u4ea7\u4e1a\u5316\u8bfe\u9898\uff1a\u5408\u4f5c\u65b9\u63d0\u4f9b\u5e94\u7528\u573a\u666f\uff08\u4f8b\u5982\u9488\u5bf9\u7279\u5b9a\u75be\u75c5\u548c\u7ec4\u7ec7\u63d0\u4f9b\u9012\u9001siRNA\u7684\u65b9\u6cd5\u548c\u624b\u6bb5\uff09 </li> </ul> </li> <li>\u53d1\u8d77\u7ec4\u7ec7\uff1a\u6e05\u534e\u5927\u5b66\u751f\u547d\u5b66\u9662\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\uff08Lab of RNA Bioinformatics\uff09</li> <li>\u6709\u6548\u65f6\u95f4\uff1a\u957f\u671f</li> </ul>"},{"location":"people/open/#_9","title":"\u7814\u7a76\u76ee\u6807","text":"<p>\u6211\u4eec\u5728RNA-siRNA/shRNA\u7ed3\u5408\uff0cRNA-\u5c0f\u5206\u5b50\u7ed3\u5408\uff0cRNA-\u86cb\u767d\u7ed3\u5408\u7684\u8ba1\u7b97\u8bbe\u8ba1\u4e0a\u79ef\u7d2f\u4e86\u5927\u91cf\u79d1\u7814\u7ecf\u9a8c\uff0c\u5e76\u5e94\u7528\u5728\u4e86HIV\u3001HCV\u7b49\u75c5\u6bd2\u7684\u9776\u6807\u7b5b\u9009\u4e0a\u3002\u5e0c\u671b\u80fd\u5e94\u7528\u5728\u764c\u75c7\u6cbb\u7597\u3001\u75c5\u6bd2\u611f\u67d3\u6cbb\u7597\u7b49\u75be\u75c5\u6cbb\u7597\u4e0a\u3002</p>"},{"location":"people/open/#_10","title":"\u9879\u76ee\u7b80\u4ecb","text":"<p>\u6211\u4eec\u548c\u8be5\u9879\u76ee\u76f8\u5173\u7684\u524d\u671f\u79d1\u7814\u57fa\u7840\u6709\uff08<sup>1</sup>\u7b2c\u4e00\u4f5c\u8005\uff0c*\u6700\u540e\u901a\u8baf\uff0c*<sup>+</sup>\uff1a\u5171\u540c\u901a\u8baf\uff09\uff1a </p> <ul> <li>1\uff09RNA\u4e8c\u7ea7\u7ed3\u6784\u9884\u6d4b\u7b97\u6cd5 (RNAstructure: Nucleic Acids Res. 2006<sup>1</sup>\uff0cRNA 2009<sup>1</sup>, Nucleic Acids Res. 2015*\uff0c2016* \uff09\uff1b</li> <li>2\uff09RNA-oligo/siRNA\u9884\u6d4b (OligoWalk: Nucleic Acids Res. 2008a<sup>1</sup>,2008b<sup>1</sup>,2008c<sup>1</sup>; OligoFormer: Bioinformatics  2024b*\uff09\u548cshRNA \u8bbe\u8ba1 (PNAS 2012)\uff1b</li> <li>3\uff09RNA-\u86cb\u767d\u7ed3\u5408\u9884\u6d4b (POSTAR: Nuc. Acids. Res. 2017*, 2019*<sup>+</sup>, 2022*\uff1bRBPgroup: Genome Biology 2017*, Cell 2019 )\uff1b</li> <li>4\uff09RNA-\u5c0f\u5206\u5b50\u7ed3\u5408\u9884\u6d4b<ul> <li>\u9776\u6807\u75c5\u6bd2\u7684\u5c0f\u5206\u5b50\u836f\u7269\u7b5b\u9009\uff08Nature Biotech. 2012\uff09;</li> <li>\u5c0f\u5206\u5b50\u8868\u578b\u7b5b\u9009\u8ba1\u7b97\u65b9\u6cd5\uff08Brief. in Bioinformatics 2019*<sup>+</sup>);</li> <li>\u9776\u6807RNA\u7684\u5c0f\u5206\u5b50\u836f\u7269AI\u8bbe\u8ba1\uff08RNAsmol Nature Comp. Sci. 2025*)\u3002</li> </ul> </li> </ul> <p>RNA-targeting drug discovery is undergoing an unprecedented revolution. Despite recent advances in this field, developing data-driven deep learning models remains challenging due to the limited availability of validated RNA-small molecule interactions and the scarcity of known RNA structures. In this context, we introduce RNAsmol, a novel sequence-based deep learning framework that incorporates data perturbation with augmentation, graph-based molecular feature representation and attention-based feature fusion modules to predict RNA-small molecule interactions. RNAsmol employs perturbation strategies to balance the bias between true negative and unknown interaction space thereby elucidating the intrinsic binding patterns between RNA and small molecules. The resulting model demonstrates accurate predictions of the binding between RNA and small molecules, outperforming other methods with average improvements of \u223c8% (AUROC) in 10-fold cross-validation, \u223c16% (AUROC) in cold evaluation (on unseen datasets), and \u223c30% (ranking score) in decoy evaluation. Moreover, we use case studies to validate molecular binding hotspots in the prediction of RNAsmol, proving the model\u2019s interpretability. In particular, we demonstrate that RNAsmol, without requiring structural input, can generate reliable predictions and be adapted to many RNA-targeting drug design scenarios. - Nature Comp. Sci. 2025</p> <p>Motivation: RNA interference (RNAi) has become a widely used experimental approach for post-transcriptional regulation and is increasingly showing its potential as future targeted drugs. However, the prediction of highly efficient siRNAs (small interfering RNAs) is still hindered by dataset biases, the inadequacy of prediction methods, and the presence of off-target effects. To overcome these limitations, we propose an accurate and robust prediction method, OligoFormer, for siRNA design. Results: OligoFormer comprises three different modules including thermodynamic calculation, RNA-FM module, and Oligo encoder. Oligo encoder is the core module based on the transformer encoder. Taking siRNA and mRNA sequences as input, OligoFormer can obtain thermodynamic parameters, RNA-FM embedding, and Oligo embedding through these three modules, respectively. We carefully benchmarked OligoFormer against six comparable methods on siRNA efficacy datasets. OligoFormer outperforms all the other methods, with an average improvement of 9% in AUC, 6.6% in PRC, 9.8% in F1 score, and 5.1% in PCC compared to the best method among them in our inter-dataset validation. We also provide a comprehensive pipeline with prediction of siRNA efficacy and off-target effects using PITA score and TargetScan score. The ablation study shows RNA-FM module and thermodynamic parameters improved the performance and accelerated convergence of OligoFormer. The saliency maps by gradient backpropagation and base preference maps show certain base preferences in initial and terminal region of siRNAs. Availability and implementation:The source code of OligoFormer is freely available on GitHub at: https://github.com/lulab/OligoFormer. Docker image of OligoFormer is freely available on the docker hub at https://hub.docker.com/r/yilanbai/oligoformer. - Bioinformatics 2024</p> <p>RNA-binding proteins (RBPs) play key roles in post- transcriptional regulation. Accurate identification of RBP binding sites in multiple cell lines and tissue types from diverse species is a fundamental en- deavor towards understanding the regulatory mech- anisms of RBPs under both physiological and patho- logical conditions. Our POSTAR annotation pro- cesses make use of publicly available large-scale CLIP-seq datasets and external functional genomic annotations to generate a comprehensive map of RBP binding sites and their association with other regulatory events as well as functional variants. Here, we present POSTAR3, an updated database with im- provements in data collection, annotation infrastruc- ture, and analysis that support the annotation of post-transcriptional regulation in multiple species in- cluding: we made a comprehensive update on the CLIP-seq and Ribo-seq datasets which cover more biological conditions, technologies, and species; we added RNA secondary structure profiling for RBP binding sites; we provided miRNA-mediated degra- dation events validated by degradome-seq; we included RBP binding sites at circRNA junction re- gions; we expanded the annotation of RBP binding sites, particularly using updated genomic variants and mutations associated with diseases. POSTAR3 is freely available at http://postar.ncrnalab.org.  - Nucleic Acids Res. 2022</p> <p>The systematic identification of effective drug combinations has been hindered by the unavailability of methods that can explore the large combinatorial search space of drug interactions. Here we present multiplex screening for interacting compounds (MuSIC), which expedites the comprehensive assessment of pairwise compound interactions. We examined ~500,000 drug pairs from 1,000 US Food and Drug Administration (FDA)-approved or clinically tested drugs and identified drugs that synergize to inhibit HIV replication. Our analysis reveals an enrichment of anti-inflammatory drugs in drug combinations that synergize against HIV. As inflammation accompanies HIV infection, these findings indicate that inhibiting inflammation could curb HIV propagation. Multiple drug pairs identified in this study, including various glucocorticoids and nitazoxanide (NTZ), synergize by targeting different steps in the HIV life cycle. MuSIC can be applied to a wide variety of disease-relevant screens to facilitate efficient identification of compound combinations. -  Natture Biotech. 2012</p> <p>shRNAs can trigger effective silencing of gene expression in mammalian cells, thereby providing powerful tools for genetic studies, as well as potential therapeutic strategies. Specific shRNAs can interfere with the replication of pathogenic viruses and are currently being tested as antiviral therapies in clinical trials. However, this effort is hindered by our inability to systematically and accurately identify potent shRNAs for viral genomes. Here we apply a recently developed highly parallel sensor assay to identify potent shRNAs for HIV, hepatitis C virus (HCV), and influenza. We observe known and previously unknown sequence features that dictate shRNAs efficiency. Validation using HIV and HCV cell culture models demonstrates very high potency of the top-scoring shRNAs. Comparing our data with the secondary structure of HIV shows that shRNA efficacy is strongly affected by the secondary structure at the target RNA site. Artificially introducing secondary structure to the target site markedly reduces shRNA silencing. In addition, we observe that HCV has distinct sequence features that bias HCV- targeting shRNAs toward lower efficacy. Our results facilitate further development of shRNA based antiviral therapies and improve our understanding and ability to predict efficient shRNAs.  - PNAS 2012</p> <p>Small interfering RNA (siRNA) are widely used to infer gene function. Here, insights in the equilibrium of siRNA-target hybridization are used for selection of efficient siRNA. The accessibilities of siRNA and target mRNA for hybridization, as measured by folding free energy change, are shown to be significantly correlated with efficacy. For this study, a partition function calculation that considers all possible secondary structures is used to predict target site accessibility; a significant improvement over calculations that consider only the predicted lowest free energy structure or a set of low free energy structures. The predicted thermodynamic features, in addition to siRNA sequence features, are used as input for a support vector machine that selects functional siRNA. The method works well for predicting efficient siRNA (efficacy  70%) in a large siRNA data set from Novartis. The positive predic- tive value (percentage of sites predicted to be efficient for silencing that are) is as high as 87.6%. The sensitivity and specificity are 22.7 and 96.5%, respectively. When tested on data from different sources, the positive predictive value increased 8.1% by adding equilibrium terms to 25 local sequence features. - Nucleic Acids Res. 2008a</p> <p></p>"},{"location":"people/open/#_11","title":"\u76f8\u5173\u4e13\u5229\u548c\u8f6f\u4ef6","text":"<ul> <li>\u4e13\u5229\u548c\u8457\u4f5c\u6743</li> <li>\u8f6f\u4ef6\u548c\u6a21\u578b</li> </ul>"},{"location":"people/open/#_12","title":"\u6280\u672f\u6210\u679c\u76f8\u5173\u62a5\u9053","text":"<ul> <li>News</li> <li>Papers</li> </ul>"},{"location":"people/open/#_13","title":"\u8054\u7cfb\u65b9\u5f0f","text":"\u5730\u5740\uff1a \u6e05\u534e\u5927\u5b66 \u751f\u547d\u79d1\u5b66\u5b66\u9662\uff0c\u751f\u7269\u4fe1\u606f\u5b66\u201c\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u201d\uff0c \u5317\u4eac\uff0c100084 \u529e\u516c\u7535\u8bdd\uff1a +86-10-62789217 E-mail\uff1a lulab1@tsinghua.edu.cn \u5b9e\u9a8c\u5ba4\u4e3b\u9875\uff1a http://lulab.life.tsinghua.edu.cn | http://www.ncRNAlab.org"},{"location":"program/conda/","title":"2.Conda in Linux","text":""},{"location":"program/conda/#condapython-in-linux","title":"Conda/Python in Linux","text":"<p>Install miniconda (python &amp; pip included) in Linux</p> <p>see more in Recommended Software for Python</p>"},{"location":"program/conda/#1install-miniconda","title":"1.Install miniconda","text":"<p>(need to repeat it for each user)</p> <p>\u6e05\u534e\u955c\u50cf\u7f51\u7ad9\u5b89\u88c5\u5e2e\u52a9\uff1a https://mirrors.tuna.tsinghua.edu.cn/help/anaconda/</p> <p>Miniconda \u662f\u4e00\u4e2a Anaconda \u7684\u8f7b\u91cf\u7ea7\u66ff\u4ee3\uff0c\u9ed8\u8ba4\u53ea\u5305\u542b\u4e86 python \u548c conda\uff0c\u4f46\u662f\u53ef\u4ee5\u901a\u8fc7 pip \u548c conda \u6765\u5b89\u88c5\u6240\u9700\u8981\u7684\u5305\u3002Miniconda \u5b89\u88c5\u5305\u53ef\u4ee5\u5230\u4ee5\u4e0b\u94fe\u63a5\u4e0b\u8f7d\u3002</p> <p>https://mirrors.tuna.tsinghua.edu.cn/anaconda/miniconda/</p> <pre><code># step 1. download the installation script\nwget https://mirrors.tuna.tsinghua.edu.cn/anaconda/miniconda/Miniconda3-py310_23.11.0-2-Linux-x86_64.sh\n\n# step 2. install\nbash Miniconda3-py310_23.11.0-2-Linux-x86_64.sh\n</code></pre> <p>Warning</p> <p>Do not install version higher than py310_23.11.0 in <code>cnode</code>, which is not compatible.</p> <p><code>wget</code> seems not working in <code>cnode</code> for mirrors.tuna.tsinghua.edu.cn, I downloaded the sh file in <code>lulab_cluster</code>, then copied it to <code>cnode</code>.</p>"},{"location":"program/conda/#2-example-of-pip-install-mkdocs","title":"2. Example of pip install: mkdocs","text":"<p>Install mkdocs using pip (need to repeat it for each user)</p> <p>See detailed instructions in mkdocs-material official site</p> <pre><code># 1. Intall mkdocs for each user\npip install mkdocs-material\n\n# 2. Install more plugins for each user\npip install mkdocs-glightbox mkdocs-video mkdocs-audio mkdocs-callouts mkdocs-redirects\n# pip install mkdocs-encryptcontent-plugin\n\n# 3. Setup shortcuts in ~/shortcuts for each user\n</code></pre>"},{"location":"program/conda/#3-example-of-conda-install-samtools","title":"3. Example of conda install: samtools","text":"<p>Warning</p> <p>The following instuction was generated by AI. It has not been tested yet. (I think you should be able to learn more from AI than from me today.)</p> <p>Installing bioinformatics software using Conda, particularly through the Bioconda channel, involves a few key steps:</p> <ul> <li>(1) Install Conda.</li> </ul> <p>If you don't already have it, install Miniconda (a lightweight version of Anaconda) or Anaconda.</p> <ul> <li>(2) Add Bioconda and Conda-Forge channels.</li> </ul> <p>These channels contain a vast collection of bioinformatics software. You can add them to your Conda configuration using:</p> <pre><code>    conda config --add channels bioconda\n    conda config --add channels conda-forge\n    conda config --set channel_priority strict\n</code></pre> <p>The channel_priority strict setting ensures that packages are preferentially installed from the highest-priority channels, reducing potential dependency conflicts.</p> <ul> <li>(3) Create a new Conda environment (recommended).</li> </ul> <p>To manage dependencies and avoid conflicts between different software, it is best practice to create a dedicated environment for each tool or project.</p> <pre><code>    conda create -n my_bioinformatics_env\n</code></pre> <p>Replace my_bioinformatics_env with a descriptive name for your environment. You can also specify a Python version if needed: conda create -n my_bioinformatics_env python=3.9. </p> <ul> <li>(4) Activate the environment.</li> </ul> <pre><code>    conda activate my_bioinformatics_env\n</code></pre> <ul> <li>(5) Install the desired bioinformatics software.</li> </ul> <p>Once the environment is active, you can install packages using conda install. </p> <p>For example, to install samtools:</p> <pre><code>    conda install samtools\n</code></pre> <p>You can also install specific versions: conda install bwa=0.7.17.</p> <ul> <li>(6) Deactivate the environment. </li> </ul> <p>When you are finished using the software in an environment, you can deactivate it:</p> <pre><code>    conda deactivate\n</code></pre> <p>Suggested by AI:</p> <p>You can also use Mamba, a faster alternative to Conda, for installing packages, especially when dealing with many dependencies. The commands are similar, replacing conda with mamba. For example: mamba install samtools.</p>"},{"location":"program/homebrew/","title":"2.Homebrew & Pip","text":""},{"location":"program/homebrew/#homebrew-pip-in-macos","title":"Homebrew &amp; Pip in MacOS","text":"<p>Install homebrew, python, pip</p>"},{"location":"program/homebrew/#1homebrew","title":"1.homebrew","text":""},{"location":"program/homebrew/#step-1-installation","title":"Step 1. Installation","text":"<pre><code>## option A. Chinese mirror site (one time for all users)\n/bin/zsh -c \"$(curl -fsSL https://gitee.com/cunkai/HomebrewCN/raw/master/Homebrew.sh)\"\n\n## option B. Official site (need FQ)(one time for all users)\n/bin/bash -c \u201c$(curl -fsSL https://raw.githubusercontent.com/Homebrew/install/HEAD/install.sh)\u201d\n</code></pre>"},{"location":"program/homebrew/#step-2-permissions","title":"Step 2. Permissions","text":"<p>Setup permissions and env. for multiple users/accounts</p> <pre><code>## Step 2.1) Setup permissions for multiple users in admin group\nsudo chgrp -R admin /opt/homebrew ; sudo chmod -R ug+w /opt/homebrew ; sudo chmod -R a+rX /opt/homebrew\n\n## Step 2.2) add these to ~/.zprofile for each user's account\neval $(/opt/homebrew/bin/brew shellenv) \n\n## Step 2.3) if installed brew using tsinghua mirror site, add these to ~/.zprofile as well\nexport HOMEBREW_PIP_INDEX_URL=https://pypi.tuna.tsinghua.edu.cn/simple \nexport HOMEBREW_API_DOMAIN=https://mirrors.tuna.tsinghua.edu.cn/homebrew-bottles/api  \nexport HOMEBREW_BOTTLE_DOMAIN=https://mirrors.tuna.tsinghua.edu.cn/homebrew-bottles \n</code></pre>"},{"location":"program/homebrew/#updateupgrade","title":"Update/Upgrade","text":"<p>update and upgrade brew if too old </p> <pre><code>brew update\nbrew upgrade\n</code></pre>"},{"location":"program/homebrew/#2-python-pip","title":"2. python &amp; pip","text":""},{"location":"program/homebrew/#install-python-using-brew","title":"Install python using brew","text":"<p>Installation</p> <p><code>brew install python</code></p> <p>Upgrade</p> <pre><code>brew update\nbrew upgrade python\nbrew link --overwrite python\n</code></pre>"},{"location":"program/homebrew/#setup-pip-with-python","title":"Setup pip with python","text":"<p>note: </p> <p>need to repeat the following for each user</p> <p>command <code>pip</code> seems different from command <code>pip3</code> </p>"},{"location":"program/homebrew/#option-1","title":"Option 1","text":"<pre><code>### Step 1\npython3 -m pip install --upgrade pip\n# or\n/Library/Developer/CommandLineTools/usr/bin/python3 -m pip install --upgrade pip\n\n### Step 2a: add this to .zprofile \nexport PATH=\"$HOME/Library/Python/3.9/bin:$PATH\"\n\n### Step 2b: may also try this instead of 2a (not tested yet)\nbrew unlink python &amp;&amp; brew link python\n</code></pre>"},{"location":"program/homebrew/#option-2-if-option-1-not-working","title":"Option 2 (if option 1 not working)","text":"<pre><code>### Step 1\nmkdir ~/venv\npython3 -m venv ~/venv\n# python3 -m pip install --upgrade pip\n\n### Step 2a\n### add this to ~/.zprofile\nexport PATH=\"$HOME/venv/bin:$PATH\"\n# pip install xyz\n\n### Step 2b (if 2a not working)\nsource ~/venv/bin/activate\n# python3 -m pip install xyz\n</code></pre>"},{"location":"program/macos/","title":"1.Mac Settings","text":""},{"location":"program/macos/#basic-settings-of-macos","title":"Basic Settings of MacOS","text":""},{"location":"program/macos/#schedule-shutdownsleepwake","title":"Schedule Shutdown/Sleep/Wake","text":"<pre><code># Schedules a repeating sleep to occur each day, Monday through Sunday, at 8pm.\nsudo pmset repeat sleep MTWRFSU 20:00:00\n\n# Schedules a repeating shutdown to occur each Saturday at 7:30pm;\n# and a repeating wake or power on event every Monday at 7:30am.\nsudo pmset repeat shutdown S 19:30:00 \nsudo pmset repeat shutdown S 19:30:00 wakeorpoweron M 7:30:00 \nsudo pmset schedule shutdown \"04/30/2025 19:30:00\"\n\n# Check\npmset -g sched\n# Cancel schedled\nsudo pmset repeat cancel\n</code></pre>"},{"location":"program/macos/#file-sharing","title":"File Sharing","text":""},{"location":"program/macos/#turn-off-volume-and-home-sharing","title":"Turn off Volume and Home Sharing","text":"<pre><code>###Turn off Volume shares (on by default)\nsudo defaults write /Library/Preferences/SystemConfiguration/com.apple.smb.server VirtualAdminShares -bool NO\n###Turn off User shares (on by default)\nsudo defaults write /Library/Preferences/SystemConfiguration/com.apple.smb.server VirtualHomeShares -bool NO\n</code></pre>"},{"location":"program/macos/#clean-time-machine-backups","title":"Clean Time Machine Backups","text":"<pre><code>alias tmlist=\"tmutil listbackups -t &gt; tm.list\"\nvim tm.list  -- only keep the ones we need to remove\nalias tmrm=\"for i in `cat tm.list`; do sudo tmutil delete -d /Volumes/Silver\\ -\\ Time\\ Machine  -t $i; done\" \n</code></pre>"},{"location":"program/mkdocs-jekyll/","title":"3.MkDocs & Jekyll","text":""},{"location":"program/mkdocs-jekyll/#mkdocs-and-jeyll-making-webpages-in-macos","title":"MkDocs and Jeyll - making webpages in MacOS","text":"<p>Install MkDocs ( prerequisite: pip )</p> <p>Install Ruby, Jekyll/Github Pages ( prerequisite: homebrew )</p>"},{"location":"program/mkdocs-jekyll/#mkdocs","title":"mkdocs","text":"<p>Install mkdocs using pip (need to repeat it for each user)</p> <p>See detailed instructions in mkdocs-material official site</p> <pre><code># 1. Intall mkdocs for each user\npip install mkdocs-material\n\n# 2. Install more plugins for each user\npip install mkdocs-glightbox mkdocs-video mkdocs-audio mkdocs-callouts mkdocs-redirects\n# pip install mkdocs-encryptcontent-plugin\n\n# 3. Setup shortcuts in ~/.shortcuts for each user\n</code></pre>"},{"location":"program/mkdocs-jekyll/#rubychruby","title":"ruby/chruby","text":"<p>Insall ruby/chruby using brew </p> <p>ruby is a prerequisite of Jekyll (see Jekyll's Quickstart )</p> <pre><code># 1. install ruby using ruby-install (one time for all users)\nbrew install chruby ruby-install\nruby-install ruby 3.4.1\n\n# 2. then, add these to .zprofile for each uesr\nsource /opt/homebrew/opt/chruby/share/chruby/chruby.sh\nsource /opt/homebrew/opt/chruby/share/chruby/auto.sh\nchruby ruby-3.4.1\n</code></pre>"},{"location":"program/mkdocs-jekyll/#jekyllgithub-pages","title":"Jekyll/Github Pages","text":"<p>Insall Jekyll using ruby/gem</p> <p>See detailed instructions in Jekyll official site</p> <pre><code># 1. Install jekyll (may need to repeat it for each user, not tested yet)\ngem install jekyll\ngem install jekyll bundler\n\n# 2. Setup shortcuts in ~/.shortcuts for each user\n</code></pre>"},{"location":"program/tips/","title":"3.Tips in Linux","text":""},{"location":"program/tips/#tips-in-linux","title":"Tips in Linux","text":""},{"location":"program/tips/#live-work-decently","title":"Live &amp; Work Decently","text":"<ul> <li>Run jobs in a cluster <ul> <li>Tips:  using VSCode to work remotely</li> <li>Tips:  install/manage software using anaconda</li> </ul> </li> <li>\u2b50\ufe0fBackup your precious code and data <ul> <li>Tips:  using git to backup your code</li> </ul> </li> <li>More Readings about programming skills:<ul> <li>\u300aBioinformatics Data Skills\u300b by Vince Buffalo</li> <li>More \"Keep Learning\" materials in our Tutorial</li> </ul> </li> </ul>"},{"location":"program/vscode/","title":"1.VS Code Remote","text":""},{"location":"program/vscode/#vs-code-remote","title":"VS Code Remote","text":"<p>We can work on a remote computer/cluster using a VS Code Extension: Remote Development.</p> <p>Recommendation: </p> <ul> <li>Backup scripts by using git in VS Code</li> </ul> <p>Tips</p> <ul> <li>\u5728VS Code\u4e0a\u7528git\u63d2\u4ef6\u65f6\uff0c\u5982\u679c\u5728\u56fd\u5185\u56e0\u4e3a\u88ab\u5899\u7684\u539f\u56e0\u8fde\u63a5github\u4f1a\u4e0d\u987a\u7545\uff0c\u53ef\u4ee5\u7b49\u7b49\u518d\u8bd5\uff1b\u6216\u8005\u8bd5\u8bd5\u76f4\u63a5\u5728\u670d\u52a1\u5668\u7684terminal\u91cc\u5b8c\u6210git\u547d\u4ee4\uff0cgit\u5728terminal\u91cc\u7684\u547d\u4ee4\u4f3c\u4e4e\u8fde\u63a5github\u4f1a\u987a\u7545\u4e00\u4e9b\u3002</li> <li>\u4e5f\u53ef\u4ee5\u5c1d\u8bd5\u56fd\u5185\u7684\u66ff\u4ee3\u4ea7\u54c1\uff0c\u5982\uff1aGitee \u9ad8\u6821\u7248 (\u5f00\u6e90\u4e2d\u56fd\u63a8\u51fa\u7684\u57fa\u4e8e Git \u7684\u4ee3\u7801\u6258\u7ba1\u548c\u534f\u4f5c\u5f00\u53d1\u5e73\u53f0)\u3002</li> </ul>"},{"location":"projects/background-en/","title":"Background and Methodology","text":""},{"location":"projects/background-en/#background-and-methodology","title":"Background and Methodology","text":"<p>[ English  |\u4e2d\u6587 ]</p>"},{"location":"projects/background-en/#goals","title":"Goals","text":"<p>\u201cRNA, not DNA, is the computational engine of the cell.\u201d ( Revolutionary Genetics Research Shows RNA May Rule Our Genome | Scientific American 2024.7. Cover Story).  </p> <p>We develop bioinformatics technology on noncoding RNAs from multiple perspectives/models of RNA structure and post-transcriptional regulation (e.g., splicing and editing); and explore its practice in the precise diagnosis and treatment of complex diseases. We utilize bioinformatics based on new AI technologies and multi-omics data to explore novel targets in the form of noncoding RNA in complex diseases such as cancer and autoimmune diseases, through cooperation with front-line doctors and experts.  While studying RNA regulation network, some targets can be used as biomarkers for personalized and precise diagnosis and treatment, and some targets can be used as drug targets for drug design through AI. </p>"},{"location":"projects/background-en/#background","title":"Background","text":"<p>About 20 thousand protein-coding genes in human were transcribed and tranlsated from only ~1.5% of human genome sequence. On the other hand, ~70% or more of the human genome  are transcribed into RNAs. Many of them are noncoding RNAs (ncRNAs), which are not well studied yet.</p> <p>\u201cBy 2020 the ENCODE project said it had identified around 37,600 noncoding genes\u2014that is, DNA stretches with instructions for RNA molecules that do not code for proteins. That is almost twice as many as there are protein-coding genes. Other tallies vary widely, from around 18,000 to close to 96,000. \u2026 In a 2024 commentary for the journal Science, the duo described these findings as part of an RNA revolution. \u2026 they undercut the way we think our biology works. Ever since the epochal discovery about DNA\u2019s double helix and how it encodes information, the bedrock idea of molecular biology has been that there are precisely encoded instructions that program specific molecules for particular tasks. But ncRNAs seem to point to a fuzzier, more collective, logic to life. It is a logic that is harder to discern and harder to understand. But if scientists can learn to live with the fuzziness, this view of life may turn out to be more complete.\u201d ( Revolutionary Genetics Research Shows RNA May Rule Our Genome | Scientific American 2024.7. Cover Story)</p> <p>RNA regulation in immune system. RNAs are dynamicly regulated during transcription. In addition, after RNA is transcribed, it will also have very complex and fine post-transcriptional regulation, such as alternative splicing (AS), alternative polyadenylation (APA), degradation, editing, modification, cellular localization and so on. These are closely related to the structure of RNA itself and the proteins that recognize RNA sequence and structure. At the same time, RNAs, especially noncoding RNAs (ncRNAs), also regulate other macromolecules, thus playing important roles in innate immune response to viruses and cancer immunity. We explore these complex regulatory processes in complex diseases such as cancer and autoimmune diseases, which are applied to immunotherapy.</p>"},{"location":"projects/background-en/#methods","title":"Methods","text":"<p>Leveraging new AI technologies for RNA modeling (i.e., RNA-Talk models) that tokenize information at sequence and/or structure levels, we discover and decipher the various molecular interactions and biological regulatory networks mediated by RNA. </p> RNA Modeling"},{"location":"projects/background/","title":"Background","text":""},{"location":"projects/background/#_1","title":"\u8bfe\u9898\u80cc\u666f\u548c\u65b9\u6cd5","text":"<p>[ English | \u4e2d\u6587 ]</p>"},{"location":"projects/background/#goals","title":"Goals","text":"<p>\u201cRNA \u800c\u4e0d\u662f DNA \u624d\u662f\u7ec6\u80de\u7684\u8ba1\u7b97\u5f15\u64ce\u3002\u201d \uff08 RNA: \u638c\u63a7\u751f\u547d\u540e\u53f0 | \u300a\u73af\u7403\u79d1\u5b66\u300b 2024\u5e747\u6708\u520a\u5c01\u9762\u6587\u7ae0\uff09</p> <p>\u6211\u4eec\u56f4\u7ed5\u975e\u7f16\u7801RNA\u53d1\u5c55\u751f\u7269\u4fe1\u606f\u5b66\u6280\u672f\uff0c\u4ece\u7ed3\u6784\u548c\u8f6c\u5f55\u540e\u8c03\u63a7\uff08\u4f8b\u5982\u526a\u63a5\u548c\u7f16\u8f91\uff09\u7b49\u591a\u4e2a\u89d2\u5ea6\u3001\u591a\u4e2a\u6a21\u578b\u63a2\u8ba8\u975e\u7f16\u7801RNA\u7684\u8c03\u63a7\u4f5c\u7528\uff0c\u5e76\u63a2\u7d22\u5176\u5728\u590d\u6742\u75be\u75c5\u7cbe\u51c6\u8bca\u7597\u4e0a\u7684\u5177\u4f53\u5b9e\u8df5\u3002\u6211\u4eec\u5145\u5206\u53d1\u6325\u751f\u7269\u4fe1\u606f\u5b66\u8fd9\u4e00\u4ea4\u53c9\u5b66\u79d1\u4f18\u52bf\uff0c\u5229\u7528\u6700\u65b0\u7684AI\u6280\u672f\u548c\u591a\u7ec4\u5b66\u6570\u636e\uff0c\u901a\u8fc7\u548c\u3010\u5317\u4eac\u534f\u548c\u3011\u3001\u3010\u5317\u5927\u4e00\u9662\u3011\u3001\u3010\u6e05\u534e\u957f\u5e9a\u3011\u7b49\u4e00\u7ebf\u533b\u751f\u4e13\u5bb6\u7684\u5408\u4f5c\uff0c\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u7b49\u590d\u6742\u75be\u75c5\u4e0a\u63a2\u7d22\u65b0\u7684\u4ee5\u975e\u7f16\u7801 RNA \u4e3a\u8868\u73b0\u5f62\u5f0f\u7684\u9776\u6807\u3002\u5728\u7814\u7a76\u5176\u514d\u75ab\u8c03\u63a7\u7f51\u7edc\u7684\u540c\u65f6\uff0c\u90e8\u5206\u9776\u6807\u53ef\u4ee5\u5e94\u7528\u4e3a\u4e2a\u6027\u5316\u7cbe\u51c6\u8bca\u7597\u65f6\u7684\u751f\u7269\u6807\u5fd7\u7269\uff0c\u90e8\u5206\u9776\u6807\u53ef\u4ee5\u505a\u4e3a\u836f\u7269\u9776\u70b9\u901a\u8fc7AI\u8fdb\u884c\u836f\u7269\u8bbe\u8ba1\uff0c\u5728\u590d\u6742\u75be\u75c5\uff08\u5982\u764c\u75c7\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff09\u7684\u4e34\u5e8a\u8bca\u65ad\u548c\u6cbb\u7597\u4e24\u4e2a\u65b9\u9762\u5b9e\u73b0\u5e94\u7528\u4ef7\u503c\u3002</p>"},{"location":"projects/background/#background","title":"Background","text":"<p>\u4eba\u7c7b\u6709\u5927\u7ea62\u4e07\u4e2a\u86cb\u767d\u7f16\u7801\u57fa\u56e0\uff0c\u4f46\u5176\u5e8f\u5217\u7684\u603b\u957f\u5ea6\u4ec5\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u76841.5%\u5de6\u53f3\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u4eba\u7c7b\u57fa\u56e0\u7ec4\u5e8f\u5217\u7684~70%\u751a\u81f3\u66f4\u591a\u90fd\u4f1a\u88ab\u8f6c\u5f55\u6210RNA\uff0c\u5b83\u4eec\u5f88\u591a\u90fd\u662f\u975e\u7f16\u7801\u7684RNA\uff08noncoding RNA\uff0cncRNA)\u3002\u4f46\u5bf9\u4e8e\u4e3a\u6570\u4f17\u591a\u7684\u975e\u7f16\u7801RNA (ncRNA)\uff0c\u6211\u4eec\u4ecd\u7136\u77e5\u4e4b\u751a\u5c11\u3002</p> <p>\u201d\u622a\u6b622020 \u5e74\uff0cENCODE \u9879\u76ee\u5df2\u9274\u5b9a\u51fa\u7ea6 37,600 \u4e2a\u975e\u7f16\u7801RNA\u7684\u57fa\u56e0\uff0c\u8fd9\u51e0\u4e4e\u662f\u86cb\u767d\u8d28\u7f16\u7801\u57fa\u56e0\u7684\u4e24\u500d\u3002\u5176\u4ed6\u7edf\u8ba1\u6570\u636e\u76f8\u5dee\u5f88\u5927\uff0c\u4ece\u7ea6 18,000 \u4e2a\u5230\u63a5\u8fd1 96,000 \u4e2a\u3002... \u5728 2024 \u5e74\u300a\u79d1\u5b66\u300b\u6742\u5fd7\u7684\u4e00\u7bc7\u8bc4\u8bba\u4e2d\uff0c\u5c06\u8fd9\u4e9b\u53d1\u73b0\u63cf\u8ff0\u4e3a RNA \u9769\u547d \u7684\u4e00\u90e8\u5206\u3002... \u8fd9\u4e9b\u975e\u7f16\u7801RNA\u52a8\u6447\u4e86\u6211\u4eec\u5bf9\u751f\u7269\u5b66\u8fd0\u4f5c\u65b9\u5f0f\u7684\u7406\u89e3\u3002\u81ea\u4ece\u5173\u4e8e DNA \u53cc\u87ba\u65cb\u7ed3\u6784\u53ca\u5176\u5982\u4f55\u7f16\u7801\u4fe1\u606f\u7684\u5212\u65f6\u4ee3\u53d1\u73b0\u4ee5\u6765\uff0c\u5206\u5b50\u751f\u7269\u5b66\u7684\u57fa\u672c\u601d\u60f3\u4e00\u76f4\u662f\uff0c\u751f\u7269\u4f53\u5b58\u5728\u7cbe\u786e\u7f16\u7801\u7684\u6307\u4ee4\uff0c\u8fd9\u4e9b\u6307\u4ee4\u53ef\u4ee5\u5bf9\u7279\u5b9a\u5206\u5b50\u8fdb\u884c\u7279\u5b9a\u4efb\u52a1\u7f16\u7a0b\u3002\u4f46\u975e\u7f16\u7801RNA \u4f3c\u4e4e\u6307\u5411\u4e86\u4e00\u79cd\u66f4\u6a21\u7cca\u3001\u66f4\u96c6\u4f53\u7684\u751f\u547d\u903b\u8f91\u3002\u8fd9\u79cd\u903b\u8f91\u66f4\u96be\u8fa8\u522b\uff0c\u66f4\u96be\u7406\u89e3\u3002\u4f46\u5982\u679c\u79d1\u5b66\u5bb6\u80fd\u591f\u5b66\u4f1a\u9002\u5e94\u8fd9\u79cd\u6a21\u7cca\u6027\uff0c\u8fd9\u79cd\u5173\u4e8e\u751f\u547d\u7684\u89c2\u70b9\u53ef\u80fd\u4f1a\u66f4\u52a0\u5b8c\u6574\u3002\u201c \uff08 RNA: \u638c\u63a7\u751f\u547d\u540e\u53f0 | \u300a\u73af\u7403\u79d1\u5b66\u300b 2024\u5e747\u6708\u520a\u5c01\u9762\u6587\u7ae0\uff09</p> <p>RNA regulation in immune system: RNA\u4e0d\u4ec5\u5728\u8f6c\u5f55\u65f6\u88ab\u52a8\u6001\u8c03\u63a7\uff0c\u800c\u4e14\u5728\u88ab\u8f6c\u5f55\u540e\u4e5f\u4f1a\u6709\u7740\u975e\u5e38\u590d\u6742\u800c\u7cbe\u7ec6\u7684\u8c03\u63a7\u5de5\u7a0b\uff0c\u4f8b\u5982\u526a\u63a5\uff0c\u4fee\u9970\uff0c\u7ec6\u80de\u5b9a\u4f4d\uff0c\u7f16\u8f91\uff0c\u52a0\u5c3e\uff0c\u964d\u89e3\u7b49\u7b49\u3002\u800c\u8fd9\u4e9b\u53c8\u548cRNA\u81ea\u8eab\u7684\u7ed3\u6784\u4ee5\u53ca\u8bc6\u522bRNA\u5e8f\u5217\u548c\u7ed3\u6784\u7684\u86cb\u767d\u606f\u606f\u76f8\u5173\u3002\u540c\u65f6\uff0cRNA\uff0c\u5c24\u5176\u662f\u975e\u7f16\u7801 RNA (ncRNA)\uff0c\u8fd8\u4f1a\u8c03\u63a7\u5176\u4ed6\u5927\u5206\u5b50\uff0c\u4ece\u800c\u5728\u4eba\u4f53\u5bf9\u75c5\u6bd2\u7684\u514d\u75ab\u5e94\u7b54\u4ee5\u53ca\u764c\u75c7\u514d\u75ab\u7b49\u91cd\u8981\u751f\u547d\u8fc7\u7a0b\u4e2d\u53d1\u6325\u4f5c\u7528\u3002\u6211\u4eec\u5728\u764c\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u7b49\u590d\u6742\u6027\u75be\u75c5\u4e2d\u63a2\u7d22\u8fd9\u4e9b\u590d\u6742\u7684\u8c03\u63a7\u8fc7\u7a0b\uff0c\u5e76\u5e94\u7528\u4e8e\u514d\u75ab\u6cbb\u7597\u3002</p>"},{"location":"projects/background/#methods","title":"Methods","text":"<p>\u6211\u4eec\u5229\u7528\u6700\u65b0\u7684\u4eba\u5de5\u667a\u80fd\u6280\u672f\u4ece\u201c\u5e8f\u5217\u201d\u548c\u201c\u7ed3\u6784\u201d\u4e24\u4e2a\u4e0d\u540c\u7684\u8868\u5f81\u5c42\u9762\u5f00\u53d1\u5404\u7c7b\u6838\u9178\u6a21\u578b\uff0c\u53bb\u53d1\u73b0\u548c\u7406\u89e3RNA\u5728\u590d\u6742\u7684\u751f\u7269\u5206\u5b50\u4e92\u4f5c\u548c\u8c03\u63a7\u7f51\u7edc\u4e2d\u7684\u4f5c\u7528\u548c\u673a\u5236\u3002</p> RNA Modeling"},{"location":"projects/funding/","title":"Funding","text":""},{"location":"projects/funding/#funding","title":"Funding \u79d1\u7814\u57fa\u91d1","text":"<p>\u3010\u4e2d\u6587\u3011</p> <ul> <li>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u96be\u6cbb\u6027\u81ea\u8eab\u514d\u75ab\u75c5\u7cbe\u51c6\u8bca\u6cbb\u4e0e\u521b\u65b0\u7597\u6cd5\u7814\u7a76\uff0c2024.12-2027.11 \u8bfe\u9898\u7ec4\u957f</li> <li> <p>\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u8ba1\u5212 \u91cd\u70b9\u4e13\u9879\uff0c\u975e\u7f16\u7801RNA\u9ad8\u901a\u91cf\u89e3\u6790\u6280\u672f\u4e0e\u4e34\u5e8a\u5e94\u7528\u7814\u53d1\uff0c2024.12-2027.11 \u8bfe\u9898\u9aa8\u5e72</p> </li> <li> <p>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c82371855\uff0c\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7cbe\u51c6\u8bca\u7597\u4e2d\u57fa\u4e8e\u975e\u7f16\u7801RNA\u7ec4\u5b66\u548c\u751f\u7269\u4fe1\u606f\u5b66\u7684\u65b0\u65b9\u6cd5\u7814\u7a76\uff0c2024-2027  \u4e3b\u6301</p> </li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u4e13\u9879\u9879\u76ee\uff0c82341101\uff0c\u57fa\u4e8eAI\u6280\u672f\u7684\u9776\u5411RNA\u7684\u836f\u7269\u8bbe\u8ba1\uff0c2024-2026  \u4e3b\u6301</li> <li>\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1 \u9762\u4e0a\u9879\u76ee\uff0c32170671\uff0c\u4f53\u6db2\u591a\u7ec4\u5b66\u6570\u636e\u6574\u5408\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u53ca\u5176\u5728\u764c\u75c7\u65e0\u521b\u68c0\u6d4b\u4e0a\u7684\u5e94\u7528\uff0c2022-2025     \u4e3b\u6301</li> <li>\u6e05\u534e\u5927\u5b66\u7cbe\u51c6\u533b\u5b66\u7814\u7a76\u9662 \u7cbe\u51c6\u533b\u7597\u6218\u7565\u9879\u76ee\uff0c \u57fa\u4e8e\u591a\u7ec4\u5b66\u6570\u636e\u7684\u667a\u80fd\u5316\u4e2d\u665a\u671f\u809d\u764c\u8f6c\u5316\u6cbb\u7597\u51b3\u7b56\u7814\u7a76\uff0c2022-2025 \u5171\u540c\u4e3b\u6301</li> <li>\u5408\u80a5\u7efc\u5408\u6027\u56fd\u5bb6\u79d1\u5b66\u4e2d\u5fc3\u5927\u5065\u5eb7\u7814\u7a76\u9662\u201c\u5168\u7403\u9074\u9009\u201d\u9879\u76ee\uff0cLX202401\uff0ccfRNA\u4e3a\u6838\u5fc3\u7684\u591a\u7ec4\u5b66\u5728\u80ba\u764c\u7b5b\u67e5\u4e0a\u7684\u5e94\u7528\u7814\u7a76\uff0c2024-2027 \u4e3b\u6301</li> </ul> <p>[English]</p> <ul> <li>2024-2027     Precision diagnosis and treatment and innovative therapy research for refractory autoimmune diseases (AIDs), co-PI, National Key Research and Development Program of China</li> <li>2024-2027     Development of high-throughput analysis  technology of non-coding RNA and its  clinical applicationd, key member, National Key Research and Development Program of China</li> <li>2024-2027     Bioinformatics study of noncoding RNA omics in precision diagnosis and treatment of autoimmune diseases, PI, National Natural Science Foundation of China</li> <li>2024-2026     AI-driven drug design targeting RNAs, PI, National Natural Science Foundation of China</li> <li>2022-2025     Bioinformatics study of body fluid multi-omics data integration for cancer diagnosis Novel, PI, National Natural Science Foundation of China</li> <li>2022-2025     Multi-Omics study for personalized neoadjuvant therapy of HCC, co-PI, Tsinghua Precision Medicine Institute</li> <li>2024-2027     cfRNA-based multi-omics application research in lung cancer screening, PI,  Hefei Comprehensive National Science Center General Health Research Institute \"Global Selection\" Project </li> </ul>"},{"location":"projects/proj-en/","title":"Research Projects @ Lu Lab","text":""},{"location":"projects/proj-en/#research-projects-lu-lab","title":"Research Projects @ Lu Lab","text":"<p>[ English  |\u4e2d\u6587 ]</p>"},{"location":"projects/proj-en/#projects-subgroups","title":"Projects &amp; Subgroups","text":"<p>We work on two major research projects centered on noncoding RNA (ncRNA): I. Bioinfo-Driven Precision Medicine, II. AI-Driven RNA Modeling &amp; Drug Design. </p> <ul> <li>Research Projects @ Lu Lab<ul> <li>Projects &amp; Subgroups<ul> <li>A1. RNAfinder</li> <li>A2. RNAfinder - Applications</li> <li>B1. RNAtalk</li> <li>B2. RNAtalk - Applications</li> </ul> </li> </ul> </li> </ul>"},{"location":"projects/proj-en/#a1-rnafinder","title":"A1. RNAfinder","text":"<p>Discoverying novel noncoding RNAs. With the advancement of sequencing technology, especially the development and maturity of sequencing technology at the single-cell and single-molecule level, we have the ability to discover new noncoding RNAs from more species, more tissues, and more cell types. For example, we can discover and study new noncoding RNAs under different environments and conditions from Transposable Elements of human genome, Meta-transcriptome of diverse microbial communities. These studies will not only expand our understanding of the diversity of life, but may also reveal new biological mechanisms cross-species.</p> <p>cell-free RNAs (cfRNAs). The cfRNA content in clinical plasma samples is very low and fragmented. Therefore, it is necessary to solve the problems of low signal-to-noise ratio and high cost of sequencing data. We apply technologies such as TSO, early barcoding, UMI, and CRISPR-Cas9 to develop novel cfRNA-seq technologies that reduce the cost of high-throughput sequencing, and improve the signal-to-noise ratio of sequencing data.</p> <p>In clinical studies like liquid biopsy, exRNA (extra-cellular RNA) is also called cfRNA (cell free RNA). Many exRNAs are noncoding RNAs (ncRNAs), like miRNA, lncRNA, srpRNA, circRN, etc. </p> Different NGS (next-generation sequencing) libraries of cfRNAs <p>double-stranded RNA (dsRNA). Three well-known types of noncoding RNA include miRNA, siRNA, and piRNA. These are distinct RNA types generated through double-stranded RNA (dsRNA) processing. Double-stranded RNA (dsRNA) is a molecule composed of two complementary RNA strands. RNA interference typically requires dsRNA, which can be introduced exogenously (such as viruses) or produced endogenously (such as repetitive sequences in human genome). Advances in research have revealed that there are far more than just these three types of dsRNA. These diverse dsRNAs play important roles in the immune system, particularly in antiviral and anti-tumor immune responses. For example, srpRNAs exert intercellular regulatory functions through exosome trafficking within the cancer microenvironment.</p> <p>More Reading: dsRNA code</p> Different types of dsRNAs in immune response"},{"location":"projects/proj-en/#a2-rnafinder-applications","title":"A2. RNAfinder - Applications","text":""},{"location":"projects/proj-en/#a21-medicine-precision-medicine","title":"A2.1 [Medicine] Precision Medicine","text":"<p>Clinical applications. By applying the above methods to liquid biopsy, we help many clinical studies like cancer screen.</p> <p>By integrating transcriptomics data with other multiomics data, we aim to explain development of complex diseases based on an integrative, multi-dimensional level.  We develop sequencing and bioinformatics methods to study cellular and extracellular transcriptome of coding and noncoding RNAs (ncRNAs) for varous immune cells of patients at the single-cell level and multi-molecular level. </p> <p>Accurately selecting the best diagnosis and treatment plan is important but difficult for complex diseases. For instance, some targeted drugs have been approved for many complex diseases, but the which benefit groups of different drugs are not yet clear, requiring accurate biomarkers. Therefore, by combining the immune cell data m with cfDNA/cfRNA in plasma and clinical data, we develop a drug-efficacy prediction model to provide a multi-modal biomarker for a precise drug instruction in the treatment of complex diseases. Meanwhile, we explore deep learning, transfer learning, similarity network fusion and other bioinformatics analysis techniques for these data. </p> <p>We apply the above methods to precision medicine, focusing on two types of diseases:  1) Immune-medicated diseases\uff1b2) Cancer.</p> <p>Cancer and autoimmune diseases are like two sides of a coin: if cancer cells escape the immune system's surveillance through some mechanism and cannot be eliminated, malignant tumors begin to grow; and when normal cells break the body's original immune tolerance mechanism for some reason, autoimmune diseases may be caused. \" -- Reverse Vaccine: A Miraculous Solution to Autoimmune Diseases, Scientific American, 2024.12.</p> <p>Multi-modal data integration. Multiple regulation events (e.g., expression, splicing, editing, fusion) can be quantified by bioinformatic analysis from NGS data like cfRNA-seq.  For the multi-modal data, such as cfRNA-seq derived multi-view data and/or multi-omics data, we need 4 steps for machine learning analysis, including 1) Data Cleaning, 2) Feature extraction and engineering, 3) Model Fitting, 4) Classifier. We develop corresponding bioinformatics method, software, database and other tools for these four steps. For instance, we integrate these multi-modal data using new AI technologies like large language and deep learning models. </p> Multi-dimensional data for liquid biopsy of cancer (Heitzer et al., Nature Reviews 2019)"},{"location":"projects/proj-en/#a22-ribozyme-structure-prediction-ribozyme-design","title":"A2.2 [Ribozyme] Structure Prediction &amp; Ribozyme Design","text":"Prediction of 2D and 3D structure of RNA <p>RNA structure prediction.  We develop structure prediction models and algorithms for RNA. The accurate prediction of RNA structure will help us better understand its regulation and function, thus improving RNA-based enzyme and vaccince design. For instance, mRNA, as well as other RNAs like circular RNA, can be used as RNA vaccines. In the design of RNA vaccines, the design of RNA structure, codons and modifications are very important research directions. Improving the stability of RNA in storage and transportation, and the effectiveness and targeting of delivery to cells and the human body are very important and cutting-edge research directions.</p> <p>RNA Design.  The introduction of new methods and new thinking in different fields can often lead to breakthrough progress in this discipline, so we pay special attention to introducing new technologies and new thinking in the latest computing field (such as new AI technologies based on large language models) into biological data. We develop novel RNA models to explore basic scientific questions such as the structure, regulation and target of RNA, especially noncoding RNA (ncRNA). Finally, these novel models will bring us a new era of enzyme, vaccine and drug design.</p>"},{"location":"projects/proj-en/#b1-rnatalk","title":"B1. RNAtalk","text":"RNAs Talk: Language of RNA <p>RNA-RNA interaction (trans-pair) (RNA targeting RNA) plays a crucial role in various biological processes, including gene regulation, RNA processing, and viral replication. Predicting RNA-RNA interactions involves identifying and characterizing the binding sites between two RNA molecules, which can provide insights into their functional relationships and regulatory mechanisms. It's important to note that predicting RNA-RNA interactions remains a challenging problem due to the complexity of RNA structures, the vast sequence space, and the limited availability of experimentally validated interaction data. Therefore, the accuracy of predictions can vary depending on the specific method used and the quality of input data. We develop and refine computational approaches for predicting RNA-RNA interactions, aiming to improve the understanding of RNA biology and facilitate the discovery of new therapeutic targets and RNA-based regulatory mechanisms.</p>"},{"location":"projects/proj-en/#b2-rnatalk-applications","title":"B2. RNAtalk - Applications","text":""},{"location":"projects/proj-en/#b21-sirna-drug-design","title":"B2.1 siRNA Drug Design","text":"<p>siRNA design. Small interfering RNA (siRNA) has become a widely used experimental approach for post-transcriptional regulation and is increasingly showing its potential as future targeted drugs. However, the prediction of highly efficient siRNAs is still hindered by dataset biases, the inadequacy of prediction methods, and the presence of off-target effects. To overcome these limitations, we develop novel AI approaches for the prediction and design of efficient siRNA.</p>"},{"location":"projects/proj-en/#b22-small-molecule-drug-design","title":"B2.2 Small-molecule Drug Design","text":"<p>Small molecule drug design targeting RNA. The number of human proteins that can be used as small-molecule drug targets is very limited\uff1aOf the ~20 thousand protein-coding genes in human (~1.5% of human genome sequence),  about 10%-15% are directly related to diseases; among these genes, it is estimated that less than 700 protein products are druggable (only ~0.05% of human genome sequence). On the other hand, ~70% or more of the human genome  are transcribed into RNAs. Most of them are noncoding RNAs (ncRNAs). In recent years, more and more researchers have tried to use RNA as a drug target, and initially proved the feasibility of this strategy. In particular, it is worth noting that Coronavirus (COVID-19) is an RNA virus, and its genome itself is also promising as a drug target. In addition, using noncoding RNA for disease treatment is also a promising research direction, for example, siRNA-based RNA interference (RNAi) system has aleady been used to develop new gene therapy methods. Due to the high complexity and variability of RNA structure and the limitations of experimental methods, our current understanding of the three-dimensional structure of RNA is still very limited, and the development of RNA-targeting drugs is still in its infancy. We will use the latest artificial intelligence technologies such as deep learning to integrate various information,  and subsequently to design drugs targeting RNAs. </p> The potential RNA-targeted druggable genome (Warner, et al., Nature Reviews | Drug Discovery\u00a0 2018)"},{"location":"projects/proj/","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":""},{"location":"projects/proj/#_1","title":"\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898","text":"<p>[ English | \u4e2d\u6587 ]</p>"},{"location":"projects/proj/#projects-subgroups","title":"Projects &amp; Subgroups","text":"<p>\u6211\u4eec\u56f4\u7ed5\u975e\u7f16\u7801 RNA\uff08ncRNA\uff09\u5728\u4e24\u4e2a\u4e3b\u8981\u7684\u79d1\u7814\u65b9\u5411\u4e0a\u8fdb\u884c\u63a2\u7d22\u548c\u7814\u7a76\uff1aI. \u751f\u4fe1\u9a71\u52a8\u7684\u7cbe\u51c6\u533b\u7597\uff1bII. AI\u9a71\u52a8\u7684\u6838\u9178\u6a21\u578b\u548c\u836f\u7269\u8bbe\u8ba1\u3002</p> <ul> <li>\u6e05\u534e\u5927\u5b66\u30fb\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 \u79d1\u7814\u8bfe\u9898<ul> <li>Projects &amp; Subgroups<ul> <li>A1. RNAfinder</li> <li>A2. RNAfinder - Applications</li> <li>B1. RNAtalk</li> <li>B2. RNAtalk - Applications</li> </ul> </li> </ul> </li> </ul>"},{"location":"projects/proj/#a1-rnafinder","title":"A1. RNAfinder","text":"<p>Discoverying novel noncoding RNAs: \u968f\u7740\u6d4b\u5e8f\u6280\u672f\u7684\u8fdb\u6b65\uff0c\u5c24\u5176\u662f\u5355\u7ec6\u80de\u3001\u5355\u5206\u5b50\u6c34\u5e73\u7684\u6d4b\u5e8f\u6280\u672f\u7684\u53d1\u5c55\u548c\u6210\u719f\uff0c\u6211\u4eec\u6709\u80fd\u529b\u4ece\u66f4\u591a\u7269\u79cd\u3001\u66f4\u591a\u7ec4\u7ec7\u3001\u66f4\u591a\u7ec6\u80de\u7c7b\u578b\u4e2d\u53d1\u73b0\u65b0\u7684\u975e\u7f16\u7801RNA\u3002\u4f8b\u5982\uff0c\u6211\u4eec\u53ef\u4ee5\u4ece\u4eba\u7c7b\u57fa\u56e0\u7ec4\u7684\u5404\u7c7b\u91cd\u590d\u533a\u57df\uff08Transposable Elements\uff09\u3001\u7eb7\u7e41\u590d\u6742\u7684\u5fae\u751f\u7269\u7fa4\u843d\u7684\u5b8f\u8f6c\u5f55\u7ec4\uff08Meta-transcriptome of Microbes\uff09\u4e2d\u53d1\u73b0\u548c\u7814\u7a76\u4e0d\u540c\u73af\u5883\u548c\u6761\u4ef6\u4e0b\u7684\u65b0\u975e\u7f16\u7801 RNA\u3002\u8fd9\u4e9b\u7814\u7a76\u4e0d\u4ec5\u5c06\u6269\u5927\u6211\u4eec\u5bf9\u751f\u547d\u591a\u6837\u6027\u7684\u7406\u89e3\uff0c\u8fd8\u53ef\u80fd\u63ed\u793a\u65b0\u7684\u3001\u8de8\u7269\u79cd\u7684\u751f\u7269\u5b66\u673a\u5236\u3002</p> <p>cell-free RNAs (cfRNAs): \u4e34\u5e8a\u8840\u6d46\u6837\u672c\u4e2d\u7684 cfRNA \u542b\u91cf\u5f88\u4f4e\u4e14\u788e\u7247\u5316\uff0c\u9700\u8981\u89e3\u51b3\u6d4b\u5e8f\u6570\u636e\u4fe1\u566a\u6bd4\u4f4e\u3001\u6210\u672c\u6602\u8d35\u7b49\u95ee\u9898\u3002\u6211\u4eec\u5e94\u7528\u6a21\u677f\u8f6c\u6362\u3001\u65e9\u671f\u6807\u8bb0\u3001\u5206\u5b50\u6807\u7b7e\u548cCRISPR-Cas9\u7b49\u6280\u672f\uff0c\u5f00\u53d1\u65b0\u578b cfRNA-seq \u6280\u672f\uff0c\u964d\u4f4e\u6784\u5efa\u9ad8\u901a\u91cf\u6d4b\u5e8f\u6587\u5e93\u7684\u7ecf\u6d4e\u6210\u672c\u5e76\u63d0\u9ad8\u4e86\u6d4b\u5e8f\u6570\u636e\u7684\u4fe1\u566a\u6bd4\u3002</p> <p>exRNA (extra-cellular RNA) \u5728\u5f88\u591a\u4e34\u5e8a\u7814\u7a76\u5c24\u5176\u662f\u6db2\u4f53\u6d3b\u68c0\u7814\u7a76\u4e2d\u53c8\u79f0\u4e3a cfRNA (cell free RNA) \uff0c\u5305\u62ec\u4e86\u5f88\u591a\u975e\u7f16\u7801 RNA (ncRNA)\uff0c\u5982 miRNA\uff0clncRNA\uff0csrpRNA\uff0ccircRNA\u7b49\u3002</p> Different NGS (next-generation sequencing) libraries of cfRNAs <p>double-stranded RNA (dsRNA): \u8457\u540d\u7684\u975e\u7f16\u7801RNA\u6709miRNA/siRNA/piRNA\u8fd9\u4e09\u7c7bsmall RNA\uff0c\u4ed6\u4eec\u662f\u901a\u8fc7\u53cc\u94feRNA\uff08dsRNA\uff09\u52a0\u5de5\u751f\u6210\u7684\u4e0d\u540cRNA\u7c7b\u578b\u3002\u53cc\u94feRNA\uff08double stranded RNA, dsRNA\uff09\u662f\u4e00\u79cd\u7531\u4e24\u6761\u4e92\u8865RNA\u94fe\u7ec4\u6210\u7684\u5206\u5b50\uff0cRNA\u5e72\u6270\u7684\u542f\u52a8\u901a\u5e38\u9700\u8981\u53cc\u94feRNA\uff08dsRNA\uff09\uff0c\u8fd9\u4e9b\u53cc\u94feRNA\u53ef\u4ee5\u662f\u5916\u6e90\uff08\u5982\u75c5\u6bd2\uff09\u5f15\u5165\u7684\uff0c\u4e5f\u53ef\u4ee5\u662f\u5185\u6e90\uff08\u5982\u4eba\u7c7b\u57fa\u56e0\u7ec4\u91cc\u7684\u91cd\u590d\u5e8f\u5217\uff09\u4ea7\u751f\u7684\u3002\u968f\u7740\u79d1\u7814\u7684\u8fdb\u5c55\uff0c\u4eba\u4eec\u53d1\u73b0\u53cc\u94feRNA\uff08dsRNA\uff09\u8fdc\u4e0d\u6b62\u4e0a\u8ff03\u79cd\u3002\u8fd9\u4e9b\u4e0d\u540c\u7684dsRNAs\u5728\u514d\u75ab\u7cfb\u7edf\u4e2d\u5177\u6709\u91cd\u8981\u4f5c\u7528\uff0c\u5c24\u5176\u662f\u5728\u6297\u75c5\u6bd2\u548c\u6297\u80bf\u7624\u514d\u75ab\u53cd\u5e94\u4e2d\u3002\u6bd4\u5982\uff0csrpRNA\u5c31\u901a\u8fc7\u764c\u75c7\u5fae\u73af\u5883\u7684\u5916\u6ccc\u4f53\u8fd0\u8f93\u53d1\u6325\u7ec6\u80de\u95f4\u7684\u8c03\u63a7\u529f\u80fd\u3002</p> <p>More Reading: dsRNA code</p> Different types of dsRNAs in immune response"},{"location":"projects/proj/#a2-rnafinder-applications","title":"A2. RNAfinder - Applications","text":""},{"location":"projects/proj/#a21-medicine-precision-medicine","title":"A2.1 [Medicine] Precision Medicine","text":"<p>Clinical applications: \u6211\u4eec\u5c06\u4e0a\u8ff0\u65b9\u6cd5\u5e94\u7528\u5728\u6db2\u4f53\u6d3b\u68c0\u4e0a\uff0c\u52a9\u529b\u89e3\u51b3\u4e34\u5e8a\u95ee\u9898\uff0c\u4f8b\u5982\u764c\u75c7\u65e9\u7b5b\u3002</p> <p>\u901a\u8fc7\u5c06\u8f6c\u5f55\u7ec4\u5b66\u6570\u636e\u4e0e\u5176\u4ed6\u591a\u7ec4\u5b66\u6570\u636e\u6574\u5408\uff0c\u6211\u4eec\u65e8\u5728\u4ece\u7efc\u5408\u7684\u3001\u591a\u7ef4\u7684\u6c34\u5e73\u4e0a\u53bb\u89e3\u91ca\u590d\u6742\u75be\u75c5\u7684\u53d1\u5c55\u3002 \u6211\u4eec\u5f00\u53d1\u6d4b\u5e8f\u548c\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u6cd5\u6765\u7814\u7a76\u7f16\u7801\u548c\u975e\u7f16\u7801 RNA (ncRNA) \u7684\u7ec6\u80de\u548c\u7ec6\u80de\u5916\u8f6c\u5f55\u7ec4\uff0c\u4ece\u5355\u7ec6\u80de\u6c34\u5e73\u548c\u591a\u5206\u5b50\u6c34\u5e73\u7814\u7a76\u60a3\u8005\u5404\u79cd\u514d\u75ab\u7ec6\u80de\u5185\u5916\u7f16\u7801\u548c\u975e\u7f16\u7801\u57fa\u56e0\u7684\u8c03\u63a7\u56fe\u8c31\u3002</p> <p>\u5bf9\u4e8e\u590d\u6742\u75be\u75c5\u6765\u8bf4\uff0c\u51c6\u786e\u9009\u62e9\u6700\u4f73\u7684\u8bca\u7597\u65b9\u6848\u5f88\u91cd\u8981\uff0c\u4f46\u4e5f\u5f88\u56f0\u96be\u3002 \u4f8b\u5982\uff0c\u4e00\u4e9b\u9776\u5411\u836f\u7269\u5df2\u88ab\u6279\u51c6\u7528\u4e8e\u8bb8\u591a\u590d\u6742\u75be\u75c5\uff0c\u4f46\u4e0d\u540c\u836f\u7269\u7684\u53d7\u76ca\u4eba\u7fa4\u5c1a\u4e0d\u6e05\u695a\uff0c\u9700\u8981\u51c6\u786e\u7684\u751f\u7269\u6807\u5fd7\u7269\u3002 \u56e0\u6b64\uff0c\u901a\u8fc7\u5c06\u514d\u75ab\u7ec6\u80de\u6570\u636e\u4e0e\u8840\u6d46\u4e2d\u7684cfDNA/cfRNA\u6570\u636e\u4ee5\u53ca\u4e34\u5e8a\u6570\u636e\u76f8\u7ed3\u5408\uff0c\u6211\u4eec\u5f00\u53d1\u836f\u6548\u9884\u6d4b\u6a21\u578b\uff0c\u4e3a\u6cbb\u7597\u590d\u6742\u75be\u75c5\u7684\u7cbe\u786e\u836f\u7269\u6307\u5bfc\u63d0\u4f9b\u591a\u6a21\u6001\u6807\u5fd7\u7269\u6a21\u578b\u3002\u540c\u65f6\uff0c\u6211\u4eec\u9488\u5bf9\u8fd9\u4e9b\u6570\u636e\u63a2\u7d22\u6df1\u5ea6\u5b66\u4e60\u3001\u8fc1\u79fb\u5b66\u4e60\u3001\u76f8\u4f3c\u6027\u7f51\u7edc\u878d\u5408\uff0c\u4ee5\u53ca\u5176\u4ed6\u751f\u7269\u4fe1\u606f\u5b66\u5206\u6790\u6280\u672f\u3002</p> <p>\u6211\u4eec\u5c06\u4e0a\u8ff0\u65b9\u6cd5\u5e94\u7528\u4e8e\u7cbe\u51c6\u533b\u7597\uff0c\u91cd\u70b9\u5173\u6ce8\u4e24\u7c7b\u75be\u75c5\uff1a1\uff09\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff1b2\uff09\u764c\u75c7\u3002</p> <p>\u201c\u764c\u75c7\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\uff0c\u8fd9\u4e24\u8005\u5c31\u50cf\u786c\u5e01\u7684\u4e24\u9762\uff1a\u82e5\u764c\u7ec6\u80de\u901a\u8fc7\u67d0\u79cd\u673a\u5236\u9003\u8131\u4e86\u514d\u75ab\u7cfb\u7edf\u76d1\u89c6\u3001\u65e0\u6cd5\u88ab\u6e05\u9664\uff0c\u6076\u6027\u80bf\u7624\u4fbf\u5f00\u59cb\u6ecb\u957f\uff1b\u800c\u5f53\u6b63\u5e38\u7ec6\u80de\u56e0\u67d0\u79cd\u539f\u56e0\u6253\u7834\u4e86\u8eab\u4f53\u539f\u672c\u7684\u514d\u75ab\u8010\u53d7\u673a\u5236\uff0c\u5c31\u53ef\u80fd\u5f15\u53d1\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3002\u201d  -- \u53cd\u5411\u75ab\u82d7\uff1a\u81ea\u8eab\u514d\u75ab\u75c5\u5947\u89e3\u300a\u73af\u7403\u79d1\u5b66\u300b(Scientific American) 2024\u5e7412\u6708\u53f7</p> <p>Multi-modal data integration:  \u6211\u4eec\u53ef\u4ee5\u7531cfRNA-seq\u7b49\u9ad8\u901a\u91cf\u6d4b\u5e8f\u65b9\u6cd5\u901a\u8fc7\u751f\u7269\u4fe1\u606f\u5206\u6790\u8ba1\u7b97\u5f97\u5230\u591a\u6a21\u6001\u6570\u636e\uff08\u4f8b\u5982\u8868\u8fbe\u3001\u526a\u63a5\u3001\u7f16\u8f91\u3001\u878d\u5408\u7b49\uff09\u3002\u5bf9\u4e8e\u8fd9\u4e9b\u591a\u7ef4\u5ea6\u3001\u591a\u6a21\u6001\u7684\u9ad8\u901a\u91cf\u6570\u636e\uff08\u4f8b\u5982 cfRNA-seq\u5206\u6790\u5f97\u5230\u7684\u591a\u6a21\u6001\u6570\u636e\uff0c\u4ee5\u53camulti-omics\u6570\u636e\uff09\uff0c\u6211\u4eec\u9700\u8981\u8fdb\u884c4\u4e2a\u6b65\u9aa4\u6765\u8fdb\u884c\u673a\u5668\u5b66\u4e60\u7b49\u5206\u6790\uff0c\u5305\u62ec 1) Data Cleaning, 2) Feature extraction and engineering, 3) Model Fitting, 4) Classifier\u3002\u6211\u4eec\u9488\u5bf9\u8fd94\u4e2a\u6b65\u9aa4\u5f00\u53d1\u76f8\u5e94\u7684\u751f\u7269\u4fe1\u606f\u5b66\u65b9\u6cd5\u3001\u8f6f\u4ef6\u3001\u6570\u636e\u5e93\u7b49\u5de5\u5177\uff0c\u4f8b\u5982\uff0c\u6211\u4eec\u63a2\u7d22\u548c\u5229\u7528\u5927\u8bed\u8a00\u6a21\u578b\u548c\u6df1\u5ea6\u5b66\u4e60\u6a21\u578b\u7b49\u65b0\u578bAI \u6280\u672f\uff0c\u8fdb\u884c\u591a\u6a21\u6001\u6570\u636e\u6574\u5408\u3002</p> Multi-dimensional data for liquid biopsy of cancer (Heitzer et al., Nature Reviews 2019)"},{"location":"projects/proj/#a22-ribozyme-structure-prediction-ribozyme-design","title":"A2.2 [Ribozyme] Structure Prediction &amp; Ribozyme Design","text":"Prediction of 2D and 3D structure of RNA <p>RNA structure prediction: \u6211\u4eec\u5f00\u53d1\u9488\u5bf9 RNA\u7ed3\u6784\u7684\u9884\u6d4b\u6a21\u578b\u548c\u7b97\u6cd5\uff0c\u5bf9 RNA \u7ed3\u6784\u7684\u51c6\u786e\u9884\u6d4b\uff0c\u5c06\u5e2e\u52a9\u6211\u4eec\u66f4\u597d\u5730\u7406\u89e3 RNA \u7684\u8c03\u63a7\u548c\u529f\u80fd\uff0c\u5e76\u5e94\u7528\u4e8e\u57fa\u4e8e RNA\u9176\u548cRNA\u75ab\u82d7\u7684\u8bbe\u8ba1\u3002\u4f8b\u5982\uff0cmRNA\uff0c\u4ee5\u53ca\u73af\u88c5RNA\uff08circular RNA\uff09\u7b49\uff0c\u53ef\u4ee5\u7528\u6765\u505a\u4e3aRNA\u75ab\u82d7\u3002\u5728 RNA \u75ab\u82d7\u8bbe\u8ba1\u4e2d\uff0cRNA \u7ed3\u6784\u3001\u5bc6\u7801\u5b50\u548c\u4fee\u9970\u7684\u8bbe\u8ba1\u90fd\u662f\u975e\u5e38\u91cd\u8981\u7684\u7814\u7a76\u65b9\u5411\u3002\u4e0d\u8bba\u662f RNA\u5e72\u6270\u8fd8\u662fRNA\u75ab\u82d7\uff0c\u63d0\u9ad8RNA \u5728\u5b58\u50a8\u548c\u8fd0\u8f93\u4e2d\u7684\u7a33\u5b9a\u6027\uff0c\u9012\u9001\u5230\u7ec6\u80de\u548c\u4eba\u4f53\u5185\u7684\u6709\u6548\u6027\u548c\u9776\u5411\u6027\uff0c\u90fd\u662f\u975e\u5e38\u91cd\u8981\u548c\u524d\u6cbf\u7684\u7814\u7a76\u65b9\u5411\u3002</p> <p>RNA Design:  \u4e0d\u540c\u9886\u57df\u7684\u65b0\u65b9\u6cd5\u548c\u65b0\u601d\u7ef4\u7684\u5f15\u5165\uff0c\u5f80\u5f80\u80fd\u5e26\u6765\u672c\u5b66\u79d1\u7684\u7a81\u7834\u6027\u8fdb\u5c55\uff0c\u6240\u4ee5\u6211\u4eec\u5c24\u5176\u6ce8\u610f\u5c06\u6700\u65b0\u7684\u8ba1\u7b97\u9886\u57df\u7684\u65b0\u6280\u672f\u548c\u65b0\u601d\u7ef4\uff08\u4f8b\u5982\u57fa\u4e8e\u5927\u8bed\u8a00\u6a21\u578b\u7684\u65b0\u578b AI \u6280\u672f\uff09\u5f15\u5165\u5230\u751f\u7269\u6570\u636e\u7684\u7814\u7a76\u4e0a\u3002\u6211\u4eec\u9488\u5bf9RNA\uff0c\u5c24\u5176\u662f \u975e\u7f16\u7801 RNA (ncRNA\uff09\uff0c\u7684\u7ed3\u6784\u3001\u8c03\u63a7\u548c\u9776\u6807\u7b49\u95ee\u9898\uff0c\u5f00\u53d1\u65b0\u578b\u7684\u6838\u9178\u6a21\u578b\u3002\u6700\u7ec8\uff0c\u8fd9\u4e9b\u65b0\u578b\u7684\u6a21\u578b\u5c06\u4f1a\u5e26\u9886\u6211\u4eec\u8fdb\u5165\u4e00\u4e2a\u5d2d\u65b0\u601d\u7ef4\u7684\u9176\u8bbe\u8ba1\u3001\u75ab\u82d7\u8bbe\u8ba1\u548c\u836f\u7269\u8bbe\u8ba1\u7684\u65b0\u65f6\u4ee3\u3002</p>"},{"location":"projects/proj/#b1-rnatalk","title":"B1. RNAtalk","text":"RNAs Talk: Language of RNA <p>RNA-RNA interaction (trans-pair) : RNA\u9776\u5411RNA\u5728\u5404\u79cd\u751f\u7269\u8fc7\u7a0b\u4e2d\u53d1\u6325\u7740\u81f3\u5173\u91cd\u8981\u7684\u4f5c\u7528\uff0c\u5305\u62ec\u57fa\u56e0\u8c03\u63a7\u3001RNA\u52a0\u5de5\u548c\u75c5\u6bd2\u590d\u5236\u3002 \u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u6d89\u53ca\u8bc6\u522b\u548c\u8868\u5f81\u4e24\u4e2a RNA \u5206\u5b50\u4e4b\u95f4\u7684\u7ed3\u5408\u4f4d\u70b9\uff0c\u8fd9\u53ef\u4ee5\u6df1\u5165\u4e86\u89e3\u5b83\u4eec\u7684\u529f\u80fd\u5173\u7cfb\u548c\u8c03\u63a7\u673a\u5236\u3002 \u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u7531\u4e8e RNA \u7ed3\u6784\u7684\u590d\u6742\u6027\u3001\u5de8\u5927\u7684\u5e8f\u5217\u7a7a\u95f4\u4ee5\u53ca\u7ecf\u8fc7\u5b9e\u9a8c\u9a8c\u8bc1\u7684\u76f8\u4e92\u4f5c\u7528\u6570\u636e\u7684\u6709\u9650\u6027\uff0c\u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u4ecd\u7136\u662f\u4e00\u4e2a\u5177\u6709\u6311\u6218\u6027\u7684\u95ee\u9898\u3002 \u56e0\u6b64\uff0c\u9884\u6d4b\u7684\u51c6\u786e\u6027\u53ef\u80fd\u4f1a\u6839\u636e\u6240\u4f7f\u7528\u7684\u5177\u4f53\u65b9\u6cd5\u548c\u8f93\u5165\u6570\u636e\u7684\u8d28\u91cf\u800c\u6709\u6240\u4e0d\u540c\u3002 \u6211\u4eec\u5f00\u53d1\u548c\u5b8c\u5584\u7528\u4e8e\u9884\u6d4b RNA-RNA \u76f8\u4e92\u4f5c\u7528\u7684\u8ba1\u7b97\u65b9\u6cd5\uff0c\u65e8\u5728\u63d0\u9ad8\u5bf9 RNA \u751f\u7269\u5b66\u7684\u7406\u89e3\uff0c\u5e76\u4fc3\u8fdb\u65b0\u7684\u6cbb\u7597\u9776\u70b9\u548c\u57fa\u4e8e RNA \u7684\u8c03\u63a7\u673a\u5236\u7684\u53d1\u73b0\u3002</p>"},{"location":"projects/proj/#b2-rnatalk-applications","title":"B2. RNAtalk - Applications","text":""},{"location":"projects/proj/#b21-sirna-drug-design","title":"B2.1 siRNA Drug Design","text":"<p>siRNA design: siRNA\u5df2\u6210\u4e3a\u4e00\u79cd\u5e7f\u6cdb\u4f7f\u7528\u7684\u8f6c\u5f55\u540e\u8c03\u63a7\u5b9e\u9a8c\u65b9\u6cd5\uff0c\u5e76\u4e14\u8d8a\u6765\u8d8a\u663e\u793a\u51fa\u5176\u4f5c\u4e3a\u672a\u6765\u9776\u5411\u836f\u7269\u7684\u6f5c\u529b\u3002 \u7136\u800c\uff0c\u9ad8\u6548siRNA\u7684\u9884\u6d4b\u4ecd\u7136\u53d7\u5230\u6570\u636e\u96c6\u504f\u5dee\u3001\u9884\u6d4b\u65b9\u6cd5\u7684\u4e0d\u8db3\u4ee5\u53ca\u8131\u9776\u6548\u5e94\u7684\u5b58\u5728\u7684\u963b\u788d\u3002\u4e3a\u4e86\u514b\u670d\u8fd9\u4e9b\u9650\u5236\uff0c\u6211\u4eec\u5f00\u53d1\u65b0\u7684\u4eba\u5de5\u667a\u80fd\u65b9\u6cd5\u6765\u9884\u6d4b\u548c\u8bbe\u8ba1\u9ad8\u6548\u7684siRNA\u3002</p>"},{"location":"projects/proj/#b22-small-molecule-drug-design","title":"B2.2 Small-molecule Drug Design","text":"<p>Small molecule drug design targeting RNA: \u53ef\u4f5c\u4e3a\u5c0f\u5206\u5b50\u836f\u7269\u9776\u6807\u7684\u4eba\u7c7b\u86cb\u767d\u6570\u91cf\u975e\u5e38\u6709\u9650\uff1a\u5728\u4eba\u7c7b\u76842\u4e07\u4e2a\u5de6\u53f3\u7684\u86cb\u767d\u7f16\u7801\u57fa\u56e0\uff08\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u76841.5%\u5de6\u53f3\uff09\u4e2d\uff0c\u5927\u7ea6\u6709 10%-15%\u4e0e\u75be\u75c5\u76f4\u63a5\u76f8\u5173\uff1b\u800c\u5728\u8fd9\u4e9b\u57fa\u56e0\u4e2d\uff0c\u636e\u4f30\u8ba1\u4ec5\u6709\u4e0d\u5230 700 \u4e2a\u7684\u86cb\u767d\u4ea7\u7269\u662f\u53ef\u4ee5\u6210\u836f\u7684 \uff08\u4ec5\u5360\u4eba\u7c7b\u57fa\u56e0\u7ec4\u603b\u957f\u5ea6\u7684 0.05%\u5de6\u53f3\uff09\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u4eba\u7c7b\u57fa\u56e0\u7ec4\u7684~70%\u751a\u81f3\u66f4\u591a\u90fd\u4f1a\u88ab\u8f6c\u5f55\u6210 RNA\uff0c\u5176\u4e2d\u5927\u591a\u662f\u975e\u7f16\u7801 RNA (ncRNA)\u3002\u56e0\u6b64\uff0c\u8fd1\u5e74\u5f00\u59cb\u6709\u8d8a\u6765\u8d8a\u591a\u7684\u7814\u7a76\u8005\u8bd5\u56fe\u5c06 RNA \u4f5c\u4e3a\u836f\u7269\u9776\u6807\uff0c\u5e76\u521d\u6b65\u8bc1\u660e\u4e86\u8fd9\u4e00\u7b56\u7565\u7684\u53ef\u884c\u6027\u3002\u5c24\u5176\u503c\u5f97\u6211\u4eec\u6ce8\u610f\u7684\u662f\uff0c\u65b0\u51a0\u75c5\u6bd2\u5c31\u662f RNA \u75c5\u6bd2\uff0c\u5176\u57fa\u56e0\u7ec4\u672c\u8eab\u4e5f\u6709\u5e0c\u671b\u88ab\u4f5c\u4e3a\u836f\u7269\u9776\u6807\u3002\u6b64\u5916\uff0c\u5229\u7528\u975e\u7f16\u7801RNA\u8fdb\u884c\u75be\u75c5\u6cbb\u7597\u4e5f\u662f\u4e00\u4e2a\u6709\u524d\u666f\u7684\u7814\u7a76\u65b9\u5411\uff0c\u4f8b\u5982\uff0c\u57fa\u4e8e siRNA \u7684RNA\u5e72\u6270\uff08RNA interference, RNAi\uff09\u7cfb\u7edf\u7b49\u5df2\u7ecf\u88ab\u7528\u4e8e\u5f00\u53d1\u65b0\u7684\u57fa\u56e0\u6cbb\u7597\u65b9\u6cd5\u3002\u7531\u4e8e RNA \u7ed3\u6784\u7684\u9ad8\u5ea6\u590d\u6742\u6027\u548c\u53ef\u53d8\u6027\uff0c\u4ee5\u53ca\u5b9e\u9a8c\u65b9\u6cd5\u7684\u9650\u5236\uff0c\u76ee\u524d\u6211\u4eec\u5bf9\u4e8e RNA \u7684\u4e09\u7ef4\u7ed3\u6784\u7684\u4e86\u89e3\u4ecd\u975e\u5e38\u6709\u9650\uff0c\u9776\u5411 RNA \u7684\u836f\u7269\u7814\u53d1\u4e5f\u5904\u5728\u8d77\u6b65\u9636\u6bb5\u3002 \u6211\u4eec\u5c06\u5145\u5206\u53d1\u6325\u4eba\u5de5\u667a\u80fd\u7684\u4f18\u52bf\uff0c\u5229\u7528\u6df1\u5ea6\u5b66\u4e60\u7b49\u6700\u65b0\u7684\u8ba1\u7b97\u6280\u672f\u6574\u5408\u591a\u65b9\u9762\u7684\u4fe1\u606f\uff0c\u8bbe\u8ba1\u65b0\u836f\u7269\u9776\u6807RNA\u3002</p> The potential RNA-targeted druggable genome (Warner, et al., Nature Reviews | Drug Discovery\u00a0 2018)"},{"location":"publications/IP/","title":"Patent","text":""},{"location":"publications/IP/#-","title":"\u9c81\u5fd7\u5b9e\u9a8c\u5ba4 - \u4e13\u5229\u548c\u8457\u4f5c\u6743","text":""},{"location":"publications/IP/#_1","title":"\u68c0\u6d4b\u65b9\u5411\u76f8\u5173\u4e13\u5229\u548c\u8f6f\u4ef6\u8457\u4f5c\u6743","text":"<ol> <li>\u57fa\u4e8e\u673a\u5668\u5b66\u4e60\u7684\u751f\u7269\u4fe1\u606f\u65b9\u6cd5 RNAfinder\uff08\u4e13\u5229\u53f7\uff1a201610806928.8\uff09(Science 2010; Genome Res. 2011; Nucleic Acids Res. 2015;2017a;2018)</li> <li>\u75d5\u91cfRNA\u6355\u83b7\u548c\u6d4b\u5e8f\u6280\u672fi-SMART (\u4e13\u5229\u53f7\uff1a201810607652X\uff09(Briefings in Bioinformatics 2018; Cell Research 2020)</li> <li>\u9488\u5bf9\u809d\u764c\u65e9\u671f\u68c0\u6d4b\u548c\u590d\u53d1\u76d1\u6d4b\u7684\u4e00\u4e2a\u65b0\u578b\u975e\u7f16\u7801exRNA\u6807\u5fd7\u7269\uff08\u4e13\u5229\u53f7:201811009464.3\uff09(Nature Comminications 2017; Clinical Chemistry 2019)</li> <li>\u4e00\u79cd\u7528\u4e8e\u809d\u7ec6\u80de\u764c\u65e9\u671f\u7b5b\u67e5\u548c\u590d\u53d1\u76d1\u6d4b\u76843-ncRNA\u7cfb\u7edf (\u4e13\u5229\u53f7\uff1a202010927225.7)\uff08Theranostics 2021)</li> <li>\u4f53\u6db2\u6837\u672c\u4e2d\u9274\u5b9a\u65b0\u578bexRNA\u751f\u7269\u6807\u5fd7\u7269\u7684\u8bd5\u5242\u76d2\u53ca\u914d\u5957\u673a\u5668\u5b66\u4e60\u7b97\u6cd5 (\u4e13\u5229\u7533\u8bf7\u53f7\uff1a202010618721.4)\uff08Nuc. Acid Res. 2024)</li> <li>\u75d5\u91cfRNA\u6355\u83b7\u548c\u6d4b\u5e8f\u6280\u672fDETECTOR-seq (\u4e13\u5229\u7533\u8bf7\u53f7\uff1a202210579444.X) (elife 2022, Cell Rep. Med. 2023, Clinic. &amp; Tranl. Med. 2024)</li> <li>\u591a\u7ec4\u5b66 AI\u6574\u5408\u65b9\u6cd5 PathFormer (\u8f6f\u4ef6\u8457\u4f5c\u6743\u53f7\uff1a2023SR0985659) (Bioinformatics 2024a)</li> <li>\u4e00\u79cd\u7ec6\u80de\u6e38\u79bbRNA\uff08cfRNA\uff09\u5cf0\u533a\u8bc6\u522b\u7684AI\u8f6f\u4ef6 cfPeak \uff08\u8f6f\u4ef6\u8457\u4f5c\u6743\u53f7\uff1a2025SR1268709\uff09\uff08Genome Biology 2025\uff09</li> </ol>"},{"location":"publications/IP/#_2","title":"\u5236\u836f\u65b9\u5411\u76f8\u5173\u4e13\u5229\u548c\u8f6f\u4ef6\u8457\u4f5c\u6743","text":"<ol> <li>RNA-protein \u7ed3\u5408\u53ca\u8c03\u63a7\u6570\u636e\u5e93 POSTAR\uff08\u8f6f\u4ef6\u8457\u4f5c\u6743\u53f7\uff1a2016R11S367236\uff09(Genome Biology 2017; Nucleic Acids Res. 2017b; 2019; 2022)</li> <li>\u5c0fRNA\u836f\u7269 AI \u8bbe\u8ba1\u8f6f\u4ef6 OligoFormer (\u8f6f\u4ef6\u8457\u4f5c\u6743\u53f7\uff1a2024SR0808920) (Bioinformatics 2024b)</li> <li>\u5c0f\u5206\u5b50\u836f\u7269 AI \u8bbe\u8ba1\u8f6f\u4ef6 RNAsmol (\u8f6f\u4ef6\u8457\u4f5c\u6743\u53f7\uff1a2025SR1112526) (Nature Comput. Sci. 2025)</li> </ol>"},{"location":"publications/news/","title":"News","text":""},{"location":"publications/news/#news-in-lu-lab","title":"News in Lu Lab","text":"<ul> <li>2025.6. Hongli Ma et al. published RNAsmol paper in Nature Computational Science. Congratulations ! </li> </ul> <ul> <li>2025.5. Pengfei Bao, Taiwei Wang et al. published cfPeak paper in Genome Biology. Congratulations !</li> </ul> <ul> <li>2024.8. Hongke Wang, Qing Zhan et al. published DETECTOR-seq paper in Clinical and Translational Medicine. Congratulations !</li> <li>2023.11. Yuhuan Tao, Shaozhen Xing et al. published a cell-free Multi-Omics paper in Cell Reports Medicine. Congratulations !</li> <li>2022.07.  Shanwen Chen, Yunfan Jin et al. published a cell-free RNA paper in eLife. Congratulations \uff01</li> </ul>"},{"location":"publications/news/#news","title":"News \u76f8\u5173\u62a5\u9053","text":"<ul> <li>2025.06. Nat Comput Sci | \u9c81\u5fd7/\u5f90\u632f\u6c5f\u56e2\u961f\u53d1\u8868\u4eba\u5de5\u667a\u80fd\u6a21\u578bRNAsmol\u9884\u6d4b\u9776\u5411RNA\u7684\u5c0f\u5206\u5b50\u836f\u7269</li> <li>2025.05. Genome Biol  | \u9c81\u5fd7/\u674e\u68a6\u6d9b\u7b49\u56e2\u961f\u5408\u4f5c\u53d1\u8868\u9488\u5bf9cfRNA\u7247\u6bb5\u7ec4\u5b66\u5206\u6790\u65b0\u65b9\u6cd5\uff0c\u52a9\u529b\u591a\u79cd\u75be\u75c5\u7684\u65e0\u521b\u8bca\u65ad</li> <li>2024.08. Clinical &amp; Trans. Med. | \u9c81\u5fd7/\u738b\u9e4f\u8fdc/\u674e\u68a6\u6d9b\u56e2\u961f\u5f00\u53d1cfRNA\u6d4b\u5e8f\u65b0\u6280\u672f\u5e76\u89e3\u6790\u8840\u6d46\u548cEV\u8f6c\u5f55\u7ec4\u7279\u5f81</li> <li>2023.11. Cell Rep Med | \u9c81\u5fd7/\u738b\u9e4f\u8fdc/\u5362\u5029\u56e2\u961f\u5408\u4f5c\u53d1\u8868\u6d88\u5316\u9053\u764c\u75c7cfDNA+cfRNA\u591a\u7ec4\u5b66\u7814\u7a76\u65b0\u6210\u679c</li> <li>2022.07. eLife | \u738b\u9e4f\u8fdc/\u9c81\u5fd7/\u5f90\u632f\u6c5f\u56e2\u961f\u5408\u4f5c\u53d1\u8868\u6cdb\u764c\u65e9\u8bca\u7814\u7a76\u65b0\u6210\u679c</li> <li>2020.11. Theranostics  | \u6e05\u534e\u5927\u5b66\u9c81\u5fd7\u3001\u6d77\u519b\u519b\u533b\u5927\u5b66\u6bb7\u5efa\u534e\u548c\u56fd\u5bb6\u809d\u764c\u79d1\u5b66\u4e2d\u5fc3\u9648\u78ca\u8bfe\u9898\u7ec4\u63ed\u793a\u9488\u5bf9\u809d\u764cAFP\u9634\u6027\u8bca\u65ad\u548c\u65e9\u671f\u8bca\u65ad\u7684\u8840\u6db2\u975e\u7f16\u7801RNA\u6807\u5fd7\u7269</li> <li>2019.12. Cell Res. | \u201c\u62ab\u7740\u7f8a\u76ae\u7684\u72fc\u201d\u2014\u2014\u764c\u75c7\u8f6c\u79fb\u7684\u65b0\u9762\u7eb1 - \u6e05\u534e\u5927\u5b66\u738b\u680b\u3001\u9c81\u5fd7Cell Res\u53d1\u6587\u63ed\u793a\u80bf\u7624\u8f6c\u79fb\u65b0\u6a21\u578b</li> <li>2019.5. Clinical Chem. | \u6e05\u534e\u5927\u5b66\u9c81\u5fd7\u7814\u7a76\u56e2\u961f\u4e0e\u5929\u6d25\u3001\u4e0a\u6d77\u7814\u7a76\u56e2\u961f\u8054\u5408\u53d1\u5e03\u6db2\u4f53\u6d3b\u68c0\u65b0\u6210\u679c\uff01\u591a\u79cd\u975e\u7f16\u7801RNA\u7ed3\u6784\u57df\u6216\u53ef\u4f5c\u4e3a\u7a33\u5b9a\u7684\u809d\u764c\u65e0\u521b\u8bca\u65ad\u6807\u5fd7\u7269</li> <li>2017.3. Nature Commn. | \u6e05\u534e\u5927\u5b66\uff0c\u4e1c\u65b9\u809d\u80c6\u533b\u9662\u53d1\u8868Nature\u5b50\u520a\u89e3\u6790\u4e0e\u764c\u75c7\u6709\u5173\u7684lncRNA</li> <li>2016.11. Nuc. Acids Res. | \u5229\u7528\u751f\u7269\u4fe1\u606f\u5b66\u53d1\u73b0\u57fa\u56e0\u7ec4\u6697\u7269\u8d28\u2013 \u6e05\u534e\u5927\u5b66\u9c81\u5fd7\u5b9e\u9a8c\u5ba4\u975e\u7f16\u7801RNA\u8f6f\u4ef6\u7cfb\u5217\u4ecb\u7ecd</li> </ul>"},{"location":"publications/pub-topics/","title":"By Topic","text":""},{"location":"publications/pub-topics/#publications-by-topic","title":"Publications  by Topic","text":"<p>\u4ee3\u8868\u6027\u6587\u7ae0\u4e2d\u6587\u89e3\u8bfb</p> <p>\u4e13\u5229\u548c\u8457\u4f5c\u6743</p> <p>Software &amp; Models</p> <p></p> <ul> <li>Publications by Topic<ul> <li>A. [RNA-Finder] Bioinfo-Driven Precision Medicine<ul> <li>cfRNAfinder: Cell-free RNA Biomarker</li> <li>ncRNAfinder: Discovering Novel Noncoding RNAs</li> </ul> </li> <li>B. [RNA-Talk] AI-Driven RNA Modeling &amp; Drug Design<ul> <li>RNA-RNA</li> <li>RNA-Ligand</li> <li>RNA-Protein</li> </ul> </li> </ul> </li> </ul>"},{"location":"publications/pub-topics/#a-rna-finder-bioinfo-driven-precision-medicine","title":"A. [RNA-Finder] Bioinfo-Driven Precision Medicine","text":""},{"location":"publications/pub-topics/#cfrnafinder-cell-free-rna-biomarker","title":"cfRNAfinder: Cell-free RNA Biomarker","text":"<ul> <li>Pengfei Bao<sup>1</sup>, Taiwei Wang<sup>1</sup>, Xiaofan Liu<sup>1</sup>, Shaozhen Xing, Hanjin Ruan, Hongli Ma, Yuhuan Tao, Qing Zhan, Efres Belmonte-Reche, Lizheng Qin, Zhengxue Han, Minghui Mao*, Mengtao Li* &amp; Zhi John Lu* (2025) Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential. Genome Biology 26, 119 (<sup>1</sup>contributed equally, *co-corresponding authors)  Github: https://github.com/lulab/cfPeak</li> <li>Hongke Wang<sup>1</sup>, Qing Zhan<sup>1</sup>, Meng Ning<sup>1</sup>, Hongjie Guo<sup>1</sup>, Qian Wang, Jiuliang Zhao, Pengfei Bao, Shaozhen Xing, Shanwen Chen, Shuai Zuo, Xuefeng Xia, Mengtao Li*, Pengyuan Wang*, Zhi John Lu* (2024) Depletion-assisted multiplexed cell-free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles Clinical and Translational Medicine 14:e1760 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Xiaofan Liu<sup>1</sup>, Yuhuan Tao<sup>1</sup>, Zilin Cai, Pengfei Bao, Hongli Ma, Kexing Li, Mengtao Li*, Yunping Zhu*, Zhi John Lu*  (2024) Pathformer: a biological pathway informed Transformer for disease diagnosis and prognosis using multi-omics data Bioinformatics 40(5), btae316 (<sup>1</sup>contributed equally, *co-corresponding authors) Github: https://github.com/lulab/Pathformer</li> <li>Mingyang Li<sup>1</sup>, Tianxiu Zhou<sup>1</sup>, Mingfei Han<sup>1</sup>, Hongke Wang, Pengfei Bao, Yuhuan Tao, Xiaoqing Chen, Guansheng Wu, Tianyou Liu, Xiaojuan Wang, Qian Lu*, Yunping Zhu*, Zhi John Lu* (2024) cfOmics: a cell-free multi-Omics database for diseases.  Nucleic Acids Research 52(D1):D607-D621 (<sup>1</sup>contributed equally, *co-corresponding authors)  Website: http://cfOmics.ncRNAlab.org</li> <li>Yuhuan Tao<sup>1</sup>, Shaozhen Xing<sup>1</sup>, Shuai Zuo<sup>1</sup>, Pengfei Bao, Yunfan Jin, Yu Li, Yingchao Wu, Shanwen Chen, Xiaojuan Wang, Yumin Zhu, Ying Feng, Xiaohua Zhang, Xianbo Wang, Qiaoran Xi, Qian Lu*, Pengyuan Wang*, Zhi John Lu*  (2023) Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood. Cell Reports Medicine 4(11):101281 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Xing, S.<sup>1</sup>, Zhu, Y.<sup>1</sup>, You, Y., Wang, S., Wang, H., Ning, M., Jin, H., Liu, Z., Zhang, X., Yu, C. * &amp; Lu, Z. J.* (2023). Cell-free RNA for the liquid biopsy of gastrointestinal cancer. WIREs RNA 14(5):e1791 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Chun Ning<sup>1</sup>, Peng Cai<sup>1</sup>, Xiaofan Liu<sup>1</sup>, Guangtao Li<sup>1</sup>, Pengfei Bao, Lu Yan, Meng Ning, Kaichen Tang, Yi Luo, Hua Guo, Lu Chen*, Zhi John Lu *, Jianhua Yin* (2023) A Comprehensive Evaluation of Full-spectrum Cell-free RNAs highlights cell-free RNA fragments for Early-Stage Hepatocellular Carcinoma Detection eBioMedicine 93:104645 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> <li>Shanwen Chen<sup>1</sup>, Yunfan Jin<sup>1</sup>, Siqi Wang<sup>1</sup>, Shaozhen Xing<sup>1</sup>, \u2026, Zhenjiang Zech Xu*, Zhi John Lu* and Pengyuan Wang* (2022) Cancer Type Classification Using Plasma Cell Free RNAs Derived from Human and Microbes. eLife 11:e75181 (<sup>1</sup>contributed equally, *co-corresponding authors) (IF: 8.7)</li> <li>Yumin Zhu<sup>1</sup>, Siqi Wang<sup>1</sup>, Xiaochen Xi<sup>1</sup>, Minfeng Zhang<sup>1</sup>, Xiaofan Liu, Weina Tang, Peng Cai, Shaozhen Xing, Pengfei Bao, Yunfan Jin, Weihao Zhao, Yinghui Chen, Huanan Zhao, Xiaodong Jia, Shanshan Lu, Yinying Lu, Lei Chen*, Jianhua Yin*, Zhi John Lu* (2021) Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. Theranostics 11(1):181-193 (<sup>1</sup>contributed equally, *co-corresponding authors) (IF: 11.556) (Patent Protected)</li> <li>Shuaishuai Teng<sup>1</sup>, Yang Eric Li<sup>1</sup>, \u2026, Zhi John Lu* and Dong Wang* (2020) Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Research 30(1):34-49 (<sup>1</sup>contributed equally, *co-corresponding authors) (IF: 25.6)</li> <li>Chang Tan<sup>1</sup>, Jingyi Cao<sup>1</sup>, Lu Chen<sup>1</sup>, Xiaochen Xi, Siqi Wang, Yumin Zhu, Liuqing Yang, Longteng Ma, Dong Wang, Jianhua Yin*, Ti Zhang* and Zhi John Lu* (2019) Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma. Clinical Chemistry 65(7):905-915  (<sup>1</sup>contributed equally, *co-corresponding authors) (IF: 8.3) (Patent Protected)</li> <li>Yang Yang<sup>1</sup>, Lei Chen<sup>1</sup>, Jin Gu<sup>1</sup>, Hanshuo Zhang<sup>1</sup>, \u2026, Hongyang Wang*, Michael Q. Zhang* and Zhi John Lu* (2017) Recurrently deregulated lncRNAs in hepatocellular carcinoma.Nature Communications 8, 14421 (<sup>1</sup>contributed equally, *co-corresponding authors) (IF: 17.69)</li> </ul>"},{"location":"publications/pub-topics/#ncrnafinder-discovering-novel-noncoding-rnas","title":"ncRNAfinder: Discovering Novel Noncoding RNAs","text":""},{"location":"publications/pub-topics/#dsrnafinder-secondary-structure-prediction-and-motif-finding","title":"dsRNAfinder: Secondary Structure Prediction and Motif finding","text":"<ul> <li>[Server] Yang Wu<sup>1</sup>, Rihao Qu<sup>1</sup>, Yiming Huang<sup>1</sup>, Binbin Shi, Mengrong Liu, Yang Li and Zhi John Lu* (2016) RNAex: an RNA secondary structure prediction server enhanced by high-throughput structure probing data. Nucleic Acids Research 44 (W1): W294-W301 (<sup>1</sup>contributed equally) (IF: 19.16)</li> <li>[Algorithm] Yang Wu<sup>1</sup>, Binbin Shi<sup>1</sup>, Xinqiang Ding, Tong Liu, Xihao Hu, Kevin Y. Yip, Zheng Rong Yang, David H. Mathews and Zhi John Lu* (2015) Improved prediction of RNA secondary structure by integrating the free energy model with restraints derived from experimental probing data. Nucleic Acids Research 43(15): 7247-59. (<sup>1</sup>contributed equally) (IF: 19.16) Github: https://github.com/lulab/RME</li> <li>[Algorithm] Lu ZJ, Gloor JW and Mathews DH (2009) Improved RNA secondary structure prediction by maximizing expected pair accuracy. RNA 15: 1805-1813. (IF: 4.9) software: RNAstructure</li> <li>[Biophysical Model] Lu ZJ, Turner DH and Mathews DH (2006) A set of nearest neighbor parameters for predicting the enthalpy change of RNA secondary structure formation. Nucleic Acids Research 34:4912-4924. (IF: 19.16)</li> </ul>"},{"location":"publications/pub-topics/#noncoding-rna-identification","title":"Noncoding RNA Identification","text":"<ul> <li>Yu-Xiang Chen1, Zhi-yu Xu1, Xueliang Ge, Suparna Sanyal, Zhi John Lu* and Babak Javid (2020) Selective translation by alternative bacterial ribosomes. PNAS 117(32):19487-19496 (1contributed equally, co-corresponding authors) (IF: 12.78)</li> <li>[Algorithm V3] Zhiyu Xu1, Long Hu1, Binbin Shi, SiSi Geng, Longchen Xu, Dong Wang &amp; Zhi John Lu* (2018) Ribosome elongating footprints denoised by wavelet transform comprehensively characterize dynamic cellular translation events. Nucleic Acids Research* 46 (18), e109-e109 (IF: 19.16) Github: https://github.com/lulab/Ribowave</li> <li>Yang Yang1, Lei Chen1, Jin Gu1, Hanshuo Zhang1, \u2026, Hongyang Wang, Michael Q. Zhang and Zhi John Lu* (2017) Recurrently deregulated lncRNAs in hepatocellular carcinoma.Nature Communications 8, 14421 (1contributed equally) (IF: 17.69)</li> <li>[Algorithm V2]  Long Hu, Zhiyu Xu, Boqin Hu and Zhi John Lu* (2017) COME: a robust coding potential calculation tool for lncRNA identification and characterization based on multiple features. Nucleic Acids Research 45(1): e2 (IF: 19.16) Github: https://github.com/lulab/COME</li> <li>[Algorithm V1]  Long Hu, Chao Di, Mingxuan Kai, Yu-Cheng T. Yang, Yang Li, Yunjiang Qiu, Xihao Hu, Kevin Y. Yip, Michael Q. Zhang and Zhi John Lu* (2015) A common set of distinct features that characterize noncoding RNAs across multiple species. *Nucleic Acids Research* 43(1): 104-114. (IF: 19.16) Github: https://github.com/lulab/RNAfeature</li> <li>Gerstein MB, Joel Rozowsky, Koon-Kiu Yan, \u2026, Lu Z, \u2026, Robert Waterston (2014) Comparative Analysis of the Transcriptome across Distant Species. Nature 512(7515):445-448.</li> <li>ENCODE Project Consortium#. (2012) An Integrated Encyclopedia of DNA Elements in the Human Genome. Nature 489, 57\u201374. (#Lu Z was a member of ENCODE Consortium) [Cover Story]</li> <li>[AlgorithmV0] Lu ZJ<sup>1</sup>, Yip KY<sup>1</sup>, Wang G, Shou C, Hillier LW, et al. (2011) Prediction and characterization of noncoding RNA in C. elegans by integrating conservation, secondary structure and high-throughput sequencing and array data. Genome Research 21: 276-2857 (<sup>1</sup>contributed equally) (IF: 10.98)</li> <li>[Algorithm V0] Gerstein MB<sup>\u2020,</sup>*, Lu ZJ<sup>\u2020</sup>, Van Nostrand EL<sup>\u2020</sup>, Cheng C<sup>\u2020</sup>, Arshinoff BI<sup>\u2020</sup>, et al. (2010) Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project.  Science 330 (6012): 1775-1787  (<sup>\u2020</sup>20 co-first authors, *15 co-corresponding authors, ~150 authors in total) [Cover Story]</li> </ul>"},{"location":"publications/pub-topics/#b-rna-talk-ai-driven-rna-modeling-drug-design","title":"B. [RNA-Talk] AI-Driven RNA Modeling &amp; Drug Design","text":""},{"location":"publications/pub-topics/#rna-rna","title":"RNA-RNA","text":""},{"location":"publications/pub-topics/#rna-sirna","title":"RNA-siRNA","text":"<ul> <li>[Language Model] Yilan Bai, Haochen Zhong, Taiwei Wang, Zhi John Lu (2024) OligoFormer: An accurate and robust prediction method for siRNA design. Bioinformatics 40 (10), btae577. software: OligoFormer</li> <li>Tan X, Lu ZJ <sup>2</sup>, Gao G, Xu QK, Hu L2, Fellmann C, Li MZ, Qu HJ, Lowe SW, Hannon GJ &amp; Elledge SJ. (2012) Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. PNAS, 109(3): 869-74 (<sup>2</sup>Lu Lab, School of Life Sciences, Tsinghua University) (IF: 12.78)</li> <li>[Server] Lu ZJ and Mathews DH (2008)  OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics.   Nucleic Acids Research  36:W104-W108. (IF: 19.16) website: OligoWalk</li> <li>[Algorithm] Lu ZJ and Mathews DH (2008) Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Research 36:640-647. (IF: 19.16) software: RNAstructure</li> <li>[Biophysical Model] Lu ZJ and Mathews DH (2008) Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design. Nucleic Acids Research 36:3738-3745. (IF: 19.16)</li> </ul>"},{"location":"publications/pub-topics/#rna-ligand","title":"RNA-Ligand","text":"<ul> <li>Hongli Ma, Letian Gao, Yunfan Jin, Jianwei Ma, Yilan Bai, Xiaofan Liu, Pengfei Bao, Ke Liu, Zhenjiang Zech Xu* and Zhi John Lu*. (2025) RNA\u2013ligand interaction scoring via data perturbation and augmentation modeling. Nature Computational Science 10.1038/s43588-025-00820-x (*co-corresponding authors)</li> <li>Kequan Lin<sup>1</sup>, Lu Li<sup>1</sup>, Yifei Dai, Huili Wang, Shuaishuai Teng, Xilinqiqige Bao, Zhi John Lu* and Dong Wang* (2019) A comprehensive evaluation of connectivity methods for L1000 data. Briefings in Bioinformatics bbz129 (<sup>1</sup>contributed equally) (IF: 11.62)</li> <li>Tan X, Hu L<sup>2</sup>, Luquette LJ, Gao G, Liu YF2, Qu HJ, Xi RB, Lu ZJ<sup>2</sup>, Park PJ &amp; Elledge SJ. (2012) Systematic Identification of Synergistic Drug Pairs Targeting HIV. Nature Biotech. 30:1125-1130 (<sup>2</sup>Lu Lab, School of Life Sciences, Tsinghua University) (IF: 54.36)</li> </ul>"},{"location":"publications/pub-topics/#rna-protein","title":"RNA-Protein","text":"<ul> <li>[Database V3] Weihao Zhao<sup>1</sup>, Shang Zhang<sup>1</sup>, \u2026, Yucheng T Yang, Zhi John Lu* (2022) POSTAR3: an updated platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Research* 50(D1):D287-D294 (IF: 19.16) Website: http://POSTAR3.ncRNAlab.org</li> <li>Rui Xiao<sup>1</sup>, Jia-Yu Chen<sup>1</sup>, Zhengyu Liang<sup>1</sup>, Daji Luo, Geng Chen, Zhi John Lu, \u2026, Michael Q. Zhang, Yu Zhou and Xiang-Dong Fu (2019) Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription. Cell 178, 107\u2013121</li> <li>[Database V2] Yumin Zhu1, Gang Xu1, Yucheng T Yang1, Zhiyu Xu, Xinduo Chen, Binbin Shi, Daoxin Xie, Zhi John Lu* and Pengyuan Wang (2019) POSTAR2: deciphering the post-transcriptional regulatory logics. Nucleic Acids Research* (D1):D203-D211 (1contributed equally) (IF: 19.16) Website: http://POSTAR2.ncRNAlab.org</li> <li>[Mathematical Model] Yang Eric Li<sup>1</sup>, Mu Xiao<sup>1</sup>, Binbin Shi<sup>1</sup>, Yu-Cheng T. Yang, Dong Wang, Fei Wang, Marco Marcia and Zhi John Lu (2017) Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA-protein binding sites. Genome Biology* 18:169 (1contributed equally) (IF: 17.91) Github: https://github.com/lulab/RBPgroup</li> <li>[Database V1] Boqin Hu<sup>1</sup>, Yu-Cheng T. Yang<sup>1</sup>, Yiming Huang, Yumin Zhu and Zhi John Lu* (2017) POSTAR: a platform of post-transcriptional regulation coordinated by RNA binding proteins. Nucleic Acids Research 45 (D1): D104-D114 (1contributed equally) (IF: 19.16) Website: http://POSTAR.ncRNAlab.org</li> </ul>"},{"location":"publications/pub/","title":"By Year","text":""},{"location":"publications/pub/#publications-by-year","title":"Publications by Year","text":"<p>\u4ee3\u8868\u6027\u6587\u7ae0\u4e2d\u6587\u89e3\u8bfb</p> <p>\u4e13\u5229\u548c\u8457\u4f5c\u6743</p> <p>Software &amp; Models</p>"},{"location":"publications/pub/#2025","title":"2025","text":"<ul> <li>Hongli Ma, Letian Gao, Yunfan Jin, Jianwei Ma, Yilan Bai, Xiaofan Liu, Pengfei Bao, Ke Liu, Zhenjiang Zech Xu* and Zhi John Lu*  (2025)  RNA\u2013ligand interaction scoring via data perturbation and augmentation modeling. Nature Computational Science 10.1038/s43588-025-00820-x (*co-corresponding authors)</li> </ul> <p>View Detail  |  Free Full-text  (view-only)</p> <ul> <li>Pengfei Bao<sup>1</sup>, Taiwei Wang<sup>1</sup>, Xiaofan Liu<sup>1</sup>, Shaozhen Xing, Hanjin Ruan, Hongli Ma, Yuhuan Tao, Qing Zhan, Efres Belmonte-Reche, Lizheng Qin, Zhengxue Han, Minghui Mao*, Mengtao Li* &amp; Zhi John Lu* (2025) Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential. Genome Biology 26, 119 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Zhendong Lu<sup>1</sup>, Pengfei Bao<sup>1</sup>, Taiwei Wang, Kairui Hu, Lina Zhang, Ling Yi, Yuanming Pan, Weiying Li, Zhi John Lu*, Jinghui Wang* &amp; Junzhong Ruan* (2025) Multi-omics data-based modeling reveals tumorigenesis- and prognosis-associated genes with clinical potential in lung adenocarcinoma BMC Cancer 25, 1743 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Yumin Zhu, Fengping Wu, Kangping Liu, Shaozhen Xing, Chun Ning, Meng Ning, Heyue Jin, Yun Shao, Zhenye Zhu, Hongke Wang, Binbin Shi, Yajin Mo, Xinping Tian, Mengtao Li, Jiuliang Zhao*, Zhi John Lu*, Ning Gu* (2025) Proceedings of cell-free noncoding RNA biomarker studies in liquid biopsy Rheumatology and Immunology Research 6(3):149\u2013158 (*co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Qiangsheng Yu, Jie Wu, Yunfan Jin, Tianxue Song, Wenrui Wang, Yuejuan Zeng, Huang Huang, Haiteng Deng, Wei Wang, Jianghui Xie, Zhi John Lu, Xiaofeng Fang, Susheng Song* &amp; Tiancong Qi* (2025) Pathogen-induced condensation of the guard cell RNA-binding protein SAIR1 fine-tunes translation for immunity. Nature Plants doi: 10.1038/s41477-025-02154-y (*co-corresponding authors)</li> </ul> <p>View Detail</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201475\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2024","title":"2024","text":"<ul> <li>Yilan Bai, Haochen Zhong, Taiwei Wang, Zhi John Lu (2024) OligoFormer: An accurate and robust prediction method for siRNA design. Bioinformatics 40 (10), btae577</li> </ul> <p>View Detail</p> <ul> <li>Hongke Wang<sup>1</sup>, Qing Zhan<sup>1</sup>, Meng Ning<sup>1</sup>, Hongjie Guo<sup>1</sup>, Qian Wang, Jiuliang Zhao, Pengfei Bao, Shaozhen Xing, Shanwen Chen, Shuai Zuo, Xuefeng Xia, Mengtao Li*, Pengyuan Wang*, Zhi John Lu* (2024) Depletion-assisted multiplexed cell-free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles Clinical and Translational Medicine 14:e1760 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Genpeng Li<sup>1</sup> , Wang Hongke<sup>1</sup> , Jinjing Zhong , Yilan Bai , Chen Wenjie , Ke Jiang , Jing Huang , Yuting Shao , Jiaye Liu , Gong Yanping, Zhang Junhui , Sun Ronghao , Tao Wei , Rixiang Gong , Zhu Jingqiang , Zhi Lu , Zhihui Li , Jianyong Lei (2024)  Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study BRITISH JOURNAL OF CANCER 130(6):925-933 (<sup>1</sup>contributed equally)</li> </ul> <p>View Detail</p> <ul> <li>Xiaofan Liu<sup>1</sup>, Yuhuan Tao<sup>1</sup>, Zilin Cai, Pengfei Bao, Hongli Ma, Kexing Li, Mengtao Li*, Yunping Zhu*, Zhi John Lu*  (2024) Pathformer: a biological pathway informed Transformer for disease diagnosis and prognosis using multi-omics data Bioinformatics 40(5), btae316 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Mingyang Li<sup>1</sup>, Tianxiu Zhou<sup>1</sup>, Mingfei Han<sup>1</sup>, Hongke Wang, Pengfei Bao, Yuhuan Tao, Xiaoqing Chen, Guansheng Wu, Tianyou Liu, Xiaojuan Wang, Qian Lu*, Yunping Zhu*, Zhi John Lu* (2024) cfOmics: a cell-free multi-Omics database for diseases. Nucleic Acids Research 52(D1):D607-D621 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>\u5218\u6653\u5e06, \u9c81\u5fd7. \u590d\u6742\u75be\u75c5\u4e2d\u591a\u7ec4\u5b66\u591a\u6a21\u6001\u6570\u636e\u7684\u751f\u7269\u4fe1\u606f\u5b66\u7814\u7a76\u8fdb\u5c55. \u79d1\u5b66\u901a\u62a5, 2024, 69: 1\u201315   Xiaofan Liu and  Zhi Lu (2024) Progress of bioinformatics studies for multi-omics and multi-modal data in complex diseases (in Chinese). Chinese Science Bulletin, 69: 1\u201315, doi: 10.1360/TB-2024-0416</li> </ul> <p>View Detail</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201469\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2023","title":"2023","text":"<ul> <li>Yuhuan Tao<sup>1</sup>, Shaozhen Xing<sup>1</sup>, Shuai Zuo<sup>1</sup>, Pengfei Bao, Yunfan Jin, Yu Li, Yingchao Wu, Shanwen Chen, Xiaojuan Wang, Yumin Zhu, Ying Feng, Xiaohua Zhang, Xianbo Wang, Qiaoran Xi, Qian Lu*, Pengyuan Wang*, Zhi John Lu*  (2023) Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood. Cell Reports Medicine 4(11):101281 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Xing, S.<sup>1</sup>, Zhu, Y.<sup>1</sup>, You, Y., Wang, S., Wang, H., Ning, M., Jin, H., Liu, Z., Zhang, X., Yu, C. * &amp; Lu, Z. J.* (2023). Cell-free RNA for the liquid biopsy of gastrointestinal cancer. WIREs RNA 14(5):e1791 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail   |  PDF</p> <ul> <li>Chun Ning<sup>1</sup>, Peng Cai<sup>1</sup>, Xiaofan Liu<sup>1</sup>, Guangtao Li<sup>1</sup>, Pengfei Bao, Lu Yan, Meng Ning, Kaichen Tang, Yi Luo, Hua Guo, Lu Chen*, Zhi John Lu *, Jianhua Yin* (2023) A Comprehensive Evaluation of Full-spectrum Cell-free RNAs highlights cell-free RNA fragments for Early-Stage Hepatocellular Carcinoma Detection eBioMedicine 93:104645 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <p>Yunfan Jin, Hongli Ma, Zhenjiang Zech Xu* and Zhi John Lu*.  BATTER: Accurate Prediction of Rho-dependent and Rho-independent Transcription Terminators in Metagenomes bioRxiv 10.1101/2023.10.02.560326  (*co-corresponding authors)    Preprint</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201466\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2022","title":"2022","text":"<ul> <li>Shanwen Chen<sup>1</sup>, Yunfan Jin<sup>1</sup>, Siqi Wang<sup>1</sup>, Shaozhen Xing<sup>1</sup>, Yingchao Wu, Yuhuan Tao, Yongchen Ma, Shuai Zuo, Xiaofan Liu, Yichen Hu, Hongyan Chen, Yuandeng Luo, Feng Xia, Chuanming Xie, Jianhua Yin, Xin Wang, Zhihua Liu, Ning Zhang, Zhenjiang Zech Xu*, Zhi John Lu*, Pengyuan Wang* (2022) Cancer Type Classification Using Plasma Cell Free RNAs Derived from Human and Microbes. eLife 11:e75181 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail </p> <p></p> <ul> <li>Haipeng Fu, Tingyu Wang, Xiaohui Kong, Kun Yan, Yang Yang, Jingyi Cao, Yafei Yuan, Nan Wang, Kehkooi Kee, Zhi John Lu &amp; Qiaoran Xi (2022) A Nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells. Nature Communications 13(1):3984</li> </ul> <p>View Detail</p> <ul> <li>Liuqing Yang, Kequan Lin, Lin Zhu, Huili Wang, Shuaishuai Teng, Lijun Huang, Shiyi Zhou, Guanbin Zhang, Zhi John Lu &amp; Dong Wang (2022) Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress. Communications Biology 5, 822</li> </ul> <p>View Detail</p> <ul> <li>Weihao Zhao<sup>1</sup>, Shang Zhang<sup>1</sup>, Yumin Zhu, Xiaochen Xi, Pengfei Bao, Ziyuan Ma, Thomas H Kapral, Shuyuan Chen, Bojan Zagrovic, Yucheng T Yang*, Zhi John Lu* (2022) POSTAR3: an updated platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Research 50(D1):D287-D294 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail  | Website</p> <ul> <li>Thomas H Kapral, Fiona Farnhammer, Weihao Zhao, Zhi J Lu and Bojan Zagrovic (2022) Widespread autogenous mRNA\u2013protein interactions detected by CLIP-seq. Nucleic Acids Research, 50(17):9984-9999</li> </ul> <p>View Detail</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201461\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2017-2021-tenured-phase-i","title":"2017 - 2021 (Tenured - Phase I)","text":"<p>2021</p> <ul> <li>Yumin Zhu<sup>1</sup>, Siqi Wang<sup>1</sup>, Xiaochen Xi<sup>1</sup>, Minfeng Zhang<sup>1</sup>, Xiaofan Liu, Weina Tang, Peng Cai, Shaozhen Xing, Pengfei Bao, Yunfan Jin, Weihao Zhao, Yinghui Chen, Huanan Zhao, Xiaodong Jia, Shanshan Lu, Yinying Lu, Lei Chen*, Jianhua Yin*, Zhi John Lu* (2021) Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. Theranostics 11(1):181-193 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Jing Gong<sup>1</sup>, Kui Xu<sup>1</sup>, Ziyuan Ma, Zhi John Lu &amp; Qiangfeng Cliff Zhang (2021) A deep learning method for recovering missing signals in transcriptome-wide RNA structure profiles from probing experiments. Nature Machine Intelligence 3:995\u20131006</li> </ul> <p>View Detail</p> <ul> <li> <p>Jia Li, Lei Sun, Xue-Liang Peng, Xiao-Ming Yu, Shao-Jun Qi, Zhi John Lu, Jing-Dong J Han, Qin Shen (2021) Integrative genomic analysis of early neurogenesis reveals a temporal genetic program for differentiation and specification of preplate and Cajal-Retzius neurons. PLoS Genetics 17(3):e1009355   View Detail</p> </li> <li> <p>Shanwen Chen, Tao Liu, Dingfang Bu, Jing Zhu, Xin Wang, Yisheng Pan, Yucun Liu, Zhi John Lu, Pengyuan Wang (2021\uff09Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer. FASEB J. 35(7):e21720</p> </li> </ul> <p>View Detail</p> <p>2020</p> <ul> <li>Shuaishuai Teng<sup>1</sup>, Yang Eric Li<sup>1</sup>, Ming Yang, Rui Qi, Yiming Huang, Qianyu Wang, Yanmei Zhang, Shanwen Chen, Shasha Li, Kequan Lin, Yang Cao, Qunsheng Ji, Qingyang Gu, Yujing Cheng, Zai Chang, Wei Guo, Pengyuan Wang, Ivan Garcia-Bassets, Zhi John Lu* and Dong Wang* (2020) Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Research 30(1):34-49 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Yu-Xiang Chen<sup>1</sup>, Zhi-yu Xu<sup>1</sup>, Xueliang Ge, Suparna Sanyal, Zhi John Lu* and Babak Javid* (2020) Selective translation by alternative bacterial ribosomes. PNAS 117(32):19487-19496 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Yu Ma<sup>1</sup>, Shang Zhang<sup>1</sup>, Chao Bi<sup>1</sup>, Chao Mei, Shang-Chuan Jiang, Xiao-Fang Wang,  Zhi John Lu* and Da-Peng Zhang* (2020) Arabidopsis exoribonuclease USB1 interacts with the PPR-domain protein SOAR1 to negatively regulate abscisic acid signaling. Journal of Experimental Botany 71(19): 5837-5851 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Kequan Lin<sup>1</sup>, Lu Li<sup>1</sup>, Yifei Dai, Huili Wang, Shuaishuai Teng, Xilinqiqige Bao, Zhi John Lu* and Dong Wang* (2020) A comprehensive evaluation of connectivity methods for L1000 data Briefings in Bioinformatics 21 (6), 2194-2205 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201453\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p> <p>2019</p> <ul> <li>Rui Xiao<sup>1,</sup>*, Jia-Yu Chen<sup>1</sup>, Zhengyu Liang<sup>1</sup>, Daji Luo, Geng Chen, Zhi John Lu, Yang Chen, Bing Zhou, Hairi Li, Xian Du, Yang Yang, Mingkui San, Xintao Wei, Wen Liu, Eric Lecuyer, Brenton R. Graveley, Gene W. Yeo, Christopher B. Burge, Michael Q. Zhang, Yu Zhou and Xiang-Dong Fu* (2019) Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription Cell 178, 107\u2013121 (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Maoguo Luo, Jianbo Bai, Bofeng Liu, Peiqiang Yan, Feifei Zuo, Hongyao Sun, Ye Sun, Xuanhao Xu, Zhihong Song, Yang Yang, Joan Massagu\u00e9, Xun Lan, Zhi Lu, Ye-Guang Chen, Haiteng Deng, Wei Xie, Qiaoran Xi (2019) H3K18ac Primes Mesendodermal Differentiation upon Nodal Signaling Stem Cell Reports 13(4):642-656</li> </ul> <p>View Detail</p> <ul> <li>Chang Tan<sup>1</sup>, Jingyi Cao<sup>1</sup>, Lu Chen<sup>1</sup>, Xiaochen Xi, Siqi Wang, Yumin Zhu, Liuqing Yang, Longteng Ma, Dong Wang, Jianhua Yin*, Ti Zhang* and Zhi John Lu* (2019) Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma Clinical Chemistry 65(7):905-915  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Yumin Zhu<sup>1</sup>, Gang Xu<sup>1</sup>, Yucheng T Yang<sup>1</sup>, Zhiyu Xu, Xinduo Chen, Binbin Shi, Daoxin Xie, Zhi John Lu*, Pengyuan Wang* (2019) POSTAR2: deciphering the post-transcriptional regulatory logics Nucleic Acids Research (D1):D203-D211  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>Shasha Li<sup>1</sup>, Shuaishuai Teng<sup>1</sup>, Junquan Xu, Guannan Su, Yu Zhang, Jianqing Zhao, Suwei Zhang, Haiyan Wang, Wenyan Qin, Zhi John Lu, Yong Guo, Qianyong Zhu and Dong Wang (2019) Microarray is an efficient tool for circRNA profiling. Briefings in Bioinformatics 20(4):1420-1433  (<sup>1</sup>contributed equally)</li> </ul> <p>View Detail</p> <p>2018</p> <ul> <li>Zhiyu Xu<sup>1</sup>, Long Hu<sup>1</sup>, Binbin Shi, SiSi Geng, Longchen Xu, Dong Wang* and Zhi John Lu* (2018) Ribosome elongating footprints denoised by wavelet transform comprehensively characterize dynamic cellular translation events. Nucleic Acids Research 46 (18), e109-e109  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail GitHub</p> <ul> <li>[spotlight]: Binbin Shi and Zhi John Lu* (2018) Decoding Plant RNA Structurome. Molecular Plant 11:3</li> </ul> <p>View Detail</p> <ul> <li>J Yuan<sup>1</sup>, J Li<sup>1</sup>, Y Yang, C Tan, Y Zhu, L Hu, Y Qi*, ZJ Lu* (2018) Stress\u2010responsive regulation of long non\u2010coding RNA polyadenylation in Oryza sativa. The Plant Journal 93:5, 814-827  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Detail</p> <ul> <li>J Gong, D Shao, K Xu, Z Lu, ZJ Lu, YT Yang, QC Zhang (2018) RISE: a database of RNA interactome from sequencing experiments. Nucleic Acids Research 46 (D1), D194-D201</li> </ul> <p>View Detail</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201444\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p> <p>2017</p> <ul> <li>Yang Eric Li<sup>1</sup>, Mu Xiao<sup>1</sup>, Binbin Shi<sup>1</sup>, Yu-Cheng T. Yang, Dong Wang, Fei Wang, Marco Marcia and Zhi John Lu (2017) Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA-protein binding sites. Genome Biology* 18:169  (<sup>1</sup>contributed equally)</li> </ul> <p>View Detail ePDF Web Site GitHub</p> <ul> <li>Yang Yang<sup>1</sup>, Lei Chen<sup>1</sup>, Jin Gu<sup>1</sup>, Hanshuo Zhang<sup>1</sup>, Jiapei Yuan, Qiuyu Lian, Guishuai Lv, Siqi Wang, Yang Wu, Yu-Cheng T. Yang, Dongfang Wang, Yang Liu, Jing Tang, Guijuan Luo, Yang Li, Long Hu, Xinbao Sun, Dong Wang, Mingzhou Guo, Qiaoran Xi, Jianzhong Xi, Hongyang Wang*, Michael Q. Zhang* and Zhi John Lu* (2017) Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nature Communications 8, 14421  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Details ePDF</p> <ul> <li>Xiaochen Xi<sup>1</sup>, Tianxiao Li<sup>1</sup>, Yiming Huang, Jiahui Sun, Yumin Zhu, Yang Yang* and Zhi John Lu* (2017) RNA Biomarkers: Frontier of Precision Medicine for Cancer. Non-Coding RNA3, 9  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Details</p> <ul> <li>Yang Yang<sup>1</sup>, Yu-Cheng T. Yang<sup>1</sup>, Jiapei Yuan, Zhi John Lu* and Jingyi Jessica Li* (2017) Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell differentiation states. Nucleic Acids Research 45 (4): 1657-1672  (<sup>1</sup>contributed equally, *co-corresponding authors)</li> </ul> <p>View Details</p> <ul> <li>Zhonglin Tang<sup>1,</sup>*, Yang Wu<sup>1</sup>, Yalan Yang, Yu-Cheng T. Yang, Zishuai Wang, Jiapei Yuan, Yang Yang, Chaoju Hua, Xinhao Fan, Guanglin Niu, Yubo Zhang, Zhi John Lu* and Kui Li* (2017) Comprehensive analysis of long non-coding RNAs highlights their spatio-temporal expression patterns and evolutional conservation in Sus scrofa. Scientific Reports 7:43166 (<sup>1</sup>contributed equally, * co-corresponding authors)</li> </ul> <p>View Details ePDF</p> <ul> <li>Dan Gao, Yingjie Han, Yang Yang, James G Herman, Enqiang Linghu, Qimin Zhan, Fran\u00e7ois Fuks, Zhi John Lu, Mingzhou Guo (2017) Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development. Epigenetics12(7):575-583</li> </ul> <p>View Details</p> <ul> <li>Long Hu, Zhiyu Xu, Boqin Hu and Zhi John Lu*  (2017)  COME: a robust coding potential calculation tool for lncRNA identification and characterization based on multiple features. **  Nucleic Acids Research 45 (1): e2</li> </ul> <p>View Details Web Site GitHub</p> <ul> <li>Boqin Hu<sup>1</sup>, Yu-Cheng T. Yang<sup>1</sup>, Yiming Huang, Yumin Zhu and Zhi John Lu* (2017) POSTAR: a platform of post-transcriptional regulation coordinated by RNA binding proteins. Nucleic Acids Research 45 (D1): D104-D114 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details Web Site</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201436\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2012-2016-tenure-track","title":"2012 - 2016 (Tenure Track)","text":"<p>2016</p> <ul> <li>Mengrong Liu<sup>1</sup>, Yu-Cheng T. Yang<sup>1</sup>, Gang Xu, Chang Tan, and Zhi John Lu (2016) CCG: an integrative resource of cancer protein-coding and long noncoding RNA genes. Discovery Medicine* 22 (123): 351-359 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details</p> <ul> <li>Yang Wu<sup>1</sup>, Rihao Qu<sup>1</sup>, Yiming Huang<sup>1</sup>, Binbin Shi, Mengrong Liu, Yang Li and Zhi John Lu* (2016) RNAex: an RNA secondary structure prediction server enhanced by high-throughput structure probing data. Nucleic Acids Research 44 (W1): W294-W301 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details Web Site</p> <ul> <li>Jiapei Yuan<sup>1</sup>, Ye Zhang<sup>1</sup>, Jinsong Dong, Xinbao Sun, Yuzhe Sun, Boon L. Lim, Dong Liu* and Zhi John Lu* (2016) Systematic characterization of novel lncRNAs responding to phosphate starvation in Arabidopsis thaliana. BMC Genomics 17:655 (<sup>1</sup>contributed equally, *: co-corresponding authors)</li> </ul> <p>View Details</p> <ul> <li>Baoping Cao<sup>1</sup>, Nanxi Song<sup>1</sup>, Meiying Zhang, Runsheng Chen, Youyong Lu, Runshen Chen*, Zhi John Lu* and Mingzhou Guo* (2016) Systematic study of novel lncRNAs in different gastrointestinal cancer cell lines. Discovery Medicine 21(115):159-171 (<sup>1</sup>contributed equally, *: co-corresponding authors)</li> </ul> <p>View Details</p> <ul> <li>[review]: Xihao Hu<sup>1</sup>, Yang Wu<sup>1</sup>, Zhi John Lu and Kevin Y. Yip. (2016) Analysis of Sequencing Data for Probing RNA Secondary Structures and Protein-RNA Binding in Studying Post-Transcriptional Regulations. Briefings in Bioinformatics 17(6): 1032-1043 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details</p> <ul> <li>Kejia Wen<sup>1</sup>, Lijuan Yang<sup>1</sup>, Tuanlin Xiong, Chao Di, Danhui Ma, Menghua Wu, Zhaoyu Xue, Xuedi Zhang, Li Long, Weimin Zhang, Jiaying Zhang, Xiaolin Bi, Junbiao Dai, Qiangfeng Zhang, Zhi John Lu and Guanjun Gao (2016) Critical roles of long noncoding RNAs in Drosophila spermatogenesis. Genome Research 26: 1233-1244 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details</p> <ul> <li>Sibo Tao<sup>1</sup>, Ye Zhang<sup>1</sup>, Xiaoyue Wang, Xiaofeng Fang, Le Xu, Zhi John Lu and Dong Liu (2016) The THO/TREX complex active in mRNA export suppresses root-associated acid phosphatase activity induced by phosphate starvation. Plant Physiology 171(4):2841-53 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details</p> <ul> <li>Sai Luo, J. Yuyang Lu, Lichao Liu, Yafei Yin, Chunyan Chen, Xue Han, Bohou Wu, Ronggang Xu, Wei Liu, Pixi Yan, Wen Shao, Zhi Lu, Haitao Li, Jie Na, Fuchou Tang, Jianlong Wang, Yong E. Zhang, Xiaohua Shen (2016) Divergent lncRNAs Regulate Gene Expression and Lineage Differentiation in Pluripotent Cells. Cell Stem Cell 21(115):159-171</li> </ul> <p>View Details</p> <p>2015</p> <ul> <li>Yang Wu<sup>1</sup>, Binbin Shi<sup>1</sup>, Xinqiang Ding, Tong Liu, Xihao Hu, Kevin Y. Yip, Zheng Rong Yang, David H. Mathews and Zhi John Lu* (2015) Improved prediction of RNA secondary structure by integrating the free energy model with restraints derived from experimental probing data. Nucleic Acids Research 43(15): 7247-59 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details GitHub</p> <ul> <li>Long Hu, Chao Di, Mingxuan Kai, Yu-Cheng T. Yang, Yang Li, Yunjiang Qiu, Xihao Hu, Kevin Y. Yip, Michael Q. Zhang and Zhi John Lu* (2015) A common set of distinct features that characterize noncoding RNAs across multiple species. Nucleic Acids Research 43(1): 104-114</li> </ul> <p>View Details Web Site</p> <ul> <li>Yu-Cheng T. Yang<sup>1</sup>, Chao Di<sup>1</sup>, Boqin Hu<sup>1</sup>, Meifeng Zhou, Yifang Liu, Nanxi Song, Yang Li, Jumpei Umetsu and Zhi John Lu* (2015) CLIPdb: a CLIP-seq database for protein-RNA interactions. BMC Genomics 16:51 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details Web Site</p> <ul> <li>Yinghan Fu, Zhengjiang Zech Xu, Zhi J. Lu, Shan Zhao, and David H. Mathews(2015) Discovery of Novel ncRNA Squences in Multiple Genome Alignments on the Basis of Conserved and Stable Secondary Structures. PloS one10(6):e0130200</li> </ul> <p>View Details</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201424\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p> <p>2014</p> <ul> <li>Chao Di<sup>1</sup>, Jiapei Yuan<sup>1</sup>, Yue Wu, Jingrui Li, Huixin Lin, Long Hu, Ting Zhang, Yijun Qi, Mark B. Gerstein, Yan Guo and Zhi John Lu* (2014) Characterization of Stress-responsive lncRNAs in Arabidopsis thaliana by Integrating Expression, Epigenetic and Structural Features. The Plant Journal 80(5), 848-861 (<sup>1</sup>contributed equally)</li> </ul> <p>View Details</p> <ul> <li>Mark B. Gerstein, Joel Rozowsky, Koon-Kiu Yan, Daifeng Wang, Chao Cheng, James B. Brown, Carrie A. Davis, LaDeana Hillier, Cristina Sisu, Jingyi Jessica Li, Baikang Pei, Arif O. Harmanci, Michael O. Duff, Sarah Djebali, Roger P. Alexander,... Chao Di, ... Zhi Lu, ... Thomas R. Gingeras and Robert Waterston.(2014) Comparative analysis of the transcriptome across distant species. Nature 512:445-448</li> </ul> <p>View Details</p> <ul> <li>YC Yang, J Umetsu, ZJ Lu* (2014) Global signatures of protein binding on structured RNAs in Saccharomyces cerevisiae. Science China Life Sciences 57 (1), 22-35 (Tsinghua Special Issue)</li> </ul> <p>View Details</p> <ul> <li>Hu X, Wong TKF, Lu ZJ, Chan TF, Lau TCK, Yiu SM and Yip KY. (2014) Computational Identification of Protein Binding Sites on RNAs using High-Throughput RNA Structure-Probing Data. Bioinformatics 30(8), 1049-1055.</li> </ul> <p>View Details</p> <ul> <li>B Ren, H Shen, ZJ Lu, H Liu, Y Xu. (2014) The phzA2-G2 Transcript Exhibits Direct RsmA-Mediated Activation in Pseudomonas aeruginosa M18. PloS one 9 (2), e89653</li> </ul> <p>View Details</p> <p>2013</p> <ul> <li>Freeberg MA, Han T,Moresco JJ, Kong A, Yang YC, Lu ZJ, Yates JR, Kim JK. (2013) Pervasive and dynamic protein binding sites of the mRNA transcriptome in Saccharomyces cerevisiae. Genome Biology 14, R13.</li> </ul> <p>View Details</p> <ul> <li>Kudron M, Niu W, Lu Z, Wang G, Gerstein M, Snyder M, Reinke V. (2013) Tissue-specific direct targets of Caenorhabditis elegans Rb/E2F dictate distinct somatic and germline programs. Genome Biology 14:R5</li> </ul> <p>View Details</p> <p>2012</p> <ul> <li>Tan X, Hu L<sup>2</sup>, Luquette JL, Gao G, Liu YF2, Qu HJ, Xi RB, Lu ZJ<sup>2</sup>, Park PJ &amp; Elledge SJ. (2012) Systematic Identification of Synergistic Drug Pairs Targeting HIV. Nature Biotech 30:1125-1130. (<sup>2</sup> Lu Lab, School of Life Sciences, Tsinghua University)</li> </ul> <p>View Details</p> <ul> <li>Tan X, Lu ZJ<sup>2</sup>, Gao G, Xu QK, Hu L<sup>2</sup>, Fellmann C, Li MZ, Qu HJ, Lowe SW, Hannon GJ &amp; Elledge SJ. (2012) Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. Proc. Natl. Acad. Sci. U. S. A., 109(3):869-74. (<sup>2</sup>Lu Lab, School of Life Sciences, Tsinghua University)</li> </ul> <p>View Details</p> <ul> <li>The ENCODE Project Consortium# (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74 (# ZJL was a member of ENCODE Consortium)</li> </ul> <p>View Details</p> <p></p> <ul> <li>He C, Li YX, Zhang G, Gu Z, Yang R, Li J, Lu ZJ, Zhou ZH, Zhang C, Wang J. (2012) MiRmat: Mature microRNA Sequence Prediction. PloS one 7 (12), e51673.</li> </ul> <p>View Details</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u201413\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2010-2011-postdoc","title":"2010 - 2011 (Postdoc)","text":"<ul> <li>Lu ZJ<sup>1</sup>, Yip KY<sup>1</sup>, Wang G, Shou C, Hillier LW, et al. (2011) Prediction and characterization of noncoding RNAs in C. elegans by integrating conservation, secondary structure, and high-throughput sequencing and array data. Genome Research 21: 276-285. (<sup>1</sup>contributed equally) [modENCODE special issue]</li> </ul> <p>View Details</p> <p></p> <ul> <li>Niu W, Lu ZJ, Zhong M, Sarov M, Murray JI, et al. (2011) Diverse transcription factor binding features revealed by genome-wide ChIP-seq in C. elegans. Genome Research 21: 245-254.</li> </ul> <p>View Details</p> <ul> <li>The ENCODE Project Consortium (2011) A User's Guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biology 9(4):e1001046 (Zhi J. Lu is a member of ENCODE)</li> </ul> <p>View Details</p> <ul> <li>Mu XJ, Lu ZJ, Kong Y, Lam HYK, Gerstein MB. (2011) Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project. Nucleic Acids Research 39 (16):7058-7076.</li> </ul> <p>View Details</p> <ul> <li>Li Y, Du X, Lu ZJ, Wu D, Zhao Y, et al. (2011) Regulatory Feedback Loop of Two phz Gene Clusters through 5' Untranslated Regions in Pseudomonas sp. M18.PLoS ONE 6(4): e19413</li> </ul> <p>View Details</p> <ul> <li>Cheng C, Yan KK, Hwang W, Qian J, Bhardwaj N, Joel R, Lu ZJ, Niu W, Alves P, Kato M, Gerstein MB. (2011) Construction and analysis of an integrated regulatory network derived from high-throughput sequencing data. PLoS Comput Biol 7: e1002190</li> </ul> <p>View Details</p> <ul> <li>Gerstein MB<sup>\u2020,</sup>*, Lu ZJ<sup>\u2020</sup>, Van Nostrand EL<sup>\u2020</sup>, Cheng C<sup>\u2020</sup>, Arshinoff BI<sup>\u2020</sup>, et al. (2010) Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project Science 330 (6012): 1775-1787  (<sup>\u2020</sup>20 co-first authors, *15 co-corresponding authors, ~150 authors in total) [Cover Story]</li> </ul> <p>View Details</p> <p></p> <ul> <li>Zhong M, Niu W, Lu ZJ, Sarov M, Murray JI, et al. (2010) Genome-Wide Identification of Binding Sites Defines Distinct Functions for Caenorhabditis elegans PHA-4/FOXA in Development and Environmental Response. PLoS Genetics  6(2): e1000848.</li> </ul> <p>View Details</p> <p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u20145\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014</p>"},{"location":"publications/pub/#2006-2009-phd","title":"2006 - 2009 (Ph.D.)","text":"<ul> <li>Lu ZJ, Gloor JW, Mathews DH. (2009) Improved RNA secondary structure prediction by maximizing expedted pair accuracy. RNA 15:1805-1813.</li> </ul> <p>View Details</p> <ul> <li>Lu ZJ, Mathews DH. (2008) Efficient siRNA selection using hybridization thermodynamics.Nucleic Acids Research 36:640-647.</li> </ul> <p>View Details</p> <ul> <li>Lu ZJ, Mathews DH. (2008) OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Research 36:W104-W108.</li> </ul> <p>View Details</p> <ul> <li>Lu ZJ, Mathews DH. (2008) Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design. Nucleic Acids Research 36:3738-3745.</li> </ul> <p>View Details</p> <ul> <li>Lu ZJ, Turner DH, Mathews DH. (2006) A set of nearest neighbor parameters for predicting the enthalpy change of RNA secondary structure formation. Nucleic Acids Research34:4912-4924.</li> </ul> <p>View Details</p> <p>More on Google Scholar</p>"},{"location":"publications/writing/","title":"<b>Tips for Writing</b>","text":""},{"location":"publications/writing/#tips-for-paper-writing","title":"Tips for Paper Writing","text":"<p>Example Manuscripts</p> <p>Publication Tips (Cover Letter, Status Enquiry Letter, etc)</p>"},{"location":"publications/writing/#i-format","title":"I. Format","text":"<p>Files for Submission</p> <ol> <li>Cover Letter.docx (1 page)</li> <li>Suggested Reviewers.docx (6 reviewers)</li> <li>Manuscript - Main text.docx (see sections below)</li> <li>Figures.pdf (save as from PPT file)</li> <li>Supplementary Info.pdf (save as from docx file)</li> <li>Supplementary file 1.xlsx, Supplementary file 2.xlsx, ...</li> </ol> <p>Sections in Main text</p> <ol> <li>Title, Authors and Affiliations</li> <li>Abstract and Keywords</li> <li>Introduction</li> <li>Results</li> <li>Conclusion and Discussion</li> <li>(Online) Methods</li> </ol> <p>Font and Line Space</p> <ol> <li>Check Font: Times New Roman, 11pt or 10.5pt</li> <li>Check Line: double space (except for References)</li> <li>No indent for the first sentence of a new paragraph.</li> </ol> <p>Abstract</p> <ul> <li>(1) Background - (2) Results - (3) Conclusions</li> </ul> <p>Keywords</p> <ul> <li>Replace with the key words we want to be searched. If number of key words is limited, we may not repeat with title only if this keyword is very important.</li> </ul>"},{"location":"publications/writing/#ii-writing-rules","title":"II. Writing Rules","text":""},{"location":"publications/writing/#grammar-and-english-writing-tools","title":"Grammar and English Writing Tools","text":"<p>Grammarly (app.grammarly.com) is very helpful. It has web version, desktop (MAC/Windows) version and chrome/firefox/safari plugin. You can also install it into your office word from this add-in.</p> <p>AI tools like ChatGPT and ChatGLM (\u667a\u8c31\u6e05\u8a00\uff09are even more powerful tools to modify and improve your English writing.</p> <ol> <li>Check plural or single.</li> <li>Check if Past tense is used when we describe results (e.g., \"We sequenced 50 samples ...\").</li> <li>Check if Present tense is used when we make a claim or conclusion (e.g., usually in the last sentence of a paragraph, \"This result suggests that \u2026\" ).</li> <li>Check number list (First, Second, Third, ...) see Firstly, Secondly, Thirdly - Grammarly Blog</li> <li>Check When do you use 'the' in English? - Learning English Grammar </li> </ol>"},{"location":"publications/writing/#terms","title":"Terms","text":"<ol> <li>Check the writing of specific terms in right format in the whole paper:<ul> <li>noncoding, cross-validation</li> <li>P-value (italicize and capitalize the P here)</li> <li>vs. (lower case with one dot after)</li> <li>i.e., something ( \",\" is needed)</li> <li>e.g., something ( \",\" is needed)</li> </ul> </li> <li>Check if the Abbreviations are consistent in the whole paper. Check if full name is used when it is mentioned first time. Occasionally, we may use full time several times in the beginning of Introduction, Methods and Suppl. Info., because they are separated documents when published.)</li> </ol>"},{"location":"publications/writing/#figure-and-figure-legend","title":"Figure and Figure Legend","text":"<p>Figure and Figure legend sometimes are more IMPORTANT than main text, because many senior readers read figures first.</p> <ol> <li>Check if Figure Legends contain sufficiently detailed descriptions. (We got this suggestion from a previous reviewer who rejected our paper.)</li> <li>Check if the colors are easy to see.  (We got this suggestion from a previous reviewer who rejected our paper.)</li> <li>Font, key's and axis label's fonts in particular, in Figure need to be as large as possible.</li> </ol>"},{"location":"publications/writing/#main-text","title":"Main Text","text":"<ol> <li>Check first and last sentence in the whole paper. To make it easy to read, in every paragraph, first and last sentences are important. Usually, first sentence introduces and summarizes the whole paragraph; last sentence concludes the whole paragraph (e.g. \"This result suggests that ...\").</li> <li>Check voice:<ol> <li>n Results, we prefer active voice, such as \"We analyzed the data \u2026\", not \"The data were analyzed \u2026\".</li> <li>In Methods, we may use passive voice sometimes , such as \" The difference was tested by a paired t test.\".</li> </ol> </li> <li>Recommended words:<ol> <li>We performed RT-qPCR (RNA-seq \u2026) for \u2026 \u2192 XX was validated (sequenced ...) by RT-qPCR.</li> <li>We built  a Random Forest model \u2026 \u2192 We used/developed a Random Forest model to \u2026</li> <li>We assayed/analyzed \u2026 datasets.</li> <li>We assessed, calculated, detected, estimated, evaluated, examined, ...</li> <li>We curated/collected \u2026 datasets from \u2026 OR 100 datasets were curated/collected from ...</li> <li>XX was significantly enriched in the noncoding sequences (t test P-value: 0.002).</li> <li>The enrichment is/was calculated with RNApromo (ref.). The P-value cutoff is/was 0.001; the xx is/was 0.5; the xx is/was 0.8. (depends on if you are talking to the audience about a plot or describe a result you have done.)</li> </ol> </li> </ol>"},{"location":"publications/writing/#statistics","title":"Statistics","text":"<ol> <li>Check every result to see if it needs statistical test: Was a test used? Which one? What is the P-value?</li> <li>Check  every enrichment to see if it was statistically determined to be enriched:  What test was used? Which one? What is the P-value?</li> </ol>"},{"location":"publications/writing/#using-the-right-tense","title":"Using the right tense","text":"<p>In your scientific paper, use verb tenses (past, present, and future) exactly as you would in ordinary writing. Use the past tense to report what happened in the past: what you did, what someone reported, what happened in an experiment, and so on. Use the present tense to express general truths, such as conclusions (drawn by you or by others) and atemporal facts (including information about what the paper does or covers). Reserve the future tense for perspectives: what you will do in the coming months or years. Typically, most of your sentences will be in the past tense, some will be in the present tense, and very few, if any, will be in the future tense.</p> <ul> <li>Past tense</li> </ul> <p>Work done</p> <p>We collected blood samples from . . .</p> <p>Groves et al. determined the growth rate of . . .</p> <p>Consequently, astronomers decided to rename . . .</p> <p>Work reported</p> <p>Jankowsky reported a similar growth rate . . .</p> <p>In 2009, Chu published an alternative method to . . .</p> <p>Irarr\u00e1zaval observed the opposite behavior in . . .</p> <p>Observations</p> <p>The mice in Group A developed, on average, twice as much . . .</p> <p>The number of defects increased sharply . . .</p> <p>The conversion rate was close to 95% . . .</p> <ul> <li>Present tense</li> </ul> <p>General truths</p> <p>Microbes in the human gut have a profound influence on . . .</p> <p>The Reynolds number provides a measure of . . .</p> <p>Smoking increases the risk of coronary heart disease . . .</p> <p>Atemporal facts</p> <p>This paper presents the results of . . .</p> <p>Section 3.1 explains the difference between . . .</p> <p>Behbood's 1969 paper provides a framework for . . .</p> <ul> <li>Future tense</li> </ul> <p>Perspectives</p> <p>In a follow-up experiment, we will study the role of . . .</p> <p>The influence of temperature will be the object of future research . . .</p> <p>Note the difference in scope between a statement in the past tense and the same statement in the present tense: \"The temperature increased linearly over time\" refers to a specific experiment, whereas \"The temperature increases linearly over time\" generalizes the experimental observation, suggesting that the temperature always increases linearly over time in such circumstances.</p> <p>In complex sentences, you may have to combine two different tenses \u2014 for example, \"In 1905, Albert Einstein postulated that the speed of light is constant . . . . \" In this sentence, postulated refers to something that happened in the past (in 1905) and is therefore in the past tense, whereas is expresses a general truth and is in the present tense.</p>"},{"location":"publications/writing/#iii","title":"III. \u7f51\u53cb\u7684\u5199\u4f5c\u5efa\u8bae","text":"<p>Effective Writing by Nature</p> <p>\u5199\u51fa\u7b2c\u4e00\u7a3f</p> <ul> <li>\u4e24\u6b65\u8d70\uff1a1\u3001\u5199\u51fa\u5c3d\u53ef\u80fd\u591a\u7684\u5185\u5bb9\uff0c\u4e0d\u8981\u62c5\u5fc3\u8bed\u6cd5\u3001\u62fc\u5199\u3001\u7ec4\u7ec7\uff1b2\u3001\u4fee\u6539\u6587\u7a3f\u53d8\u5f97\u66f4\u597d\u3002\uff08\u53c2\u8003\u6d77\u660e\u5a01\u7684\u5199\u4f5c\u65b9\u5f0f\uff09</li> <li>\u5f53\u4f60\u5199\u4f5c\u65f6\uff0c\u4e0d\u8981\u7f16\u8f91\uff01\u5199\u4f5c\u548c\u7f16\u8f91\u4f7f\u7528\u4e0d\u540c\u7684\u534a\u8111\uff0c\u4ea4\u53c9\u8fd9\u4e24\u4ef6\u4e8b\u4e0d\u5bb9\u6613\u3002</li> <li>\u6bcf\u4e2a\u7ed3\u679c\u548c\u76f8\u5e94\u7684\u8ba8\u8bba\u4e00\u8d77\u5199\uff0c\u4ee5\u514d\u4e4b\u540e\u5fd8\u8bb0\u7ed3\u679c\u7684\u89e3\u91ca\u548c\u610f\u4e49\u3002\u518d\u5199\u65b9\u6cd5\uff0c\u6700\u540e\u5199\u4ecb\u7ecd\uff08\u57fa\u4e8e\u7ed3\u679c\u548c\u8ba8\u8bba\uff09\u3002</li> <li>\u7528\u7167\u7247\u505a\u7c7b\u6bd4\uff1a<ul> <li>Introduction\uff1aWhy was the picture taken?</li> <li>Results\uff1aWhat do you see?</li> <li>Conclusion and Discussion\uff1aWhat does it mean?</li> <li>Methods\uff1aHow was it taken\uff1f</li> </ul> </li> </ul> <p>\u7f16\u8f91\u6700\u7ec8\u7a3f</p> <ul> <li>\u9605\u8bfb\u6295\u7a3f\u671f\u520a\u7684\u300eInstructions for authors\u300f\uff0c\u4e86\u89e3\u671f\u520a\u671f\u671b\u7684\u884c\u6587\u98ce\u683c\u3002</li> <li>\u4ecb\u7ecd\u90e8\u5206\u8bf4\u660e\u672c\u7814\u7a76\u7684\u7406\u7531\uff0c\u4e0d\u662f\u6587\u732e\u7efc\u8ff0\u3002\u8ba8\u8bba\u90e8\u5206\u4e0d\u7528\u300e\u53ef\u80fd\u300f\uff0c\u5982\u679c\u4e0d\u786e\u5b9a\u7ed3\u8bba\uff0c\u505a\u66f4\u591a\u7684\u5b9e\u9a8c\u3002</li> <li>\u7ed3\u679c\u90e8\u5206\u4e0d\u4f7f\u7528\u300ecould\u300f\u3001\u300ecan\u300f\uff08\u53d7\u4e2d\u6587\u5f71\u54cd\uff09\uff0c\u51cf\u5c11\u4e0d\u786e\u5b9a\u6027\u3002</li> <li>\u4e0d\u4f7f\u7528\u300eetc\u300f\u3001\u300eand so on\u300f\uff0c\u8fd9\u4e9b\u8bcd\u8bf4\u660e\u4f5c\u8005\u61d2\u3002</li> <li>\u300eobserved\u300f\u5f88\u5f31\u5f88\u88ab\u52a8\uff0c\u6539\u7528\uff1aassess, calculate, detect, estimate, evaluate, examine...</li> <li>\u4e0d\u7528\u300eobviously\u300f\uff0c\u8bfb\u8005\u4e0d\u4e00\u5b9a\u5bb9\u6613\u7406\u89e3\u3002</li> <li>\u7ed3\u679c\u90e8\u5206\u907f\u514d\u300esignificantly\u300f\uff0c\u6539\u4e3a\u62a5 P-value \u3002\u8ba8\u8bba\u90e8\u5206\u53ef\u7528\u3002</li> </ul>"},{"location":"reading/","title":"Literature Reading","text":""},{"location":"reading/#literature-reading","title":"Literature Reading","text":"<ul> <li>Recommended Reading List</li> <li>PDFs of Lu Lab Publications</li> </ul> <p>Important</p> <p>-- Startup Readings --</p>"},{"location":"reading/#tips-for-literature-search","title":"Tips for Literature Search","text":"<p>How to automatically receive related literature update every week?</p>"},{"location":"reading/#1-using-pubmed","title":"1. Using Pubmed","text":"<ul> <li>(1) Register for an NCBI account</li> <li>(2) Create a search rules, for example:</li> </ul> <p>((\"Nature\"[Jour] OR \"Science\"[Jour] OR \"Nature biotechnology\"[Journal] OR \"Nature Methods\"[Jour] OR \"Nature Medicine\"[Journal] OR \"Cell Systems\"[Jour] OR \"Nature COMMUNICATIONS\"[Jour] ) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] )) OR ((\"Genome Research\"[Jour] OR \"Genome Biology\"[Jour]) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] ))</p> <ul> <li>(3) Search in Pubmed Search box and click 'Creat alert' button to creat search notifications.</li> </ul>"},{"location":"reading/#2-using-scopus","title":"2. Using Scopus","text":"<ul> <li>(1) Register for an Scopus account</li> <li>(2) User Center\u2014My Scopus\u2014Alerts to creat search notifications.</li> </ul>"},{"location":"reading/#3-google-scholar-searching-tips","title":"3. Google Scholar Searching Tips","text":"<p>http://www.educatorstechnology.com/2013/04/9-tips-every-teacher-should-know-about.html</p>"},{"location":"reading/index-bak/","title":"Literature Reading","text":""},{"location":"reading/index-bak/#literature-reading","title":"Literature Reading","text":"<ul> <li>PDFs of  Paper Reading Sharing (Recommended Reading List)</li> <li>PPTs of Journal Club</li> <li>PDFs of Lu Lab Publications</li> </ul>"},{"location":"reading/index-bak/#startup-readings","title":"Startup Readings","text":""},{"location":"reading/index-bak/#more-readings","title":"More Readings","text":"<ul> <li>Literature Reading:<ul> <li>Literature Reading: reading/index.md</li> <li>Seq. Tech.:</li> <li>Interaction-seq: reading/seq-tech/interaction-seq.md</li> <li>Single-Cell-seq: reading/seq-tech/single-cell-seq-tech.md</li> <li>cfRNA/DNA-seq: reading/seq-tech/cfrna-seq-tech.md</li> <li>Omics Data Analysis:</li> <li>Transcriptomics: <ul> <li>cfRNA Analysis: reading/omics/rna/cfrna.md</li> <li>Regulome Analysis: reading/omics/rna/regulome.md</li> <li>POSTAR Analysis: reading/omics/rna/postar.md</li> </ul> </li> <li>MultiOmics:<ul> <li>MultiOmics Data Analysis: reading/omics/multiomics/multiomics.md</li> <li>Single Cell Data Analysis: reading/omics/multiomics/single-cell-data-analysis.md</li> <li>Genetic &amp; Function Analysis: reading/omics/multiomics/genetic-and-function-analysis.md</li> </ul> </li> <li>Microbiome: reading/omics/microbiome.md</li> <li>Precision Medicine: </li> <li>Cancer: <ul> <li>ncRNA in Cancer: reading/med/cancer/ncrna.md</li> <li>Cancer Immunotherapy: reading/med/cancer/cancer-immunotherapy.md</li> </ul> </li> <li>Immunity: <ul> <li>RNA in Immune System: reading/med/immunity/RNA-immune.md</li> <li>Immune Diseases: reading/med/immunity/immune-diseases.md</li> </ul> </li> <li>Liquid Biopsy:  <ul> <li>Overview: reading/med/liquid-biopsy/index.md       </li> <li>cfRNA: reading/med/liquid-biopsy/cfRNA.md</li> <li>cfDNA +: reading/med/liquid-biopsy/cfDNA.md</li> <li>Panel and Database: reading/med/liquid-biopsy/panel-and-screen.md</li> </ul> </li> <li>Artificial Intelligence:</li> <li>Overview: reading/ai/index.md </li> <li>Multi-modal: reading/ai/multi-modal.md</li> <li>RNA Modeling - SEQ: <ul> <li>RNA 2nd Structure Prediction: reading/ai/rna-modeling-seq/rna-2nd-structure.md</li> <li>RNA Motif &amp; dsRNAfinder: reading/ai/rna-modeling-seq/rna-motif-and-dsrnafinder.md</li> <li>RNA-RNA Interaction: reading/ai/rna-modeling-seq/rna-rna-interaction.md</li> <li>RNA-Oligo: reading/ai/rna-modeling-seq/rna-oligo.md</li> </ul> </li> <li>RNA Modeling - STRUCTURE: <ul> <li>RNA 3D Structure Prediction: reading/ai/rna-modeling-structure/rna-3d-structure-prediction.md</li> <li>RNA-Ligand: reading/ai/rna-modeling-structure/rna-ligand.md</li> <li>RNA-Protein: reading/ai/rna-modeling-structure/rna-protein.md</li> <li>RNA &amp; Protein Design: reading/ai/rna-modeling-structure/rna-and-protein-design.md</li> </ul> </li> </ul> </li> </ul>"},{"location":"reading/index-bak/#tips-for-literature-search","title":"Tips for Literature Search","text":"<p>How to automatically receive related literature update every week?</p>"},{"location":"reading/index-bak/#1-using-pubmed","title":"1. Using Pubmed","text":"<ul> <li>(1) Register for an NCBI account</li> <li>(2) Create a search rules, for example:</li> </ul> <p>((\"Nature\"[Jour] OR \"Science\"[Jour] OR \"Nature biotechnology\"[Journal] OR \"Nature Methods\"[Jour] OR \"Nature Medicine\"[Journal] OR \"Cell Systems\"[Jour] OR \"Nature COMMUNICATIONS\"[Jour] ) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] )) OR ((\"Genome Research\"[Jour] OR \"Genome Biology\"[Jour]) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] ))</p> <ul> <li>(3) Search in Pubmed Search box and click 'Creat alert' button to creat search notifications.</li> </ul>"},{"location":"reading/index-bak/#2-using-scopus","title":"2. Using Scopus","text":"<ul> <li>(1) Register for an Scopus account</li> <li>(2) User Center\u2014My Scopus\u2014Alerts to creat search notifications.</li> </ul>"},{"location":"reading/index-bak/#3-google-scholar-searching-tips","title":"3. Google Scholar Searching Tips","text":"<p>http://www.educatorstechnology.com/2013/04/9-tips-every-teacher-should-know-about.html</p>"},{"location":"reading/startup/","title":"<b>Startup Readings</b>","text":""},{"location":"reading/startup/#startup-readings","title":"Startup Readings","text":"<ul> <li>PDFs of Startup Reading</li> </ul> <ul> <li>Startup Readings<ul> <li>A1. RNAfinder</li> <li>A2. RNAfinder - Applications<ul> <li>A2.1 [Medicine] Precision Medicine</li> <li>A2.2 [Ribozyme] Structure Prediction &amp; Ribozyme Design</li> </ul> </li> <li>B1. RNAtalk</li> <li>B2. RNAtalk - Applications<ul> <li>B2.1 [RNA-RNA] siRNA Drug Design</li> <li>B2.2 [RNA-Ligand] Small-molecule Drug Design</li> <li>B2.3 [RNA-Protein] RBP &amp; Post-transcriptional Regulation</li> </ul> </li> </ul> </li> </ul>"},{"location":"reading/startup/#a1-rnafinder","title":"A1. RNAfinder","text":"<p>(\u9002\u5408\u751f\u7269\u548c\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\uff09</p> <p>Novelty: TE-RNA, mbRNA, dsRNA, cfRNA</p> <ul> <li>cfRNAfinder <ul> <li>Representative cfRNA Studies</li> <li>More Readings about Liquid Biopsy</li> </ul> </li> <li>dsRNAfinder &amp; TE-cfRNA <ul> <li>2025 bioRXiv - Comprehensive Mapping of Human dsRNAome Reveals Conservation, Neuronal Enrichment, and Intermolecular Interactions</li> <li>2023 Nature BME - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer </li> </ul> </li> <li>MB-cfRNA (Microbial cfRNA) <ul> <li>2025 Nature Genetics - Blood DNA virome associates with autoimmune diseases and COVID-19 </li> <li>2022 eLife - Cancer Type Classification Using Plasma Cell Free RNAs Derived from Human and Microbes  [Lu Lab Paper]</li> <li>2020 Nature - RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach</li> </ul> </li> <li>MB-RNA Struture <ul> <li>2021 Genome Biology - Comparative genomics identifies thousands of candidate structured RNAs in human microbiomes</li> <li>2025 Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential [Lu Lab Paper]</li> <li>2024 Nature Biotechnology - RIP-PEN-seq identifies a class of kink-turn RNAs as splicing regulators</li> </ul> </li> <li>cf-Rfam Database<ul> <li>cfOmics</li> <li>Rfam 15.0</li> <li>exoRBase 3.0</li> </ul> </li> <li>New AI model for RNA Code (motif &amp; structure) <ul> <li>[Review] 2025 Nature Reviews - Decoding the interactions and functions of non-coding RNA with artificial intelligence</li> <li>2024 Nature Machine Intelligence - An interpretable RNA foundation model for exploring functional RNA motifs in plants</li> <li>2021 Nature - MicroRNA sequence codes for small extracellular vesicle release and cellular retention</li> <li>More: dsRNA code</li> </ul> </li> </ul>"},{"location":"reading/startup/#a2-rnafinder-applications","title":"A2. RNAfinder - Applications","text":""},{"location":"reading/startup/#a21-medicine-precision-medicine","title":"A2.1 [Medicine] Precision Medicine","text":"<p>(\u9002\u5408\u533b\u5b66\u548c\u751f\u7269\u80cc\u666f\u7684\u540c\u5b66\uff09\uff08\u5408\u4f5c\uff1a Hospitals\uff09 </p> <ul> <li>Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood. Cell Reports Medicine 2023 [Lu Lab Paper]</li> <li>dsRNAome Manuscript [Lu Lab Paper]</li> <li>More: Immune Diseases Cell 2021; SLE Cell 2022; modENCODE Science 2010</li> </ul>"},{"location":"reading/startup/#a22-ribozyme-structure-prediction-ribozyme-design","title":"A2.2 [Ribozyme] Structure Prediction &amp; Ribozyme Design","text":"<p>(\u9002\u5408\u751f\u7269\u548c\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\uff09\uff08\u5408\u4f5c\uff1a Structure lab) </p> <ul> <li>2024 Nature Methods - [RfamGen]Deep generative design of RNA family sequences</li> <li>2024 Nature machine intelligence - A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions</li> </ul>"},{"location":"reading/startup/#b1-rnatalk","title":"B1. RNAtalk","text":"<p>(\u9002\u5408\u751f\u7269\u548c\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\uff09\uff08\u5408\u4f5c\uff1a Biology lab\uff09 </p> <p>Novelty: Novel RNA-centered  (TE-RNA, mbRNA, sRNA; DT2)</p> <ul> <li>Type I. Novel Seq-tech<ul> <li>VASA-seq NBT 2022 \uff08DT2 - [Lu Lab]\uff09</li> <li>MUSIC-seq Nature 2024</li> <li>UDA-seq Nature Methods 2025</li> <li>More: RIC-seq Nature 2020/2023; GRID-seq NBT 2017, etc</li> </ul> </li> <li>Type II-A. Novel AI Model<ul> <li>2023 Nature Methods - SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks</li> <li>2021 NAR - ImmReg: the regulon atlas of immune-related pathways across cancer types</li> </ul> </li> <li>Type II-B. Benchmark &amp; Database<ul> <li>2024 Nature Methods  - Benchmarking algorithms for single-cell multi-omics prediction and integration</li> </ul> </li> </ul>"},{"location":"reading/startup/#b2-rnatalk-applications","title":"B2. RNAtalk - Applications","text":""},{"location":"reading/startup/#b21-rna-rna-sirna-drug-design","title":"B2.1 [RNA-RNA] siRNA Drug Design","text":"<p>(\u9002\u5408\u751f\u7269\u548c\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\uff09</p> <p>(\u5408\u4f5c\uff1a Drug Companies\uff09</p> <ul> <li>OligoFormer: 2024 Bioinformatics  - OligoFormer: An accurate and robust prediction method for siRNA design. Bioinformatics [Lu Lab Paper]</li> </ul>"},{"location":"reading/startup/#tech-a-scdt2-screen-platform-big-data-generalization-platform","title":"(Tech. A) scDT2 Screen Platform --&gt; Big Data Generalization Platform","text":"<ul> <li>High-throughput Seq Data:  2024 Nature Biotechnology - Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling</li> <li>UDA-seq: Nature Methods 2025</li> <li>2012 PNAS - Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy [Lu Lab Paper]</li> </ul>"},{"location":"reading/startup/#tech-b-interaction-seq","title":"(Tech. B) Interaction-seq","text":"<ul> <li>MUSIC-seq: 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>RIC-seq: 2020 Nature- RIC-seq for global in situ profiling of RNA\u2013RNA spatial interactions</li> </ul>"},{"location":"reading/startup/#tech-c-fusing-enzymes-ago2adar2","title":"(Tech. C) Fusing Enzymes: AGO2+ADAR2","text":"<ul> <li>2023 Nature Biotech. - Detection of transcriptome-wide microRNA\u2013target interactions in single cells with agoTRIBE</li> </ul>"},{"location":"reading/startup/#tech-d-transcriptional-profile","title":"(Tech. D) Transcriptional Profile","text":"<ul> <li>2021 Nature biotechnology - Prediction of Drug Efficacy from Transcriptional Profiles with Deep Learning </li> <li>2020 BIB - Comprehensive evaluation of connectivity methods for L1000 data [Lu Lab Paper]</li> </ul>"},{"location":"reading/startup/#app-1-tech-a-tech-b-or-c-off-target-site","title":"(App 1) Tech. A + Tech. B or C --&gt;   Off-target Site","text":"<ul> <li>2024 Nature Biotechnology - Tracking-seq reveals the heterogeneity of off-target effects in CRISPR\u2013Cas9-mediated genome editing</li> </ul>"},{"location":"reading/startup/#app-2-tech-b-interactome-on-target-site","title":"(App 2) Tech. B  --&gt; Interactome (on-target site)","text":"<ul> <li>MUSIC-seq: 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> </ul>"},{"location":"reading/startup/#app-3-tech-a-tech-d-and-c-rna-drug-synergy","title":"(App 3) Tech. A + Tech. D (and C)  --&gt;  RNA Drug Synergy","text":"<ul> <li>2025 Nature Communications - Building a unified model for drug synergy analysis powered by large language models</li> <li>2012 Nature Biotech - Systematic Identification of Synergistic Drug Pairs Targeting HIV [Lu Lab Paper]</li> </ul>"},{"location":"reading/startup/#app-4-tech-a-tech-d-screen-novel-rna-drugs","title":"(App 4) Tech. A + Tech. D  --&gt; Screen novel RNA drugs","text":"<ul> <li>2010 Nature Review | Drug Discovery - Aptamers as therapeutics</li> <li>2025 Nature Biotechnology - Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates</li> </ul>"},{"location":"reading/startup/#b22-rna-ligand-small-molecule-drug-design","title":"B2.2 [RNA-Ligand] Small-molecule Drug Design","text":"<p>(\u9002\u5408\u8ba1\u7b97\u548c\u751f\u7269\u80cc\u666f\u7684\u540c\u5b66\uff09</p> <p>(\u5408\u4f5c\uff1a Drug Companies, Computation Labs, Chemistry Labs)</p> <ul> <li>Generation of 3D molecules in pockets via a language model. Nature Machine Intelligence, 2024</li> <li>RNAsmol: RNA\u2013ligand interaction scoring via data perturbation and augmentation modeling. Nature Computational Science 2025 [Lu Lab Paper]</li> </ul>"},{"location":"reading/startup/#b23-rna-protein-rbp-post-transcriptional-regulation","title":"B2.3 [RNA-Protein] RBP &amp; Post-transcriptional Regulation","text":"<p>(\u9002\u5408\u751f\u7269\u548c\u8ba1\u7b97\u80cc\u666f\u7684\u540c\u5b66\uff09</p> <ul> <li>2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> <li>POSTAR3 - NAR 2022  [Lu Lab Paper]</li> <li>RBPgroup - Genome Biology 2017 [Lu Lab Paper]</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/","title":"Overview","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/#liquid-biopsy","title":"Liquid Biopsy","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/#i","title":"I. \u5173\u4e8e\u6db2\u4f53\u6d3b\u68c0\u6280\u672f\u7684\u79d1\u666e","text":"<p>News</p> <ul> <li>2022 Nature - GRAIL and the quest for earlier multi-cancer detection</li> <li>2022 - \u80bf\u7624\u65e9\u7b5b\uff0c\u7fa4\u96c4\u8c01\u80fd\u9010\u9e7f\uff1f(Wechat link | Everhub link) </li> <li>2022 - New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening (Cancer Cell Commentary)</li> <li>2022 - Omics and AI advance biomarker discovery for liver disease (Nature Medicine News)</li> <li>2019 - \u4e3a\u4f55\u6295\u8d44\u8005\u5bf9\u764c\u75c7ctDNA\u6db2\u4f53\u6d3b\u68c0\u4f9d\u65e7\u201c\u4fe1\u5fc3\u6ee1\u6ee1\uff0c\u70ed\u60c5\u9ad8\u6da8\u201d - NBT\u89e3\u6790\u80cc\u540e\u539f\u56e0 ( Wechat link | Nature Biotech. )</li> <li>2019 - \u5f00\u542f\u80bf\u7624\u65e9\u7b5b\u65b0\u7eaa\u5143\uff0c\u6db2\u6001\u6d3b\u68c0\u84c4\u52bf\u5f85\u53d1 ( Everhub link; Wechat link )</li> </ul> <p>Patents</p> <ul> <li>2019 - Nature Biotech. - Recent patents in cancer detection </li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/#ii-reviews-of-liquid-biopsy","title":"II. Reviews of Liquid Biopsy","text":"<ul> <li>2022 Nature Reviews - Circulating tumour DNA \u2014 looking beyond the blood</li> <li>2022 Science - Early Detection of Cancer</li> <li>\u2728 2022 Nature Biomedical Engineering - Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics</li> <li>2021Mol. Cancer - The role and application of small extracellular vesicles in gastric cancer</li> <li>\u2728 2021 Science - Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies</li> <li>\u2728 2020 Nature - Outlook - Putting extracellular RNA to the diagnostic test</li> <li>2020 Nature Reviews - RNA delivery by extracellular vesicles in mammalian cells and its applications</li> <li>2020 Science - The biology, function, and biomedical applications of exosomes</li> <li>\u2728 2020 Genome Biology - The promise and challenge of cancer microbiome research</li> <li>2019 Cell - Review - The Role of Non-coding RNAs in Oncology</li> <li>\u2728 2018 Nature Reviews | clinica l oncology - Clinical utility of circulating non-coding RNAs \u2014 an update</li> <li>\u2728 2018 Nature Reviews | Genetics - Current and future perspectives of liquid biopsies in genomics-driven oncology</li> <li>2018 Nature Reviews | Clin Oncol. - Extracellular vesicles in cancer - implications for future improvements in cancer care</li> <li>2018 NEJM - Circulating Extracellular Vesicles in Human Disease (\u7ffb\u8bd1\u7248)</li> <li>2018 NEJM - Application of Cell-free DNA Analysis to Cancer Treatment (\u7ffb\u8bd1\u7248)</li> <li>2018 NEJM - Sequencing of circulating cell-free dna during pregnancy (\u7ffb\u8bd1\u7248)</li> </ul> <p>Comparison of different liquid biopsy tech. : Comparison Table</p>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/","title":"1. cf-seq Tech","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#cfrna-seq-cfdna-seq-tech","title":"cfRNA-seq &amp; cfDNA-seq Tech.","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#i-cfrna-seq-protocols-technologies","title":"I. cfRNA-seq Protocols &amp; Technologies","text":"<ul> <li>2022 Clin. Transl. Med. - Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids</li> <li>\u2705 Purification: 2021 bioRxiv - Performance of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study</li> <li>\u2705 Storage &amp; Transportation: 2021 Nature Commn. - Grail - A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection</li> <li>Comparison: RNA biology 2018 - Evaluation of methodologies for microRNA biomarker detection by next generation sequencing</li> <li>Barcode: Nature Methods 2015 - Simultaneous generation of many RNA-seq libraries in a single reaction</li> <li>Multiplex: Nature Methods 2019 - Simultaneous multiplexed amplicon sequencing and transcriptome profiling in single cells</li> <li>UMI: Nature Methods 2012 - Counting absolute numbers of molecules using unique molecular identifiers, Nature Methods 2014 - Quantitative single-cell RNA-seq with unique molecular identifiers</li> <li>SMART-seq2(TSO): Nature Protocol 2014 - Full length RNA-seq from single cells using Smart-seq2</li> <li>Pico-seq:<ul> <li>\u2728 DASH/CRISPR: Genome Biology 2016 - Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications</li> <li>Pico Patent: Pico Patent Application Publication</li> </ul> </li> <li>SILVER-seq: 2019 PNAS - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#ii-cfrna-and-ev-purification-method","title":"II. cfRNA and EV Purification Method","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#1-exosome-and-ev","title":"1. Exosome and EV","text":"<ul> <li>2022 bioRxiv - Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles</li> <li>RNP: 2021 Nature Cell Biol. - Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets</li> <li>2021 Nature Methods - Exosome detection via the ultrafast-isolation system: EXODUS</li> <li>\u2728 2021 JEV - Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium</li> <li>Extracellular carriers: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers</li> <li>Exosome preview: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication</li> <li>\u2728 Exosome composition: Cell article 2019 - Reassessment of Exosome Composition</li> <li>exRNA carriers: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids</li> <li>Exosome PD-L1: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#2-ev-and-rnp-purification-method","title":"2. EV and RNP Purification Method","text":"<ul> <li>2022 JEV - Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma \u2013 Contributions of platelet extracellular vesicles in plasma samples</li> <li>SEC: 2020 Molecular Therapy - Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research</li> <li>MV+sEV+RNP: 2017 Nature Communication - Coding and noncoding landscape of extracellular RNA</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#iii-cfrna-commercial-kit","title":"III. cfRNA Commercial Kit","text":"<ul> <li>V1-NEB: E7300-NEB small RNA kit</li> <li>V2-SMART: SMARTer smRNA-Seq Kit for Illumina User Manual</li> <li>V2-SMART: SMARTer Stranded Total RNA-Seq Kit - Pico Input Mammalian User Manual</li> <li>V3-Pico: Long cfRNA-seq Kit</li> <li>Clontech technology-low input RNA library kit</li> <li>Clontech technology-pico kit</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#iv-cfrna-papers-recommended-by-hk-wang","title":"IV. cfRNA Papers recommended by HK Wang","text":"<ul> <li>\u2705 [Smart-seq3]2020 Nature Biotech -Single-cell RNA counting at allele and isoform resolution using Smart-seq3 </li> <li>[UMI]2012 Nature Methods -Counting absolute numbers of molecules using unique molecular identi\ufb01ers </li> <li>[Barcode]2015 Nature Methods -Simultaneous generation of many rna-seq libraries in a single reaction </li> <li>\u2705 [DASH]2016 Genome Biology -Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications </li> <li>[Phospho\u2010seq]2019 EMBO J. -Phospho\u2010RNA\u2010seq - a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma </li> <li>[SILVER\u2010seq]2019 PNAS -Extracellular RNA in a single droplet of human serum re\ufb02ects physiologic and disease states </li> <li>[CATS\u2010seq]2014 RNA Biology -Capture and Amplification by Tailing and Switching (CATS) </li> <li>[Pico-similar]2013 RNA Biology -Peregrine - A rapid and unbiased method to produce strand-specific RNA-Seq libraries from small quantities of starting material</li> <li>[Review]2018 NAR -Capturing the \u2018ome\u2019: the expanding molecular toolbox for RNA and DNA library construction</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#v-cfdna-tech","title":"V. cfDNA Tech.","text":"<p>Nanopore</p> <ul> <li>2021 Mol. Cancer - Nanopore sequencing from liquid biopsy analysis of copy number variations from cell-free DNA of lung cancer patients</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#vi-cfdna-methylation-tech","title":"VI. cfDNA Methylation Tech.","text":"<ul> <li>TAPS</li> <li>2022 NAR - Whole-genome long-read TAPS deciphers DNA methylation patterns at base resolution using PacBio SMRT sequencing technology</li> <li>\u2728[cfTAPS] 2021 Science Advances - Cell-free DNA TAPS provides multimodal information for early cancer detection</li> <li>\u2728[TAPS] 2019 Nature Biotech. - Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution</li> <li>MeDIP</li> <li>2022 NCOMMN. - The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors</li> <li>2020 Nat Medicine - Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes</li> <li>\u2728[cfMeDIP] 2019 Nature Protocol - Preparation of cfMeDIP-seq libraries for methylome</li> <li>\u2728[cfMeDIP] 2018 Nature - Sensitive tumour detection and classification using plasma cell-free DNA methylomes</li> <li>BS </li> <li>2022 Nature Cancer - cfDNA methylome profiling for detection and subtyping of small cell lung cancers</li> <li>2021 Nature Biomedical Engineering - Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning</li> <li>\u2728 [Targeted BS] 2021 Annals of Oncology - Grail and CCGA Consortium - Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set</li> <li>\u2728 [Targeted BS] 2020 Annals of Oncology - Grail and CCGA Consortium - Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA</li> <li>[chips] 2018 Nature - DNA methylation-based classification of central nervous system tumours</li> <li>[WGBS] 2017 Nature Genetics -  Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA</li> <li>[WGBS] 2013 PNAS - Noninvasive detection of cancer-associated genome- wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing</li> <li>5Hmc</li> <li>2019 Gut - Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma</li> <li>2019 Blood Adv - Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma</li> <li>2017 Cell Res - 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers</li> <li>Nanopore</li> <li>2022 Genome Biology - Detecting cell\u2010of\u2010origin and cancer\u2010specific methylation features of cell\u2010free DNA from Nanopore sequencing</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#1-more-reading-on-cfdnamet-seq","title":"1. More reading on cfDNAmet-seq","text":"<ul> <li>2020 Sci Adv - Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. </li> <li>2019 Clin Chem - Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing</li> <li>2017 Genomic Medicine - Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans.</li> <li>2015 Cell Res - Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients </li> <li>2014 Clin Epigenetics - Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/1.%20cf-seq%20Tech/#2-validation-of-dnamet","title":"2. Validation of DNAmet","text":"<ul> <li>[mqMSP] 2021 PNAS - Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy</li> <li>[qMSP]2019  Clin Epigenetics - Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood</li> <li>[MSRE] 2016 Clin Epigenetics  - Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer</li> <li>[qMSP] 2019 Theranostics - Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/","title":"2. cfRNA","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#cfrna","title":"cfRNA","text":"<p>\u2705 or \u2728 : recommended readings</p> <p>cfRNA (cell-free RNA) is also called exRNA (extracellular RNA)</p>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#i-representative-cfrna-studies","title":"I. Representative cfRNA Studies","text":"<p>DETECTOR-seq method:</p> <ul> <li>\u2705 2024 Clinical and Translational Med - Depletion-assisted multiplexed cell-free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles</li> </ul> <p>Targeted RNA-seq strategy:</p> <ul> <li>\u27052025 Nature - An ultrasensitive method for detection of cell-free RNA</li> <li>2025 Nature Med - Clinical utility of targeted RNA sequencing in cancer molecular diagnostics</li> <li>2022 Nature - Early prediction of preeclampsia in pregnancy with cell-free RNA</li> <li>2022 Nature - RNA profiles reveal signatures of future health and disease in pregnancy</li> </ul> <p>Add TE-RNA:</p> <ul> <li>\u27052023 Nature BME - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer</li> </ul> <p>Add microbial RNA:</p> <ul> <li>\u27052025 Nature Biotechnology - Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples</li> <li>\u27052022 eLife - Cancer type classification using plasma cell-free RNAs derived from human and microbes</li> </ul> <p>Add Fragmented RNA:</p> <ul> <li>\u27052025 Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential</li> </ul> <p>Combine with other cfOmics:</p> <ul> <li>\u2705 2023 Cell Rep Med. - Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood</li> </ul> <p>Cell-of-origin (classify type of cancer)</p> <ul> <li>\u2705 2022 Nature Biotech - Cell types of origin of the cell-free transcriptome</li> <li>2021 Nature\u00a0- MicroRNA sequence codes for small extracellular vesicle release and cellular retention</li> </ul> <p>Mechanism study of candidate RNA:</p> <ul> <li>2018 Nature Med. - Cancer cells exploit an orphan RNA to drive metastatic progression</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#ii-cfrna-studies","title":"II. cfRNA Studies","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#cancer","title":"Cancer","text":"<p>Long</p> <ul> <li>2025 Nature Communications - Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients</li> <li>\u2705 Targeted long cfRNA-seq: 2025 Nature - An ultrasensitive method for detection of cell-free RNA</li> <li>\u27052025 Nature Med - Clinical utility of targeted RNA sequencing in cancer molecular diagnostics</li> <li>\u27052025 Nature Biotechnology - Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples</li> <li>\u2705 cfDNA+cfDNAmet+cfRNA-S+cfRNA-L - 2023 Cell Reports Medicine - Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood</li> <li>2023 Nature biomedical engineering - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer</li> <li>2023 Nature Commn. - Terminal modi\ufb01cations independent cell-free RNA sequencing enables sensitive early cancer detection and classi\ufb01cation</li> <li>2022 NPJ precision oncology - Plasma cell-free RNA pro\ufb01ling distinguishes cancers from premalignant conditions in solid and hematologic malignancies</li> <li>2021 Clinical Chem. - Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma</li> <li>long cfRNA-mRNA: 2021 Nature Commn. - Grail - A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection</li> <li>long evRNA-mRNA: 2021 Mol Cancer - Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer </li> <li>long cfRNA-ncRNA - 2021 Theranostics - Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>\u2728 long evRNA-seq: 2020 GUT Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma</li> <li>mRNA/lncRNA fragments: 2019 EMBO J.  - Phospho\u2010RNA\u2010seq: a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma</li> <li>SILVER-seq: 2019 PNAS - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states</li> <li>long evRNA-seq: 2019 Clinical Chemistry - Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis</li> <li>exoRBase: 2018 NAR - exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes</li> <li>2018 PNAS - Human plasma and serum extracellular small RNA reference profiles and their clinical utility</li> <li>exRNA Components: 2017 Nature Communication - Coding and noncoding landscape of extracellular RNA</li> <li>Prospective Review: 2017 Noncoding RNA - RNA Biomarkers: Frontier of Precision Medicine for Cancer</li> </ul> <p>Long - Platelet</p> <ul> <li>\u2705 Platelet RNA: 2022 Cancer Cell - Detection and localization of early- and late-stage cancers using platelet RNA</li> <li>2022 Genome Medicine - RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study</li> <li>Platelet RNA: 2015 Cancer Cell - RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics</li> <li>Platelet RNA: 2017 Cancer Cell - Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets</li> </ul> <p>Small/Frag.</p> <ul> <li>\u27052025Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential</li> <li>\u2728 oncRNA: 2024 bioRxiv - Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers</li> <li>unannotated exRNAs: 2021 GUT - Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer</li> <li>small exosomal RNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>small cfRNA: 2015 Scientific Report - Plasma extracellular RNA profiles in healthy and cancer patients</li> <li>structured ncRNA domain (small cfRNA-seq): 2019 Clinical chemistry  - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma</li> <li>\u2728 oncRNA: 2018 Nature Med. - Cancer cells exploit an orphan RNA to drive metastatic progression</li> <li>miRNA7: 2011 JCO - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus\u2013Related Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#pregnancy","title":"Pregnancy","text":"<ul> <li>2025    Nature Communications   Maternal plasma cell-free RNA as a predictor of early and late-onset preeclampsia throughout pregnancy</li> <li>(ccfDNA - 2023 Lancet Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study)</li> <li>\u2705 long cfRNA-seq: 2022 Nature  Early prediction of preeclampsia in pregnancy with cell-free RNA</li> <li>Captured long cfRNA-seq: 2022 Nature RNA profiles reveal signatures of future health and disease in pregnancy</li> <li>2020 Science translational medicine - Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia</li> <li>\u2705 Long cfRNA-seq: 2018 Science - Noninvasive blood tests for fetal development predict gestational age and preterm delivery</li> <li>long cfRNA-seq: 2017 Clinical chemistry - Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#infectious-diseases","title":"Infectious Diseases","text":"<ul> <li>2024 Nature Communications - Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis</li> <li>2022 Genome Res. - Plasma cell-free RNA characteristics in COVID-19 patients</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#neural-diseases","title":"Neural Diseases","text":"<ul> <li>small cfRNA - 2021 PNAS -  - Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology</li> <li>long cfRNA-mRNA: 2020 Science Advance - Noninvasive characterization of Alzheimer\u2019s disease by circulating cell-free messenger RNA next-generation sequencing</li> <li>cfRNA: 2020 Current Biology - Presymptomatic increase of an extracellular RNA in blood plasma is associated with the development of Alzheimer\u2019s disease</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/2.%20cfRNA/#ercc-2019-cell-papers","title":"ERCC  (2019 Cell papers)","text":"<ul> <li>Collections of exRNA Consortium (ERCC) @ Cell</li> <li>Outlook collection of Nature (Could tracking RNA in body fluids reveal disease? )</li> </ul> <ul> <li>exceRpt: Cell system 2019 - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling</li> <li>Extracellular carriers: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers</li> <li>ERCC perspective: Cell perspective 2019 - The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research</li> <li>Exosome preview: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication</li> <li>\u2728 Exosome composition: Cell article 2019 - Reassessment of Exosome Composition</li> <li>exRNA carriers: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids</li> <li>Small exRNA-seq: Cell resource 2019 - Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation</li> <li>Exosome PD-L1: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/","title":"3. cfRNA Analysis","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#cfrna-seq-analysis","title":"cfRNA-seq Analysis","text":"<p>\u2705 or \u2728 : recommended readings</p>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#0-data-pre-process","title":"0. Data Pre-process","text":"<ul> <li>[Pipeline of long and small cfRNA-seq] exSEEK Tutorial @ gitbook<ul> <li>[Alternative Pipeline] cfRNA-SEEK Github @ GitHub</li> </ul> </li> <li>[Pipeline of small cfRNA-seq] 2019 Cell Sys. - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling</li> <li>[Data Matrix of Multiple Variances] see more in RNA POSTAR Analysis about calculating features like editing, splicing, APA, chimeric RNA, etc</li> <li>Learn from cfDNA features</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#i-rna-code-cell-of-origin","title":"I. RNA Code &amp; Cell-of-Origin","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#i1-rna-code-motif-and-structure","title":"I.1 RNA code: Motif and Structure","text":"<p>Background/Introduction </p> <ul> <li>\u2705 2024 Cell Genomics - Revealing the grammar of small RNA secretion</li> <li>\u2705 2023 PNAS - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs</li> <li>\u2705 [miRNA motif/code] 2021 Nature - MicroRNA sequence codes for small extracellular vesicle release and cellular retention</li> <li>G-quadruplex - 2020 Genome biology - RNA G-quadruplex structures exist and function in vivo in plants</li> <li>G-quadruplex - 2016 Science - RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#i2-deconvolution-localization","title":"I.2 Deconvolution &amp; Localization","text":"<ul> <li>2025 Nature Biotechnology - Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples</li> <li>\u2705 [Deconvolution]:  2022 Nature Biotech. - Cell types of origin of the cell-free transcriptome</li> <li>2021 Nature Biotech. - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin</li> <li>2017Genome Biology - CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#ii-cfrna-fragmentation","title":"II. cfRNA fragmentation","text":"<ul> <li>\u27052025 Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential</li> <li>Peak calling: 2022 Genome Biology - GoPeaks: histone modification peak calling for CUT\\&amp;Tag</li> <li>2021 PNAS - Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology</li> <li>2021 NAR - Computational meta-analysis of ribosomal RNA fragments: potential targets and interaction mechanisms</li> <li>sRNA cluster: 2021 Gut - Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer</li> <li>2020 Mol. Cancer - Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer</li> <li>Fragmented ribosomes: 2020 NAR - Fragmentation of extracellular ribosomes and tRNAs shapes the extracellular RNAome</li> <li>\u2705 mRNA frag. :  2020 elife - Identification of protein-protected mRNA fragments and structured excised intron RNAs in human plasma by TGIRT-seq peak calling</li> <li>tsRNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>mRNA/lncRNA frag.: 2019 EMBO J. - Phospho\u2010RNA\u2010seq: a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma</li> <li>srpRNA domain (RNA7SL1): 2019 Clinical Chem. - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#iii-feature-selection","title":"III. Feature Selection","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#iii1-signature-genes","title":"III.1.  Signature Genes","text":"<ul> <li>\u2705  [TmS: total mRNA expression] 2022Nature Biotech. - Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression</li> <li>\u2705  2021 Nature Biotech. - Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID</li> <li>2021 Nature Machine Intelligence - Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms</li> <li>2021 Genome Res. - NS-Forest: A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing</li> <li>2019 Briefings in Bioinformatics - A comprehensive evaluation of connectivity methods for L1000 data Briefings in Bioinformatics</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#iii2-network-approach","title":"III.2. Network Approach","text":"<ul> <li>2022Nature Commn. - Network-based machine learning approach to predict immunotherapy response in cancer patients</li> <li>\u2705 [P-Net] 2021 Nature -  Biologically informed deep neural network for prostate cancer discovery</li> <li>2021 Nature Computational Science -  Modeling gene regulatory networks using neural network architectures</li> <li>2021Cell - A modular master regulator landscape controls cancer transcriptional identity</li> <li>2020 Bioinformatics - Varmole: A biologically drop-connect deep neural network model for prioritizing disease risk variants and genes</li> <li>2017Nature Methods- SCENIC: single-cell regulatory network inference and clustering</li> <li>2018Nature COMMN.- Pathway based subnetworks enable cross-disease biomarker discovery</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#iv-data-clean-normalization-batch-correction-etc","title":"IV. Data Clean - normalization, batch correction, etc","text":"<p>Issues for single-cell and cell-free RNA-seq data</p> <ul> <li>(1) Dropout/Sparseness and Imputation</li> <li>(2) Heterogeneity and Normalization</li> <li>(3) Batch effect and Confounder</li> <li>(Pseudo-time and Others)</li> </ul> <p>Tutorial</p> <ul> <li>\u2705  Review:  2021Nature Biotech. - Computational principles and challenges in single-cell data integration</li> <li>2019Nature Methods - A discriminative learning approach to differential expression analysis for single-cell RNA-seq</li> <li>\u2705 2018Nature Biotech. - Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors</li> <li>MNN: 2017Nature Biotech. - Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors</li> <li>\u2705 Review: 2017Nature Methods - Normalizing single-cell RNA sequencing data: challenges and opportunities</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#v-classification-models","title":"V. Classification Models","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/3.%20cfRNA%20Analysis/#pre-training-and-transfer-learning","title":"Pre-training and Transfer Learning","text":"<ul> <li>\u2705 2023 Nature Methods - SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes</li> <li>2022 BIB - A universal approach for integrating super large-scale single-cell transcriptomes by exploring gene rankings</li> <li>2022 bioRxiv - Generative pretraining from large-scale transcriptomes: Implications for single-cell deciphering and clinical translation</li> <li>\u2705 2021 bioRxiv - scBERT: a Large-scale Pretrained Deep Langurage Model for Cell Type Annotation of Single-cell RNA-seq Data</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/","title":"4. cfDNA+","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#cfdna-and-other-blood-tests","title":"cfDNA and other blood tests","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#i-cfdna","title":"I. cfDNA","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#multianalyte-multiomics","title":"Multianalyte &amp; Multiomics","text":"<ul> <li> <p>2024 Cell Reports Medicine - Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis</p> </li> <li> <p>\u2705 cfDNA+cfDNAmet+cfRNA-S+cfRNA-L - 2023 Cell Reports Medicine - Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood</p> </li> <li> <p>\u2705 cfDNA+cfDNAmet - 2023 Cancer Discovery - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA </p> </li> <li> <p>cf-WGS+cf-WGBS - 2022 Cancer Cell - Evaluation of cell-free DNA approaches for multi- cancer early detection</p> </li> <li> <p>CancerSEEK+PET-CT: 2020 Science - Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention</p> </li> <li> <p>\u2705 ~60 cfDNA + 8 proteins (CancerSEEK): 2018 Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test</p> </li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#cfdnambdna","title":"cfDNA/mbDNA","text":"<ul> <li>2025  Nature Methods - Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling   </li> <li>2025 Nature Medicine - Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics</li> <li>2024 Science Translational Medicine - Machine learning to detect the SINEs of cancer</li> <li>2023 GB - The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection</li> <li>2023 Nature Genetics - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer</li> <li>2023 STM - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer</li> <li>\u2705 [end-motif ] 2023 PNAS - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs</li> <li>2022 Cancer Discovery - Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes</li> <li>cfDNA SNV+met: 2022 Science Trans. Med. - Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection</li> <li>Captured ctDNA SNV+CNV: 2020 Nature - Integrating genomic features for noninvasive early lung cancer detection</li> <li>Microbiome: 2020 Nature - Microbiome analyses of blood and tissues suggest cancer diagnostic approach </li> <li>Fragmentome (DELFI): 2022 Cancer Discovery - Detecting liver cancer using cell-free DNA fragmentomes</li> <li>Fragmentome (DELFI): 2021 Nature Commn. - Detection and characterization of lung cancer using cell-free DNA fragmentomes</li> <li>\u2705 Fragmentome (DELFI): 2019 Nature - Genome-wide cell-free DNA fragmentation in patients with cancer</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#cfdna-methylation","title":"cfDNA Methylation","text":"<ul> <li>\u2705 [Grail, cfDNA vs. cfDNAmet] - 2022 Cancer Cell - Evaluation of cell-free DNA approaches for multicancer early detection</li> <li>[Grail, Targeted BS] 2022 ESMO congress - PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test</li> <li>[Grail, Targeted BS] 2021 Annals of Oncology - Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set</li> <li>[Grail, Targeted BS] 2020 Annals of Oncology - Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA</li> <li>\u2728 [meDIP] 2018 Nature - Sensitive tumour detection and classification using plasma cell-free DNA methylomes</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#cfdnamet-and-histone-modification","title":"cfDNAmet and histone modification","text":"<ul> <li>2023 Nature Medicine - Liquid biopsy epigenomic profiling for cancer subtyping</li> <li>2021 Nature Biotech. - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#ii-others","title":"II. Others","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#cfrna","title":"cfRNA","text":"<p>see cfRNA</p>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#tcr","title":"TCR","text":"<ul> <li>2020 - Science Transl. Med. - De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#proteome","title":"Proteome","text":"<ul> <li>2025  Science - A human pan-disease blood atlas of the circulating proteome</li> <li>[Plasma proteome] 2023 Nature - Organ aging signatures in the plasma proteome track health and disease</li> <li>[Plasma proteome] 2022 Nature Medicine - Noninvasive proteomic biomarkers for alcohol-related liver disease</li> <li>[MS-EVP] Exosomic proteins: 2020 Cell - Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers</li> <li>[APPA] 2020 Sci Adv - Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#metabolome","title":"Metabolome","text":"<ul> <li>2024 Nature Commn. - Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/4.%20cfDNA%2B/#others","title":"Others","text":"<ul> <li>2025 Cell Research - DNA remnants in red blood cells enable early detection of cancer</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/","title":"5. Panel and Database","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#panel-and-database","title":"Panel and Database","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#0-databases","title":"0. Databases","text":"<ul> <li>2024 NAR - cfOmics: a cell-free multi-Omics database for diseases</li> <li>2021 NAR - exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human bio\ufb02uids</li> <li>2020 NAR - Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles</li> <li>2020 NAR - CFEA a cell-free epigenome atlas in human disease</li> <li>2019 NAR - BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#i-ngs-analysis","title":"I. NGS Analysis","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#rna-seq-analysis-differential-expression","title":"RNA-seq Analysis - Differential Expression","text":"<ul> <li>2021 Theranostics - Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>circRNA: 2020 PLOS Comp. Bio. - seekCRIT: Detecting and characterizing differentially expressed circular RNAs using high-throughput sequencing data</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#rna-seq-analysis-more","title":"RNA-seq Analysis - More","text":"<ul> <li>see more RNA-seq analysis pipelines in Tutorial: RNA Regulation Analysis</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#ii-meta-analysis","title":"II. Meta-Analysis","text":"<ul> <li>[Protein markers] 2016 Lancet Neurol - CSF and blood biomarkers for the diagnosis of Alzheimer's disease- a systematic review and meta-analysis</li> <li>[DNA markers] 2014 Nat Genetics - Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk</li> <li>[lncRNA markers] 2005 Cancer Res. - Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis</li> <li>[Practical Review] 2015 Korean J Radiol Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers</li> <li>Part I. General Guidance and Tips</li> <li>Part II. Statistical Methods of Meta-Analysis</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#iii-large-cohort-validationscreen","title":"III. Large-cohort Validation/Screen","text":""},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#cfrna-panels","title":"cfRNA Panels","text":"<ul> <li>2022 Mol Cancer - A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study</li> <li>\u2728 miRNA panel: 2022 Mol Cancer - A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study</li> <li>\u2728 circRNA  panel: 2022 Mol Cancer - Diagnostic efcacy of circular RNAs as noninvasive liquid biopsy biomarkers for early detection of gastric cancer</li> <li>\u2728 mRNA panel: 2021 Mol Cancer - Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer</li> <li>lncRNAs+miRNAs: 2021 Theranostics -Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>miRNAs: 2020 Gut - Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population</li> <li>miRNAs: 2020 PNAS - Development of a serum miRNA panel for detection of early stage non-small cell lung cancer</li> <li>\u2728 small exosomal RNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>\u2728 miRNA7: 2011 JCO - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus\u2013Related Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#other-detectiondiagnosis-panels","title":"Other Detection/Diagnosis Panels","text":"<ul> <li>\u2705 (neoadjuvant biomarker) 2022 Mol. Cancer - A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer</li> <li>\u2705 (SLE biomarker) 2022 Lancet Rheumatol - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial</li> <li>ctDNA+Protein (CancerSEEK): 2018 - Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test</li> <li>2019 - iScience - Early Cancer Detection from Multianalyte Blood Test Results</li> <li>2021 - Bioinformatics - CancerEMC frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA</li> <li>ctDNA+Protein+Clinical Info: 2019 - PNAS - Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy</li> </ul>"},{"location":"reading/A.RNAfinder/1.1%20cfRNAfinder/5.%20Panel%20and%20Database/#other-prognosis-panels","title":"Other Prognosis Panels","text":"<ul> <li>Progosis ctDNA: 2019 JCO - Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma</li> <li>Prognosis ctDNA: 2019 JAMA Oncology - Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer</li> <li>Prognosis ctDNA: 2019 Translational Med. - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer</li> <li>Prognosis ctDNA\uff1a2019 JAMA Oncology - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer</li> <li>Liquid vs. tissue biopsy\uff1a 2019 Nature Medicine - Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/","title":"Overview","text":""},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/#ncrna-finder","title":"ncRNA Finder","text":""},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/#1-ai-models-for-rna","title":"1. AI models for RNA","text":"<ul> <li>RiNALMo</li> <li>HydraRNA</li> <li>RNAErnie</li> <li>Ernie-RNA </li> <li>structRFM</li> </ul> <ul> <li> <p>\u2705 [Review] 2025 Nature Reviews - Decoding the interactions and functions of non-coding RNA with artificial intelligence</p> </li> <li> <p>2025    Nature Communications - ERNIE-RNA: an RNA language model with structure-enhanced representations</p> </li> <li>2025    Nature Communications - RiNALMo: general-purpose RNA language models can generalize well on structure prediction tasks</li> <li>2025    Genome Biology - HydraRNA: a hybrid architecture based full-length RNA language model</li> <li>2025 Nature Communications - Generative and predictive neural networks for the design of functional RNA molecules</li> <li>\u2705 [RfamGen] 2024 Nature Methods - Deep generative design of RNA family sequences</li> <li>2024 Nature Machine Intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>\u2705 2024 Nature machine intelligence - A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/","title":"1. dsRNAfinder","text":""},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/#dsrnafinder-rna-codemotif","title":"dsRNAfinder &amp; RNA code/motif","text":""},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/#0-overview","title":"0. Overview","text":"<ul> <li>Short-distance folding:  RNAstructure; RNAfold (free energy minimization methods) see RNA Secondary Structure Prediction</li> <li>Long distance (&gt;200nt) pairing:   SuperFold for long distance base pairs (folding)  2014 Nature Methods</li> <li>Motif finder:</li> <li>CGF: 2012 Nature  - TESISER: Systematic discovery of structural elements governing stability of mammalian messenger RNAs</li> <li>HMM+SHAPE: 2018 Genome Biology - PATTERNA - 2018 Genome Biology PATTERNA: transcriptome-wide  search for functional RNA elements via structural data signatures</li> <li>Graph Kernel: GraphProt - 2014 Genome Biology </li> <li>CFG: TEISER (2012 Nature)</li> <li>SCFG: Rfam/Infernal;  CMfinder (2006 Bioinformatics); RNApromo - 2008 PNAS </li> </ul> <ul> <li>RNAstructure/Mfold and RNAfold perform good for sequence less than 200nt.</li> <li>SuperFold uses partition in RNAstructure package to predict partition functions for subsequences of long RNA, then merge the results. Therefore, it claims to perform better on long distance base pairs.</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/#i-motif-finding-methods","title":"I. Motif finding methods","text":"<ul> <li>\u2705  2024 Nature machine intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>1994 Proc Int Conf Intell Syst Mol Biol Fitting a mixture model by expectation maximization to discover motifs in biopolymers</li> <li>2005 NBT Assessing computational tools for the discovery of transcription factor binding sites</li> <li>2006 Bioinformatics CMfinder: a covariance model based RNA motif finding algorithm</li> <li>2008 Plos Computational Biology Discovering Sequence Motifs with Arbitrary Insertions and Deletions</li> <li>2008 PNAS Computational prediction of RNA structural motifs involved in post transcriptional regulatory processes</li> <li>2014 Nature Method RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)</li> <li>2015 Plos Computational Biology Structure-Based Alignment and Consensus Secondary Structures for Three HIV-Related RNA Genomes</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/#i1-dsrnafinder","title":"I.1 dsRNAfinder","text":"<ul> <li>2024  Molecular Cell - Alternative polyadenylation determines the functional landscape of inverted Alu repeats</li> <li>2025 bioRXiv - Comprehensive Mapping of Human dsRNAome Reveals Conservation, Neuronal  Enrichment, and Intermolecular Interactions</li> <li>2023    Nature - Complementary Alu sequences mediate enhancer\u2013promoter selectivity</li> <li>2023 BioRxiv - dsRID: Editing-free in silico identification of dsRNA region using long-read RNA-seq data</li> <li>2021  Nature Communications - Conserved long-range base pairings are associated  with pre-mRNA processing of human genes</li> <li>Long distance (&gt;200nt) pairing:   SuperFold for long distance base pairs (folding)  2014 Nature Methods</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/1.%20dsRNAfinder/#ii-rna-motif-in-human","title":"II. RNA motif in human","text":"<ul> <li>2021 Science [TEISER] - A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/","title":"2. mbRNAfinder","text":""},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#microbial-rna-analysis","title":"Microbial RNA Analysis","text":"<p>\u2705 : recommended readings</p>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#0-virome","title":"0. Virome","text":"<ul> <li>2024 Genome Biology - VirRep: a hybrid language representation learning framework for identifying viruses from human gut metagenomes</li> <li>\u2705 2024 Cell - Using artificial intelligence to document the hidden RNA virosphere</li> <li>\u2705 2023 Cell - Mining metatranscriptomes reveals a vast world of viroid-like circular RNAs</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#seq-tech","title":"Seq-tech","text":"<ul> <li>\u2705 2025 Nature Biotechnology - Detection of viral sequences at single-cell resolution identifies novel viruses associated with host gene expression changes</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#i-microbiome-in-blood","title":"I. Microbiome in blood","text":"<ul> <li>\u2705 2025 Nature Genetics - Blood DNA virome associates with autoimmune diseases and COVID-19</li> <li>2025 Nature Biotechnology - Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples</li> <li>2022 eLife - Cancer type classification using plasma cell-free RNAs derived from human and microbes</li> <li>2020 Nature - Microbiome analyses of blood and tissues suggest cancer diagnostic approach </li> <li>2020 Microbiome - Separating the signal from the noise in metagenomic cell-free DNA sequencing</li> <li>2019 PNAS -  A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#ii-ncrnasrna-in-microbiome","title":"II. ncRNA/sRNA in microbiome","text":"<ul> <li> 2024 Cell Host and Microbe - The RNA landscape of the human commensal Segatella copri reveals a small RNA essential for gut colonization</li> <li>2024 Science - Hydrolytic endonucleolytic ribozyme (HYER) is programmable for sequence-specific DNA cleavage</li> <li>2023 Science - Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering</li> <li>\u2705 2021 Genome Biology - Comparative genomics identifies thousands of candidate structured RNAs in human microbiomes</li> <li>2019 Cell - Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes</li> <li>2017 Science - Protein structure determination using metagenome sequence data</li> <li>2019 Molecular Systems Biology - Unraveling the hidden universe of small proteins in bacterial genomes</li> <li>2009 Nature - Metatranscriptomics reveals unique microbial small RNAs in the ocean\u2019s water column. </li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#iii-cancer-microbiome","title":"III. Cancer microbiome","text":"<ul> <li>\u2705 2024 Cell - A pan-cancer analysis of the microbiome in metastatic cancer</li> <li>[Review] 2022 Science - Engineering bacteria as interactive cancer therapies</li> <li>2022 Nature - Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer</li> <li>\u2705 2022 Cell - Pan-cancer analyses reveal cancer-type-speci\ufb01c fungal ecologies and bacteriome interactions</li> <li>2022 Cell - A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors</li> <li>[Review] 2021 Cancer Cell  - Microbiome and cancer</li> <li>[Review] 2021 Science  - The microbiome and human cancer</li> <li>2020 Science - The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria</li> <li>2020 Cell - A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/A.RNAfinder/1.2%20ncRNAfinder/2.%20mbRNAfinder/#iv-host-microbe","title":"IV. Host &amp; Microbe","text":"<ul> <li>\u2705 2022 Nature Microbe - Identification of shared and disease-specific host gene\u2013microbiome associations across human diseases using multi-omic integration</li> <li>2020 EMBO J. -  Mouse circulating extracellular vesicles contain virus-derived siRNAs active in antiviral immunity</li> <li>2018 Cell Host &amp; Microbe - Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota. </li> <li>2016 Cell Host &amp; Microbe - The Host Shapes the Gut Microbiota via Fecal MicroRNA</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/","title":"1. Immune RNA","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#rna-in-immune-system","title":"RNA in Immune System","text":"<p>\u2705 : recommended readings</p>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#1-dsrna-and-immunity","title":"1. dsRNA and immunity","text":"<p>Background/Introduction </p> <ul> <li>2025    Nature Genetics - ADAR1 editing is necessary for only a small subset of cytosolic dsRNAs to evade MDA5-mediated autoimmunity</li> <li>\u2705 2025 Nature Reviews Genetics - Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease</li> <li>[IRAlus Review] 2024 Experimental &amp; Molecular Medicine - Inverted Alu repeats: friends or foes in the human transcriptome</li> <li>2024 Nature Communications - Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells</li> <li>[Review] 2024 Molecular Cell - The competitive landscape of the dsRNA world</li> <li>2024 Nature - dsRNA formation leads to preferential nuclear export and gene expression</li> <li>\u2705 2024 Nature Reviews Immunology - Novel insights into double-stranded RNA-mediated immunopathology</li> <li>\u2705  2022 Nature Review - Mol Cell Biol. - Cellular origins of dsRNA, their recognition and consequences</li> <li>2021 Cancer Discovery - Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin</li> <li>2022 Nature Reviews Immunology - The roles of extracellular vesicles in the immune system</li> <li>2022 Immunity - Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity</li> <li>2021 Genome Biology - Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways</li> <li>[review] 2019 noncoding RNA - Endogenous Double-Stranded RNA</li> <li>2018 - JCO - Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients.</li> <li>\u2705  2016 Cell Host &amp; Microbe - The Evolution of Antiviral Defense Systems</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#dsrna-identification-and-prediction","title":"dsRNA identification and prediction","text":"<ul> <li>see RNA Motif &amp; dsRNAfinder#i.1-dsrnafinder</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#2-ncrna-te-rna-and-immunity","title":"2. ncRNA, TE-RNA and immunity","text":"<ul> <li>\u2705 2024 Immunity - Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells</li> <li>2023 Science Immunology - Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements</li> <li>[review] 2022 Journal of Autoimmunity - Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease</li> <li>[review] 2022 Journal of Autoimmunity - Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations</li> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> <li>2012 Nature Reviews Rheumatology - MicroRNAs\u2014novel regulators of systemic lupus erythematosus pathogenesis</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#3-rna-editing-and-immunity","title":"3. RNA editing and immunity","text":"<ul> <li>\u2705  2022 Nature - RNA editing underlies genetic risk of common inflammatory diseases</li> <li>2022 Cancer Res. - Single-cell analysis in lung adenocarcinoma implicates RNA editing in cancer innate immunity and patient prognosis</li> <li>2020 Genome Biology - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection</li> <li>2018 Cell - Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/1.%20Immune%20RNA/#4-rna-modification-and-immunity","title":"4. RNA modification and immunity","text":"<ul> <li>\u2705  [review] 2023 Trends in Immunology - \u2018(m 6 )A\u2019 stands for \u2018autoimmunity\u2019: reading, writing, and erasing RNA modi\ufb01cations during in\ufb02ammation</li> <li>\u2705 2020 Immunity  - m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/","title":"2. Cancer RNA","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#ncrna-in-cancer","title":"ncRNA in Cancer","text":"<p>\u2705 : recommended readings</p>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#0-basics","title":"0. Basics","text":"<ul> <li>\u2705 [Review] 2021 Nature Review | Cancer - Long noncoding RNAs in cancer metastasis</li> <li>2021 Nature Biotechnology - The RNA Atlas expands the catalog of human non-coding RNAs</li> <li>2020 Nature - PCAWG - Analyses of non-coding somatic drivers in 2,658 cancer whole genomes</li> <li>2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>\u2705  [Review] 2019 Cell The Role of Non-coding RNAs in Oncology</li> <li>[lncRNA Profiling] 2015 Nature Genetics - MiTranscriptome - The Landscape of Long Noncoding RNAs in the Human Transcriptome</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#i-novel-ncrnas","title":"I. Novel ncRNAs","text":"<ul> <li>\u2705 2024 Nature Genetics - Computational prediction and experimental validation identify functionally conserved lncRNAs from zebrafish to human</li> <li>[Perspective] 2022 Nature Cell Biology - Exploring the expanding universe of small RNAs </li> <li>\u2705 2021 Nature Cell Biology - PANDORA-seq expands the repertoire of regulatory small RNAs by overcoming RNA modifications </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#ii-te-rnarepeats","title":"II. TE-RNA/Repeats","text":"<ul> <li>2024 Nature reviews cancer -  Towards targeting transposable elements for cancer therapy</li> <li>\u2705 2024 Genome Biology - Divergent composition and transposon-silencing activity of small RNAs in mammalian oocytes</li> <li>[review] 2017 Nature Reviews Cancer - Transposable elements in cancer</li> <li>2022 Nature Genetics - LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#iii-tsrnarsrna-and-mt-rna","title":"III. tsRNA/rsRNA and MT-RNA","text":"<ul> <li>[Function] 2022 Cell Metab. - Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth</li> <li>[Marker] 2022 Frontier Medicine - Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis</li> <li>[Function] 2021 Mol. Cancer - A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer</li> <li>[Profiling] 2020 NAR - Fragmentation of extracellular ribosomes and tRNAs shapes the extracellular RNAome</li> <li>[Marker] 2019 Mol. Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>[Function] 2015 Cell - Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#iv-circrna","title":"IV. circRNA","text":"<ul> <li>[Review] 2021 Mol Cancer Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies</li> <li>[Function] 2020 Signal Transduction and Targeted Therapy CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX</li> <li>[Review] 2019 EMBJ Past, present, and future of circRNAs</li> <li>2013 Nature Circular RNAs are a large class of animal RNAs with regulatory potency</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/2.%20Cancer%20RNA/#v-other-noncoding-rnas","title":"V. Other noncoding RNAs","text":"<ul> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/","title":"3. Immune Diseases","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#immune-diseases","title":"Immune Diseases","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#i-reviews","title":"I. Reviews","text":"<ul> <li> <p>\u2705 [review] 2024 Nature Immunology - The immunology of systemic lupus erythematosus</p> </li> <li> <p>[review] 2023 Nature Reviews Nephrology - Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants</p> </li> <li>[review] 2023 Nature Reviews Rheumatology - Precision medicine in systemic lupus erythematosus</li> <li>[review] 2023 Nature Reviews Rheumatology - Post-transcriptional checkpoints in autoimmunity </li> <li>[review] 2022 Nature Reviews Rheumatology - The role of mitochondria in rheumatic diseases</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#ii-scrna-profiling","title":"II. scRNA Profiling","text":"<ul> <li>2024 Cell Reports Medicine - Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE</li> <li>2022 Signal transduction and targeted therapy - Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia</li> <li>\u2705 2022 Science - Single-cell RNA-seq reveals cell type\u2013specific molecular and genetic associations to lupus</li> <li>\u2705 2022 Cell - Distinct transcriptome architectures underlying lupus establishment and exacerbation</li> <li>\u2705 2021 Cell - Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases</li> <li>2022 Nature Med - Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial</li> <li>2021 PNAS - The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients</li> <li>2020 Nature Immunology - Mapping systemic lupus erythematosus heterogeneity at the single-cell level</li> <li>2019 Nature - Analysis of the B cell receptor repertoire in six immune-mediated diseases</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#iii-scmulti-omics-profiling","title":"III. scMulti-Omics Profiling","text":"<ul> <li>\u2705 2023 Immunity - Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection</li> <li>\u2705 2023 Nature - Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes</li> <li>2023 Nature cell biology - Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal\u2013 fetal interface following SARS-CoV-2 infection</li> <li>2022 Cell Reports - Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus</li> <li>2021 Science Immunology - Integrated single-cell transcriptomics and epigenomics reveals strong germinal center\u2013associated etiology of autoimmune risk loci</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#iv-cart-t","title":"IV. CART-T","text":"<ul> <li>2022 Nature Leukemia - Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/3.%20Immune%20Diseases/#v-biomarkers","title":"V. Biomarkers","text":"<ul> <li>(SLE biomarker) 2022 Lancet Rheumatol - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/4.%20Cancer%20Immunotherapy/","title":"4. Cancer Immunotherapy","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/4.%20Cancer%20Immunotherapy/#cancer-immunotherapy","title":"Cancer Immunotherapy","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/4.%20Cancer%20Immunotherapy/#1-cancer-immunotherapy","title":"1. Cancer Immunotherapy","text":"<ul> <li>2024 Cell - Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer </li> <li>2024 Cancer Cell - Integrated multi-omics profiling to dissect thespatiotemporal evolution of metastatichepatocellular carcinoma</li> <li>[review] 2023 Cell - Delivering the next generation of cancer immunotherapies with RNA</li> <li>2023 Cancer Cell - ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome</li> <li>2023 Cancer Cell - The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients</li> <li>\u2705 (neoadjuvant biomarker) 2022 Mol. Cancer - A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer</li> <li>\u2705 (neoadjuvant) 2022 Cell - Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy</li> <li>(neoadjuvant) 2022 Nature Med  - Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer</li> <li>2021 Cancer Cell - Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</li> <li>(non-neo adjuvant) 2021 Nature - ctDNA guiding adjuvant immunotherapy in urothelial carcinoma</li> <li>2020 Science Advance - Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/4.%20Cancer%20Immunotherapy/#2-cancer-microenvironment","title":"2. Cancer microenvironment","text":"<ul> <li>2019 - Nat Genetics - Landscape of B cell immunity and related immune evasion in human cancers</li> <li>2018 - Nat Biotech - Evaluation of immune repertoire inference methods from RNA-seq data</li> <li>2016 - Nature Genetics - Landscape of tumor-infiltrating T cell repertoire of human cancers</li> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/4.%20Cancer%20Immunotherapy/#3-neoantigen","title":"3. Neoantigen","text":"<ul> <li>[review] 2021 Nature - Advances in the development of personalized neoantigen-based therapeutic cancer vaccines</li> <li>[review] 2017 Cell - Applications of Immunogenomics to Cancer</li> <li>2020 NCOMM - Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/","title":"Analysis - Genetics & Function","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#genetic-function-analysis","title":"Genetic &amp; Function Analysis","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#i-rna-epigenetics","title":"I. RNA &amp; Epigenetics","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#1-genetics-post-gwas","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>\u2705 2024 Nature Genetics - Genetic mapping across autoimmune diseases reveals shared associations and mechanisms</li> <li>2024 Nature Communications - Integrating single cell expression quantitative trait loci summary statistics to understand complex trait risk genes</li> <li>2022 Nature genetics - Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data</li> <li>2022 Cancer Discovery - Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles Somatic Mutations and 3D Genomic Architecture</li> <li>\u2705 2020  Nature protocols - Tutorial: a guide to performing polygenic risk score analyses</li> <li>2019 Nature Communications - SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell speci\ufb01c enhancer that controls disease-critical microRNA expression</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#2-rna-function-analysis","title":"2. RNA &amp; Function Analysis","text":"<ul> <li>2024 Cell Reports Medicine - Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#ii-rna-editing-and-splicing","title":"II. RNA editing and splicing","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#1-genetics-post-gwas_1","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>\u27052024 Nature Genetics - Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases</li> <li>2024 Nature Communications - Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms</li> <li>\u2705 2022 Nature - RNA editing underlies genetic risk of common inflammatory diseases</li> <li>2022 Nature Genetics - Genetic control of RNA splicing and its distinct role in complex trait variation</li> <li>\u2705  2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>2020 Genome Biology - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection</li> <li>2019 Nature Genetics - An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#2-functional-regulation","title":"2. Functional Regulation","text":"<ul> <li>2017 Genome Research - Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.  </li> <li>2015 Cancer cell - The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#iii-rna-modification","title":"III. RNA modification","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#1-genetics-post-gwas_2","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>[m6a-qtl in 129 tissue m6a-seq] 2021 Nature Genetics - Genetic drivers of m 6 A methylation in human brain, lung, heart and muscle</li> <li>\u2705 [m6a-qtl in 60 celllines] 2020 Nature Genetics - Genetic analyses support the contribution of mRNA N 6 -methyladenosine (m 6 A) modification to human disease heritability</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Genetics%20%26%20Function/#2-functional-regulation_1","title":"2. Functional Regulation","text":"<ul> <li>\u2705 [m6a regulators in public 9804 samples] 2021 Molecular Cancer - Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types</li> <li>[rna mod. regulators in 1697 public crc samples] 2021 Molecular Cancer - Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer</li> <li>[rna mod. regulators in 13358 public tissue rna-seq] 2020 Genome Biology - Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/","title":"Analysis - RNA Regulation","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#postar-post-transcriptional-regulation-analysis","title":"POSTAR: POST-trAnscriptional Regulation Analysis","text":"<p>POSTAR Database: (POST-trAnscriptional Regulation)  http://POSTAR.ncRNAlab.org</p>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#0-postar-genetics","title":"0. POSTAR &amp; Genetics","text":"<ul> <li>2024 Nature Communications - Systematic identi\ufb01cation of posttranscriptional regulatory modules</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#1-as-alternative-splicing","title":"1. AS: Alternative splicing","text":"<p>Reviews</p> <ul> <li>Alternative splicing as a regulator of development and tissue identity. (Nature Reviews, 2017)</li> <li>RNA mis-splicing in disease. (Nature Reviews, 2015)</li> </ul> <p>Research</p> <ul> <li>Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. (Science, 2018)</li> <li>An Arabidopsis PWI and RRM motif-containing protein is critical for pre-mRNA splicing and ABA responses. (Nature communications, 2015)</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#11-splicing-cancer","title":"1.1 Splicing &amp; Cancer","text":"<ul> <li>2020 - Nature Reviews - Roles and mechanisms of alternative splicing in cancer \u2014 implications for care</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#2-apa-alternative-polyadenylation","title":"2. APA: Alternative polyadenylation","text":"<p>Reviews</p> <ul> <li>Alternative polyadenylation of mRNA precursors. (Nature Reviews, 2017)</li> <li>Alternative cleavage and polyadenylation: extent, regulation and function. (Nature Reviews, 2013)</li> </ul> <p>Research</p> <ul> <li>Dynamic analysis of alternative polyadenylation from RNA-seq reveal a 30-UTR landscape across seven tumour types. (Nature communications, 2014)</li> <li>Cellular stress alters 3\u2032UTR landscape through alternative polyadenylation and isoform-specific degradation. (Nature communications, 2018)</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#3-rna-editing","title":"3. RNA editing","text":"<p>Review</p> <ul> <li>A-to-I RNA editing \u2014 immune protector and transcriptome diversifier. (Nature Reviews, 2018)</li> <li>RNA editing-dependent epitranscriptome diversity in cancer stem cells. (Nature Reviews, 2017)</li> </ul> <p>Research</p> <ul> <li>Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. (Genome Research, 2017) </li> <li>The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. (Cancer cell, 2015)</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#4-dna-mutation-using-rna-seq","title":"4. DNA mutation using RNA-seq","text":"<ul> <li>RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues (Science, 2019) </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#5-rna-modification","title":"5. RNA modification","text":"<ul> <li>2022 Nature Methods - Detection of m6A from direct RNA sequencing using a multiple instance learning framework</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#6-rna-velocity","title":"6. RNA Velocity","text":"<ul> <li>2020 - Nature Biotech. - Generalizing RNA velocity to transient cell states through dynamical modeling</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#7-translation-ribo-seq","title":"7. Translation: Ribo-seq","text":"<p>\u5173\u4e8eRNA\u7ffb\u8bd1\uff08Ribo-seq\uff09</p> <ul> <li>ORF finding </li> <li>RiboCode: 2018 NAR</li> <li>RiboWave: 2018 NAR</li> <li>RiboTaper: 2016 Nature Methods</li> <li>Difference of Translation Efficiency</li> <li>RiboDiff: 2017 Bioinformatics </li> <li>Xtail: 2016 Nature Communications</li> </ul> Preprocessing ORF Iden. Quantification TE Translation elongation Integrative &amp; visualization Rfoot DeepRibo scikit-ribo diricore Plastid RiboWaltz FLOSS RiboDiff I\u03c7nos Rfeet RiboWave ORF-RATER riborex PausePred RiboGalaxy PRICE Xtail ROSE RiboProfiling RiboCode RiboMiner riboSeqR RiboHMM RiboTools RibORF RIVIT RiboTaper Shoelaces RP-BP tRanslatome SPECtre POSTAR TITER"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#71-riboshape","title":"7.1. RiboShape","text":"<ul> <li>\u2705 2023 Nature - Pervasive downstream RNA hairpins dynamically dictate start-codon selection</li> <li>2021 Genome Biology Wheat in vivo RNA structure landscape reveals a prevalent role of RNA structure in modulating translational subgenome expression asymmetry</li> <li>\u2705 2018 Cell (e. coli, proposed a model)  Pervasive regulatory functions of mRNA structure revealed by high-resolution SHAPE probing</li> <li>2018 Mol. Cell (e. coli)- A Stress Response that Monitors and Regulates mRNA Structure Is Central to Cold Shock Adaptation</li> <li>2020 Genome Biology (zebrafish) RNA structural dynamics regulate early embryogenesis through controlling transcriptome fate and function</li> <li>\u2705 2017 Nature - Global translational reprogramming is a fundamental layer of immune regulation in plants</li> <li>2014 NAR (proposed a model) - Deciphering the rules by which dynamics of mRNA secondary structure affect translation efficiency in Saccharomyces cerevisiae</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#72-motif","title":"7.2 Motif","text":"<ul> <li>2015 Cell - polyU hairpin -  EIN2-Directed Translational Regulation of Ethylene Signaling in Arabidopsis</li> <li>2021 PNAS - polyU internal loop - Structural analyses of an RNA stability element interacting with poly(A)</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20RNA%20Regulation/#8-quantum-biology","title":"8. Quantum Biology","text":"<ul> <li>2014 Nature Physics - Quantum coherence in photosynthesis for efficient solar-energy conversion</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/","title":"Analysis - Single Cell","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#single-cell-data-analysis","title":"Single Cell Data Analysis","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#i-scmultiomics","title":"I. scMultiOmics","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#i1-representative-integration-analysis","title":"I.1 Representative Integration Analysis","text":"<ul> <li>\u2705 2024 Science - Single-cell genomics and regulatory networks for 388 human brains</li> <li>\u2705 2018 Science (machine learning model) - Comprehensive functional genomic resource and integrative model for the human brain</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#i2-others","title":"I.2 Others","text":"<ul> <li>\u2705 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>\u2705 2023 Nature - Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes</li> <li>\u2705 2023 Nature Genetics - Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases</li> <li>2023 Nature - Epigenetic regulation during cancer transitions across 11 tumour types</li> <li>2023 Nature Methods - SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks</li> <li>2022 Cell - Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution</li> <li>2021 Cancer Cell - Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</li> <li>2021 Nature Genetics - Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer\u2019s disease </li> <li>2021 Nature Genetics - Single-cell chromatin accessibility identifies pancreatic islet cell type\u2013 and state-specific regulatory programs of diabetes risk</li> <li>2021 Genome Biology - Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways</li> <li>2018 Science - Single-cell multiomics sequencing and analyses of human colorectal cancer</li> </ul> <p>(1) Multi-Omics Data Integration Tools</p> <ul> <li>2021 Brief Bioinfo - A comparative study of multi-omics integration tools</li> <li>2017 PLoS computational biology - mixOmics: An R package for \u2018omics feature selection and multiple data integration</li> </ul> <p>(2) Bulk Multi-Omics Studies</p> <ul> <li>\u2705 2023 Immunity - Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection</li> <li>\u2705  2023 Nature Genetics - Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability</li> <li>\u2705  2021 Nature - Multi-omic machine learning predictor of breast cancer therapy response</li> <li>2021 Cell - Integrated analysis of multimodal single-cell data</li> <li>2021 Nature Commn - An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer</li> <li>\u2705  2020 Nature Medicine - Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#ii-scrna","title":"II. scRNA","text":"<ul> <li>\u2705 2023 Nature Genetics - Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution </li> <li>\u2705 2021 Science - The coding and long noncoding single-cell atlas of the developing human fetal striatum</li> <li>2021 PNAS - Single-cell quanti\ufb01cation of a broad RNA spectrum reveals unique noncoding patterns associated with cell types and states</li> <li>2020 Nature Cell Biol. - Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#iii-scrna-post-transcriptional-regulation","title":"III. scRNA: Post-transcriptional Regulation","text":"<ul> <li>2024 Nature Commn - Interrogations of single-cell RNA splicing landscapes with SCASL define new cell identities with physiological relevance</li> <li>2024 Nature Commn - Divergent landscapes of A-to-I editing in postmortem and living human brain</li> <li>2022 Nature Commn - Cellular and genetic drivers of RNA editing variation in the human brain</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Analysis%20-%20Single%20Cell/#iv-scatac-seq","title":"IV. scATAC-seq","text":"<ul> <li>\u2705 2024 Immunity -  Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells</li> <li>2024 Nature Cell Biology - Mapping the chromatin accessibility landscape of zebrafish embryogenesis at single-cell resolution by SPATAC-seq</li> <li>2024 Nature Cell Biology - A single-cell atlas of chromatin accessibility in mouse organogenesis</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/","title":"Multi-modal Model","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/#multi-modal-models","title":"Multi-modal Models","text":"<p>Note</p> <ul> <li>Foundation Models:<ul> <li>2024 Nature - A pathology foundation model for cancer diagnosis and prognosis prediction</li> <li>[RNA] 2024 Nature Machine Intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>[scRNA-seq] 2024 Nature Methods - Large-scale foundation model on single-cell transcriptomics</li> </ul> </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/#i-llms-for-multi-modal-data","title":"I. LLMs for Multi-modal Data","text":"<ul> <li>\u2705 2024 Nature machine intelligence  - A transformer-based weakly supervised computational pathology method for clinical-grade diagnosis and molecular marker discovery of gliomas</li> <li>2024 Nature Methods - scGPT: toward building a foundation model for single-cell multi-omics using generative AI</li> <li>\u2705  2023 Nature - Foundation models for generalist medical artificial intelligence</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/#ii-deep-learning-models-for-multi-modal-data","title":"II. Deep Learning Models for Multi-modal Data","text":"<ul> <li>2022 Nature Reviews - Obtaining genetics insights from deep learning via explainable artificial intelligence</li> <li>2022 Genome Biology - A benchmark study of deep learning\u2011based multi\u2011omics data fusion methods for cancer</li> <li>\u2705 2022 Cancer Cell - Pan-cancer integrative histology-genomic analysis via multimodal deep learning</li> <li>2022 Nature Biotech. - Multi-omics single-cell data integration and regulatory inference with graph-linked embedding</li> <li>\u2728 2021 Nature Communications - MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification</li> <li>\u2728 2021 Bioinformatics - PathCNN: interpretable convolutional neural networks for survival prediction and pathway analysis applied to glioblastoma</li> <li>2021 Nature Machine Intelligence - Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms</li> <li>2021 Bioinformatics -  Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data</li> <li>2018 Clinical Cancer Research - Deep Learning\u2013Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/#iii-other-models-for-multi-modal-data","title":"III. Other Models for Multi-modal Data","text":"<ul> <li>2024 Nature Communications -  Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights</li> <li>2023 Nature - Transfer learning enables predictions in network biology</li> <li>2022 BIB - Blood-based transcriptomic signature panel identification for cancer diagnosis: benchmarking of feature extraction methods</li> <li>\u2705 2022 Bioinformatics - MOMA: a multi-task attention learning algorithm for multi-omics data interpretation and classification</li> <li>\u2728 2022 BIB - A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection</li> <li>2019 Bioinformatics - DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</li> <li>2019 Bioinformatics - Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multi-modal%20Model/#iv-more-deep-learning-models","title":"IV. More Deep Learning Models","text":"<ul> <li>Deep Learning on RNA<ul> <li>3D Structure prediction of RNA: 2021 Science - Geometric deep learning of RNA structure</li> <li>2D structure (Transfer learning): 2019 Nature Commn. - SPOT-RNA: RNA secondary structure prediction using an ensemble of two-dimensional deep neural networks and transfer learning</li> <li>RNA/DNA-Protein Binding (DeepBind): 2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> <li>AS of RNA: 2019 Cell - Predicting Splicing from Primary Sequence with Deep Learning</li> <li>AS of RNA (DARTS): 2019 Nature Methods - Deep-learning augmented RNA-seq analysis of transcript splicing</li> <li>APA of RNA: 2019 Cell - A Deep Neural Network for Predicting and Engineering Alternative Polyadenylation</li> </ul> </li> <li>Deep Learning on DNA<ul> <li>2022 Nature - The evolution, evolvability and engineering of gene regulatory DNA</li> </ul> </li> <li>Deep Learning on Protein<ul> <li>2022 Nature Biotech. - Using deep learning to annotate the protein universe</li> <li>AlphaFold2 - 2021 Nature - Highly accurate protein structure prediction with AlphaFold</li> <li>Baker et al. - 2021 Science - Accurate prediction of protein structures and interactions using a three-track neural network</li> </ul> </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/","title":"Multiomics Analysis","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/#multi-omics-data-analysis","title":"Multi-Omics Data Analysis","text":""},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/#1-review","title":"1. Review","text":"<ul> <li>2021 Systems Med - Multiple Omics Data Integration</li> <li>\u27282019 Nature Reviews - Current and future perspectives of liquid biopsies in genomics-driven oncology</li> <li>\u27282017 Genome Biology - Multi-omics approaches to disease</li> <li>2017 Trend in Genetics - Single-Cell Multiomics: Multiple Measurements from Single Cells</li> <li>2014 Nature Reviews - Principles and methods of integrative genomic analyses in cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/#2-research-article","title":"2. Research Article","text":"<ul> <li>2021 Nature Commn - An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer</li> <li>2020 Cell - Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer</li> <li>2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>2020 Nature Medicine - Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.</li> <li>2018 Science - Comprehensive functional genomic resource and integrative model for the human brain</li> <li>\u2728 2018 Science - Single-cell multiomics sequencing and analyses of human colorectal cancer</li> <li>2015 Nature - Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease</li> <li>2014 NMETH - Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics </li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/#3-method","title":"3. Method","text":"<ul> <li>\u2705 2024 Nature Methods - Benchmarking algorithms for single-cell multi-omics prediction and integration</li> <li>\u2728 2021 Bioinformatics -  Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data</li> <li>2020 Bioinformatics - Varmole: A biologically drop-connect deep neural network model for prioritizing disease risk variants and genes</li> <li>2019 Bioinformatics - DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</li> <li>\u2728 2019 Bioinformatics - Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.</li> <li>2018 Clinical Cancer Research - Deep Learning\u2013Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer</li> </ul>"},{"location":"reading/A.RNAfinder/2.1%20Precision%20Medicine/Multiomics%20Analysis/#4-tool","title":"4. Tool","text":"<ul> <li>\u2728 2021 Brief Bioinfo - A comparative study of multi-omics integration tools</li> <li>\u2728 2017 PLoS computational biology - mixOmics: An R package for \u2018omics feature selection and multiple data integration</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/","title":"2nd Structure Prediction","text":""},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#rna-2nd-structure-prediction","title":"RNA 2nd Structure Prediction","text":"<p>\u2705 : Recommended</p>"},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#i-rna-secondary-structure-prediction","title":"I. RNA Secondary Structure Prediction","text":""},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#1-basics","title":"1. Basics","text":"<ul> <li>\u2705 Course: \u751f\u7269\u4fe1\u606f\u5b66\uff08\u6e05\u534e\u5927\u5b66\uff09;  \u751f\u7269\u7269\u7406\u5b66\uff08\u6e05\u534e\u5927\u5b66\uff09</li> <li>\u2705 Teaching Slides and Videos:  Models for RNA secondary structure prediction</li> <li>Book:   \u300aBiological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids\u300bby Richard Durbin, Sean R. Eddy, Anders Krogh, Graeme Mitchison  (English | \u4e2d\u6587)</li> </ul> <ul> <li>Energy Model - RNAstructure/Mfold  and RNAfold </li> <li>\u2705 How do RNA folding algorithms work? (Sean R Eddy) 2004 Nature Biotech </li> <li>What is dynamic programming? (Sean R Eddy) 2004 Nature Biotech</li> <li>SCFG Model (Rfam/Infernal)</li> <li>\u2705 What is a hidden Markov model? (Sean R Eddy) 2004 Nature Biotech </li> <li>You can read the SCFG section in the book above (\u300aBiological Sequence Analysis\u300b). </li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#2-recent-research-articles-and-reviews","title":"2. Recent Research Articles and Reviews","text":"<ul> <li>\u2705 2025    Nature Communications - RiNALMo: general-purpose RNA language models can generalize well on structure prediction tasks</li> <li>2025  Genome Biology    HydraRNA: a hybrid architecture based full-length RNA language model    </li> <li>2025 Nature Communications - Deep generalizable prediction of RNA secondary structure via base pair motif energy</li> <li>[review] 2023 BIB - Recent trends in RNA informatics: a review of machine learning and deep learning for RNA secondary structure prediction and RNA drug discovery</li> <li>[review] 2022 PNAS - Thoughts on how to think (and talk) about RNA structure</li> <li>2022 Nucleic Acids Research -UFold_fast and accurate RNA secondary structure prediction with deep learning</li> <li>2020 ICLR - RNA Secondary Structure Prediction By Learning Unrolled Algorithms (Chinese comments)</li> <li>(Transfer learning) 2019 Nature Commn. - SPOT-RNA: RNA secondary structure prediction using an ensemble of two-dimensional deep neural networks and transfer learning</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#ii-structure-probing-experiments","title":"II. Structure Probing Experiments","text":""},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#1-structure-probing-methods","title":"1. Structure probing methods","text":"<p>\u5173\u4e8eRNA \u4e8c\u7ea7\u7ed3\u6784\u9ad8\u901a\u91cf\u6d4b\u5e8f\u65b9\u6cd5 </p>"},{"location":"reading/A.RNAfinder/2.2%20Structure/2nd%20Structure%20Prediction/#2-structure-probing-data-analysis","title":"2. Structure probing data analysis","text":"<ul> <li>2022 Nature Methods - RNA secondary structure packages evaluated and improved by high-throughput experiments</li> <li>2021 Genome Biology - diffBUM-HMM a robust statistical modeling approach for detecting RNA flexibility changes in high-throughput structure probing data</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/3D%20Structure%20Prediction/","title":"3D Structure Prediction","text":""},{"location":"reading/A.RNAfinder/2.2%20Structure/3D%20Structure%20Prediction/#rna-3d-structure-prediction","title":"RNA 3D Structure Prediction","text":"<p>Note</p> <ul> <li>Autoregressive Approach:<ul> <li>AlphaFold 2, Nature, 2021</li> <li>RoseTTAFold2, bioRxiv, 2023</li> </ul> </li> <li>Diffusion Approach: <ul> <li>RFDiffusion, Nature, 2023</li> <li>RoseTTAFold All-Atom, Science, 2024</li> <li>AlphaFold 3 (All-Atom), Nature, 2024</li> </ul> </li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/3D%20Structure%20Prediction/#0-protein-tertiary-structure-prediction","title":"0. Protein Tertiary Structure Prediction","text":"<p>Learn from Protein structure prediction</p> <ul> <li>All Atom Models</li> <li>\u2705 2024 Nature - Accurate structure prediction of biomolecular interactions with AlphaFold\u20093</li> <li>\u2705 2024 Science - Generalized biomolecular modeling and design with RoseTTAFold All-Atom</li> <li>\u2705 2024 Nature - Conformational ensembles of the human intrinsically disordered proteome</li> <li> 2021 Nature \u2013 AlphaFold2: Highly accurate protein structure prediction with AlphaFold</li> <li> 2017 Science - Protein structure determination using metagenome sequence data </li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/3D%20Structure%20Prediction/#1-rna-tertiary-structure-prediction","title":"1. RNA Tertiary Structure Prediction","text":"<ul> <li>2022 PNAS - Thoughts on how to think (and talk) about RNA structure</li> <li>2022 bioRxiv - Accurate de novo prediction of RNA 3D structure with transformer network</li> <li>2022 bioRxiv - DeepFoldRNA: De Novo RNA Tertiary Structure Prediction at Atomic Resolution using Geometric Potentials from Deep Learning</li> <li>2022 arxiv - E2Efold-3D: End-to-End Deep Learning Method for accurate de novo RNA 3D Structure Prediction</li> <li>2022 bioRxiv - Accurate prediction of nucleic acid and protein-nucleic acid complexes using RoseTTAFoldNA</li> <li>\u2705 2021 Science - ARES: Geometric deep learning of RNA structure</li> <li>[Graphical Modeling] 2021 Methods Mol Biol - Modeling and Predicting RNA Three-Dimensional Structures</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/RNA%20%26%20Protein%20Design/","title":"RNA & Protein Design","text":""},{"location":"reading/A.RNAfinder/2.2%20Structure/RNA%20%26%20Protein%20Design/#rna-protein-design","title":"RNA &amp; Protein Design","text":"<p>Note</p> <ul> <li>Autoregressive Approach:<ul> <li>AlphaFold 2, Nature, 2021</li> <li>RoseTTAFold2, bioRxiv, 2023</li> </ul> </li> <li>Diffusion Approach: <ul> <li>RFDiffusion, Nature, 2023</li> <li>RoseTTAFold All-Atom, Science, 2024</li> <li>AlphaFold 3 (All-Atom), Nature, 2024</li> </ul> </li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/RNA%20%26%20Protein%20Design/#0-protein-design","title":"0. Protein Design","text":"<ul> <li>\u2705 [review] 2024 NBT - Machine learning for functional protein design</li> <li>\u2705 2024 Science - Generalized biomolecular modeling and design with RoseTTAFold All-Atom</li> <li>\u2705 2023 Nature - De novo design of protein structure and function with RFdiffusion</li> <li>[benchmark] 2024 NBT - Computational scoring and experimental evaluation of enzymes generated by neural networks</li> <li>2023 Nature - Illuminating protein space with a programmable generative model </li> <li>2022 Nature Biotech. - Large language models generate functional protein sequences across diverse families</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/RNA%20%26%20Protein%20Design/#i-rna-design","title":"I. RNA Design","text":"<ul> <li>2025 Nature Communications - Generative and predictive neural networks for the design of functional RNA molecules</li> <li>\u2705 [RfamGen] 2024 Nature Methods - Deep generative design of RNA family sequences</li> <li>2024 Nature Machine Intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>\u2705 2024 Nature machine intelligence - A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions</li> <li>2024 Cell Genome - Revealing the grammar of small RNA secretion using interpretable machine learning</li> <li>2024 Nature Methods - Deep generative design of RNA family sequences</li> <li>2023 bioRXiv - CodonBERT- Large Language Models for mRNA Design and Optimization</li> <li>2023 BIB - Integrated mRNA sequence optimization using deep learning</li> <li>2021 NAR - Theoretical basis for stabilizing messenger RNA through secondary structure design</li> </ul>"},{"location":"reading/A.RNAfinder/2.2%20Structure/RNA%20%26%20Protein%20Design/#ii-rna-vaccine-design","title":"II. RNA Vaccine Design","text":"<ul> <li>\u2705 2023 Nature reviews drug discovery - Tailor made: the art of therapeutic mRNA design </li> <li>[LinearDesign]: 2023 Nature - Algorithm for optimized mRNA design improves stability and immunogenicity</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/","title":"RNA-Ligand","text":""},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#rna-ligand-small-molecule-drug-design","title":"RNA-Ligand: small molecule drug design","text":"<p>Note</p> <ul> <li>Autoregressive Approach:<ul> <li>Pocket2Mol, ICML, 2022</li> <li>PocketFlow, Nature Mach. Intell., 2024</li> <li>Lingo3DMol, Nature Mach. Intell., 2024</li> </ul> </li> <li>Diffusion Approach: <ul> <li>TargetDiff, ICLR, 2023</li> <li>PMDM, Nature Commn., 2024</li> <li>[Review] Diffusion Models for Molecules: A Survey of Methods and Tasks, 2025, arXiv:2502.09511</li> </ul> </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#drug-rna","title":"Drug RNA","text":"<ul> <li>2022 Nature Reviews | Genetics - Drug delivery systems for RNA therapeutics</li> <li>\u2705 2022 Cell Death and Disease - RNA-based therapeutics: an overview and prospectus</li> <li>\u2705 2021 Nature Reviews | Drug Discovery - Noncoding RNA therapeutics \u2014 challenges and potential solutions </li> <li>2021 Nature Nanotechnology -  The current landscape of nucleic acid therapeutic</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#rna-ligand-small-molecule-interaction-prediction","title":"RNA-ligand (small molecule) Interaction Prediction","text":"<p>Reviews</p> <ul> <li>\u2705 2024 Nature reviews chemistry - Small molecule approaches to targeting RNA</li> <li>\u2705 2022 Nature Reviews Drug Discovery - Targeting RNA structures with small molecules</li> <li>2021 Nature Reviews Drug Discovery - Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules</li> <li>2020 J. of Med. Chem. - How We Think about Targeting RNA with Small Molecules</li> <li>\u2705 2018 Nature Reviews Drug Discovery - Principles for targeting RNA with drug-like small molecules</li> <li>\u4ee5RNA\u4e3a\u9776\u6807\u7684\u5c0f\u5206\u5b50\u836f\u7269\u7684\u7814\u7a76\u8fdb\u5c55 - \u77e5\u4e4e</li> <li>\u836f\u7269\u7814\u53d1\u7684\u5168\u65b0\u9886\u57df\uff1a\u9776\u5411RNA\uff0c\u9a76\u5411\u65b0\u84dd\u6d77 - \u5fae\u4fe1</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#0-protein-ligand-prediction-methods","title":"0. Protein-ligand prediction methods","text":"<ul> <li>2024 Nature Machine Intelligence - Generic protein\u2013ligand interaction scoring by integrating physical prior knowledge and data augmentation modelling</li> <li>2023 Nature machine intelligence - Calibrated geometric deep learning improves kinase\u2013drug binding predictions</li> <li>2023 Nature machine intelligence - Learning characteristics of graph neural networks predicting protein\u2013ligand affinities</li> <li>2023 Nature Machine Intell. - Interpretable bilinear attention network with domain adaptation improves drug\u2013target prediction</li> <li>2022 Nature Biotech. - Prediction of protein\u2013ligand binding affinity from sequencing data with interpretable machine learning</li> <li>2020 Cell - A Deep Learning Approach to Antibiotic Discovery</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#i-known-examples-experiments","title":"I. Known Examples &amp; Experiments","text":"<ul> <li>\u2705 Targeting miRNA precursor and mRNA\u2019s UTR:  Programming inactive RNA-binding small molecules into bioactive degraders, Nature 2023</li> <li>\u2705 Targeting lncRNA Xist with compounds that disrupt RNA structure and X inactivation,  Nature 2022</li> <li>2021 Nature Biotech. - First small-molecule drug targeting RNA gains momentum</li> <li>2020 SLAS Discovery - Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space</li> <li>Targeting mRNA splicing (SMN2 exon7): A small molecule (SMN-C5) targeting RNA for a specific splicing correction of SMN2 exon7 to treat spinal muscular atrophy,  Nature Chem. Biol. 2019</li> <li>Targeting Ribo-switch: Selective small-molecule inhibition of an RNA structural element, Nature 2015</li> <li>Targeting HIV TAR: Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble, Nature Chem. Biol.  2011 </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#ii-rna-element-druggable-by-ligand","title":"II. RNA element druggable by ligand","text":"<ul> <li>2023 BIB - Structural interaction fingerprints and machine learning for predicting and explaining binding of small molecule ligands to RNA</li> <li>2022 BIB - RLBind: a deep learning method to predict RNA\u2013ligand binding sites</li> <li>2021-Bioinformatics-Recognition of small molecule\u2013RNA binding sites using RNA sequence and structure</li> <li>2019 Nature Chem. Biol. - Structural basis of a small molecule targeting RNA for a specific splicing correction</li> <li>2019 Methods in Enzymology Volume 623 - Differentiation and classification of RNA motifs using small molecule-based pattern recognition</li> <li>2018 Nature Chemical Biology - Small molecules that target group II introns are potent antifungal agents</li> <li>[Riboswitch] </li> <li>2017 PNAS - Bioinformatic analysis of riboswitch structures uncovers variant classes with altered ligand specificity</li> <li>2014 PNAS - Functional conservation despite structural divergence in ligand-responsive RNA switches</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#iii-rna-ligand-interaction-prediction","title":"III. RNA-ligand interaction prediction","text":"<ul> <li>\u2705 2023 Nature Machine Intell. - Large-scale chemical language representations capture molecular structure and properties</li> <li>2023 Nature Communications - Sequence-based drug design as a concept in computational drug design</li> <li>\u2705  [Drug RNA] 2020 NAR - Augmented base pairing networks encode RNA-small molecule binding preferences</li> <li>[Graphical Modeling] 2021 Methods Mol Biol - Modeling and Predicting RNA Three-Dimensional Structures</li> <li>2015 WIREs Comput Mol Sci - Modeling of ribonucleic acid ligand interactions</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Ligand/RNA-Ligand/#iv-ribotac","title":"IV. RIBOTAC","text":"<ul> <li>RIBOTAC (Ribonuclease Targeting Chimera) and PROTAC: </li> <li>[review] PROTAC targeted protein degraders: the past is prologue, Nature Reviews Drug Discovery 2022</li> <li>RIBOTAC &amp; PROTAC \u4ecb\u7ecd</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/","title":"RNA-Protein","text":""},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/#rna-protein","title":"RNA-Protein","text":""},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/#rna-protein-interaction-prediction","title":"RNA-Protein Interaction Prediction","text":""},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/#reviews","title":"Reviews","text":"<ul> <li>2018 Nature Reviews - A brave new world of RNA-binding proteins</li> <li>2018 Mol Cell - Advances in CLIP Technologies for Studies of Protein-RNA Interactions.pdf</li> <li>2018 Annual Reviews - Data Science Issues in Studying Protein\u2013RNA Interactions with CLIP Technologies </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/#database","title":"Database","text":"<p>POSTAR3: http://POSTAR.ncRNAlab.org</p>"},{"location":"reading/B.RNAtalk/RNA-Protein/RNA-Protein/#research","title":"Research","text":"<ul> <li>NMF: 2017 Genome Biology - Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA\u2013protein binding sites</li> <li>Deep Learning: 2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/","title":"Overview","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/#rna-rna-interaction","title":"RNA-RNA Interaction","text":"<p>2025 Nature Reviews | molecular cell biology  -  Decoding the interactions and functions of non-coding RNA with artificial intelligence https://doi.org/10.1038/s41580-025-00857-w</p>"},{"location":"reading/B.RNAtalk/RNA-RNA/Analysis%20-%20Regulome/","title":"Analysis - Regulome","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/Analysis%20-%20Regulome/#rna-regulation-analysis","title":"RNA Regulation Analysis","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/Analysis%20-%20Regulome/#i-rna-rna-interaction-prediction","title":"I. RNA-RNA Interaction Prediction","text":"<ul> <li>2026 Nature Commn. - The role of low-complexity repeats in RNA\u2013RNA interactions and a deep learning framework for duplex prediction</li> <li>2017 Bioinformatics - A comprehensive benchmark of RNA\u2013RNA interaction prediction tools for all domains of life</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Analysis%20-%20Regulome/#ii-co-expression-regulome","title":"II. Co-expression Regulome","text":"<ul> <li>2020 Nature Commn. - Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers</li> <li>2021 NAR - ImmReg: the regulon atlas of immune-related pathways across cancer types</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/","title":"Seq - Interaction","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#interaction-seq","title":"Interaction-seq","text":"<p>Computational Method</p>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#i-rna-rna","title":"I. RNA-RNA","text":"<ul> <li> <p>2025 Nature communications biology  - Cellular dsRNA interactome captured by K1 antibody reveals the regulatory map of exogenous RNA sensing</p> </li> <li> <p>\u2705 [review] 2024 Molecular Cell - Technological advancements in deciphering RNA-RNA interactions</p> </li> <li> <p>\u2705 2024 Cell - snoRNA-facilitated protein secretion revealed by transcriptome-wide snoRNA target identification</p> </li> <li> <p>\u2705 2024 Nature Biotechnology - KARR-seq reveals cellular higher-order RNA structures and RNA\u2013RNA interactions</p> </li> <li> <p>2023 Nature - Complementary Alu sequences mediate enhancer\u2013promoter selectivity</p> </li> <li> <p>[review] 2022 Current Opinion in Genetics &amp; Development - Architecture of RNA\u2013RNA interactions</p> </li> <li> <p>\u2705 2020 Nature - RIC-seq for global in situ profiling of RNA\u2013RNA spatial interactions</p> </li> <li> <p>\u2705 2020 Nature - RIC-seq for global in situ profiling of RNA\u2013RNA spatial interactions. </p> </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#ii-rna-dna","title":"II. RNA-DNA+","text":"<ul> <li>\u2705 MUSIC-seq: 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>2024 Nature Leukemia - The landscape of RNA-chromatin interaction reveals samll non-coding RNAs as essential mediators of leukemia maintenance  </li> <li>2022 Nature Protocols - SPRITE: a genome-wide method for mapping higher-order 3D interactions in the nucleus using combinatorial split-and-pool barcoding</li> <li>2017 Nature Biotech. - GRID-seq reveals the global RNA\u2013chromatin interactome</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#iii-off-target","title":"III. Off-target","text":"<p>Computational Methods</p>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#1-screen-methods","title":"1. Screen methods","text":"<ul> <li>2024 Nature Biotechnology - Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Interaction/#2-sgrna-offtarget-experimental-methods","title":"2. sgRNA offtarget - experimental methods","text":"<ul> <li>2024 Nat. Biotech. - Tracking-seq reveals the heterogeneity of off-target effects in CRISPR\u2013Cas9-mediated genome editing</li> <li>2023 Nat. Methods - Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+</li> <li>2019 Science - Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/","title":"Seq - Single Cell","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#single-cell-seq-tech","title":"Single-Cell-seq Tech.","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#0-novel-rna-seq","title":"0. Novel RNA-seq","text":"<ul> <li>\u2705 2024 Nature Biotech. - RIP-PEN-seq identifies a class of kink-turn RNAs as splicing regulators</li> <li>\u2705 2021 NBT - Quantitative mapping of the cellular small RNA landscape with AQRNA-seq</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#i-sc-total_rna","title":"I. sc-Total_RNA","text":"<ul> <li>2024 Nature Communications - Single-cell total-RNA pro\ufb01ling unveils regulatory hubs of transcription factors</li> <li>\u2705 2022 Nature Biotech. - High-throughput total RNA sequencing in single cells using VASA-seq</li> <li>2022 Nature Biotech. Spatial mapping of the total transcriptome by in situ polyadenylation</li> <li>[mbRNA split-pool]  2020 Science - Microbial single-cell RNA sequencing by split-pool barcoding</li> <li>\u2705 [scRNA split-pool] - 2018 Science - SPLiT-seq reveals cell types and lineages in the developing brain and spinal cord </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#ii-scmulti-omics","title":"II. scMulti-Omics","text":"<ul> <li>\u2705 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>[Review] 2024 EMM - Advances in single-cell omics and multiomics for high-resolution molecular profiling</li> <li> [Review] 2023 Nature Genetics - Methods and applications for single-cell and spatial multi-omics</li> <li>\u2705 2022 Nature Methods - ISSAAC-seq enables sensitive and flexible multimodal profiling of chromatin accessibility and gene expression in single cells</li> <li>\u2705 [Split-pool RNA+ATAC] 2020 Cell - Chromatin Potential Identi\ufb01ed by Shared Single-Cell Pro\ufb01ling of RNA and Chromatin</li> <li>[Split-pool RNA+ATAC] 2019 Nature Structure Molecular Biology -  An ultra high-throughput method for single-cell joint analysis of open chromatin and transcriptome</li> <li>[scATAC - split-pool] 2019 Nat. Biotechnol. - Droplet-based combinatorial indexing for massive-scale single-cell chromatin accessibility.</li> <li>[review] 2017 Trend in Genetics - Single-Cell Multiomics: Multiple Measurements from Single Cells *</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#iii-scrna-mod","title":"III. scRNA-mod","text":"<ul> <li>\u2705 2023 Nature Biotechnology - Single-cell m6A mapping in vivo using picoMeRIP\u2013seq</li> <li>2023 Nature Review - The roles and implications of RNA m6A modification in cancer</li> <li>2023 Nature Commn. - scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development</li> <li>\u2705  2022 Nature Methods - Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution</li> <li>2022 Nature Biotech. - Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI</li> <li>2022 Mol. Cell  - scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells. </li> <li>[RNA mod Review] - 2022 Experimental &amp; Molecular Medicine - Detection technologies for RNA modifications</li> <li>2019 PNAS - Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/Seq%20-%20Single%20Cell/#iv-scribo-seq","title":"IV. scRibo-seq","text":"<ul> <li>\u2705 2021 Nature - Single-cell Ribo-seq reveals cell cycle-dependent translational pausing</li> <li>2022 NAR - Identifying ribosome heterogeneity using ribosome pro\ufb01ling</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/","title":"siRNA Drug Design","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#sirna-drug-design","title":"siRNA Drug Design","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#i-sirnaaso","title":"I. siRNA/ASO","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#0-review","title":"0. Review","text":"<ul> <li>2025 Nature Signal Transduction and Targeted Therapy - Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines   </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#1-efficacy-prediction","title":"1. Efficacy prediction","text":"<ul> <li>Our papers: NAR 2008a, 2008b, 2008c</li> <li>2018 BMC Genomics, SiRNA silencing efficacy prediction based on a deep architecture </li> <li>2008 Bioinformatics, siDRM: an effective and generally applicable online siRNA design tool</li> <li>2007 NAR - Comparison of approaches for rational siRNA design leading to a new efficient and transparent method</li> <li>2006 BMC Bioinformatics  - Computational models with thermodynamic and composition features improve siRNA design</li> <li>2006 BMC Bioinformatics - An accurate and interpretable model for siRNA efficacy prediction</li> <li>2005 Nature Biotech. - Design of a genome-wide siRNA library using an artificial neural network</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#2-off-target","title":"2. Off-target","text":"<p>Wet-lab Methods</p> <ul> <li>\u2705 2024 Bioinformatics - SeedMatchR: identify off-target effects mediated by siRNA seed regions in RNA-seq experiments</li> <li>\u2705 2017 Cell Systems - Explicit Modeling of siRNA-Dependent On- and Off-Target Repression Improves the Interpretation of Screening Results</li> <li>2013 Biomed Res Int.  - SeedSeq: Off-Target Transcriptome Database</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#3-modification-toxicity","title":"3. Modification &amp; Toxicity","text":"<ul> <li>2023 Advanced Drug Delivery Reviews  - A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics</li> <li>2020 Signal Transduction and Targeted Therapy - Therapeutic siRNA: state of the art</li> <li>2016 Scientific Reports - siRNAmod: A database of experimentally validated chemically modified siRNAs</li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#ii-sgrna","title":"II. sgRNA","text":""},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#1-sgrna-activity","title":"1. sgRNA activity","text":"<ul> <li>\u2705 2018 Nature Biotech. - Deep learning improves prediction of CRISPR\u2013Cpf1 guide RNA activity</li> <li>more sgRNA papers </li> </ul>"},{"location":"reading/B.RNAtalk/RNA-RNA/siRNA%20Drug%20Design/#2-sgrna-offtarget-computational-methods","title":"2. sgRNA offtarget - computational methods","text":"<ul> <li>2024 Nucleic Acids Research - Generating, modeling and evaluating a large-scale set of CRISPR/Cas9 off-target sites with bulges</li> <li>[Benchmark] 2023 BIB - Benchmarking deep learning methods for predicting CRISPR/Cas9 sgRNA on- and off-target activities</li> <li>[review] 2023 BIB - Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review</li> <li>2023 Nature Communications - Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints</li> <li>\u2705 [off-target] 2016 Nature Biotech. -Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9</li> </ul>"}]}